HOME
>
臨床医学：内科
>
血液
> CD分類ハンドブック追補版（1996）細胞膜分化抗原の国際分類

CD分類ハンドブック追補版（1996）細胞膜分化抗原の国際分類

出版社：	癌と化学療法社
著者：	新保敏和(著) 石黒精(著) 日本BRM学会(編)
発行日：	1998-11-30
分野：	臨床医学：内科 > 血液
ISBN：	9784906225354
電子書籍版：	1998-11-30 （初版）

章別単位での購入はできません

ブラウザ、アプリ閲覧

5,225 円(税込)

商品紹介

１９９６年に開催された第６回国際ワークショップで改変、追加されたCDに関する解説を目的に刊行した。

表紙
推薦のことば
はしがき
目次
I. 本書の特色とその利用法
II. CD分類の必要性と意義
1. CD分類の必要性とその意義
2. モノクローナル抗体の臨床への応用
III. 国際ワークショップの歴史
1. 第1回国際ワークショップ(パリ,1982年)
2. 第2回国際ワークショップ(ボストン,1984年)
3. 第3回国際ワークショップ(オックスフォード,1986年)
4. 第4回国際ワークショップ(ウィーン,1989年)
5. 第5回国際ワークショップ(ボストン,1993年)
6. 第6回国際ワークショップ(神戸,1996年)
7. 第7回国際ワークショップ(ハロゲイト,2000年開催予定)
IV. CD分類の成り立ち
1. モノクローナル抗体の評価法
2. CD分類の命名法
3. CD分類と系列分類
4. CD分類の意味と論文での記載法
V. 一覧表と索引集の利用の仕方
1. CD分類の項目別解説
2. CD分類の一覧表
3. モノクローナル抗体の索引
4. 細胞系列からみたCD分類
5. 各CD分類に関する主要文献リストとインターネット検索用のdatabase accession numbers一覧表
VI. 改変または新規に登録されたCD分類の項目別解説
1) CD45RC
2) CD52
3) CD65
4) CD65s
5) CD66f
6) CD84
7) CD90
8) CD101
9) CD109
10) CD114
11) CD116
12) CD121a
13) CDw123
14) CD124
15) CDw125
16) CD127
17) CD130
18) CDw131
19) CD132
20) CD134
21) CD135
22) CDw136
23) CDw137
24) CD138
25) CD139
26) CD140a
27) CD140b
28) CD141
29) CD142
30) CD143
31) CD144
32) CDw145
33) CD146
34) CD147
35) CD148
36) CDw149
37) CDw150
38) CD151
39) CD152
40) CD153
41) CD154
42) CD155
43) CD156
44) CD157
45) CD158a
46) CD158b
47) CD161
48) CD162
49) CD163
50) CD164
51) CD165
52) CD166
VII. CD分類の一覧表
VIII. 全CD分類に関する文献リスト一覧
1) CD1
2) CD2
3) CD3
4) TCR
5) CD4
6) CD5
7) CD6
8) CD7
9) CD8
10) CD9
11) CD10
12) CD11a
13) CD11b
14) CD11c
15) CDw12
16) CD13
17) CD14
18) CD15
19) CD15s
20) CD16
21) CDw17
22) CD18
23) CD19
24) CD20
25) CD21
26) CD22
27) CD23
28) CD24
29) CD25
30) CD26
31) CD27
32) CD28
33) CD29
34) CD30
35) CD31
36) CD32
37) CD33
38) CD34
39) CD35
40) CD36
41) CD37
42) CD38
43) CD39
44) CD40
45) CD41
46) CD42a
47) CD42b
48) CD42c
49) CD42d
50) CD43
51) CD44とCD44s
52) CD44R
53) CD45とCD45R
54) CD46
55) CD47
56) CD48
57) CD49a
58) CD49b
59) CD49c
60) CD49d
61) CD49e
62) CD49f
63) CD50
64) CD51
65) CD52
66) CD53
67) CD54
68) CD55
69) CD56
70) CD57
71) CD58
72) CD59
73) CDw60
74) CD61
75) CD62E
76) CD62L
77) CD62P
78) CD63
79) CD64
80) CD65
81) CD65s
82) CD66a
83) CD66b
84) CD66c
85) CD66d
86) CD66e
87) CD66f
88) CD68
89) CD69
90) CD70
91) CD71
92) CD72
93) CD73
94) CD74
95) CDw75
96) CDw76
97) CD77
98) CDw78
99) CD79αとCD79β
100) CD80
101) CD81
102) CD82
103) CD83
104) CD84
105) CD85
106) CD86
107) CD87
108) CD88
109) CD89
110) CD90
111) CD91
112) CDw92
113) CDw93
114) CD94
115) CD95
116) CD96
117) CD97
118) CD98
119) CD99とCD99R
120) CD100
121) CD101
122) CD102
123) CD103
124) CD104
125) CD105
126) CD106
127) CD107a
128) CD107b
129) CDw108
130) CD109
131) CD114
132) CD115
133) CD116
134) CD117
135) CDw119
136) CD120aとCD120b
137) CD121a
138) CDw121b
139) CD122
140) CDw123
141) CD124
142) CDw125
143) CD126
144) CD127
145) CDw128
146) CD130
147) CDw131
148) CD132
149) CD134
150) CD135
151) CDw136
152) CDw137
153) CD138
154) CD139
155) CD140aとCD140b
156) CD141
157) CD142
158) CD143
159) CD144
160) CDw145
161) CD146
162) CD147
163) CD148
164) CDw149
165) CDw150
166) CD151
167) CD152
168) CD153
169) CD154
170) CD155
171) CD156
172) CD157
173) CD158a
174) CD158b
175) CD161
176) CD162
177) CD163
178) CD164
179) CD165
180) CD166
IX. 全CD分類に関するインターネット検索用のdatabase accession numbers一覧
X. 略語一覧表
XI. 索引
あとがき
奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

V. 一覧表と索引集の利用の仕方

P.11 掲載の参考文献

・Leucocyte Typing VI, ed. Kishimoto, T. et al.:Garland Publishing, Inc., New York, 1997.

・Leucocyte Typing V, ed. Schlossman, S. F. et al.:Oxford University Press, Oxford, 1995.

・Leucocyte Typing VI, ed. Knapp, W. et al.:Oxford University Press, Oxford, 1989.

・Leucocyte Typing III, ed. McMichael, et al.:Oxford University Press, Oxford, 1987.

・Leucocyte Typing II, ed. Reinherz, E. L. et al.:Springer Verlag, Berlin, 1986.

・Leucocyte Typing, ed. Bernard, A. et al.:Springer Verlag, Berlin, 1984.

・Kishimoto, T. et al.:Update of CD antigen, 1996. J. Immunol. 158:3035-3036, 1997.

PubMed

VI. 改変または新規に登録されたCD分類の項目別解説

P.14 掲載の参考文献

◎Altin, J. G. and Sloan, E. K.:The role of CD 45 and CD 45-associated molecules in T cell activation. Immunol. Cell Biol. 75 (5) :430-445, 1997.

◎Bell, E. B., Sparshott, S. M. and Bunce, C.:CD 4+ T-cell memory, CD 45 R subsets and the persistence of antigen-a unifying concept, Immunol. Today 19 (2) :60-64, 1998.

◎Barclay, A. N. and McCall, M. N.:CD 45;from alloantigen to mapping of restricted epitopes using recombinant soluble CD 45 isoforms. Biochem. Soc. Trans. 20 (1) :161-164, 1992.

◎Chan, A. C., Desai, D. M. and Weiss, A:The role of protein tyrosine kinases and protein tyrosine in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:555-592, 1994.

◎Justement, L. B.:The role of CD 45 in signal transduction. Adv. Immunol. 66:1-65, 1997.

◎Trowbridge, L. S. and Thomas, M. L.:CD 45:an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12:85-116, 1994.

・Arendt, C. W. and Ostergaard, H. L.:CD 45 protein-tyrosine phosphatase is specifically associated with a 116-kDa tyrosine-phosphorylated glycoprotein. J. Biol. Chem. 270 (5) :2313-2319, 1995.

・Basadonna, G. P., Auersvald, L., Khuong, C. Q. et al.:Antibody-mediated targeting of CD 45 isoforms:A novel strategy. Proc. Natl. Acad. Sci. USA 95 (7) :3821-3826, 1998.

・Bruyns, E., Hendricks-Taylor, L. R., Meuer, S. et al.:Identification of the sites of interaction between lymphocyte phosphatase-associated phosphoprotein (LPAP) and CD 45. 1. Biol. Chem. 270 (52) :31372-31376, 1995.

・Byth, K. F., Conroy, L. A., Howlett, S. et al.:CD 45-null transgenic mice reveal a positive regulatory role for CD 45 in early thymocyte development, in the selection of CD 4+CD 8+ thymocytes, and B cell maturation. J. Exp. Med. 183 (4) :1707-1718, 1996.

・Cyster, J. G., Healy, J. I., Kishihara, K. et al.:Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD 45. Nature 381 (6580) :325-328, 1996.

・Czyzyk, J. K., Fernsten, P. D., Brtva, T. R. et al.:CD 45 and Src-related protein tyrosine kinases regulate the T cell response to phorbol esters. Biochem. Biophys. Res. Commun. 243 (2) :444-450, 1998.

・Felberg, J. and Johnson, P.:Characterization of Recombinant CD 45 Cytoplasmic Domain Proteins. Evidence for intramolecular and intermolecular interactions. J. Biol. Chem. 273 (28) :17839-17845, 1998.

・Greer, S. F., Lin, J., Clarke, C. H. et al.:Major histocompatibility class II-mediated signal transduction is regulated by the protein-tyrosine phosphatase CD 45. J. Biol. Chem. 273 (19) :11970-11979, 1998.

・Johnson, P., Ostergaard, H. L., Wasden, C. et al.:Mutational analysis of CD 45. A leukocyte-specific protein tyrosine phosphatase. J. Biol. Chem. 267 (12) :8035-8041, 1992.

・Leitenberg, D., Novak, T. J., Farber, D. et al.:The extracellular domain of CD 45 controls association with the CD 4-T cell receptor complex and the response to antigen-specific stimulation. J. Exp. Med. 183 (1) :249-259, 1996.

・Matsuda, A., Motoya, S., Kimura, S. et al.:Disruption of lymphocyte function and signaling in CD 45-associated protein-null mice. J. Exp. Med. 187 (11) :1863-870, 1998.

・Majeti, R., Bilwes, A. M., Noel, J. P. et al.:Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279 (5347) :88-91, 1998.

PubMed

・Morimoto, C., Letvin, N. L., Distaso, J. A. et al.:The isolation and characterization of the human suppressor inducer T cell subset. J. Immunol. 134 (3) :1508-1515, 1985.

PubMed

・Okumura, M., Matthews, R. J., Robb, B. et al.:Comparison of CD 45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains. J. Immunol. 157 (4) :1569-1575, 1996.

・Perillo, N. L., Pace, K. E., Seilhamer, J. J. et al.:Apoptosis of T cells mediated by galectin-1. Nature 378 (6558) :736-739, 1995.

PubMed

・Pingel, J. T. and Thomas, M. L.:Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 58 (6) :1055-1065, 1989.

・Racila, E., Euhus, D., Weiss, A. J. et al.:Detection and characterization of carcinoma cells in the blood. Proc. Natl. Acad. Sci. USA 95 (8) :4589-4594, 1998.

PubMed

・Streuli, M., Krueger, N. X., Thai, T. et al.:Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. EMBO J. 9 (8) :2399-2407, 1990.

PubMed

・Zapata, J. M., Pulido, R., Acevedo, A. et al.:Human CD 45 RC specificity. A novel marker for T cells at different maturation and activation stages. J. Immunol. 152 (8) :3852-3861, 1994.

P.17 掲載の参考文献

◎Hale, G., Xia, M. Q., Tighe, H. P. et al.:The CAMPATH-1 antigen (CDw 52) . Tissue Antigens 35 (3) :118-127, 1990.

◎Hale, G. and Phillips, J. M.:Clinical trials with CAMPATH-1 and other monoclonal antibodies. Biochem. Soc. Trans. 23 (4) :1057-1063, 1995.

◎Kirchhoff, C. and Hale, G.:Cell-to-cell transfer of glycosylphosphatidylinositol-anchored membrane proteins during sperm maturation. Mol. Hum. Reprod. 2 (3) :177-184, 1996.

PubMed

・Ellerbrock, K., Pera, I., Hartung, S. et al.:Gene expression in the dog epididymis:a model for human epididymal function. Int. J. Androl. 17 (6) :314-323, 1994.

・Hale, G. and Users, H. W. C.:Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. Blood 91 (8) :3079-3083, 1998.

・Kirchhoff, C., Pera, I., Derr, P. et al.:The molecular biology of the sperm surface. Post-testicular membrane remodelling. Adv. Exp. Med. Biol. 424:221-232, 1997.

PubMed

・Kubota, H., Okazaki, H., Onuma, M. et al.:Identification and gene cloning of a new phosphatidylinositol-linked antigen expressed on mature lymphocytes. Down-regulation by lymphocyte activation. J. Immunol. 145 (11) :3924-3931, 1990.

PubMed

・Osterborg, A., Fassas, A. S., Anagnostopoulos, A. et al.:Humanized CD 52 monoclonal antibody Campath-1 H as first-line treatment in chronic lymphocytic leukaemia. Br. J. Haematol. 93 (1) :151-153, 1996.

・Osterborg, A., Dyer, M. J., Bunjes, D. et al.:Phase II multicenter study of human CD 52 antibody in previously treated treatment in chronic lymphocytic leukemia. J. Clin. Oncol. 15 (4) :1567-1574, 1997.

・Perry, A. C., Jones, R. and Hall, L.:Identification of an abundant monkey epididymal transcript encoding a homologue of human CAMPATH-1 antigen precursor. Biochim. Biophys. Acta 1171:122-124, 1992.

PubMed

・Riechmann, L., Clark, M., Waldmann, H. et al.:Reshaping human antibodies for therapy. Nature 332 (6162) :323-327, 1988.

PubMed

・Schroter, S., Kirchhoff, C., Yeung, C. H. et al.:Purification and structural analysis of sperm CD 52, a GPI-anchored membrane protein. Adv. Exp. Med. Biol. 424:233-234, 1997.

・Treumann, A., Lifely, M. R., Schneider, P. et al.:Primary structure of CD 52. J. Biol. Chem. 270 (11) :6088-6099, 1995.

・Valentin, H., Gelin, C., Coulombel, L. et al.:The distribution of the CDW 52 molecule on blood cells and characterization of its involvement in T cell activation. Transplantation 54 (1) :97-104, 1992.

・Xia, MQ., Tone, M., Packman, L. et al.:Characterization of the CAMPATH-1 (CDw 52) antigen:biochemical and cDNA cloning reveal an unusually small peptide backbone. Eur. J. Immunol. 21 (7) :1677-1684, 1991.

・Xia, MQ., Hale, G. and Waldmann, H.:Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw 52) antigen. Mol Immunol. 30 (12) :1089-1096, 1993.

P.19 掲載の参考文献

・Knapp, W., Majdic, O., Stockinger, H. et al.:Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia. Med. Oncol. Tumor Pharmacother. 1 (4) :257-262, 1984.

PubMed

・Kniep, B., Peter-Katalinic, J., Muthing, J. et al.:The CDw 65 monoclonal antibodies VIM-8 and VIM-11 bind to the neutral glycolipid V 3 FucnLc 8 Cer. J. Biochem. (Tokyo) 119 (3) :456-462, 1996

P.20 掲載の参考文献

・Goelz, S. E., Hession, C., Goff, D. et al.:ELFT:a gene that directs the expression of an ELAM-1 ligand. Cell 63 (6) :1349-1356, 1990.

PubMed

・Janssen, J. L. W. D., Borkhardt, A., Spadinger, U. et al.:Pre-pre-B acute lymphoblastic leukemia:high frequency of alternatively spliced ALL 1-AF 4 transcripts and absence of minimal residual disease during complete remission. Blood 84 (11) :3835-3842, 1994.

・Knapp, W., Strobl, H. and Majdic, O.:Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry 18 (4) :187-198, 1994.

PubMed

・Lowe, J. B., Kukowska-Latallo, J. F., Nair, R. P. et al.:Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1-dependent cell adhesion. J. Biol. Chem. 266 (26) :17467-17477, 1991.

・Lund-Johansen, F., Olweus, J., Horejsi, V. et al.:Activation of human phagocytes through carbohydrate antigens (CD 15, sialyl-CD 15, CDw 17, and CDw 65) . J. Immunol. 148 (10) :3221-3229, 1992.

・Macher, B. A., Buehler, J., Scudder, P. et al.:A novel carbohydrate, differentiation antigen on fucogangliosides of human myeloid cells recognized by monoclonal antibody VIM-2. J. Biol. Chem. 263 (21) :10186-10191, 1988.

P.22 掲載の参考文献

◎Thompson, J. A., Grunert, F. and Zimmermann, W.:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5 (5) :344-366, 1991.

PubMed

・Barnett, T. R., Pickle, W. D. and Elting, J. J.:Characterization of two new members of the pregnancy-specific beta 1-glycoprotein family from the myeloid cell line KG-1 and suggestion of two distinct classes of transcription unit. Biochemistry 29 (44) :10213-10218, 1990.

・Oikawa, S., Inuzuka, C., Kuroki, M. et al.:A pregnancy-specific beta 1-glycoprotein, a CEA gene family member, expressed in a human promyelocytic leukemia cell line, HL-60:structures of protein, mRNA and gene. Biochem. Biophys. Res. Commun. 163 (2) :1021-1031, 1989.

・Tatarinov, Y. S.:Trophoblast-specific beta 1-glycoprotein as a marker for pregnancy and malignancies. Gynecol. Obstet. Invest. 9 (2-3) :65-97, 1978.

・Teglund, S., Olsen, A., Khan, W. N. et al.:The pregnancy specific glycoprotein (PSG) gene cluster on human chromosome 19:fine structure of the 11 PSG genes and identification of 6 new genes forming a third subgroup within the carcinoembryonic antigen (CEA) family. Genomics 23 (3) :669-684, 1994.

・Watanabe, S. and Chou, J. Y.:Human pregnancy-specific beta 1-glycoprotein:a new member of the carcinoembryonic antigen gene family. Biochem. Biophys. Res. Commun. 152 (2) :762-768, 1988.

PubMed

P.23 掲載の参考文献

◎de la Fuente, M. A.:Leukocyte Typing VI, BC 25/193.

・de Ia Fuente, M. A., Pizcueta, P., Nadal, M. et al.:CD 84 leukocyte antigen is a new member of the Ig superfamily. Blood 90 (6) :2398-2405, 1997.

P.25 掲載の参考文献

◎Killeen, N.:T-cell regulation:Thy-1-hiding in full view. Curr. Biol. 7 (12) :R 774-777, 1997.

・Blair, A., Hogge, D. E., Ailles, L. E. et al.:Lack of expression of Thy-1 (CD 90) on acute myeloid leukemia cells long-term proliferative ability in vitro and in vivo. Blood 89 (9) :3104-3112, 1997.

・Craig, W., Kay, R., Cutler, R. L. et al.:Expression of Thy-1 on human hematopoietic progenitor cells. J. Exp. Med. 177 (5) :1331-1342, 1993.

PubMed

・Feng, H., Zhao, W. Q., Bernard, C. C. et al.:Purified antichick Thy-1 IgG abolishes intermediate and long-term memory. Physiol. Behav. 53 (2) :215-219, 1993.

PubMed

・Geba, G. P., Wegner, C. D., Wolyniec, W. W. et al.:Nonatopic asthma:in vivo airway hyper-reactivity adoptively transferred to naive mice by THY-1 (+) and B 220 (+) antigen-specific cells that lack surface expression of CD 3. J. Clin. Invest. 100 (3) :629-638, 1997.

・Hueber, A. O., Raposo, G., Pierres, M. et al.:Thy-1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism. J. Exp. Med. 179 (3) :785-796, 1994.

PubMed

・Jeng, C. J., McCarroll, S. A., Martin, T. F. et al.:Thy-1 is a component common to multiple populations of synaptic vesicles. J. Cell Biol. 140 (3) :685-698, 1998.

PubMed

・Lancki, D. W., Qian, D., Fields, P. et al.:Differential requirement for protein tyrosine kinase Fyn in the functional activation of antigen-specific T lymphocyte clones through the TCR or Thy-1. J. Immunol. 154 (9) :4363-4370, 1995.

・Lee, W. S., Jain, M. K., Arkonac, B. M. et al.:Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ. Res. 82 (8) :845-851, 1998.

PubMed

・Mayani, H. and Lansdorp, P. M.:Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 83 (9) :2410-2417, 1994.

PubMed

・Nosten-Bertrand, M., Errington, M. L., Murphy, K. P. et al.:Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1. Nature 379 (6568) :826-829, 1996.

PubMed

・Page, D. M., Tokugawa, Y., Silver, J. et al.:Role of Thy-1 in T cell development. J. Immunol. 159 (11) :5285-5292, 1997.

・Seki, T., Spurr, N., Obata, F. et al.:The human Thy-1 gene:structure and chromosomal location. Proc. Natl. Acad. Sci. USA 82 (19) :6657-6661, 1985.

・Seki, T., Chang, H. C., Moriuchi, T. et al.:A hydrophobic transmembrane segment at the carboxyl terminus of thy-1. Science 227 (4687) :649-651, 1985.

PubMed

・Tiveron, M. C., Barboni, E., Pliego, Rivero, F. B. et al.:Selective inhibition of neurite outgrowth on mature astrocytes by Thy-1 glycoprotein. Nature 355 (6362) :745-748, 1992.

PubMed

・Tse, A. G., Barclay, A. N., Watts, A. et al.:A glycophospholipid tail at the carboxyl terminus of the Thy-1 glycoprotein of neurons and thymocytes. Science 230 (4729) :1003-1008, 1985.

・Vidal, M., Morris, R., Grosveld, F. et al.:Tissue-specific control elements of the Thy-1 gene. EMBO J. 9 (3) :833-840, 1990.

PubMed

・Williams, A. F. and Gagnon, J.:Neuronal cell Thy-1 glycoprotein:homology with immunoglobulin. Science 216 (4547) :696-703, 1982.

PubMed

・Williams, A. F., Parekh, R. B., Wing, D. R. et al.:Comparative analysis of the N-glycans of rat, mouse and human Thy-1. Site-specific oligosaccharide patterns of neural Thy-1, a member of the immunoglobulin superfamily. Glycobiology 3 (4) :339-348, 1993.

P.27 掲載の参考文献

・Bagot, M., Martinel, I., Charue, D. et al.:CD 101 is expressed by skin dendritic cells. Role in T-lymphocyte activation. Tissue Antigens 50 (5) :439-448, 1997.

・Bagot, M., Martinel, I., Charue, D. et al.:Functional role of CD 101 on skin dendritic cells. Adv. Exp. Med. Biol. 417:227-232, 1997.

・Gouttefangeas, C., Jacquot, S., Meffre, E. et al.:Differential proliferative responses in subsets of human CD 28+cells delineated by BB 27 mAb. Int. Immunol. 6 (3) :423-430, 1994.

・Rivas, A., Ruegg, C. L., Zeitung, J. et al.:V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies. J. Immunol. 154 (9) :4423-4433, 1995.

・Ruegg, C. L., Rivas, A., Madani, N. D. et al.:V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V 7 gene. J. Immunol. 154 (9) :4434-4443, 1995.

・Russell, G. J., Parker, C. M., Sood, A. et al.:p126 (CDw 101) , a costimulatory molecule preferentially expressed on mucosal T lymphocytes. J. Immunol. 157 (8) :3366-3374, 1996.

P.28 掲載の参考文献

・Bordin, J. O., Kelton, J. G., Warner, M. N. et al.:Maternal immunization to Gov system alloantigens on human platelets. Transfusion 37 (8) :823-828, 1997.

PubMed

・Brashem-Stein, C., Nugent, D. and Bernstein, I. D.:Characterization of an antigen expressed on activated human T cells platelets. J. Immunol. 140 (7) :2330-2333, 1988.

・Haregewoin, A., Solomon, K., Hom, R. C. et al.:Cellular expression of a GPI-linked T cell activation protein. Cell Immunol. 156 (2) :357-370, 1994.

PubMed

・Kelton, J. G., Smith, J. W., Horsewood, P. et al.:Gova/b alloantigen system on human platelets. Blood 75 (11) :2172-2176, 1990.

PubMed

・Smith, J. W., Hayward, C. P., Horsewood, P. et al.:Characterization and localization of the Gova/b alloantigens to the glycosylphosphatidylinositol-anchored protein CDw109 on human platelets. Blood 86 (7) :2807-2814, 1995.

・Sutherland, D. R., Yeo, E., Ryan, A. et al.:Identification of a cell-surface antigen associated with activated T lymphoblasts and activated platelets. Blood 77 (1) :84-93, 1991.

PubMed

P.30 掲載の参考文献

◎Avalos, B. R.:Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88 (3) :761-777, 1996.

PubMed

◎de Koning, J. P. and Touw, I. P.:Advances in understanding the biology and function of the G-CSF receptor. Curr. Opin. Hematol. 3 (3) :180-184, 1996.

◎Tidow, N. and Welte, K.:Advances in understanding postreceptor signaling in response to granulocyte colony stimulating factor. Curr. Opin. Hematol. 4 (3) :171-175, 1997.

PubMed

・Asano, Y., Yokoyama, T., Shibata, S. et al.:Effect of the chimeric soluble granulocyte colony-stimulating factor receptor on the proliferation of leukemic blast cells from patients with acute myeloblastic leukemia. Cancer Res. 57 (16) :3395-3397, 1997.

PubMed

・Bernard, T., Gale, R. E., Evans, J. P. et al.:Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. Br. J. Haematol. 101 (1) :141-149, 1998.

・Bussolino, F., Wang, J. M., Defilippi, P. et al.:Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337 (6206) :471-473, 1989.

PubMed

・de Koning, J. P., Soede-Bobok, A. A., Schelen, A. M. et al.:Proliferation signaling and activation of Shc, p 21 Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood 91 (6) :1924-1933, 1998.

・Dong, F., Brynes, R. K., Tidow, N. et al.:Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N. Engl. J. Med. 333 (8) :487-493, 1995.

PubMed

・Dong, F., Hoefsloot, L. H., Schelen, A. M. et al.:Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc. Natl. Acad. Sci. USA 91 (10) :4480-4484, 1994.

PubMed

・Fukunaga, R., Seto, Y., Mizushima, S. et al.:Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc. Natl. Acad. Sci. USA 87 (22) :8702-8706, 1990.

PubMed

・Fukunaga, R., Ishizaka-Ikeda, E., Pan, C. X. et al.:Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 10 (10) :2855-2865, 1991.

PubMed

・Hunter, M. G. and Avalos, B. R.:Phosphatidylinositol 3'-kinase and SH 2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor. J. Immunol. 160 (10) :4979-4987, 1998.

・Kasper, B., Herbst, A., Pilz, C. et al.:Severe congenital neutropenia patients with point mutations in the granulocyte colony-stimulating factor (G-CSF) receptor mRNA express a normal G-CSF receptor protein. Blood 90 (7) :2839-2841, 1997.

PubMed

・Layton, J. E., Iaria, J., Smith, D. K. et al.:Identification of a ligand-binding site on the granulocyte colony-stimulating factor receptor by molecular modeling and mutagenesis. J. Biol. Chem. 272 (47) :29735-29741, 1997.

PubMed

・Liu, F., Wu, H. Y., Wesselschmidt, R. et al.:Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5 (5) :491-501, 1996.

・Liu, F., Poursine-Laurent, J., Wu, H. Y. et al.:Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood 90 (7) :2583-2590, 1997.

PubMed

・Nicholson, S. E., Oates, A. C., Harpur, A. G. et al.:Tyrosine kinase JAK 1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc. Natl. Acad. Sci. USA 91 (8) :2985-2988, 1994.

・Rauprich, P., Kasper, B., Tidow, N. et al.:The protein tyrosine kinase JAK 2 is activated in neutrophils from patients with severe congenital neutropenia. Blood 86 (12) :4500-4505, 1995.

・Shimozaki, K., Nakajima, K., Hirano, T. et al.:Involvement of STAT 3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J. Biol. Chem. 272 (40) :25184-25189, 1997.

PubMed

・Tidow, N., Pilz, C., Teichmann, B. et al.:Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Blood 89 (7) :2369-2375, 1997.

PubMed

・Uzumaki, H., Okabe, T., Sasaki, N. et al.:Identification and characterization of receptors for granulocyte stimulating factor on human placenta and trophoblastic cells. Proc. Natl. Acad. Sci. USA 86 (23) :9323-9326, 1989.

PubMed

・Yamasaki, K., Naito, S., Anaguchi, H. et al.:Solution structure of an extracellular domain containing the WSxWS motif of the granulocyte colony-stimulating factor receptor and its interaction with ligand. Nat. Struct. Biol. 4 (6) :498-504, 1997.

PubMed

・Zhang, D. E., Zhang, P., Wang, N. D. et al.:Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc. Natl. Acad. Sci. USA 94 (2) :569-574, 1997.

PubMed

・Ziegler, S. F., Bird, T. A., Morella, K. K. et al.:Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction. Mol. Cell. Biol. 13 (4) :2384-2390, 1993.

PubMed

P.33 掲載の参考文献

◎Miyajima, A., Mui, A. L., Ogorochi, T. et al.:Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82 (7) :1960-1974, 1993.

PubMed

◎Miyajima, A., Kinoshita, T., Wakao, H. et al.:Signal transduction by the GM-CSF, IL-3 and IL-5 receptors. Leukemia 11 (Suppl. 3) :418-422, 1997.

・Crosier, K. E., Wong, G. G., Mathey-Prevot, B. et al.:A functional isoform of the human granulocyte/macrophage colony-stimulating factor receptor has an unusual cytoplasmic domain. Proc. Natl. Accad. Sci. USA 88 (17) :7744-7748, 1991.

・Crosier, K. E., Hall, LR., Vitas, M. R. et al.:Expression and functional analysis of two isoforms of the human GM-CSF receptor alpha chain in myeloid development and leukaemia. Br. J. Haematol. 98 (3) :540-548, 1997.

PubMed

・Gearing, D. P., King, J. A., Gough, N. M. et al.:Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J. 8 (12) :3667-3376, 1989.

PubMed

・Hayashida, K., Kitamura, T., Gorman, D. M. et al.:Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF) :reconstitution of a high-affinity GM-CSF receptor. Proc. Natl. Acad. Sci. USA 87 (24) :9655-9659, 1990.

PubMed

・Heaney, M. L., Vera, J. C., Raines, M. A. et al.:Membrane-associated and soluble granulocyte/macrophage-colony-stimulating factor receptor alpha subunits are independently regulated in HL-60 cells. Proc. Natl. Acad. Sci. USA 92 (6) :2365-2369, 1995.

PubMed

・Iversen, P. O., Hercus, T. R., Zacharakis, B. et al.:The apoptosis-inducing granulocyte-macrophage colony-stimulating factor (GM CSF) analog E21R functions through specific regions of the heterodimeric GM-CSF receptor and requires interleukin-1 beta-converting enzyme-like proteases. J. Biol. Chem. 272 (15) :9877-9883, 1997.

PubMed

・Jubinsky, P. T., Laurie, A. S., Nathan, D. G. et al.:Expression and function of the human granulocyte-macrophage colony stimulating factor receptor alpha subunit. Blood 84 (12) :4174 4185, 1994.

・Kitamura, T., Hayashida, K., Sakamaki, K. et al.:Reconstitution of functional receptors for human granulocyte/macrophage colony stimulating factor (GM-CSF) :evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor. Proc. Natl. Acad. Sci. USA 88 (12) :5082-5086, 1991.

PubMed

・Matsuguchi, T., Zhao, Y., Lilly, M. B. et al.:The cytoplasmic domain of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha subunit is essential for both GM-CSF-mediated growth and differentiation. J. Biol. Chem. 272 (28) :17450-17459, 1997.

PubMed

・Murray, E. W., Pihl, C., Morcos, A. et al.:Ligand-independent cell surface expression of the human soluble granulocyte-macrophage colony-stimulating factor receptor alpha subunit depends on co-expression of the membrane-associated receptor beta subunit. J. Biol. Chem. 271 (26) :15330-15335, 1996.

・Nicola, N. A., Wycherley, K., Boyd, A. W. et al.:Neutralizing and nonneutralizing monoclonal antibodies to the human granulocyte-macrophage colony-stimulating factor receptor alpha-chain. Blood 82 (6) :1724-1731, 1993.

・Park, L. S., Martin, U., Sorensen, R. et al.:Cloning of the low-affinity murine granulocyte-macrophage stimulating factor receptor and reconstitution of a high-affinity receptor complex. Proc. Natl. Acad. Sci. USA 89 (10) :4295-4299, 1992.

PubMed

・Rajotte, D., Cadieux, C., Haman, A. et al.:Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition. J. Exp. Med. 185 (11) :1939-1950, 1997.

・Ronco, L. V., Silverman, S. L., Wong, S. G. et al.:Identification of conserved amino acids in the human macrophage colony-stimulating factor receptor alpha subunit for function. Evidence for formation of a heterodimeric receptor complex prior to ligand binding. J. Biol. Chem. 269 (1) :277-283, 1994.

・Sakamaki, K., Miyajima, I., Kitamura, T. et al.:Critical cytoplasmic domains of the common beta subunit of CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J. 11 (10) :3541-3549, 1992.

PubMed

・Till, K. J., Burthem, J., Lopez, A. et al.:Granulocyte-macrophage colony-stimulating factor receptor:stage-specific expression and function on late B cells. Blood 88 (2) :479-486, 1996.

PubMed

・Watanabe, S., Kubota, H., Sakamoto, K. M. et al.:Characterization of cis-acting sequences and trans-acting signals regulating early growth response 1 and c-fos promoters through the granulocyte-macrophage colony-stimulating factor receptor in BA/F 3 cells. Blood 89 (4) :1197-1206, 1997.

・Woodcock, J. M., McClure, B. J., Stomski, F. C. et al.:The human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor exists as a preformed receptor complex that can be activated by GM-CSF, interleukin-3, or interleukin-5. Blood 90 (8) :3005-3017, 1997.

PubMed

・Yasuda, Y., Nishijima, I., Watanabe, S. et al.:Human granulocyte-macrophage colony-stimulating factor (hGM-CSF) induces inhibition of intrathymic T-cell development in hGM-CSF receptor transgenic mice. Blood 89 (4) :1349-1356, 1997.

PubMed

P.37 掲載の参考文献

◎Kuno, K. and Matsushima, K.:The IL-1 receptor signaling pathway. J. Leukoc. Biol. 56 (5) :542-547, 1994.

PubMed

◎O'Neill, L. A. and Greene, C.:Signal transduction pathways activated by the IL-1 receptor family:ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63 (6) :650-657, 1998.

◎Sims, J. E., Giri, J. G. and Dower, S. K.:The two interleukin-1 receptors play different roles in IL-1 actions. Clin. Immunol. Immunopathol. 72 (1) :9-14, 1994.

PubMed

・Akeson, A. L., Woods, C. W., Hsieh, L. C. et al.:AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL) -1 receptor and blocks in vivo responses to IL-1. J. Biol. Chem. 271 (48) :30517-30523, 1996.

PubMed

・Bergers, G., Reikerstorfer, A., Braselmann, S. et al.:Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 13 (5) :1176-1188, 1994.

PubMed

・Cohen, P. E. and Pollard, J. W.:Normal sexual function in male mice lacking a functional type I interleukin-1 (IL-1) receptor. Endocrinology 139 (2) :815-818, 1998.

PubMed

・Cao, Z., Henzel, W. J. and Gao, X.:IRAK:a kinase associated with the interleukin-1 receptor. Science 271 (5252) :1128-1131, 1996.

・Guo, C., Dower, S. K., Holowka, D. et al.:Fluorescence resonance energy transfer reveals interleukin (IL) -1-dependent aggregation of IL-1 type I receptors that correlates with receptor activation. J. Biol. Chem. 270 (46) :27562-27568, 1995.

PubMed

・Glaccum, M. B., Stocking, K. L., Charrier, K. et al.:Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159 (7) :3364-3371, 1997.

PubMed

・Greenfeder, S. A., Nunes, P., Kwee, L. et al.:Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270 (23) :13757-13765, 1995.

PubMed

・Groves, R. W., Rauschmayr, T., Nakamura, K. et al.:Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J. Clin. Invest. 98 (2) :336-344, 1996.

PubMed

・Kanakaraj, P., Schafer, P. H., Cavender, D. E. et al.:Interleukin (IL) -1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 187 (12) :2073-2079, 1998.

PubMed

・Labow, M., Shuster, D., Zetterstrom, M. et al.:Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159 (5) :2452-2461, 1997.

PubMed

・Martin, M., Bol, G. F., Eriksson, A. et al.:Interleukin-1-induced activation of a protein kinase co-precipitating with the type I interleukin-1 receptor in T cells. Eur. J. Immunol. 24 (7) :1566-1571, 1994.

・Schreuder, H., Tardif, C., Trump-Kallmeyer, S. et al.:A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386 (6621) :194-200, 1997.

PubMed

・Sims, J. E., March, C. J., Cosman, D. et al.:cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241 (4865) :585-589, 1988.

PubMed

・Sims, J. E., Acres, RB., Grubin, C. E. et al:Cloning the interleukin 1 receptor from human T cells. Proc. Natl. Acad. Sci. USA 86 (22) :8946-8950, 1989.

・Sims, J. E., Gayle, M. A., Slack, J. L. et al.:Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90 (13) :6155-6159, 1993.

PubMed

・Sims, J. E., Painter, S. L. and Gow, I. R.:Genomic organization of the type I and type II IL-1 receptors. Cytokine 7 (6) :483-490, 1995.

PubMed

・Slack, J., McMahan, C. J., Waugh, S. et al.:Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors. J. Biol. Chem. 268 (4) :2513-2524, 1993.

PubMed

・Wesche, H., Korherr, C., Kracht, M. et al.:The interleukin-1 receptor accessory protein (IL-1 RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases) . J. Biol. Chem. 272 (12) :7727-7731, 1997.

P.40 掲載の参考文献

◎Miyajima, A., Mui, A. L., Ogorochi, T. et al.:Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82 (7) :1960-1974, 1993.

PubMed

◎Miyajima, A., Kinoshita, T., Wakao, H. et al.:Signal transduction by the GM-CSF, IL-3 and IL-5 receptors. Leukemia 11 (Suppl. 3) :418-422, 1997.

・Bagley, C. J., Phillips, J., Cambareri, B. et al.:A discontinuous eight-amino acid epitope in human interleukin-3 binds the alpha-chain of its receptor. J. Biol. Chem. 271 (50) :31922-31928, 1996.

・Barry, S. C., Korpelainen, E., Sun, Q. et al.:Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function. Blood 89 (3) :842-852, 1997.

・Hara, T. and Miyajima, A.:Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3) . EMBO J. 11 (5) :1875-1884, 1992.

PubMed

・Hara, T., Ichihara, M., Takagi, M. et al.:Interleukin-3 (IL-3) poor-responsive inbred mouse strains carry the identical deletion of a branch point in the IL-3 receptor alpha subunit gene. Blood 85 (9) :2331-2336, 1995.

PubMed

・Ichihara, M., Hara, T., Takagi, M. et al.:Impaired interleukin-3 (IL. 3) response of the A/J mouse is caused by a branch point deletion in the IL-3 receptor alpha subunit gene. EMBO J. 14 (5) :939-950, 1995.

・Kitamura, T., Sato, N., Arai, K. et al.:Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM CSF receptors. Cell 66 (6) :1165-1174, 1991.

PubMed

・Lantz, C. S., Boesiger, J., Song, C. H. et al.:Role for interleukin 3 in mast-cell and basophil development and in immunity to parasites. Nature 392 (6671) :90-93, 1998.

PubMed

・Liu, L., Jefferson, A. B., Zhang, X. et al.:A novel phosphatidylinositol-3, 4, 5-trisphosphate 5-phosphatase associates with the interleukin-3 receptor. J. Biol. Chem. 271 (47) :29729-29733, 1996.

・Miyajima, I., Levitt, L., Hara, T. et al, :The murine interleukin-3 receptor alpha subunit gene:chromosomal localization, genomic structure, and promoter function. Blood 85 (5) :1246-1253, 1995.

PubMed

・Sato, N., Caux, C., Kitamura, T. et al.:Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells. Blood 82 (3) :752-761, 1993.

PubMed

・Sun, Q., Woodcock, J. M., Rapoport, A. et al.:Monoclonal antibody 7 G 3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist. Blood 87 (1) :83-92, 1996.

・Woodcock, J. M., Bagley, C. J., Zacharakis, B. et al.:A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL) -3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands. J. Biol. Chem. 271 (42) :25999-26006, 1996.

PubMed

P.42 掲載の参考文献

◎Chomarat, P. and Banchereau, J.:An update on interleukin-4 and its receptor. Eur. Cytokine Netw. 8 (4) :333-344, 1997.

PubMed

◎Keegan, A. D. and Zamorano, J.:Regulation of gene expression, growth, and cell survival by IL-4:contribution of multiple signaling pathways. Cell Res. 8 (1) :1-13, 1998.

PubMed

◎Yanagihara, Y., Ikizawa, K., Kajiwara, K. et al.:Functional significance of IL-4 receptor on B cells in IL-4-induced human IgE production. J. Allergy Clin. Immunol. 96 (6 Pt 2) :1145-1151, 1995.

◎Nasert, S., Millner, M., Herz, U. et al.:Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4 R) in allergic diseases. Behring Inst. Mitt. 96:118-130, 1996.

・Bonder, C. S., Dickensheets, H. L., Finlay-Jones, J. J. et al.:Involvement of the IL-2 receptor gamma-chain (gammac) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production. J. Immunol. 160 (8) 14048-4056, 1998.

・Doucet, C., Brouty-Boye, D., Pottin-Clemenceau, C. et al.:Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest 101 (10) :2129-2139, 1998.

PubMed

・Fujiwara, H., Hanissian, S. H., Tsytsykova, A. et al.:Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA 94 (11) :5866-5871, 1997.

・Gavett, S. H., O'Hearn, D. J., Karp, C. L. et al.:Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am. J. Physiol. 272 (2 Pt 1) :L 253-261, 1997.

・Idzerda, R. L., March, C. J., Mosley, B. et al.:Human interleukin-4 receptor confers biological responsiveness and defines a novel receptor superfamily. J. Exp. Med. 171 (3) :861-873, 1990.

PubMed

・Kondo, M., Takeshita, T., Ishii, N. et al:Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262 (5141) :1874-1877, 1993.

PubMed

・Kubo, M., Ransom, J., Webb, D. et al.:T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT 6. EMBO J. 16 (13) :4007-4020, 1997.

・Kuperman, D., Schofield, B., Wills-Karp, M. et al.:Signal transducer and activator of transcription factor 6 (Stat 6) -deficient mice are protected from antigen-induced airway hyper responsiveness and mucus production. J. Exp. Med. 187 (6) :939-948, 1998.

・Noben-Trauth, N., Shultz, L. D., Brombacher, F. et al.:An interleukin 4 (IL-4) -independent pathway for CD 4+Tcell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 94 (20) :10838-10843, 1997.

・Russell, S. M., Keegan, A. D., Harada, N. et al.:Interleukin-2 receptor gamma chain:a functional component of the interleukin-4 receptor. Science 262 (5141) :1880-1883, 1993.

PubMed

・Schnarr, B., Ezernieks, J., Sebald, W. et al.:IL-4 receptor complexes containing or lacking the gamma C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins. Int. Immunol. 9 (6) :861-868, 1997.

PubMed

・Takeda, K., Tanaka, T., Shi, W. et al.:Essential role of Stat 6 in IL-4 signalling. Nature 380 (6575) :627-630, 1996.

・Wang, H. Y., Zamorano, J. and Keegan, A. D.:A role for the insulin-interleukin (IL) -4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis. J. Biol. Chem. 273 (16) :9898-9905, 1998.

PubMed

・Zhang, J. G., Hilton, D. J., Willson, T. A. et al.:Identification, purification, and characterization of a soluble interleukin (IL) -13 binding protein. Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor alpha-chains. J. Biol. Chem. 272 (14) :9474-9480, 1997.

PubMed

・Zuany-Amorim, C., Ruffie, C., Haile, S. et al.:Requirement for gammadelta T cells in allergic airway inflammation. Science 280 (5367) :1265-1267, 1998.

PubMed

P.45 掲載の参考文献

◎Devos, R., Plaetinck, G., Cornelis, S. et al.:Interleukin-5 and its receptor:a drug target for eosinophilia associated with chronic allergic disease. J. Leukoc. Biol. 57 (6) :813-819, 1995.

◎Koike, M. and Takatsu, K.:IL-5 and its receptor:which role do they play in the immune response? Int. Arch. Allergy Immunol. 104 (1) :1-9, 1994.

PubMed

◎Miyajima, A., Kinoshita, T., Wakao, H. et al.:Signal transduction by the GM-CSF, IL-3 and IL-5 receptors. Leukemia 11 (Suppl. 3) :418-422, 1997.

◎Takatsu, K., Takaki, S. and Hitoshi, Y.:Interleukin-5 and its receptor system:implications in the immune system and inflammation. Adv. Immunol. 57:145-190, 1994.

PubMed

・Cornelis, S., Plaetinck, G., Devos, R. et al.:Detailed analysis of the IL-5-IL-5R alpha interaction:characterization of crucial residues on the ligand and the receptor. EMBO J. 14 (14) :3395-3402, 1995.

PubMed

・Edgerton, M. D., Graber, P., Willard, D. et al.:Spatial orientation of the alpha and betac receptor chain binding sites on monomeric human interleukin-5 constructs. J. Biol. Chem. 272 (33) :20611-20618, 1997.

PubMed

・Kikuchi, Y., Yasue, T., Miyake, K. et al.:CD 38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain:synergistic effects with interleukin 5. Proc. Natl. Acad. Sci. USA 92 (25) :11814-11818, 1995.

・Li, J., Cook, R., Doyle, M. L. et al.:Monomeric isomers of human interleukin 5 show that 1:1 receptor recruitment is sufficient for function. Proc. Natl. Acad. Sci. USA 94 (13) :6694-6699, 1997.

PubMed

・Monahan, J., Siegel, N., Keith, R. et al.:Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor. J. Immunol. 159 (8) :4024-4034, 1997.

PubMed

・Murata, Y., Takaki, S., Migita, M. et al.:Molecular cloning and expression of the human interleukin 5 receptor. J. Exp. Med. 175 (2) :341-351, 1992.

PubMed

・Pereira, E., Goldblatt, J., Rye, P. et al.:Mutation analysis of interleukin-5 in an asthmatic cohort. Hum. Mutat. 11 (1) :51-54, 1998.

・Pazdrak, K., Adachi, T. and Alam, R.:Src homology 2 protein tyrosine phosphatase (SHPTP 2) / Src homology 2 phosphatase 2 (SHP 2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival. J. Exp. Med. 186 (4) :561-568, 1997.

・Takaki, S., Murata, Y., Kitamura, T. et al.:Reconstitution of the functional receptors for murine and human interleukin 5. J. Exp. Med. 177 (6) :1523-1529, 1993.

PubMed

・Tavernier, J., Devos, R., Cornelis, S. et al:A human high affinity interleukin-5 receptor (IL5R) is composed of an IL 5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66 (6) :1175-1184, 1991.

・Tavernier, J., Tuypens, T., Plaetinck, G. et al.:Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. Proc. Natl. Acad. Sci. USA 89 (15) :7041-7045, 1992.

PubMed

・Wang, P., Wu, P., Cheewatrakoolpong, B. et al.:Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils. J. Immunol. 160 (9) :4427-4432, 1998.

PubMed

・Yasue, T., Nishizumi, H., Aizawa, S. et al.:A critical role of Lyn and Fyn for B cell responses to CD 38 ligation and interleukin 5. Proc. Natl. Acad. Sci. USA 94 (19) :10307-10312, 1997.

・Yoshida, T., Ikuta, K., Sugaya, H. et al.:Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5 R alpha-deficient mice. Immunity 4 (5) :483-494, 1996.

・Zhang, J., Kuvelkar, R., Cheewatrakoolpong, B. et al.:Evidence for multiple promoters of the human IL-5 receptor alpha subunit gene:a novel 6-base pair element determines cell-specific promoter function. J. Immunol. 159 (11) :5412-5421, 1997.

PubMed

P.48 掲載の参考文献

◎Candeias, S., Muegge, K. and Durum, S. K.:IL-7 receptor and VDJ recombination:trophic versus mechanistic actions. Immunity 6 (5) :501-508, 1997.

PubMed

◎Komschlies, K. L., Grzegorzewski, K. J. and Wiltrout, R. H.:Diverse immunological and hematological effects of interleukin 7:implications for clinical application. J. Leukoc. Biol. 58 (6) :623-633, 1995.

PubMed

・Adachi, S., Yoshida, H., Honda, K. et al.:Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage. Int. Immunol. 10 (1) :1-6, 1998.

PubMed

・Akashi, K., Kondo, M. and Weissman, I. L.:Two distinct pathways of positive selection for thymocytes. Proc. Natl. Acad. Sci. USA 95 (5) :2486-2491, 1998.

PubMed

・Akashi, K., Kondo, M., von Freeden-Jeffry, U. et al.:Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89 (7) :1033-1041, 1997.

PubMed

・Corcoran, A. E., Riddell, A., Krooshoop, D. et al.:Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391 (6670) :904-907, 1998.

PubMed

・Crompton, T., Outram, S. V., Buckland, J. et al.:Distinct roles of the interleukin-7 receptor alpha chain in fetal and adult thymocyte development revealed by analysis of interleukin-7 receptor alpha-deficient mice. Eur. J. Immunol. 28 (6) :1859-1866, 1998.

PubMed

・Fujihashi, K., McGhee, J. R., Yamamoto, M. et al.:An interleukin-7 internet for intestinal intraepithelial T cell development:knockout of ligand or receptor reveal differences in the immunodeficient state. Eur. J. Immunol. 27 (9) :2133-2138, 1997.

PubMed

・Goodwin, R. G., Friend, D., Ziegler, S. F. et al.:Cloning of the human and murine interleukin-7 receptors:demonstration of a soluble form and homology to a new receptor superfamily. Cell 60 (6) :941-951, 1990.

PubMed

・Kondo, M., Takeshita, T., Higuchi, M. et al.:Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 263 (5152) :1453-1454, 1994.

PubMed

・Kondo, M., Weissman, I. L. and Akashi, K.:Identification of clonogenic common lymphoid progenitors in mouse marrow. Cell 91 (5) :661-672, 1997.

PubMed

・Maeurer, M. J. and Lotze, M. T.:Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity. Int. Rev. Immunol. 16 (3-4) :309-322, 1998.

・Namen, A. E., Lupton, S., Hjerrild, K. et al.:Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 333 (6173) :571-573, 1988.

PubMed

・Noguchi, M., Nakamura, Y., Russell, S. M. et al.:Interleukin-2 receptor gamma chain:a functional component of the interleukin-7 receptor. Science 262 (5141) :1877-1880, 1993.

PubMed

・Peschon, J. J., Morrissey, P. J., Grabstein, K. H. et al.:Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180 (5) :1955-1960, 1994.

PubMed

・Watanabe, M., Ueno, Y., Yalima, T. et al.:Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J. Exp. Med. 187 (3) :389-402, 1998.

PubMed

P.51 掲載の参考文献

◎Akira, S., Yoshida, K., Tanaka, T. et al.:Targeted disruption of the IL-6 related genes:gp 130 and NF-IL-6. Immmunol. Rev. 148:221-253, 1995.

◎Kishimoto, T., Akira, S., Narazaki, M. et al.:Interleukin-6 family of cytokines and gp 130. Blood 86 (4) :1243-1254, 1995.

◎Taga, T. and Kishimoto, T.:Gp 130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:797-819, 1997.

◎Wollert, K. C. and Chien, K. R.:Cardiotrophin-1 and the role of gp 130-dependent signaling pathways in cardiac growth and development. J. Mol. Med. 75 (7) :492-501, 1997.

・Bravo, J., Staunton, D., Heath, J. K. et al.:Crystal structure of a cytokine-binding region of gp 130. EMBO J. 117 (6) :1665-1674, 1998.

・Fujio, Y., Kunisada, K., Hirota, H. et al.:Signals through gp 130 upregulate bcl-x gene expression via STAT 1-binding cis-element in cardiac myocytes. J. Clin. Invest. 99 (12) :2898-2905, 1997.

・Gearing, DP., Comeau, M. R., Friend, D. J. et al.:The IL-6 signal transducer, gp 130:an oncostatin M receptor and affinity converter for the LIF receptor. Science 255 (5050) :1434-1437, 1992.

・Hibi, M., Murakami, M., Saito, M. et al.:Molecular cloning and expression of an IL-6 signal transducer, gp 130. Cell 63 (6) :1149-1157, 1990.

・Horsten, U., Muller-Newen, G., Gerhartz, C. et al.:Molecular modeling-guided mutagenesis of the extracellular part of gp 130 1eads to the identification of contact sites in the interleukin-6 (IL-6) /IL6 receptor/gp 130 complex. J. Biol. Chem. 272 (38) :23748-23757, 1997.

・Ip, N. Y., Nye, S. H., Boulton, T. G. et al.:CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp 130. Cell 69 (7) :1121-1132, 1992.

・Murakami, M., Hibi, M., Nakagawa, N. et al.:IL-6-induced homodimerization of gp 30 and associated activation of a tyrosine kinase. Science 260 (5115) :1808-1810, 1993.

・Pennica, D., Shaw, K. J., Swanson, T. A. et al.:Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp 130 signaling complex. J. Biol. Chem. 270 (18) :10915-10922, 1995.

・Shimon, I., Yan, X., Ray, D. W. et al.:Cytokine-dependent gp 130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J. Clin. Invest. 100 (2) :357-363, 1997.

・Stahl, N., Boulton, T. G., Farruggella, T. et al.:Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 receptor components. Science 263 (5143) :92-95, 1994.

PubMed

・Stahl, N., Farruggella, T. J., Boulton, T. G. et al.:Choice of STATs and other substrates specifiedby modular tyrosine-based motifs in cytokine receptors. Science 267 (5202) :1349-1353, 1995.

PubMed

・Starr, R., Novak, U., Willson, T. A. et al.:Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp 130 in cell type-specific signal transduction. J. Biol. Chem. 272 (32) :19982-19986, 1997.

・Sui, X., Tsuji, K., Tajima, S. et al.:Erythropoietin-independent erythrocyte production:signals through gp 130 and c-kit dramatically promote erythropoiesis from human CD 34+cells. J. Exp. Med. 183 (3) :837-845, 1996.

・Tajima, S., Tsuji, K., Ebihara, Y. et al.:Analysis of interleukin 6 receptor and gp 130 expressions and proliferative capability of human CD 34+cells. J. Exp. Med. 184 (4) :1357-1364, 1996.

・Yamanaka, Y., Nakajima, K., Fukada, T. et al.:Differentiation and growth arrest signals are generated through the cytoplasmic region of gp 130 that is essential for Stat 3 activation. EMBO J. 15 (7) :1557-1565, 1996.

・Yoshida, K., Taga, T., Saito, M. et al.:Targeted disruption of gp 130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 93 (1) :407-411, 1996.

・Wang, X. J., Taga, T., Yoshida, K. et al.:gp 130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T cells in vivo by interleukin-6. Blood 91 (9) :3308-3314, 1998.

・Zhang, J. G., Zhang, Y., Owczarek, C. M. et al.:Identification and characterization of two distinct truncated forms of gp 130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma. J. Biol. Chem. 273 (17) :10798-10805, 1998.

P.54 掲載の参考文献

◎Bagley, C. J., Woodcock, J. M., Stomski, F. C. et al.:The structural and functional basis of cytokine receptor activation:lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3) , and IL-5 receptors. Blood 89 (5) :1471-1482, 1997.

PubMed

◎Miyajima, A., Mui, A. L., Ogorochi, T. et al.:Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82 (7) :11960-1974, 1993.

・Dirksen, U., Nishinakamura, R., Groneck, P. et al.:Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J. Clin. Invest. 100 (9) :2211-2217, 1997.

PubMed

・Gale, R. E., Freeburn, R. W., Khwaja, A. et al.:A truncated isoform of the human beta chain common to the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3) , and IL-5 with increased mRNA expression in some patients with acute leukemia. Blood 91 (1) :54-63, 1998.

・Gorman, D. M., Itoh, N., Kitamura, T. et al.:Cloning and expression of a gene encoding an interleukin 3 receptor-like protein:identification of another member of the cytokine receptor gene family. Proc. Natl. Acad. Sci. USA 87 (14) :5459-5463, 1990.

PubMed

・Hara, T. and Miyajima, A.:Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3) . EMBO J. 11 (5) :1875-1884, 1992.

PubMed

・Itoh, N., Yonehara, S., Schreurs, J. et al.:Cloning of an interleukin-3 receptor gene:a member of a distinct receptor gene family. Science 247 (4940) :324-327, 1990.

PubMed

・Itoh, T., Muto, A., Watanabe, S. et al.:Granulocyte-macrophage colony-stimulating factor provokes RAS activation and transcription of c-fos through different modes of signaling. J. Biol. Chem. 271 (13) :7587-7592, 1996.

PubMed

・Kitamura, T., Sato, N., Arai, K. et al.:Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 66 (6) :1165-1174, 1991.

PubMed

・Matsuguchi, T., Inhorn, R. C., Carlesso, N. et al.:Tyrosine phosphorylation of p95 Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210 BCR/ABL. EMBO J. 14 (2) :257-265, 1995.

・Nishinakamura, R., Nakayama, N., Hirabayashi, Y. et al.:Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL 3 receptor-deficient mice are normal. Immunity 2:211-222, 1995.

PubMed

・Nishinakamura, R., Miyajima, A., Mee, P. J. et al.:Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. Blood 88 (7) :2458-2464, 1996.

PubMed

・Quelle, F. W., Sato, N., Witthuhn, B. A. et al.:JAK 2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14 (7) :4335-4341, 1994.

PubMed

・Sato, N., Caux, C., Kitamura, T. et al.:Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells. Blood 82 (3) :752-761, 1993.

PubMed

・Sato, N., Sakamaki, K., Terada, N. et al.:Signal transduction by the high-affinity GM-CSF receptor:two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J. 12 (11) :4181-4189, 1993.

PubMed

・Smith, A., Metcalf, D. and Nicola, N. A.:Cytoplasmic domains of the common beta-chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines. EMBO J. 16 (3) :451-464, 1997.

PubMed

・Stomski, F. C., Woodcock, J. M., Zacharakis, B. et al.:Identification of a Cys motif in the common beta chain of the interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 receptors essential for disulfide-linked receptor heterodimerization and activation of all three receptors. J. Biol. Chem. 273 (2) :1192-1199, 1998.

PubMed

・Tavernier, J., Devos, R., Cornelis, S. et al.:A human high affinity interleukin-5 receptor (IL 5 R) is composed of an IL 5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66 (6) :1175-1184, 1991.

PubMed

P.57 掲載の参考文献

◎Leonard, W. J., Shores, E. W. and Love, P. E.:Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol. Rev. 148:97-114, 1995.

PubMed

◎Leonard, W. J.:The molecular basis of X-linked severe combined immunodeficiency:defective cytokine receptor signaling. Annu. Rev. Med. 47:229-239, 1996.

PubMed

◎Sugamura, K., Asao, H., Kondo, M. et al.:The common gamma-chain for multiple cytokine receptors. Adv. Immunol. 59:225-277, 1995.

PubMed

◎Sugamura, K., Asao, H., Kondo, M. et al.:The interleukin-2 receptor gamma chain:its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 14:179-205, 1996.

◎Voss, S. D., Hong, R. and Sondel, P. M.:Severe combined immunodeficiency, interleukin-2 (IL-2) , and the IL-2 receptor:experiments of nature continue to point the way. Blood 83 (3) :626-635, 1994.

PubMed

・Bani, L., David, D., Fevrier, M. et al.:Interleukin-2 receptor beta and gamma chain dysregulation during the inhibition of CD 4 T cell activation by human immunodeficiency virus-1 gp120. Eur. J. Immunol. 27 (9) :2188-2194, 1997.

・Boesteanu, A., Silva, A. D. D., Nakajima, H. et al.:Distinct roles for signals relayed through the common cytokine receptor gamma chain and interleukin 7 receptor alpha chain in natural T cell development. J. Exp. Med. 186 (2) :331-336, 1997.

・Chen, M., Cheng, A., Chen, Y. Q. et al.:The amino terminus of JAK 3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. Proc. Natl. Acad. Sci. USA 94 (13) :6910-6915, 1997.

・Dawson, C. H., Brown, B. L. and Dobson, P. R.:A 70-kDa protein facilitates interleukin-4 signal transduction in the absence of the common gamma receptor chain. Biochem. Biophys. Res. Commun. 233 (1) :279-282, 1997.

PubMed

・Kondo, M., Takeshita, T., Ishii, N. et al.:Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262 (5141) :1874-1877, 1993.

PubMed

・Kondo, M., Takeshita, T., Higuchi, M. et al.:Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 263 (5152) :1453-1454, 1994.

PubMed

・Kondo, M., Akashi, K., Domen, J. et al.:Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity 7 (1) :155-162, 1997.

PubMed

・Malissen, M., Pereira, P., Gerber, D. J. et al.:The common cytokine receptor gamma chain controls survival of gamma/delta T cells. J. Exp. Med. 186 (8) :1277-1285, 1997.

PubMed

・Nakajima, H. and Leonard, W. J:Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain:defective Fas ligand expression in gamma-chain-deficient mice. J. Immunol. 159 (10) :4737-4744, 1997.

PubMed

・Nielsen, O. H., Kirman, I., Johnson, K. et al.:The circulating common gamma chain (CD 132) in inflammatory bowel disease. Am. J. Gastroenterol. 93 (3) :323-328, 1998.

・Noguchi, M., Nakamura, Y., Russell, S. M. et al.:Interleukin-2 receptor gamma chain:a functional component of the interleukin-7 receptor. Science 262 (5141) :1877-1880, 1993.

PubMed

・Noguchi, M., Yi, H., Rosenblatt, H. M. et al.:Interleukin-2 receptor gamma chain mutation results in X-linked combined immunodeficiency in humans. Cell 73 (1) :147-157, 1993.

・Noguchi, M., Sarin, A., Aman, M. J. et al.:Functional cleavage of the common cytokine receptor gamma chain (gamma c) by calpain. Proc. Natl. Acad. Sci. USA 94 (21) :11534-11539, 1997.

・Russell, S. M., Keegan, A. D., Harada, N. et al.:Interleukin-2 receptor gamma chain:a functional component of the interleukin-4 receptor. Science 262 (5141) :1880-1883, 1993.

PubMed

・Scharton-Kersten, T., Nakajima, H., Yap, G. et al.:Infection of mice lacking the common cytokine receptor gamma-chain (gamma (c)) reveals an unexpected role for CD 4+ T lymphocytes in early IFN-gamma-dependent resistance to Toxoplasma gondii. J. Immunol. 160 (6) :2565-2569, 1998.

・Takeshita, T., Asao, H., Ohtani, K. et al.:Cloning of the gamma chain of the human IL-2 receptor. Science 257 (5068) :379-382, 1992.

PubMed

P.60 掲載の参考文献

◎Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

Liu, Y. J. and Banchereau, J.:Regulation of B-cell commitment to plasma cells or to memory B cells. Semin. Immunol. 9 (4) :235-240, 1997.

PubMed

◎Weinberg, A. D.:Antibodies to OX-40 (CD 134) can identify and eliminate autoreactive T cells:implications for human autoimmune disease. Mol. Med. Today 4 (2) :76-83, 1998.

・al-Shamkhani, A., Birkeland, M. L., Puklavec, M. et al.:OX 40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX 40 ligand. Eur. J. Immunol. 26 (8) :1695-1699, 1996.

・Al-Shamkhani, A., Mallett, S., Brown, M. H. et al.:Affinity and kinetics of the interaction between soluble trimeric OX 40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX 40 on activated T cells. J. Biol. Chem. 272 (8) :5275-5282, 1997.

・Arch, R. H. and Thompson, C. B.:4-1 BB and Ox 40 are members of a tumor necrosis factor (TNF) -nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappa B. Mol. Cell. Biol. 18 (1) :558-565, 1998.

・Baum, P. R., Gayle, R. Br., Ramsdell, F. et al.:Molecular characterization of murine and human OX 40/OX 40 ligand systems:identification of a human OX 40 ligand as the HTLV-1-regulated protein gp 34. EMBO. J. 13 (17) :3992-4001, 1994.

・Duerkop, H., Latza, U., Himmelreich, P. et al.:Expression of the human OX 40 (hOX 40) antigen in normal and neoplastic tissues. Br. J. Haematol. 91 (4) :927-931, 1995.

・Godfrey, W. R., Fagnoni, F. F., Harara, M. A. et al.:Identification of a human OX-40 ligand, a costimulator of CD 4+ T cells with homology to tumor necrosis factor. J. Exp. Med. 180 (2) :757-762, 1994.

・Higashimura, N., Takasawa, N., Tanaka, Y. et al.:Induction of OX 40, a receptor of gp 34, on T cells by trans-acting transcriptional activator, Tax, of human T-Cell leukemia virus type I. Jpn. J. Cancer Res. 87 (3) :227-231, 1996.

・Imura, A., Hori, T., Imada, K. et al.:The human OX 40/gp 34 system directly mediates adhesion of activated cells to vascular endothelial cells. J. Exp. Med. 183 (5) :2185-2195, 1996.

・Kawamata, S., Hori, T., Imura, A. et al.:Activation of OX 40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2-and TRAF 5-mediated NF-kappa B activation. J. Biol. Chem. 273 (10) :5808-5814, 1998.

・Latza, U., Durkop, H., Schnittger, S. et al.:The human OX 40 homolog:cDNA structure, expression and chromosomal assignment of the ACT 35 antigen. Eur. J. Immunol. 24 (3) :677-683, 1994.

・Mallett, S., Fossum, S. and Barclay, A. N.:Characterization of the MRC OX 40 antigen of activated CD 4 positive T lymphocytes-a molecule related to nerve growth factor receptor. EMBO J. 9 (4) :1063-1068, 1990.

・Miura, S., Ohtani, K., Numata, N. et al.:Molecular cloning and characterization of a novel glycoprotein, gp 34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40 tax. Mol. Cell. Biol. 11 (3) :1313-1325, 1991.

・Ohshima, Y., Tanaka, Y., Tozawa, H. et al.:Expression and function of OX 40 ligand on human dendritic cells. J. Immunol. 159 (8) :3838-3848, 1997.

・Stuber, E. and Strober, W.:The T cell-B cell interaction via OX 40-OX 40 L is necessary for the T cell-dependent humoral immune response. J. Exp. Med. 183 (3) :979-989, 1996.

・Tittle, T. V., Weinberg, A. D., Steinkeler, C. N. et al.:Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease. Blood 89 (12) :4652-4658, 1997.

・Weinberg, A. D., Bourdette, D. N., Sullivan, T. J. et al.:Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat. Med. 2 (2) :183-189, 1996.

PubMed

P.63 掲載の参考文献

◎Drexler, H. G.:Expression of FLT 3 receptor and response to FLT 3 ligand by leukemic cells. Leukemia 10 (4) :588-599, 1996.

◎Lyman, S. D. and Williams, D. E.:Biology and potential clinical applications of flt 3 ligand. Curr. Opin. Hematol. 2 (3) :177-181, 1995.

PubMed

◎Lyman, S. D. and Jacobsen, S. E.:c-kit ligand and Flt 3 ligand:stem/progenitor cell factors with overlapping yet distinct activities. Blood 91 (4) :1101-1134, 1998.

PubMed

◎Lynch, D. H.:Induction of dendritic cells (DC) by Flt 3 Ligand (FL) promotes the generation of tumor-specific immune responses in vivo. Crit. Rev. Immunol. 18 (1-2) :99-107, 1998.

・Gaffney, P. M., Lund, J. and Miller, J. S.:FLT-3 ligand and marrow stroma-derived factors promote CD 3 gamma, CD 3 delta, CD 3 zeta, and RAG-2 gene expression in primary human CD 34+LIN-DR-marrow progenitors. Blood 91 (5) :1662-1670, 1998.

・Gotze, K. S., Ramirez, M., Tabor, K. et al.:Flt 3 high and Flt 3 low CD 34+ progenitor cells isolated from human bone marrow are functionally distinct. Blood 91(6) :1947-1958, 1998.

・Hannum, C., Culpepper, J., Campbell, D. et al.:Ligand for FLT 3/FLK 2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368 (6472) :643-648, 1994.

・Juan, T. S., McNiece, I. K., Van, G. et al.:Chronic expression of murine flt 3 ligand in mice results in increased circulating white blood cell levels and abnormal cellular infiltrates associated with splenic fibrosis. Blood 90 (1) :76-84, 1997.

PubMed

・Lavagna, C., Marchetto, S., Birnbaum, D. et al.:Identification and characterization of a functional murine FLT 3 produced by exon skipping. J. Biol. Chem. 270 (7) :3165-3171, 1995.

・Lavagna-Sevenier, C., Marchetto, S., Birnbaum, D. et al.:The CBL-related protein CBLB participates in FLT 3 and interleukin-7 receptor signal transduction in pro-B cells. J. Biol. Chem. 273 (24) :14962-14967, 1998.

・Lyman, S. D., James, L., Johnson, L. et al.:Cloning of the human homologue of the murine flt 3 ligand:a growth factor for early hematopoietic progenitor cells. Blood 83 (10) :2795-2801, 1994.

・Mackarehtschian, K., Hardin, J. D., Moore, K. A. et al.:Targeted disruption of the flk 2/flt 3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3 (1) :147-161, 1995.

・Matthews, W., Jordan, C. T., Wiegand, G. W. et al.:A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65 (7) :1143-1152, 1991.

PubMed

・Rappold, I., Ziegler, B. L., Kohler, I. et al.:Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT 3 (CD 135) receptor tyrosine kinase. Blood 90 (1) :111-125, 1997.

・Rosnet, O., Schiff, C., Pebusque, M. J. et al.:Human FLT 3/FLK 2 gene:cDNA cloning and expression in hematopoietic cells. Blood 82 (4) :1110 1119, 1993.

・Rusten, L. S., Lyman, S. D., Veiby, O. P. et al.:The FLT 3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD 34+bone marrow progenitor cells in vitro. Blood 87 (4) :1317-1325, 1996.

・Small, D., Levenstein, M., Kim, E. et al.:STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD 34+human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc. Natl. Acad. Sci. USA 91 (2) :459-463, 1994.

・Zeigler, F. C., Bennett, B. D., Jordan, C. T. et al.:Cellular and molecular characterization of the role of the flk-. 2/flt-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 84 (8) :2422-2430, 1994.

PubMed

P.66 掲載の参考文献

・Collesi, C., Santoro, M. M., Gaudino, G. et al.:A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol. Cell. Biol. 16 (10) :5518-5526, 1996.

・Gaudino, G., Follenzi, A., Naldini, L. et al.:RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 13 (15) :3524-3532, 1994.

PubMed

・Gaudino, G., Avantaggiato, V., Follenzi, A. et al.:The proto oncogene RON is involved in development of epithelial, bone and neuro endocrine tissues. Oncogene 11 (12) :2627 2637, 1995.

・Han, S., Stuart, L. A. and Degen, S. J.:Characterization of the DNF 15 S 2 locus on human chromosome 3:identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 30 (40) :9768-9780, 1991.

・Iwama, A., Okano, K., Sudo, T. et al.:Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 83 (11) :3160-3169, 1994.

PubMed

・Iwama, A., Yamaguchi, N. and Suda, T.:STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J. 15 (21) :5866-5875, 1996.

PubMed

・Li, B. Q., Wang, M. H., Kung, H. F. et al.:Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor. Biochem. Biophys. Res. Commun. 216 (1) :110-118, 1995.

PubMed

・Medico, E., Mongiovi, A. M., Huff, J. et al:The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro. Mol. Biol. Cell 7 (4) :495-504, 1996.

PubMed

・Ronsin, C., Muscatelli, F., Mattei, M. G. et al.:A novel putative receptor protein tyrosine kinase of the met family. Oncogene 8 (5) :1195-1202, 1993.

PubMed

・Skeel, A., Yoshimura, T., Showalter, S. D. et al.:Macrophage stimulating protein:purification, partial amino acid sequence, and cellular activity. J. Exp. Med. 173 (5) :1227-1234, 1991.

PubMed

・Wang, M. H., Cox, G. W., Yoshimura, T. et al:Macrophage-stimulating protein inhibits induction of nitric oxide production by endotoxin-or cytokine-stimulated mouse macrophages. J. Biol. Chem. 269 (19) :14027-14031, 1994.

PubMed

・Wang, M. H., Gonias, S. L., Skeel, A. et al.:Proteolytic activation of single-chain precursor macrophage-stimulating protein by nerve growth factor-gamma and epidermal growth factorbinding protein, members of the kallikrein family. J. Biol. Chem. 269 (19) :13806-13810, 1994.

・Wang, M. H., Ronsin, C., Gesnel, M. C. et al.:Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science 266 (5182) :117-119, 1994.

PubMed

・Wang, M. H., Yoshimura, T., Skeel, A. et al.:Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade. J. Biol. Chem 7. 269 (5) :3436-3440, 1994.

・Wang, M. H., Skeel, A. and Leonard, E. J.:Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J. Clin. Invest 97 (3) :720-727, 1996.

PubMed

・Wang, M. H., Julian, F. M., Breathnach, R. et al.:Macrophage stimulating protein (MSP) binds to its receptor via the MSP beta chain. J. Biol. Chem. 272 (27) :16999-17004, 1997.

・Yoshimura, T., Yuhki, N., Wang, M. H. et al.:Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST 1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J. Biol. Chem. 268 (21) :15461-15468, 1993.

P.68 掲載の参考文献

◎Armitage, R. J.:Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6 (3) :407-413, 1994.

PubMed

◎Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

・Alderson, M. R., Smith, C. A., Tough, T. W. el al.:Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24 (9) :2219-2227, 1994.

・DeBenedette, M. A., Chu, N. R., Pollok, K. E. et al.:Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M 12 B lymphomas by cAMP. J. Exp. Med. 181 (3) :985-992, 1995.

・Garni-Wagner, B. A., Lee, Z. H., Kim, Y. J. et al.:4-1BB is expressed on CD45RAhiROhi transitional T cell in humans. Cell Immunol. 169 (1) :91-98, 1996.

PubMed

・Hurtado, J. C., Kim, S. H., Pollok, K. E. et al.:Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD 28. J. Immunol. 155 (7) :3360-3367, 1995.

・Jang, I. K., Lee, Z. H., Kim, Y. J. et al.:Human 4-1BB (CD 137) signals are mediated by TRAF 2 and activate nuclear factor-kappa B. Biochem. Biophys. Res. Commun. 242 (3) :613-620, 1998.

・Kim, Y. J., Pollok, K. E., Zhou, Z. et al.:Novel T cell antigen 4-1BB associates with the protein tyrosine kinase p56 lck 1. J. Immunol. 151 (3) :1255-1262, 1993.

・Kwon, B. S. and Weissman, S. M.:cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. USA 86 (6) :1963-1967, 1989.

PubMed

・Loo, D. T., Chalupny, N. J., Bajorath, J. et al.:Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB. J. Biol. Chem. 272 (10) :6448-6456, 1997.

PubMed

・Melero, I., Shuford, W. W., Newby, S. A. et al.:Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3 (6) :682-685, 1997.

PubMed

・Melero, I., Bach, N., Hellstrom, K. E. et al.:Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand:synergy with the CD 28 co-stimulatory pathway. Eur. J. Immunol. 28 (3) :1116-1121, 1998.

PubMed

・Michel, J., Fritsche, J., Kreutz, M. et al.:CD 137 (ILA/4-1BB) , a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol. 160 (5) :2488-2494, 1998.

・Pollok, K. E., Kim, Y. J., Zhou, Z. et al.:Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol. 150 (3) :771-781, 1993.

PubMed

・Saoulli, K., Lee, S. Y., Cannons, J. L. et al.:CD 28-independent, TRAF 2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187 (11) :1849-1862, 1998.

・Schwarz, H., Valbracht, J., Tuckwell, J. et al.:ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood 85 (4) :1043-1052, 1995.

PubMed

・Schwarz, H., Blanco, F. J., von Kempis, J. et al.:ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood 87 (7) :2839-2845, 1996.

・Zhou, Z., Kim, S., Hurtado, J. et al.:Characterization of human homologue of 4-1BB and its ligand. Immunol. Lett. 45 (1-2) :67-73, 1995.

PubMed

P.71 掲載の参考文献

◎Bernfield, M., Kokenyesi, R., Kato, M. et al.:Biology of the syndecans:a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8:365-393, 1992.

PubMed

◎Couchman, J. R. and Woods, A.:Syndecans, signaling, and cell adhesion. J. Cell. Biochem. 61 (4) :578-584, 1996.

PubMed

◎Elenius, K. and Jalkanen, M.:Function of the syndecans-a family of cell surface proteoglycans. J. Cell Sci. 107 (Pt 11) :2975-2982, 1994.

◎Inki, P. and Jalkanen, M.:The role of syndecan-1 in malignancies. Ann. Med. 28 (1) :63-67, 1996.

PubMed

・Asundi, V. K. and Carey, D. J.:Self-association of N-syndecan (syndecan-3) core protein is mediated a novel structural motif in the transmembrane domain and ectodomain flanking region. J. Biol. Chem. 270 (44) :26404-26410, 1995.

・Aviezer, D., Hecht, D., Safran, M. et al.:Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79 (6) :1005-1013, 1994.

PubMed

・Carbone, A., Gaidano, G., Gloghini, A. et al.:Differential expression of BCL-6, CD 138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related Hodgkin's lymphomas. Blood 91 (3) :747-755, 1998.

・Carey, D. J., Bendt, K. M. and Stahl, RC.:The cytoplasmic domain of syndecan-1 is required for cytoskeleton association but not detergent insolubility. Identification of essential cytoplasmic domain residues. J. Biol. Chem. 271 (25) :15253-15260, 1996.

・Cook, D. M., Hinkes, M. T., Bernfield, M. et al.:Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT 1. Oncogene 13 (8) :1789-1799, 1996.

・Dhodapkar, M. V., Abe, E., Theus, A. et al.:Syndecan-1 is a multifunctional regulator of myeloma pathobiology:control of tumor cell survival, growth, and bone cell differentiation. Blood 91 (8) :2679-2688, 1998.

PubMed

・Kato, M., Wang, H., Bernfield, M. et al.:Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. J. Biol. Chem. 269 (29) :18881-18890, 1994.

PubMed

・Kato, M., Wang, H., Kainulainen, V. et al.:Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat. Med. 4 (6) :691-697, 1998.

PubMed

・Kokenyesi, R. and Bernfield, M.:Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1. J. Biol. Chem. 269 (16) :12304-12309, 1994.

PubMed

・Larrain, J., Cizmeci Smith, G. Troncoso V. et al.:Syndecall 1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid. J. Biol. Chem. 272 (29) :18418-18424, 1997.

PubMed

・Lories, V., Cassiman, J. J., Van den Berghe, H. et al.:Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. J. Biol. Chem. 267 (2) :1116-1122, 1992.

PubMed

・Mali, M., Jaakkola, P., Arvilommi, A. M. et al.:Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. J. Biol. Chem. 265 (12) :6884-6889, 1990.

PubMed

・Saunders, S., Jalkanen, M., O'Farrell, S. et al.:Molecular cloning of syndecan, an integral membrane proteoglycan. J. Cell. Biol. 108 (4) :1547-1556, 1989.

PubMed

・Subramanian, S. V., Fitzgerald, M. L. and Bernfield, M.:Regulated shedding of syndecan-1 and-4 ectodomains by thrombin and growth factor receptor activation. J. Biol. Chem. 272 (23) :14713-14720, 1997.

PubMed

・Vihinen, T., Maatta, A., Jaakkola, P. et al.:Functional characterization of mouse syndecan-1 promoter. J. Biol. Chem. 271 (21) :12532-12541, 1996.

PubMed

・Yayon, A., Klagsbrun, M., Esko, J. D. et al.:Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64 (4) :841-848, 1991

PubMed

P.74 掲載の参考文献

◎Hadam, M. R.:Leukocyte Typing VI, B 35.

・Grotjahn, C., Heuring, A., Lohmeyer, J. et al.:Leukocyte Typing VI section B 28. 4/642.

・Hardie, D. L., Hill, D. S., Casamayor, M. et al.:Leukocyte Typing VI section B 28. 6/644.

P.77 掲載の参考文献

◎Ataliotis, P. and Mercola, M.:Distribution and functions of platelet-derived growth factors and their receptors during embryogenesis. Int. Rev. Cytol. 172:95-127, 1997.

PubMed

◎Claesson-Welsh, L.:Platelet-derived growth factor receptor signals. J. Biol. Chem. 269 (51) :32023-32026, 1994.

PubMed

◎Claesson-Welsh, L.:Mechanism of action of platelet-derived growth factor. Int. J. Biochem. Cell Biol. 28 (4) :373-385, 1996.

PubMed

◎Lindahl, P. and Betsholtz, C.:Not all myofibroblasts are alike:revisiting the role of PDGF-A and PDGF-B using PDGF-targeted mice. Curr. Opin. Nephrol. Hypertens. 7 (1) :21-26, 1998.

PubMed

◎Showalter, H. D. and Kraker, A. J.:Small molecule inhibitors of the platelet-derived growth factor receptor, the fibroblast growth factor receptor, and Src family tyrosine kinases. Pharmacol. Ther. 76 (1-3) :55-71, 1997.

・Claesson-Welsh, L., Eriksson, A., Westermark, B. et al.:cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc. Natl. Acad. Sci. USA 86 (13) :4917-4921, 1989.

・Crosby, J. R., Seifert, R. A., Soriano, P. et al.:Chimaeric analysis reveals role of Pdgf receptors in all muscle lineages. Nat. Genet. 18 (4) :385-388, 1998.

PubMed

・Gelderloos, J. A., Rosenkranz, S., Bazenet, C. et al.:A role for Src in signal relay by the platelet-derived growth factor alpha receptor. J. Biol. Chem. 273 (10) :5908-5915, 1998.

PubMed

・Gronwald, R. G., Grant, F. J., Haldeman, B. A. et al.:Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor:evidence for more than one receptor class. Proc. Natl. Acad. Sci. USA 85 (10) :3435-3439, 1988.

PubMed

・Habib, A. A., Hognason, T., Ren, J. et al.:The epidermal growth factor receptor associates with and recruits phosphatidylinositol 3-kinase to the platelet-derived growth factor beta receptor. J. Biol. Chem. 273 (12) :6885-6891, 1998.

・Hart, C. E., Seifert, R. A., Ross, R. et al.:Synthesis, phosphorylation, and degradation of multiple forms of the platelet-derived growth factor receptor studied using a monoclonal antibody. J. Biol. Chem. 262 (22) :10780-10785, 1987.

PubMed

・Joly, M., Kazlauskas, A., Fay, F. S. et al.:Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science 263 (5147) :684-687, 1994.

PubMed

・Jousset, C., Carron, C., Boureux, A. et al.:Adomain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J. 16 (1) :69-82, 1997.

・Kelly, J. D., Haldeman, B. A., Grant, FJ. et al.:Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit. J. Biol. Chem. 266:8987-8992, 1991.

PubMed

・Kitami, Y., Inui, H., Uno, S. et. al.:Molecular structure and transcriptional regulation of, the gene for the platelet-derived growth factor alpha receptor in cultured vascular smooth muscle cells. J. Clin. Invest. 96 (1) :558-567, 1995.

・Kundra, V., Escobedo, J. A., Kazlauskas, A. et al.:Regulation of chemotaxis by the plateletderived growth factor receptor-beta. Nature 367 (6462) :474-476, 1994.

PubMed

・Lokker, N. A., O'Hare, J. P., Barsoumian, A. et al.:Functional importance of plateles derived growth factor (PDGF) receptor extracellular immunoglobulin-like domains. Identification of PDGF binding site and neutralizing monoclonal antibodies. J. Biol. Chem. 272 (52) :33037-33044, 1997.

・Mosselman, S., Claesson-Welsh, L., Kamphuis, J. S. et al.:Developmentally regulated expression of two novel platelet-derived growth factor alpha-receptor transcripts in human teratocarcinoma cells. Cancer 54 (1) :220 225, 1994.

・Schatteman, G. C., Morrison. . Graham, K., van Koppen, A. et al.:Regulation and role of PDGF receptor alpha subunit expression during embryogerlesis. Development 115 (1) :123, 131, 1992.

・Schneller, M., Vuori, K. and Ruoslahti, E.:Alphavbeta 3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J. 16 (18) :5600 5607, 1997.

・Seifert, R. A., Hart, C. E., Phillips, P. E. et al.:Two different subunits as sociate to create isoform specific platelet derived growth factor receptors. J. Biol. Chem. 264 (15) :87718778, 1989.

・Soriano, P.:Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 8 (16) :1888-1896, 1994.

PubMed

・Tiesman, J. and Hart, C. E.:Identification of a soluble receptor for platelet-derived growth factor in cell-conditioned medium and human plasma. J. Biol. Chem. 268 (13) :9621-9628, 1993.

PubMed

・Yang, Z., Oemar, B. S., Carrel, T. et al.:Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels:role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors. Circulation 97 (2) :181-187, 1998.

PubMed

・Yu, Z., Su, L., Hoglinger, O. et al.:SHP 1 associates with both platelet-derived growth factor receptor and the p 85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 273 (6) :3687-3694, 1998.

P.80 掲載の参考文献

◎Esmon, C. T.:Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J. 9 (10) :946-955, 1995.

◎Nesheim, M., Wang, W., Boffa, M. et al.:Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost. 78 (1) :386-391, 1997.

PubMed

◎Ohlin, A. K., Norlund, L. and Marlar, R. A.:Thrombomodulin gene variations and thromboembolic disease. Thromb. Haemost. 78 (1) :396 400, 1997.

◎Sadler, J. E.:Thrombomodulin Structure and function. Thromb. Haemost. 78 (1) :392-395, 1997.

PubMed

・Bajzar, L., Morser, J. and Nesheim, M.:TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin thrombomodulin complex. J. Biol. Chem. 271 (28) :16603 16608, 1996.

・Bajzar, L., Nesheim, M., Morser, J. et al.:Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 273 (5) :2792-2798, 1998.

PubMed

・Conway, E. M., Pollefeyt, S., Collen, D. et al.:The amino terminal lectin-like domain of thrombomodulin is required constitutive endocytosis. Blood 89 (2) :652-661, 1997.

PubMed

・Healy, A. M., Rayburn, H. B., Rosenberg, RD. et al.:Absence of the blood-clotting regulator thrombomodulin causes lethality in mice before development of a functional cardiovascular system. Proc. Natl. Acad. Sci. USA 92 (3) :850-854, 1995.

PubMed

・Ireland, H., Kunz, G., Kyriakoulis, K. et al.:Thrombomodulin gene mutations associated with myocardial infarction. Circulation 96 (1) :15-18, 1997.

PubMed

・Jansson, J. H., Boman, K., Brannstrom, M. et al.:High concentration of thrombomodulin in plasma is associated with hemorrhage:a prospective study in patients receiving long-term anticoagulant treatment. Circulation 96 (9) :2938-2943, 1997.

PubMed

・Norlund, L., Zoller, B. and Ohlin, A. K.:A novel thrombomodulin gene mutation in a patient suffering from sagittal sinus thrombosis. Thromb. Haemost. 78 (4) :1164-1166, 1997.

・Ohlin, A. K. and Marlar, R. E.:The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease. Blood 85 (2) :330-336, 1995.

・Sampoli, Benitez, B. A., Hunter, M. J., Meininger, D. P. et al.:Structure of the fifth EGF-like domain of thrombomodulin:An EGF-like domain with a novel disulfide-bonding pattern. J. Mol. Biol. 273 (4) :913-926, 1997.

PubMed

・Teasdale, MS., Bird, C. H. and Bird, P.:Internalization of the anticoagulant thrombomodulin is constitutive does not require a signal in the cytoplasmic domain. Immunol. Cell Biol. 72 (6) :480-488, 1994.

・Tomura, S., Deguchi, F., Marumo, F. et al.:Enhanced presence of thrombomodulin in the glomeruli of lupus glomerulonephritis. Clin. Nephrol. 41 (4) :205-210, 1994.

PubMed

・Weiler-Guettler, H., Christie, P. D., Beeler, D. L. et al.:Atargeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J. Clin. Invest. 101 (9) :1983-1991, 1998.

・White, C. E., Hunter, M. J., Meininger, D. P. et al.:The fifth epidermal growth factor-like domain of thrombomodulin does not have an epidermal growth factor-like disulfide bonding pattern. Proc. Natl. Acad. Sci. USA 93 (19) :10177-10182, 1996.

・Zhang, Y., Weiler-Guettler, H., Chen, J. et al:Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J. Clin. Invest. 101 (7) :1301-1309, 1998.

PubMed

P.83 掲載の参考文献

◎Mackman, N.:Regulation of the tissue factor gene. Thromb. Haemost. 78 (1) :747-754, 1997.

PubMed

◎Osterud, B.:Tissue factor:a complex biological role. Thromb. Haemost. 78 (1) :755-758, 1997.

PubMed

◎Ruf, W. and Mueller, B. M.:Tissue factor in cancer angiogenesis and metastasis. Curr. Opin. Hematol. 3 (5) :379-384, 1996.

PubMed

◎Semeraro, N. and Colucci, M.:Tissue factor in health and disease. Thromb. Haemost. 78 (1) :759-764, 1997.

PubMed

◎Taubman, M. B., Fallon, J. T., Schecter, A. D. et al.:Tissue factor in the pathogenesis of atherosclerosis. Thromb. Haemost. 78 (1) :200-204, 1997.

PubMed

・Albrecht, S., Luther, T., Grossmann, H. et al.:An ELISA for tissue factor using monoclonal antibodies. Blood Coagul. Fibrinolysis 3 (3) :263-270, 1992.

PubMed

・Cadroy, Y., Dupouy, D. and Boneu, B.:Arachidonic acid enhances the tissue factor expression of mononuclear cells by the cyclo-oxygenase-1 pathway:beneficial effect of n-3 fatty acids. J. Immunol. 160 (12) :6145-6150, 1998.

・Fan, Z., Larson, P. J., Bognacki, J. et al.:Tissue factor regulates plasminogen binding and activation. Blood 91 (6) :1987-1998, 1998.

PubMed

・Holschermann, H., Kohl, O., Maus, U. et al.:Cyclosporin A inhibits monocyte tissue factor activation in cardiac transplant recipients. Circulation 96 (12) :4232-4238, 1997.

PubMed

・Huang, Z. F., Higuchi, D., Lasky, N. et al.:Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 90 (3) :944-951, 1997.

PubMed

・Huang, M., Syed, R., Stura, E. A. et al.:The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF. G9 complex. J. Mol. Biol. 275 (5) :873-894, 1998.

PubMed

・Kemball-Cook, G., Johnson, D. J., Takamiya, O. et al.:Coagulation factor VII GIn 100-->Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function. J. Biol. Chem. 273 (14) :8516-8521, 1998.

・Lee, G. F and Kelley, R. F.:A novel soluble tissue factor variant with an altered factor VIIa binding interface. J. Biol. Chem. 273 (7) :4149-4154, 1998.

PubMed

・Morrissey, J. H., Fair, D. S. and Edgington, T. S.:Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb. Res. 52 (3) :247-261, 1988.

PubMed

・Mueller, B. M. and Ruf, W.:Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J. Clin. Invest. 101 (7) :1372-1378, 1998.

PubMed

・Oltrona, L., Speidel, C. M., Recchia, D. et al.:Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation 96 (2) :646-652, 1997.

PubMed

・Ott, I., Fischer, E. G., Miyagi, Y. et. al.:A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J. Cell Biol. 140 (5) :1241-1253, 1998.

・Parry, G. C., Erlich, J. H., Carmeliet, P. et al.:Low levels of tissue factor are compatible with development and hemostasis in mice. J. Clin. Invest. 101 (3) :560-569, 1998.

PubMed

・Pendurthi, U. R., Alok, D. and Rao, L. V.:Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells:up-regulation of poly (A) polymerase. Proc. Natl. Acad. Sci. USA 94 (23) :12598-12603, 1997.

PubMed

・Poulsen, L. K., Jacobsen, N., Sorensen, B. B. et al.:Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J. Biol. Chem. 273 (11) :6228-6232, 1998.

PubMed

・Samad, F., Pandey, M. and Loskutoff, D. J.:Tissue factor gene expression in the adipose tissues of obese mice. Proc. Natl. Acad. Sci. USA 95 (13) :7591-7596, 1998.

PubMed

・Schecter, A. D., Giesen, P. L., Taby, O. et al.:Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J. Clin. Invest. 100 (9) :2276-2785, 1997.

PubMed

・Solovey, A., Gui, L., Key, N. S. et al:Tissue factor expression by endothelial cells in sickle cell anemia. J. Clin. Invest. 101 (9) :1899-1904, 1998.

PubMed

・Toomey, J. R., Kratzer, K. E., Lasky, N. M. et al.:Effect of tissue factor deficiency on mouse and tumor development. Proc. Natl. Acad. Sci. USA 94 (13) :6922-6926, 1997.

PubMed

P.86 掲載の参考文献

◎Berglund, L.:A recurrent theme with a new spin:ACE polymorphism and cardiovascular disease. J. Lab. Clin. Med. 131 (6) :485-486, 1998.

◎Corvol, P., Michaud, A., Soubrier, F. et al.:Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. J. Hypertens. Suppl. 13 (Suppl. 3) :S 3-10, 1995.

◎Singer, D. R., Missouris, C. G. and Jeffery, S.:Angiotensin converting enzyme gene polymorphism. What to do about all the confusion. Circulation 94 (3) :236 239, 1996.

・Agerholm Larsen, B., Nordestgaard, B. G., Steffensen, Real.:ACE gene polymorphism:ischemic heart disease and longevity in 10, 150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 95 (10) :2358 2367, 1997.

・Cambien, F., Poirier, O., Lecerf, L. et al.:Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359 (6396) :641-644, 1992.

PubMed

・Cambien, F., Costerousse, O., Tiret, L. et al.:Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90 (2) :669-676, 1994.

PubMed

・Chuang, L. M., Chiu, K. C., Chiang, FT. et al.:Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolism 46 (10) :1211-1214, 1997.

PubMed

・Hubert, C., Houot, A. M., Corvol, P. et al.:Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J. Biol. Chem. 266 (23) :15377-15383, 1991.

・Isaac, R. E., Williams, T. A., Sajid, M. et al.:Cleavage of arginyl-arginine and lysyl-arginine from the C-terminus of pro-hormone peptides by human germinal angiotensin I-converting enzyme (ACE) and the C-domain of human somatic ACE. Biochem. J. 328 (Pt 2) :587-591, 1997.

・Jaspard, E., Wei, L. and Alhenc-Gelas, F.:Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II) . Studies with bradykinin and other natural peptides. J. Biol. Chem. 268 (13) :9496-9503, 1993.

PubMed

・Kario, K., Kanai, N., Saito, K. et al.:Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 93 (9) :1630-1633, 1996.

PubMed

・Katsuya, T., Koike, G., Yee, T. W. et al.:Association of angiotensinogen gene T 235 variant with increased risk of coronary heart disease. Lancet 345 (8965) :1600-1603, 1995.

・Krege, J. H., John, S. W., Langenbach, LL. et al.:Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375 (6527) :146-148, 1995.

PubMed

・Lindpaintner, K., Pfeffer, M. A., Kreutz, R. et al.:A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 332 (11) :706-711, 1995.

PubMed

・Ludwig, E., Corneli, P. S., Anderson, J. L. et al.:Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 91 (8) :2120-2124, 1995.

・Muzykantov, VR., Atochina, E. N., Ischiropoulos, H. et al.:Immunotargeting of antioxidant enzyme to the pulmonary endothelium. Proc. Natl. Acad. Sci. USA 93 (11) :5213-5218, 1996.

・Nagi, D. K., Foy, C. A., Mohamed-Ali, V. et al.:Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians metabolism 47 (5) :622-626, 1998.

PubMed

・O'Donnell, C. J., Lindpaintner, K., Larson, M. G. et al.:Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97 (18) :1766-1772, 1998.

・Ribichini, F., Steffenino, G., Dellavalle, A. et al.:Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme:a major risk factor and a marker of risk for coronary stent restenosis. Circulation 97 (2) :147-154, 1998.

・Ruiz, J., Blanche, H., Cohen, N. et al.:Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 91 (9) :3662-3665, 1994.

PubMed

・Sharma, P., Smith, I., Maguire, G. et al.:Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet 349 (9065) :1602-1603, 1997.

PubMed

・Soubrier, F., Alhenc-Gelas, F., Hubert, C. et al.:Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. USA 85 (24) :9386-9390, 1988.

PubMed

・Tiret, L., Bonnardeaux, A., Poirier, O. et al.:Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344 (8927) :910-913, 1994.

PubMed

P.89 掲載の参考文献

・Ali, J., Liao, F., Martens, E. et al.:Vascular endothelial cadherin (VE-cadherin) :cloning and role in endothelial cell-cell adhesion. Microcirculation 4 (2) :267-277, 1997.

PubMed

・Bach, T. L., Barsigian, C., Chalupowicz, D. G. et al.:VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp. Cell. Res. 238 (2) :324-334, 1998.

PubMed

・Breier, G., Breviario, F., Caveda, L. et al.:Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood 87 (2) :630-641, 1996.

PubMed

・Caveda, L., Martin-Padura, I., Navarro, P. et al.:Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin) . J. Clin. Invest. 98 (4) :886-893, 1996.

PubMed

・Dejana, E., Corada, M. and Lampugnani, MG.:Endothelial cell-to-cell junctions. FASEB J. 9 (10) :910-918, 1995.

PubMed

・Gotsch, U., Borges, E., Bosse, R. et al.:VE-cadherin antibody accelerates neutrophil recruitment in vivo. J. Cell Sci. 110 (Pt 5) :583-588, 1997.

・Herren, B., Levkau, B., Raines, E. W. et al:Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis:evidence for a role for caspases and metalloproteinases. Mol. Biol. Cell 9 (6) :1589-1601, 1998.

PubMed

・Huber, P., Dalmon, J., Engiles, J. et al.:Genomic structure and chromosomal mapping of the mouse VE-cadherin (Cdh 5) . Genomics 32 (1) :21-28, 1996.

・Lampugnani, MG., Resnati, M., Raiteri, M. et al.:A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J. Cell Biol. 118 (6) :1511-1522, 1992.

PubMed

・Lampugnani, M. G., Corada, M., Caveda, L. et al.:The molecular organization of endothelial cell to cell junctions:differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin) . J. Cell Biol. 129 (1) :203-217, 1995.

PubMed

・Matsuyoshi, N., Toda, K., Horiguchi, Y. et al.:In vivo evidence of the critical role of cadherin-5 in murine vascular integrity. Proc. Assoc. Am. Physicians 109 (4) :362-371, 1997.

PubMed

・Navarro, P., Caveda, L., Breviario, F. et al.:Catenin-dependent and-independent functions of vascular endothelial cadherin. J. Biol. Chem. 270 (52) :30965-30972, 1995.

PubMed

・Navarro, P., Ruco, L. and Dejana, E.:Differential localization of VE-and N-cadherins in human endothelial cells:VE-cadherin competes with N-cadherin for junctional localization. J. Cell Biol. 140 (6) :1475-1484, 1998.

・Tanihara, H., Kido, M., Obata, S. et al.:Characterization of cadherin-4 and cadherin-5 reveals new aspects of cadherins. J. Cell Sci. 107 (Pt 6) :1697-1704, 1994.

P.90 掲載の参考文献

・Ben-Aissa, H., Paulie, S., Koho, H. et al.:Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder. Br. J. Cancer 52 (1) :65-72, 1985.

PubMed

・Ben-Aissa, H., Paulie, S., Koho, H. et al.:Monoclonal antibodies against carcinoma cells of the human urinary bladder:immunohistochemical staining of tissues. Anticancer Res. 6 (2) :165-170, 1986.

PubMed

・Koho, H., Paulie, S., Ben-Aissa, H. et al.:Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence. Cancer Immunol. Immunother. 17 (3) :165-172, 1984.

PubMed

・Paulie, S., Koho, H., Ben-Aissa, H. et al.:Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. II. Identification of the cellular target structures by immunoprecipitation and SDS-PAGE. Cancer Immunol. Immunother. 17 (3) :173-179, 1984.

PubMed

P.92 掲載の参考文献

◎Bardin, N., George, F., Mutin, M. et al:S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 48 (5) :531-539, 1996.

PubMed

◎Johnson, J. P., Rummel, M. M., Rothbacher, U. et al.:MUC18:A cell adhesion molecule with a potential role in tumor growth and tumor cell dissemination. Curr. Top. Microbiol. Immunol. 213 (Pt 1) :95 105, 1996.

・Bardin, N., Frances, V., Combes, V. et al.:CD 146:biosynthesis and production of a soluble form in human cultured endothelial cells. FEBS Lett. 421 (1) :12-14, 1998.

・George, F., Brouqui, P., Boffa, M. C. et al.:Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 82 (7) :2109-2116, 1993.

PubMed

・Hsu, M. Y., Palazzo, J. P. and Herlyn, M.:The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. Am. J. Pathol. 151 (3) :745-751, 1997.

PubMed

・Lehmann, J. M., Riethmuller, G. and Johnson, J. P.:MUC 18, a marker of tumor progression in human melanoma, shows similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc. Natl. Acad. Sci. USA 86 (24) :9891-9895, 1989.

・Majdic, O., Fischer, G. F., Petzelbauer, P. et al.:MUC 18/MCAM (CD 146) , an activation antigen of human T lymphocytes. J. Immunol 158 (5) :2107-2115, 1997.

・Rummel, M. M., Sers, C. and Johnson, J. P.:Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC 18/MCAM. Cancer Res. 56 (9) :2218-2223, 1996.

・Sers, C., Kirsch, K., Rothbacher, U. et al.:Genomic organization of the melanoma-associated glycoprotein MUC 18:implications for the evolution of the immunoglobulin domains. Proc. Natl. Acad. Sci. USA 90 (18) :8514-8518, 1993.

・Shih, I. M., Elder, D. E., Hsu, M. Y. et al.:Regulation of Mel-CAM/MUC 18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am. J. Pathol. 145 (4) :837-845, 1994.

・Shih, I. M. and Kurman, R. J.:Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab. Invest. 75 (3) :377-388, 1996.

PubMed

・Shih, I. M., Speicher, D., Hsu, M. Y. et al.:Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM. Cancer Res. 57 (17) :3835-3840, 1997.

PubMed

P.95 掲載の参考文献

・Altruda, F., Cervella, P., Gaeta, M. L. et al.:Cloning of cDNA for a novel mouse membrane glycoprotein (gp 42) :shared identity to histocompatibility antigens, immunoglobulins and neural-cell adhesion molecules. Gene 85 (2) :445-451, 1989.

・Berditchevski, F., Chang, S., Bodorova, J. et al.:Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha 3 beta 1 complexes with EMMPRIN/basigin/OX 47/M 6. J. Biol. Chem. 272 (46) :29174-29180, 1997.

・Biswas, C.:Tumor cell stimulation of collagenase production by fibroblasts. Biochem. Biophys. Res. Commun. 109 (3) :1026-1034, 1982.

PubMed

・Biswas, C., Zhang, Y., DeCastro, R. et al.:The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 55 (2) :434-439, 1995.

PubMed

・Fadool, J. M. and Linser, P. J.:5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina. Dev. Dyn. 196 (4) :252-262, 1993.

PubMed

・Fadool, J. M. and Linser, P. J.:Evidence for the formation of multimeric forms of the 5A11/HT7 antigen. Biochem. Biophys. Res. Commun. 229 (1) :280-286, 1996.

PubMed

・Felzmann, T., Gadd, S., Majdic, O. et al.:Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis. J. Clin. Immunol. 11 (4) :205-212, 1991.

PubMed

・Fossum, S., Mallett, S. and Barclay, A. N.:The MRC OX-47 antigen is a member of the immunoglobulin superfamily with an unusual transmembrane sequence. Eur. J. Immunol. 21 (3) :671-679, 1991.

PubMed

・Igakura, T., Kadomatsu, K., Taguchi, O. et al.:Roles of basigin, a member of the immunoglobulin superfamily, in behavior as to an irritating odor, lymphocyte response, and blood-brain barrier. Biochem. Biophys. Res. Commun. 224 (1) :33-36, 1996.

・Igakura, T., Kadomatsu, K., Kaname, T. et al.:A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev. Biol. 194 (2) :152-165, 1998.

・Kanekura, T., Miyauchi, T., Tashiro, M. et al.:Basigin, a new member of the immunoglobulin superfamily:genes in different mammalian species, glycosylation changes in the molecule from adult organs and possible variation in the N-terminal sequences. Cell Struct. Funct. 16 (1) :23-30, 1991.

・Kasinrerk, W., Fiebiger, E., Stefanova, I. et al.:Human leukocyte activation antigen M 6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT 7 molecule. J. Immunol. 149 (3) :847-854, 1992.

・Kirsch, A. H., Diaz, L. A. Jr., Bonish, B. et al.:The pattern of expression of CD 147/neurothelin during human T-cell ontogeny as defined by the monoclonal antibody 8D6. Tissue Antigens 50 (2) :147-152, 1997.

・Kuno, N., Kadomatsu, K., Fan, Q. W. et al.:Female sterility in mice lacking the basigin gene, which encodes a transmembrane glycoprotein belonging to the immunoglobulin superfamily. FEBS Lett. 425 (2) :191-194, 1998.

・Miyauchi, T., Masuzawa, Y. and Muramatsu, T.:The basigin group of the immunoglobulin superfamily:complete conservation of a segment in and around transmembrane domains of human and mouse basigin and chicken HT7 antigen. J. Biochem. (Tokyo) 110 (5) :770-774, 1991.

PubMed

・Nehme, C. L., Cesario, M. M., Myles, D. G. et al.:Breaching the diffusion barrier that compartmentalizes the transmembrane glycoprotein CE 9 to the posterior-tail plasma membrane domain of the rat spermatozoon. J. Cell Biol. 120 (3) :687-694, 1993.

・Nehme, C. L., Fayos, BE. and Bartles, J. R.:Distribution of the integral plasma membrane glycoprotein CE 9 (MRC OX-47) among rat tissues and its induction by diverse stimuli of metabolic activation. Biochem. J. 310 (Pt 2) :693-698, 1995.

・Schlosshauer, B. and Herzog, K. H.:Neurothelin:an inducible cell surface glycoprotein of blood-brain barrier-specific endothelial cells and distinct neurons. J. Cell Biol. 110 (4) :1261-1274, 1990.

PubMed

・Spring, F. A., Holmes, C. H., Simpson, K. L. et al:The Oka blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues. Eur. J. Immunol. 27 (4) :891-897, 1997.

PubMed

・Seulberger, H., Lottspeich, F. and Risau, W.:The inducible blood-brain barrier specific molecule HT 7 is a novel immunoglobulin-like cell surface glycoprotein. EMBO J. 9 (7) :2151-2158, 1990.

P.97 掲載の参考文献

◎Fauman, E. B. and Saper, M. A.:Structure and function of the protein tyrosine phosphatases. Trends Biochem. Sci. 21 (11) :413-417, 1996.

PubMed

◎Fischer, E. H., Charbonneau, H. and Tonks, N. K.:Protein tyrosine phosphatases:a diverse family of intracellular and transmembrane enzymes. Science 253 (5018) :401-406, 1991.

PubMed

・de la Fuente-Garcia, M. A., Nicolas, J. M., Freed, J. P. E. et al.:CD 148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 91 (8) :2800-2809, 1998.

・Honda, H., Inazawa, J., Nishida, J. et al.:Molecular cloning, characterization, and chromosomal localization of a novel protein-tyrosine phosphatase, HPTP eta. Blood 84 (12) :4186-4194, 1994.

PubMed

・Hundt, M. and Schmidt, R. E.:Functional characterization of receptor-type protein tyrosine transduction of human neutrophils. Eur. J. Immunol. 27 (12) :3532-3535, 1997.

・Jallal, B., Mossie, K., Vasiloudis, G. et al.:The receptor-like protein-tyrosine phosphatase DEP-1 is constitutively associated with a 64-kDa protein serine/threonine kinase. J. Biol. Chem. 272 (18) :12158-12163, 1997.

PubMed

Keane, M. M., Lowrey, G. A., Ettenberg, S. A. et al.:The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res. 56 (18) :4236-4243, 1996.

PubMed

・Kuramochi, S., Matsuda, S., Matsuda, Y. et al.:Molecular cloning and characterization of Byp, a murine receptor-type tyrosine phosphatase similar to human DEP-1. FEBS Lett. 378 (1) :7-14, 1996.

PubMed

・Ostman, A., Yang, Q. and Tonks, N. K.:Expression of DEP-1, a receptor-like protein-tyrosinephosphatase, is enhanced with increasing cell density. Proc. Natl. Acad. Sci. USA 91 (21) :9680-9684, 1994.

・Palou, E., de la Fuente-Garcia, M. A. and Nicolas, J. M.:CD 148, a membrane protein tyrosine phosphatase, is able to induce tyrosine phosphorylation on human lymphocytes. Immunel. Lett. 57 (1-3) :101-103, 1997.

P.99 掲載の参考文献

◎Horejsi, V.:Leukocyte Typing VI, NL 24/581.

P.101 掲載の参考文献

◎Davis, S. J. and van der Merwe, P. A.:The structure and ligand interactions of CD 2:implications for T-cell function. Immunol. Today 17 (4) :177-187, 1996,

・Aversa, G., Chang, C. C., Carballido, J. M. et al.:Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J. Immunol. 158 (9) :4036-4044, 1997.

PubMed

・Cocks, B. G., Chang, C. C., Carballido, J. M. et al.:A novel receptor involved in T-cell activation. Nature 376 (6537) :260-263, 1995.

・Ferrante, P., Fusi, M. L., Saresella, M. et al.:Cytokine production and surface marker expression in acute and stable multiple sclerosis:altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM) -expressing lymphocytes in acute multiple sclerosis. J. Immunol. 160 (3) :1514-1521, 1998.

PubMed

・Pinchouk, V. G., Sidorenko, S. P., Gluzman, D. F. et al.:Monoclonal antibodies IPO-3 and IPO-10 against human B cell differentiation antigens. Anticancer Res. 8 (6) :1377-1380, 1988.

・Polacino, P. S., Pinchuk, L. M., Sidorenko, S. P. et al.:Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells. J. Med. Primatol. 25 (3) :201-209, 1996.

・Punnonen, J., Cocks, B. G., Carballido, J. M. et al.:Soluble and membrane-bound forms of signaling lyrnphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185 (6) :993-1004, 1997.

・Sidorenko, S. P., Vetrova, EP., Yurchenko, O. V. et al.:Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping. Neoplasma 39 (1) :3-9, 1992.

PubMed

・Sidorenko, S. P. and Clark, E. A.:Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J. Immunol. 151 (9) :4614-4624, 1993.

P.102 掲載の参考文献

◎Wright, M. D. and Tomlinson, M. G.:The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15 (12) :588-594, 1994.

PubMed

・Ashman, L. K., Aylett, G. W., Mehrabani, P. A. et al.:The murine monoclonal antibody, 14A2. H1, identifies a novel platelet surface antigen. Br. J. Haematol. 79 (2) :263-270, 1991.

PubMed

・Fitter, S., Tetaz, T. J., Berndt, M. C. et al.:Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3. Blood 86 (4) :1348-1355, 1995.

PubMed

・Hasegawa, H., Utsunomiya, Y., Kishimoto, K. et al.:SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily. J. Virol 70 (5) :3258-3263, 1996.

PubMed

・Hasegawa, H., Watanabe, H., Nomura, T. et al.:Molecular cloning and expression of mouse homologue of SFA-1 (PETA-3 (CD 151) , a member of the transmembrane 4 superfamily. Biochim. Biophys. Acta 1353 (2) :125-130, 1997.

・Hasegawa, H., Kishimoto, K., Yanagisawa, K. et al.:Assignment of SFA-1 (PETA-3) , a member of the transmembrane 4 superfamily, to human chromosome 11p15. 5 by fluorescence in situ. Genomics 40 (1) :193-196, 1997.

PubMed

・Roberts, J. J., Rodgers, S. E., J. D., Ashman, L. K. et al.:Platelet activation induced by a murine monoclonal antibody directed against a novel tetra-span antigen. Br. J. Haematol. 89 (4) :853-860, 1995.

・Sincock, P. M., Mayrhofer, G. and Ashman, L. K.:Localization of the transmembrane 4 superfamily (TM 4 SF) member PETA-3 (CD 151) in normal human tissues:comparison with CD 9, CD 63, and alpha 5 beta 1 integrin. J. Histochem. Cytochem. 45 (4) :515-525, 1997.

・Yanez-Mo, M., Alfranca, A., Cabanas, C. et al.:Regulation of endothelial cell motility by complexes of tetraspan molecules CD 81/TAPA-1 and CD 151/PETA-3 with alpha 3 beta 1 integrin localized at endothelial lateral junctions. J. Cell. Biol. 141 (3) :791-804, 1998.

P.105 掲載の参考文献

◎Allison, J. P. and Krummel, M. F.:The Yin and Yang of T cell costimulation. Science 270 (5238) :932-933, 1995.

PubMed

◎Linsley, P. S.:Distinct roles for CD 28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J. Exp. Med. 182 (2) :289-292, 1995.

◎Linsley, P. S. and Golstein, P.:Lymphocyte activation:T-cell regulation by CTLA-4. Curr. Biol. 6 (4) :398-400, 1996.

PubMed

・Azuma, M., Ito, D., Yagita, H. et al.:B70 antigen is a second ligand for CTLA-4 and CD 28. Nature 366 (6450) :76-79, 1993.

・Bradshaw, J. D., Lu, P., Leytze, G. et al.:Interaction of the cytoplasmic tail of CTLA-4 (CD 152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochemistry 36 (50) :15975-15982, 1997.

・Brunet, J. E., Denizot, F., Luciani, MF. et al.:A new member of the immunoglobulin superfamily-CTLA-4. Nature 328 (6127) :267-270, 1987.

・Chai, J. G., Bartok, I., Scott, D. et al.:T:T antigen presentation by activated murine CD 8+T cells induces anergy and apoptosis. J. Immunol. 160 (8) :3655-3665, 1998.

・Chambers, C. A., Sullivan, T. J. and Allison, J. P.:Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD 4+Tcells. Immunity 7 (6) :885-895, 1997.

・Freeman, G. J., Borriello, F., Hodes, R. J. et al.:Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262 (5135) :907-909, 1993.

PubMed

・Greene, J. L., Leytze, G. M., Emswiler, J. et al.:Covalent dimerization of CD 28/CTLA-4 and oligomerization of CD 80/CD 86 regulate T cell costimulatory interactions. J. Biol. Chem. 271 (43) :26762-26771, 1996.

・Harper, K., Balzano, C., Rouvier, E. et al.:CTLA-4 and CD 28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147 (3) :1037-1044, 1991.

・Horspool, J. H., Perrin, P. J., Woodcock, J. B. et al.:Nucleic acid vaccine-induced immune responses require CD 28 costimulation and are regulated by CTLA 4. J. Immunol. 160 (6) :2706-2714, 1998.

・Krummel, M. F. and Allison, J. P.:CD 28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182 (2) :459-465, 1995.

・Leach, D. R., Krummel, M. F. and Allison, J. P.:Enhancement of antitumor immunity by CTLA-4 blockade. Science 271 (5256) :1734-1736, 1996.

PubMed

・Lenschow, D. J., Zeng, Y., Thistlethwaite, JR. et al.:Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA 4 1g. Science 257 (5071) :789-792, 1992.

・Linsley, P. S., Brady, W., Urnes, M. et al.:CTLA-4 is a second receptor for the B cell activation antigen B 7. J. Exp. Med. 174 (3) :561-569, 1991.

・Linsley, P. S., Nadler, S. G., Bajorath, J. et al.:Binding stoichiometry of the cytotoxic T lymphocyte-associated 4 (CTLA-4) . A disulfide-linked homodimer binds two CD 86 molecules. J. Biol. Chem. 270 (25) :15417-15424, 1995.

・Linsley, P. S., Bradshaw, J., Greene, J. et al.:Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4 (6) :535-543, 1996.

PubMed

・Luhder, F., Hoglund, P., Allison, J. P. et al.:Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187 (3) :427-432, 1998.

PubMed

・Marengere, L. E., Waterhouse, P., Duncan, G. S. et al.:Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272 (5265) :1170-1173, 1996.

PubMed

・Peach, R. J., Bajorath, J., Naemura, J. et al.:Both extracellular immunoglobin-like domains of CD 80 contain residues critical for binding T cell surface receptors CTLA-4 and CD 28. J. Biol. Chem. 270 (36) :21181-21187, 1995.

・Ronchese, F., Hausmann, B., Hubele, S. et al.:Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD 4+ T cells and defective antibody production in vivo. J. Exp. Med. 179 (3) :809-817, 1994.

PubMed

・Siegall, C. B., Haggerty, H. G., Warner, G. L. et al.:Prevention of immunotoxin-induced immunogenicity by coadministration with CTLA4Ig enhances antitumor efficacy. J. Immunol. 159 (10) :5168-5173, 1997.

PubMed

・Tivol, E. A., Borriello, F., Schweitzer, A. N. et al.:Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3 (5) :541-547, 1995.

PubMed

・van der Merwe, P. A., Bodian, D. L., Daenke, S. et al.:CD 80 (B7-1) binds both CD 28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185 (3) :393-403, 1997.

・Walunas, T. L., Lenschow, D. J., Bakker, C. Y. et al:CTLA-4 can function as a negative regulator of T cell activation. Immunity 1 (5) :405-413, 1994.

PubMed

・Walunas, T. L. and Bluestone, J. A.:CTLA 4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol. 160 (8) :3855-3860, 1998.

・Waterhouse, P., Penninger, J. M., Timms, E. et al.:Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270 (5238) :985-988, 1995.

PubMed

P.108 掲載の参考文献

◎Del Prete, G., Maggi, E., Pizzolo, G. et al.:CD 30, Th 2 cytokines and HIV infection:a complex and fascinating link. Immunol. Today 16 (2) :76-80, 1995.

◎Gruss, HJ. and Dower, S. K.:Tumor necrosis factor ligand superfamily :involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

・Amakawa, R., Hakem, A., Kundig, T. M. et al.:Impaired negative selection of T cells in Hodgkin's disease antigen CD 30-deficient mice. Cell 84 (4) :551-562, 1996.

・Croager, E. J. and Abraham, L. J.:Characterisation of the human CD 30 ligand gene structure. Biochim. Biophys. Acta 135 (3) :231-235, 1997. 3

・Del Prete, G., De Carli, M., D'Elios, M. M. et al.:CD 30-mediated signaling promotes the development of human T helper 2 like T cells. J. Exp. Med. 182 (6) :1655-1661, 1995.

・Gattei, V., Degan, M., Gloghini, A. et al.:CD 30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood 89 (6) :2048-2059, 1997.

・Gruss, H. J., Pinto, A., Gloghini, A. et al.:CD 30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. Am. J. Pathol. 149 (2) :469-481, 1996.

・Lee, S. Y., Park, C. G. and Choi, Y.:T cell receptor-dependent cell death of T cell hybridomas mediated by the CD 30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183 (2) :669-674, 1996.

・Maggi, E., Annunziato, F., Manetti, R. et al.:Activation of HIV expression by CD 30 triggering in CD 4+ T cells from HIV-infected individuals. Immunity 3 (2) :251-255, 1995.

・McDonald, P. P., Cassatella, M. A., Bald, A. et al.:CD 30 ligation induces nuclear factor-kappa B activation in human T cell lines. Eur. J. Immunol. 25 (10) :2870-2876, 1995.

・Nishioka, Y., Davis, L. S., Lipsky, P. E. et al.:Regulation of human B cell function by recombinant CD 40 ligand and other TNF-related ligands. J. Immunol. 155 (5) :2369-2378, 1995.

・Powell, I. F., Li, T., Jack, H. M. et al.:Construction and expression of a soluble form of human CD 30 ligand with functional activity. J. Leukoc. Biol. 63 (6) :752-757, 1998.

・Romagnani, P., Annunziato, F., Manetti, R. et al.:High CD 30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus. Blood 91 (9) :3323-3332, 1998.

・Smith, C. A., Gruss, H. J., Davis, T. et al.:CD 30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73 (7) :1349-1360, 1993.

・Wiley, S. R., Goodwin, R. G. and Smith, C. A.:Reverse signaling via CD 30 ligand. J. Immunol. 157 (8) :3635-3639, 1996.

P.110 掲載の参考文献

◎Armitage, R. J., Maliszewski, C. R., Alderson, M. R. et al.:CD 40 L:a multi-functional ligand. Semin. Immunol. 5 (6) :401-412, 1993.

◎Banchereau, J., Bazan, F., Blanchard, D. et al.:The CD 40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922, 1994.

◎Callard, R. E., Armitage, R. J., Fanslow, W. C. et al.:CD 40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14 (11) :559-564, 1993.

◎Foy, T. M., Aruffo, A., Bajorath, J. et al.:Immune regulation by CD 40 and its ligand GP 39. Annu. Rev. Immunol. 14:591-617, 1996.

◎Grewal, I. S., Borrow, P., Pamer, E. G. et al.:The CD 40-CD 154 system in anti-infective host defense. Curr. Opin. Immunol. 9 (4) :491-497, 1997.

◎Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

◎Liu, Y. J. and Banchereau, J.:Regulation of B-cell commitment to plasma cells or to memory B cells. Semin. Immunol. 9 (4) :235-240, 1997.

PubMed

◎Noelle, R. J.:CD 40 and its ligand in host defense. Immunity 4:415-419, 1996.

◎Spriggs, M. K., Fanslow, W. C., Armitage, R. J. et al.:The biology of the human ligand for CD 40. J. Clin. Immunol. 13 (6) :373-380, 1993.

◎Van Kooten, C. and Banchereau, J.:CD 40-CD 40 ligand:a multifunctional receptor-ligand pair. Adv. Immunol. 61:1-77, 1996.

・Allen, R. C., Armitage, R. J., Conley, M. E. et al.:CD 40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259 (5097) :990-993, 1993.

・Armitage, R. J., Fanslow, W. C., Strockbine, L. et al:Molecular and biological characterization of a murine ligand for CD 40. Nature 357 (6373) :80-82, 1992.

・Campbell, K. A., Ovendale, P. J., Kennedy, M. K. et al.:CD 40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4 (3) :283-289, 1996.

・Cantwell, M., Hua, T., Pappas, J. et al.:Acquired CD 40-ligand deficiency in chronic lymphocytic leukemia. Nat. Med. 3 (9) :984-989, 1997.

・Dullforce, P., Sutton, D. C. and Heath, A. W.:Enhancement of T cell-independent immune responses in vivo by CD 40 antibodies. Nat. Med. 4 (1) :88-91, 1998.

・Grewal, I. S., Foellmer, H. G., Grewal, K. D. et al.:Requirement for CD 40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273 (5283) :1864-1867, 1996.

・Grouard, G., Rissoan, M. C., Filgueira, L. et al.:The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL) -3 and CD 40-ligand. J. Exp. Med. 185 (6) :1101-1111, 1997.

・Henn, V., Slupsky, J. R., Grafe, M. et al.:CD 40 ligand on activated platelets triggers an inflammatory reaction endothelial cells. Nature 391 (6667) :591-594, 1998.

・Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D. et al.:The human T cell antigen gp 39, a member of the TNF gene family, is a ligand for the CD 40 receptor:expression of a soluble form of gp 39 with B cell co-stimulatory activity. EMBO J. 11 (12) :4313-4321, 1992.

・Kato, K., Cantwell, M. J., Sharma, S. et al.:Gene transfer of CD 40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J. Clin. Invest. 101 (5) :1133-1141, 1998.

・Kilger, E., Kieser, A., Baumann, M. et al:Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD 40 receptor. EMBO J. 17 (6) :1700-1709, 1998.

・Kirk, A. D., Harlan, D. M., Armstrong, N. N. et al.:CTLA 4-Ig and anti-CD 40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94 (16) :8789-8794, 1997.

・Kornbluth, R. S., Kee, K. and Richman, D. D.:CD 40 ligand (CD 154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc. Natl. Acad. Sci. USA 95 (9) :5205-5210, 1998.

・Kuhne, M. R., Robbins, M., Hambor, J. E. et al:Assembly and regulation of the CD 40 receptor complex in human B cells. J. Med. 186 (2) :337-342, 1997.

・Lei, X. F., Ohkawara, Y., Stampfli, M. R. et al.:Disruption of antigen-induced inflammatory responses in CD 40 ligand knockout mice. J. Clin. Invest 101 (6) :1342-1353, 1998.

・Mackey, M. F., Gunn, J. R., Ting, P. P. et al.:Protective immunity induced by tumor vaccines requires interaction between CD 40 and its ligand, CD 154. Cancer Res. 57 (13) :2569-2574, 1997.

・Renshaw, B. R., Fanslow, W. Cr., Armitage, R. J. et al.:Humoral immune responses in CD 40 ligand-deficient mice. J. Exp. Med. 180 (5) :1889-1900, 1994.

・Spriggs, M. K., Armitage, R. J., Strockbine, L. et al.:Recombinant human CD 40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176 (6) :1543-1550, 1992.

・Zhou, P. and Seder, R. A.:CD 40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum. J. Exp. Jed. 187 (8) :1315-1324, 1998.

P.113 掲載の参考文献

・Aoki, J., Koike, S., Ise, I. et al.:Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J. Biol. Chem. 269 (11) :8431-8438, 1994.

PubMed

・Aoki, J., Koike, S., Asou, H. et al.:Mouse homolog of poliovirus receptor-related gene 2 product, mPRR 2, mediates homophilic cell aggregation. Exp. Cell. Res. 235 (2) :374-384, 1997.

・Bernhardt, G., Harber, J., Zibert, A. et al.:The poliovirus receptor:identification of domains and amino acid residues critical for virus binding. Virology 203 (2) :344-356, 1994.

PubMed

・Eberle, F., Dubreuil, P., Mattei, M. G. et al.:The human PRR 2 gene, related to the human poliovirus receptor gene (PVR) , is the true homolog of the murine MPH gene. Gene 159 (2) :267-272, 1995.

・Freistadt, M. S., Fleit, H. B. and Wimmer, E.:Poliovirus receptor on human blood cells:a possible extraneural site of poliovirus replication. Virology 195 (2) :798-803, 1993;

PubMed

・Geraghty, R. J., Krummenacher, C., Cohen, G. H. et al.:Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280 (5369) :1618-1620, 1998.

PubMed

・Gromeier, M., Lu, H. H., Bernhardt, G. et al.:The human poliovirus receptor. Receptor-virus interaction and parameters of disease specificity. Ann. N. Y. Acad. Sci. 753:19-36, 1995.

・Horie, H., Koike, S., Kurata, T. et al.:Transgenic mice carrying the human poliovirus receptor:new animal models for study of poliovirus neurovirulence. J. Virol. 68 (2) :681-688, 1994.

PubMed

・Koike, S., Horie, H., Ise, I. et al.:The poliovirus receptor protein is produced both as membrane-bound secreted forms. EMBO J. 9 (10) :3217-3224, 1990.

・Leon-Monzon, M. E., Illa, I. and Dalakas, M. C.:Expression of poliovirus receptor in human spinal cord and muscle. Ann. N. Y. Acad. Sci. 753:48-57, 1995.

PubMed

・Lopez, M., Eberle, F., Mattei, MG. et al.:Complementary DNA characterization and chromosomal localization of a human gene related to the poliovirus receptor-encoding gene. Gene 155 (2) :261-265, 1995.

・Mahon, B. P., Katrak, K., Nomoto, A. et al.:Poliovirus-specific CD 4+Th 1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J. Exp. Med. 181 (4) :1285-1292, 1995.

・Mendelsohn, C. L., Wimmer, E. and Racaniello, V. R.:Cellular receptor for poliovirus:molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56 (5) :855-865, 1989.

PubMed

・Morrison, M. E., He, Y. J., Wien, M. W. et al.:Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J. Virol. 68 (4) :2578-2588, 1994.

PubMed

・Taffs, R. E., Chernokhvostova, Y. V., Dragunsky, EM. et al.:Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge. J. Infect. Dis. 175 (2) :441-444, 1997.

PubMed

・Yang, W. X., Terasaki, T., Shiroki, K. et al.:Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 229 (2) :421-428, 1997.

・Zhang, S. and Racaniello, V. R.:Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. J. Virol. 71 (7) :4915-4920, 1997.

PubMed

P.115 掲載の参考文献

◎Blobel, C. P.:Metalloprotease-disintegrins:links to cell adhesion and cleavage of TNF alpha and Notch. Cell 90 (4) :589-592, 1997.

PubMed

◎Wolfsberg, T. G., Primakoff, P., Myles, D. G. et al.:ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain:multipotential functions in cell-cell and cellmatrix interactions. J. Cell Biol. 131 (2) :275-278, 1995.

◎Wolfsberg, T. G. and White, J. M.:ADAMs in fertilization and development. Dev. Biol. 180 (2) :389-401, 1996.

PubMed

・Blobel, C. P., Wolfsberg, T. G., Turck, C. W. et al.:A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Natzare 356 (6366) :248-252, 1992.

・Emi, M., Katagiri, T., Harada, Y. et al.:A novel metalloprotease/disintegrin-like gene at 17q21. 3 is somatically rearranged in two primary breast cancers. Nat. Genet. 5 (2) :151-157, 1993.

PubMed

・Kataoka, M., Yoshiyama, K., Matsuura, K. et al.:Structure of the murine CD156 gene, characterization of its promoter, and chromosomal location. J. Biol. Chem. 272 (29) :18209-18215, 1997.

PubMed

・Myles, D. G., Kimmel, L. H., Blobel, C. P. et al.:Identification of a binding site in the disintegrin domain of fertilin required for sperm-egg fusion. Proc. Natl. Acad. Sci. USA 91 (10) :4195-4198, 1994.

PubMed

・Wolfsberg, T. G., Bazan, J. F., Blobel, C. P. et al.:The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain:structural, functional, and evolutionary implications. Proc. Natl. Acad. Sci. USA 90 (22) :10783-10787, 1993.

・Yoshida, S., Setoguchi, M., Higuchi, Y. et al.:Molecular cloning of cDNA encoding MS 2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int. Immunol. 2 (6) :585-591, 1990.

・Yagami-Hiromasa, T., Sato, T., Kurisaki, T. et al.:A metalloprotease-disintegrin participating in myoblast fusion. Nature 377 (6550) :652-656, 1995.

PubMed

・Yoshiyama, K., Higuchi, Y., Kataoka, M. et al.:CD 156 (human ADAM 8) :expression, primary amino acid sequence, and location. Genomics 41 (1) :56-62, 1997.

P.117 掲載の参考文献

・Dong, C., Wang, J., Neame, P. et al.:The murine BP-3 gene encodes a relative of the CD 38/NAD family. Int. Immunol. 6 (9) :1353-1360, 1994.

・Goldstein, S. C. and Todd, R. F.:Structural and biosynthetic features of the Mo 5 human myeloid differentiation antigen. Tissue Antigens 41 (4) :214-218, 1993.

・Hirata, Y., Kimura, N., Sato, K. et al.:ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1. FEBS Lett. 356 (2-3) :244-248, 1994.

・Ishihara, K., Kobune, Y., Okuyama, Y. et al.:Stage-specific expression of mouse BST-1/BP-3 on the early B and T progenitors prior to gene rearrangement of antigen receptor. Int. Immunol. 8 (9) :1395-1404, 1996.

・Itoh, M., Ishihara, K., Tomizawa, H. et al.:Molecular cloning of murine BST-1 having homology with CD 38 and ADP-ribosyl cyclase. Biochem. Biophys. Res. Commun. 203 (2) :1309-1317, 1994.

・Kaisho, T., Ishikawa, J., Oritani, K. et al:BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth. Proc. Natl. Acad. Sci. USA (12) :5325-5329, 1994.

PubMed

・Lee, B. O., Ishihara, K., Denno, K. et al.:Elevated levels of the soluble form of bone marrowstromal cell 1 in the sera of patients with severe rheumatoid arthritis. Arthritis Rheum. 39 (4) :629-637, 1996.

・McNagny, K. M., Cazenave, P. A. and Cooper, M. D.:BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice. J. Immuol. 141 (8) :2551-2556, 1988.

・McNagny, K. M., Bucy, RP. and Cooper, M. D.:Reticular cells in peripheral lymphoid tissues express the phosphatidylinositol-linked BP-3 antigen. Eur. J. Immunol. 21 (2) :509-515, 1991.

PubMed

・Muraoka, O., Tanaka, H., Itoh, M. et al.:Genomic structure of human BST-1. Immunol. Lett. 54 (1) :1-4, 1996.

PubMed

・Okuyama, Y., Ishihara, K., Kimura, N. et al.:Human BST-1 expressed on myeloid cells functions as a receptor. Biochem. Biophys. Res. Commun. 228 (3) :838-845, 1996.

PubMed

・Todd, R. F., Roach, J. A. and Arnaout, M. A.:The modulated expression of Mo 5, a human myelomonocytic plasma antigen. Blood 65 (4) :964-973, 1985.

・Vicari, A. P., Bean, A. G. and Zlotnik, A.:A role for BP-3/BST-1 antigen in early T cell development. Int. Immunol. 8 (2) :183-191, 1996.

P.119 掲載の参考文献

◎Binstadt, B. A., Brumbaugh, K. M. and Leibson, P. J.:Signal transduction by human NK cell MHC-recognizing receptors. Immunol. Rev. 155:197-203, 1997.

PubMed

◎Long, E. O. and Wagtmann, N.:Natural killer cell receptors. Curr. Opin. Immunol. 9 (3) :344-350, 1997.

PubMed

◎Mingari, MC., Moretta, A. and Moretta, L.:Regulation of KIR expression in human T cells:a safety mechanism that may impair protective T-cell responses. Immunol. Today 19 (4) :153-157, 1998.

◎Moretta, A., Bottino, C., Vitale, M. et al.:Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14:619-648, 1996.

◎Moretta, A., Biassoni, R., Bottino, C. et al.:Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155:105-117, 1997.

◎Moretta, A. and Moretta, L.:HLA class I specific inhibitory receptors. Curr. Opin. Immunol. 9 (5) :694-701, 1997.

・Biassoni, R., Pessino, A., Malaspina, A. et al.:Role of amino acid position 70 in the binding affinity of p 50. 1and p 58. 1 receptors for HLA-Cw 4 molecules. Eur. J. Immunol. 27 (12) :3095-3099, 1997.

・Frohn, C., Schlenke, P. and Kirchner, H.:The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB 6 GL 183) in individuals with different HLA phenotypes. Immunology 92 (4) :567-570, 1997.

・Mandelboim, O., Pazmany, L., Davis, D. M. et al:Multiple receptors for HLA-G on human natural killer cells. Proc. Natl. Acad. Sci. USA 94 (26) :14666-14670, 1997.

PubMed

・Mingari, M. C., Vitale, C., Cantoni, C. et al.:Interleukin-15-induced maturation of human natural killer cells from early thymic precursors:selective expression of CD 94/NKG 2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27 (6) :1374-1380, 1997

・Melero, I., Salmeron, A., Balboa, M. A. et al.:Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J. Immunol. 152 (4) :1662-1673, 1994.

・Moretta, A., Bottino, C., Pende, D. et al.:Identification of four subsets of human CD 3-CD 16+natural killer (NK) cells by the expression of clonally distributed functional surface molecules:correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 172 (6) :1589-1598, 1990.

・Uhrberg, M., Valiante, N. M., Shum, B. P. et al.:Human diversity in killer cell inhibitory receptor genes. Immunity 7 (6) :753-763, 1997.

PubMed

P.121 掲載の参考文献

◎Binstadt, B. A., Brumbaugh, K. M. and Leibson, P. J.:Signal transduction by human NK cell MHC-recognizing receptors. Immunol. Rev. 155:197-203, 1997.

PubMed

◎Long, E. O. and Wagtmann, N.:Natural killer cell receptors. Curr. Opin. Immunol. 9 (3) :344-350, 1997.

PubMed

◎Mingari, M. C., Moretta, A. and Moretta, L.:Regulation of KIR expression in human T cells:a safety mechanism that may impair protective T-cell responses. Immunol. Today 19 (4) :153-157, 1998.

◎Moretta, A., Bottino, C., Vitale, M. et al.:Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14:619-648, 1996.

◎Moretta, A., Biassoni, R., Bottino, C. et al.:Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155:105-117, 1997.

◎Moretta, A. and Moretta, L.:HLA class I specific inhibitory receptors. Curr. Opin. Immunol. 9 (5) :694-701, 1997.

・Biassoni, R., Cantoni, C., Falco, M. et al.:The human leukocyte antigen (HLA) -C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183 (2) :645-650, 1996.

PubMed

・Burshtyn, DN., Scharenberg, A. M., Wagtmann, N. et al.:Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4 (1) :77-85, 1996.

PubMed

・Cambiaggi, A., Verthuy, C., Naquet, P. et al.:Natural killer cell. acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw 3 specific killer cell inhibitory receptor. Proc. Natl. Acad. Sci. USA 94 (15) :8088-8092, 1997.

・Colonna, M. and Samaridis, J.:Cloning of immunoglobulin-superfamily members associated with HLA-HLA-B recognition by human natural killer cells. Science 268 (5209) :405-408, 1995.

PubMed

・Ferrini, S., Cambiaggi, A., Meazza, R. et al.:Tcell clones expressing the natural killer cellrelated p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 24 (10) :2294-2298, 1994.

・Frohn, C., Schlenke, P. and Kirchner, H.:The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB 6 GL 183) in individuals with different HLA phenotypes. Immunology 92 (4) :567-570, 1997.

・Mandelboim, O., Pazmany, L., Davis, D. M. et al.:Multiple receptors for HLA-G on human natural killer cells. Proc. Natl. Acad. Sci. USA 94 (26) :14666-14670, 1997.

PubMed

・Moretta, A., Tambussi, G., Bottino, C. et al.:A novel surface antigen expressed by a subset of human CD 3-CD 16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J. Exp. Med. 171:695-714, 1990.

・Uhrberg, M., Valiante, N. M., Shum, B. P et al.:Human diversity in killer cell inhibitory receptor genes. Immunity 7 (6) :753-763, 1997.

PubMed

・Vely, F., Olivero, S., Olcese, L. et al.:Differential association of phosphatases with hematopoietic co-receptors bearing immunoreceptor tyrosine-based inhibition motifs. Eur. J. Immunol. 27 (8) :1994-2000, 1997.

PubMed

・Wagtmann, N., Rajagopalan, S., Winter, C. C. et al.:Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3 (6) :801-809, 1995.

PubMed

・Wagtmann, N., Biassoni, R., Cantoni, C. et al.:Molecular clones of the p 58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains. Immunity 2 (5) :439-449, 1995.

・Zappacosta, F., Borrego, F., Brooks, A. G. et al.:Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell mediated lysis. Proc. Natl. Acad. Sci. USA 94 (12) :6313-6318, 1997.

PubMed

P.124 掲載の参考文献

◎Bix, M. and Locksley, R. M.:Natural T cells. Cells that co-express NKRP-1 and TCR. J. Immunol. 155 (3) :1020-1022, 1995.

PubMed

◎Poggi, A., Tomasello, E. and Costa, P.:NKRP 1 A and p 40 molecules are involved in regulation of activation and maturation of human NK cells. Res. Immunol. 148 (3) :179-184, 1997.

◎See, D. M., Khemka, P., Sahl, L. et al.:The role of natural killer cells in viral infections. Scand. J. Immunol. 46 (3) :217-224, 1997.

PubMed

◎Sivakumar, P. V., Puzanov, I., Williams, N. S. et al.:Ontogeny and differentiation of murine natural killer cells and their receptors. Curr. Top. Microbiol. Immunol. 230:161-190, 1998.

PubMed

◎Yokoyama, W. M. and Seaman, WE.:The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells:the NK gene complex. Annu. Rev. Immunol. 11:613-635, 1993.

PubMed

・Al-Aoukaty, A., Rolstad, B. and Maghazachi, A. A.:Functional coupling of NKR-P1 receptors to various heterotrimeric G proteins in rat interleukin 2 activated natural killer cells. J. Biol. Chem. 272 (50) :31604-31608, 1997.

PubMed

・Arase, N., Arase, H., Park, S. Y. et al.:Association with FcRgamma is essential for activation signal through NKR P1 (CD 161) in natural killer (NK) cells and NK1. 1+T cells. J. Exp. Med. 186 (12) :1957-1963, 1997.

・Bezouska, K., Yuen, C. T., O'Brien, J. et al.:Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 372 (6502) :150-157, 1994.

PubMed

・Bezouska, K., Kren, V., Kieburg, C. et al.:GlcNAc-terminated glycodendrimers form defined precipitates with the soluble dimeric receptor of rat natural killer cells, sNKR-P1A. FEBS Lett. 426 (2) :243-247, 1998.

PubMed

・Bix, M. and Locksley, RM:Natural T cells. Cells that co-express NKRP-1 and TCR. J. Immunol. 155 (3) :1020-1022, 1995.

PubMed

・Brissette-Storkus, C., Kaufman, C. L., Pasewicz, L. et al.:Characterization and function of the NKR-P1 dim/T cell receptor-alpha beta+subset of rat T cells. J. Immunol. 152 (2) :388-396, 1994.

・Chambers, W. H., Vujanovic, N. L., DeLeo, A. B. et al.:Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 169 (4) :1373-1389, 1989.

PubMed

・Giorda, R., Rudert, W. A., Vavassori, C. et al.:NKR-P1, a signal transduction molecule on natural killer cells. Science 249 (4974) :1298-1300, 1990.

PubMed

・Giorda, R., Weisberg, EP., Ip, T. K. et al.:Genomic structure and strain-specific expression of the natural killer cell receptor NKR-P1. J. Immunol 149 (6) :1957-1963, 1992.

PubMed

・Gumperz, J. E. and Parham, P.:The enigma of the natural killer cell. Nature 378 (6554) :245-248, 1995.

PubMed

・Kung, S. K. and Miller, RG.:The NK1. 1 antigen in NK-mediated F1 antiparent killing in vitro. J. Immunol. 154:1624-1633, 1995.

PubMed

・Lanier, LL., Chang, C. and Phillips, J. H.:Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol 153 (6) :2417-2428, 1994.

・Poggi, A., Costa, P., Morelli, L. et al.:Expression of human NKRPIA by CD 34+immature thymocytes:NKRP1A-mediated regulation of proliferation and cytolytic activity. Eur. J. Immunol. 26 (6) :1266-1272, 1996.

・Poggi, A., Costa, P., Tomasello, E. et al.:IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. Eur. J. Immunol. 28 (5) :1611-1616, 1998.

PubMed

・Poggi, A., Rubartelli, A. and Zocchi, M. R.:Involvement of dihydropyridine-sensitive calcium channels in human dendritic cell function. Competition by HIV-1 Tat. J. Biol. Chem. 273 (13) :7205-7209, 1998.

・Renedo, M., Arce, I., Rodriguez, A. et al.:The human natural killer gene complex is located on chromosome 12p12-p13. Immunogenetics 46 (4) :307-311, 1997.

PubMed

・Ryan, JC., Niemi, E. C., Nakamura, M. C. et al.:NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J. Exp. Med. 181 (5) :1911-1915, 1995.

PubMed

P.127 掲載の参考文献

◎Andrews, R. K., Lopez, J. A. and Berndt, M. C.:Molecular mechanisms of platelet adhesion and activation. Int. J. Biochem. Cell Biol. 29 (1) :91-105, 1997.

PubMed

◎Furie, B. and Furie, B. C.:Leukocyte crosstalk at the vascular wall. Thromb. Haemost. 78 (1) :306-309, 1997.

PubMed

◎McEver, R. P. and Cummings, R. D.:Perspectives series:cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J. Clin. Invest. 100 (3) :485-491, 1997.

PubMed

◎Rosen, S. D. and Bertozzi, C. R.:Two selectins converge on sulphate. Leukocyte adhesion. Czarr. Biol. 6 (3) :261-264, 1996.

PubMed

・Borges, E., Pendl, G., Eytner, R. et al.:The binding of T cell-expressed P-selectin glycoprotein ligand-1 to E-and P-selectin is differentially regulated. J. Biol. Chem. 272 (45) :28786-28792, 1997.

・Fuhlbrigge, R. C., Kieffer, J. D., Armerding, D. et al.:Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389 (6654) :978-981, 1997.

PubMed

・Hidari, K. J., Weyrich, A. S., Zimmerman, G. A. et al.:Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J. Biol. Chem. 272 (45) :28750-28756, 1997.

PubMed

・Hirose, M., Kawashima, H. and Miyasaka, M.:A functional epitope on P-selectin that supports binding of P-selectin to P-selectin glycoprotein ligand-1 but not to sialyl Lewis X oligosaccharides. Int. Immunol. 10 (5) :639-649, 1998.

・Koenig, A., Norgard-Sumnicht, K., Linhardt, R. et al.:Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J. Clin. Invest. 101 (4) :877-889, 1998.

PubMed

・Laszik, Z., Jansen, P. J., Cummings, RD. et al.:P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some non hematopoietic cells. Blood 88 (8) :3010-3021, 1996.

・Li, F., Wilkins, P. P., Crawley, S. et al.:Post-translational modifications of recombinant P-selectin ligand-1 required for binding to P-and E-selectin. J. Biol. Chem. 271 (6) :3255-3264, 1996.

・Li, F., Erickson, H. P., James, J. A. et al.:Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies. J. Biol. Chem. 271 (11) :6342-6348, 1996.

PubMed

・Liu, W., Ramachandran, V., Kang, J. et al.:Identification of N-terminal residues on P-selectin glycoprotein ligand-1 required for binding to P-selectin. J. Biol. Chem. 273 (12) :7078-7087, 1998.

・Mehta, P., Patel, K. D., Laue, T. M. et al.:Soluble monomeric P-selectin containing only the lectin and epidermal growth factor domains binds to P-selectin glycoprotein ligand-10 on leukocytes. Blood 90 (6) :2381-2389, 1997

・Moore, K. L., Stults, N. L., Diaz, S. et al.:Identification of a specific glycoprotein ligand for P-selectin (CD 62) on myeloid cells. J. Cell Biol. 118 (2) :445-456, 1992.

・Norman, K. E., Moore, K. L., McEver, R. P. et al.:Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood 86 (12) :4417-4421, 1995.

PubMed

・Ouyang, Y., Lane, W. S. and Moore, K. L.:Tyrosylprotein sulfotransferase:purification and molecular cloning of an enzyme that catalyzes tyrosine O-sulfation, a common posttranslational modification of eukaryotic proteins. Proc. Natl. Acad. Sci. USA 95 (6) :2896-2901, 1998.

PubMed

・Pouyani, T. and Seed, B.:PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell 83 (2) :333-343, 1995.

PubMed

・Sako, D., Chang, X. J., Barone, K. M. et al.:Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 75 (6) :1179-1186, 1993.

・Sako, D., Comess, K. M., Barone, K. M. et al.:A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell 83 (2) :323-331, 1995.

PubMed

・Shao, J. Y., Ting-Beall, H. P. and Hochmuth, R. M.:Static and dynamic lengths of neutrophil microvilli. Proc. Natl. Acad. Sci. US 1 95 (12) :6797-6802, 1998.

・Snapp, K. R., Ding, H., Atkins, K. et al.:A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P-and L-selectin. Blood 91 (1) :154-164, 1998.

・Tu, L., Chen, A., Delahunty, M. D. et al.:L-selectin binds to P-selectin glycoprotein ligand-10 on leukocytes:interactions between the lectin, epidermal growth factor, and consensus repeat domains of the selectins determine ligand binding specificity. J. Immunol. 157 (9) :3995-4004, 1996.

・Vachino, G., Chang, X. J., Veldman, G. M. et al.:P--selectin glycoprotein ligand-1 is the major counter receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J. Biol. Chem. 270 (37) :2196621974, 1995.

・Veldman, G. M., Bean, K. M., Cumming, D. A. et al.:Gellomic organization and chromosomal localization of the gene encoding human P-selectin glycoprotein ligand. J. Biol. Chem. 270 (27) :16470, 16475, 1995.

・Walcheck, B., Moore, K. L., McEver, R. P. et al.:Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL. . . J. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J. Clin. Invest. 98 (5) :1081-1087, 1996.

・Wilkins, P. P., Moore, K. L., McEver, R. P. et al.:Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin. J. Biol. Chem. 270 (39) :22677-22680, 1995.

P.129 掲載の参考文献

◎Backe, E., Schwarting, R., Gerdes, J. et al.:Ber-MAC 3:new monoclonal antibody that defines human monocyte/macrophage differentiation antigen. J. Clin. Pathol. 44 (11) :936-945, 1991.

PubMed

・Law, S. K., Micklem, K. J., Shaw, J. M. et al.:A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Ezar. J. Immunol. 23 (9) :2320-2325, 1993.

・Pulford, K., Micklem, K., McCarthy, S. et al.:A monocyte/macrophage antigen recognized by the four antibodies Ber-MAC 3, Ki-M 8 and SM 4. Immunology 75 (4) :588-595, 1992.

・Radzun, H. J., Kreipe, H., Bodewadt, S. et al.:Ki-M 8 monoclonal antibody reactive with an intracytoplasmic antigen monocyte/macrophage lineage. Blood 69 (5) :1320-1327, 1987.

・Wijngaard, P. L., Metzelaar, M. J., MacHugh, N. D. et al.:Molecular characterization of the WC 1 antigen expressed specifically bovine CD 4-CD 8-gamma delta T lymphocytes. J. Immunol. 149 (10) :3273-3277, 1992.

P.131 掲載の参考文献

◎Zannetttino, A. C. W.:Leukocyte Typing VI, AS 33/456.

・Masuzawa, Y., Miyauchi, T., Hamanoue, M. et al.:A novel core protein as well as polymorphic epithelial mucin carry peanut agglutinin binding sites in human gastric carcinoma cells:sequence analysis and examination of gene expression. J. Biochem. (Tokyo) 112 (5) :609-615, 1992.

PubMed

P.132 掲載の参考文献

・Bhattacharya-Chatterjee, M., Pride, M. W., Seon, B. K. et al.:Idiotype vaccines against human T cell acute lymphoblastic leukemia. J. Generation and characterization of biologically active monoclonal anti-idiotopes. J. Immunol. 139 (4) :1354-1360, 1987.

・Bruggers, C. S., Patel, D. D., Scearce, R. M. et al.:AD 2, a human molecule involved in the interaction of T cells with epidermal keratinocytes and thymic epithelial cells. J. Immunol. 154:2012-2022, 1995.

・Hara, H. and Seon, B. K.:Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins:nude mouse models. Proc. Natl. Acad. Sci. USA 84 (10) :3390-3394, 1987.

PubMed

・Seon, B. K., Negoro, S., Barcos, M. P. et al.:Monoclonal antibody SN 2 defining a human T cell leukemia-associated cell surface glycoprotein. J. Immunol. 132 (4) :2089-2095, 1984.

・Seon, B. K., Fukukawa, T., Jackson, A. L. et al.:Human T-cell leukemia-associated cell surface glycoprotein GP 37:studies with three monoclonal antibodies and a rabbit antiserum. Mo J. Immunol. 23 (6) :569-580, 1986.

・Seon, B. K.:Similarity of TALLA-1, a T-cell acute lymphoblastic leukemia an, to GP 37 [letter]. Int. J. Cancer 63 (3) :474, 1995.

・Yokota, S., Hara, H., Luo, Y. et al.:Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin. Cancer Res. 50 (1) :32-37, 1990.

P.134 掲載の参考文献

◎Aruffo, A., Bowen, M. A., Patel, D. D. et al.:CD 6-ligand interactions:a paradigm for SRCR domain function? Immunol. Today 18 (10) :498-504, 1997.

・Bajorath, J., Bowen, M. A. and Aruffo, A.:Molecular model of the N-terminal receptor-binding domain of the human CD 6 ligand ALCAM. Protein Sci. 4 (8) :1644-1647, 1995.

・Bowen, M. A., Patel, DD., Li, X. et al.:Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM) , a CD 6 ligand. J. Exp. Med. 181 (6) :2213-2220, 1995.

・Bowen, M. A., Bajorath, J., Siadak, A. W. et al.:The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD 6 with a 1:1 stoichiometry. J. Biol. Chem. 271 (29) :17390-17396, 1996.

・Bowen, M. A., Bajorath, J., D'Egidio, M. et al.:Characterization of mouse ALCAM (CD 166) :the CD 6-binding domain is conserved in different homologs and mediates cross-species binding. Eur. J. Immunol. 27 (6) :1469-1478, 1997.

・Burns, F. R., von Kannen, S., Guy, L. et al.:DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension. Neuron 7 (2) :209-220, 1991.

PubMed

・Corbel, C., Pourquie, O., Cormier, F. et al.:BEN/SC 1/DM-GRASP, a homophilic adhesion molecule, is required for in vitro myeloid colony formation by avian hemopoietic progenitors. Proc. J. Natl. Acad. Sci. USA 93 (7) :2844-2849, 1996.

・De Bernardo, A. P. and Chang, S.:Heterophilic interactions of DM-GRASP:GRASP-NgCAM interactions involved in neurite extension. J. Cell J. Biol. 133 (3) :657-666, 1996.

・Degen, W. G., van Kempen, L. C., Gijzen, E. G. at al.:MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule) . Am. J. Pathol. 152 (3) :805-813, 1998.

・Kanki, J. P., Chang, S. and Kuwada, J. Y.:The molecular cloning and characterization of potential chick DM-GRASP homologs in zebrafish and mouse. J. Neuro biol. 25 (7) :831-845, 1994.

・Patel, D. D., Wee, S. F., Whichard, LP. et al.:Identification and characterization of a 100-kD ligand for CD 60n human thymic epithelial cells. J. Exp. Med. 181 (4) :1563-1568, 1995.

・Peduzzi, J. D., Irwin, M. H. and Geisert, EE. Jr.:Distribution and characteristics of a 90 kDa protein, KG-CAM, in the rat CNS. Brain Res. 640 (1-2) :296-307, 1994.

・Pesando, J. M., Hoffman, P. and Abed, M.:Antibody-induced antigenic modulation is antigen dependent:characterization of 22 proteins on a malignant human B cell line. J. Immunol. 137:3689-3695, 1986.

・Pourquie, O., Corbel, C., Le Caer, J. P et al.:BEN, a surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems. Proc. Natl. Acad. Sci USA 89 (12) :5261-5265, 1992.

・Skonier, J. E., Bowen, M. A., Emswiler, J. et al.:Recognition of diverse proteins by members of the immunoglobulin superfamily:delineation of the receptor binding site in the human CD 6 ligand ALCAM. Biochemistry 35 (38) :12287-12291, 1996.

・Tanaka, H., Matsui, T., Agata, A. et al.:Molecular cloning and expression of a novel adhesion molecule, SC 1. Neuron 7 (4) :535-545, 1991.

VIII. 全CD分類に関する文献リスト一覧

P.264 掲載の参考文献

1) Day, A. J.:The C-type carbohydrate recognition domain (CRD) superfamily. Biochem. Soc. Trans. 22 (1) :83-88, 1994

1) Hemler, M. E.:VLA proteins in the integrin family:structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8:365-400, 1990.

PubMed

1) Aoki, J., Koike, S., Ise, I. et al.:Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J. Biol. Chem. 269 (11) :8431-8438, 1994.

PubMed

1) Hadam, M. R.:Leukocyte Typing VI, B 35.

1) Blobel, C. P.:Metalloprotease-disintegrins:links to cell adhesion and cleavage of TNF alpha and Notch. Cell 90 (4) :589-592, 1997.

PubMed

1) Bagley, C. J., Woodcock, J. M., Stomski, F. C. et al.:The structural and functional basis of cytokine receptor activation:lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3) , and IL-5 receptors. Blood 89 (5) :1471-1482, 1997.

PubMed

1) June, C. H., Ledbetter, J. A., Linsley, P. S. et al.:Role of the CD 28 receptor in T-cell activation. Immunol. Today 11 (6) :211-216, 1990.

1) de Totero, D., Francia, di Celle, P., Cignetti, A. et al.:The IL-2 receptor complex:expression and function on normal and leukemic B cells. Leukemia 9 (9) :1425-1431, 1995.

PubMed

1) Bernfield, M., Kokenyesi, R., Kato, M. et al.:Biology of the syndecans:a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8:365-393, 1992.

PubMed

1) Hohaus, S., Murea, S., Voso, M. T. et al.:Mobilization and selection of CD 34+cells. Recent Results Cancer Res. 144:1-7, 1998.

1) Bird, M. I., Foster, M. R., Priest, R. et al.:Selectins:physiological and pathophysiological roles. Biochem. Soc. Trans. 25 (4) :1199-1206, 1997.

PubMed

1) Miyajima, A., Mui, A. L., Ogorochi, T. et al.:Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82 (7) :1960-1974, 1993.

PubMed

1) Morimoto, C., Iwata, S. and Tachibana, K.:VLA-4-mediated signaling. Curr. Top. Microbiol. Immunol. 231:1-22, 1998.

PubMed

1) Dong, C., Wang, J., Neame, P. et al.:The murine BP-3 gene encodes a relative of the CD 38/NAD family. Int. Immunol. 6 (9) :1353-1360, 1994.

1) Altruda, F., Cervella, P., Gaeta, M. L. et al.:Cloning of cDNA for a novel mouse membrane glycoprotein (gp 42) :shared identity to histocompatibility antigens, immunoglobulins and neural-cell adhesion molecules. Gene 85 (2) :445-451, 1989

1) Davis, S. J. and van der Merwe, P. A.:The structure and ligand interactions of CD 2:implications for T-cell function. Immunol. Today 17 (4) :177-187, 1996.

1) Hemler, M. E.:VLA proteins in the integrin family:structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8:365-400, 1990.

PubMed

1) Binstadt, B. A., Brumbaugh, K. M. and Leibson, P. J.:Signal transduction by human NK cell MHC-recognizing receptors. Immunol. Rev. 155:197 203, 1997.

1) Faumall, E. B. and Saper, M. A.:Structure and function of the protein tyrosine phosphatases. Trends Biochem. Sci. 21 (11) :413-417, 1996.

1) Fox, D. A., Millard, J. A., Kan, L. et al.:Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw 60 antigen. J. Clin. Invest. 86 (4) :1124-1136, 1990.

1) Downey, J. S. and Han, J.:Cellular activation mechanisms in septic shock. Front. Biosci. 3:d 468-476, 1998.

1) Chan, A. C., Desai, D. M. and Weiss, A.:The role of protein tyrosine kinases and protein tyrosine in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:555-592, 1994.

1) Jungalwala, F. B.:Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system-a review. Neurochem. Res. 19 (8) :945-957, 1994.

1) Berglund, L.:A recurrent theme with a new spin:ACE polymorphism and cardiovascular disease. J. Lab. Clin. Med. 131 (6) :485-486, 1998.

1) Shipp, M. A. and Look, A. T.:Hematopoietic differentiation antigens that are membrane associated enzymes:cutting is the key! Blood 82 (4) :1052 1070, 1993.

1) Buhl, A. M. and Cambier, J. C.:Co-receptor and accessory regulation of B-cell antigen receptor signal transduction. Immunol. Rev. 160:127-138, 1997.

PubMed

1) Akira, S., Yoshida, K., Tanaka, T. et al.:Targeted disruption of the IL-6 related genes:gp 130 and NF-IL-6. Immunol. Rev. 148 :221-253, 1995.

1) de Totero, D., Francia, di Celle, P., Cignetti, A. et al.:The IL-2 receptor complex:expression and function on normal and leukemic B cells. Leukemia 9 (9) :1425-1431, 1995.

PubMed

1) Cresswell, P.:Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293, 1994.

PubMed

1) Ahearn, J. M. and Fearon, D. T.:Structure and function of the complement receptors, CR 1 (CD 35) and (CD 21) . Adv. Immunol. 46:183-219, 1989.

1) Knapp, W., Majdic, O., Stockinger, H. et al.:Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia. Med. Oncol. Tumor Pharmacother. 1 (4) :257-262, 1984.

PubMed

1) Bertran, J., Magagnin, S., Werner, A. et al.:Stimulation of system y (+) -like amino acid transport by the heavy chain of human 4 F 2 surface antigen in Xenopus laevis oocytes. Proc. Natl. Acad. Sci. USA 89 (12) :5606-5610, 1992.

1) Esmon, CT.:Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. Faseb J. 9 (10) :946-955, 1995.

1) Binstadt, B. A., Brumbaugh, K. M. and Leibson, P. J.:Signal transduction by human NK cell MHC-recognizing receptors. Immunol. Rev. 155:197-203, 1997.

PubMed

1) Goelz, S. E., Hession, C., Goff, D. et al.:ELFT:agene that directs the expression of an ELAM-1 ligand. Cell 63 (6) :1349-1356, 1990.

1) Hemler, M. E.:VLA proteins in the integrin family:structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8:365-400, 1990.

PubMed

1) Aigner, S., Ruppert, M., Hubbe, M. et al.:Heat stable antigen (mouse CD 24) supports myeloid cell binding to endothelial and platelet P-selectin. Int. Immunol. 7 (10) :1557, 1565, 1995.

1) Haynes, B. F., Denning, S. M., Singer, K. H. et al.:Ontogeny of T-cell precursors:a model for the initial stages of human T-cell development. Immunol. Today 10 (3) :87-91, 1989.

1) Nagel, G. and Grunert, F.:From genes to proteins:the nonspecific cross-reacting antigens. Tumour Biol. 16 (1) :17-22, 1995.

PubMed

1) Colotta, F., Dower, S. K. Sims, J. E. et al.:The type II "decoy" receptor:a novel regulatory pathway for interleukine 1. Today 15 (12) :562-566, 1994.

PubMed

1) Bast, BJ., Zhou, L. J., Freeman, G. J. et al.:The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2, 6-sialyltransferase. J. Cell Biol. 116 (2) :423-435, 1992.

1) Bonnefoy, J. Y., Lecoanet-Henchoz, S., Aubry, J. P. et al.:CD 23 and B-cell activation. Curr. Opin. Immunol. 7 (3) :355-359, 1995.

1) Bast, B. J., Zhou, L. J., Freeman, G. J. et al.:The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2, 6-sialyltransferase. J. Cell Biol. 116 (2) :423-435, 1992.

1) Brakebusch, C., Hirsch, E., Potocnik, A. et al.:Genetic analysis of beta 1 integrin function:confirmed, new and revised roles for a crucial family of cell adhesion molecules. J. Cell Sci. 110 (Pt 23) :2895-2904, 1997.

1) Carlos, T. M. and Harlan, J. M.:Leukocyte-endothelial adhesion molecules. Blood 84 (7) :2068-2101, 1994.

PubMed

1) Cooper, N. R., Moore, M. D. and Nemerow, G. R.:Immunobiology of CR 2, the B lymphocyte receptor for Epstein-Barr and the C 3 d complement fragment. Annu. Rev. Immunol. 6:85-113, 1988.

1) Kokholm, K., -Noren, O. and Sjostrom, H.:Structure and expression of aminopeptidase N. Adv. Exp. Med. Biol. 421:47-57, 1997.

PubMed

1) Greenwalt, D. E., Lipsky, R. H., Ockenhouse, C. F. et al.:Membrane glycoprotein CD 36:a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 80 (5) :1105-1115, 1992.

1) Drexler, H. G.:Expression of FLT 3 receptor and response to FLT 3 ligand by leukemic cells. Leukemia 10 (4) :588-599, 1996.

1) Bird, M. I., Foster, M. R., Priest, R. et al.:Selectins:physiological and pathophysiological roles. Biochem. Soc. Trans. 25 (4) :1199-1206, 1997.

PubMed

1) Canonica, G. W., Ciprandi, G., Pesce, G. P. et al.:ICAM-1 on epithelial cells in allergic subjects:a hallmark of allergic inflammation. Int. Arch. Allergy Immunol. 107 (1-3) :99-102, 1995.

1) Mackman, N.:Regulation of the tissue factor gene. Thromb. Haemost. 78 (1) :747-754, 1997.

PubMed

1) Hemler, M. E.:VLA proteins in the integrin family:structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8:365-400, 1990.

PubMed

1) Bix, M. and Locksley, R. M.:Natural T cells. Cells that co-express NKRP-1 and TCR. J. Immunol. 155 (3) :1020-1022, 1995.

PubMed

1) Wright, M. D. and Tomlinson, M. G.:The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15 (12) :588-594, 1994.

PubMed

1) Horejsi, V.:Leukocyte Typing VI, NL 24/581.

1) Killeen, N.:T-cell regulation:Thy-1-hiding in full view. Curr. Biol. 7 (12) :R 774-777, 1997.

1) Davis, S. J. and van der Merwe, P. A.:The structure and ligand interactions of CD 2:implications for T-cell function. Immunol. Today 17 (4) :177-187, 1996,

1) Marinov, J., Koubek, K. and Stary, J.:Expression of CDw 12 and CD 17 cell surface antigens on leukemic cells from patients with blood malignancies. Folia Biol. (Praha) 39 (3) :124-128, 1993.

1) Center, D. M., Kornfeld, H. and Cruikshank, W. W.:Interleukin 16 and its function as a CD 4 ligand. Immunol. Today 17 (10) :476-481, 1996.

1) Arnaout, M. A.:Leukocyte adhesion molecules deficiency:its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol. Rev. 114:145-180, 1990.

PubMed

1) Ataliotis, P. and Mercola, M.:Distribution and functions of platelet-derived growth factors and their receptors during embryogenesis. Int. Rev. Cytol. 172:95-127, 1997.

PubMed

1) Karlsson, K. A.:Animal glycosphingolipids as membrane attachment sites for bacteria. Annu. Rev. Biochem. 58:309-350, 1989.

PubMed

1) Fukuda, M.:Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J. Biol. Chem. 266 (32) :21327-21330, 1991.

PubMed

1) Funderud, S.:Leukocyte Typing VI, BC 19/178.

1) Baggiolini, M., Dewald, B. and Moser, B.:Interleukin-8 and related chemotactic cytokines-CXC and CC. Adv. Immunol. 55:97-179, 1994.

1) Cambier, J. C., Pleiman, C. M. and Clark, M. R.:Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 12:457-486, 1994.

1) Maecker, H. T., Todd, S. C. and Levy, S.:The tetraspanin superfamily:molecular facilitators. FASEB J. 11 (6) :428-442, 1997.

1) Nagel, G. and Grunert, F.:From genes to proteins:the nonspecific cross-reacting antigens. Tumour Biol. 16 (1) :17 22, 1995.

1) Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

1) Andrews, R. K., Lopez, J. A. and Berndt, M. C.:Molecular mechanisms of platelet adhesion and activation. Int. J. Biochem. Cell Biol. 29 (1) :91-105, 1997.

PubMed

1) Shaw, S. K., Brenner, M. B.:The beta 7 integrins in mucosal homing and retention. Semin. Immunol. 7 (5) :335-342, 1995.

PubMed

1) Davies, A. and Lachmann, P. J.:Membrane defence against complement lysis:the structure and properties of CD 59. Immunol. Res. 12 (3) :258-275, 1993.

1) Davis, S. J. and van der Merwe, P. A.:The structure and ligand interactions of CD 2:implications for T-cell function. Immunol. Today 17 (4) :177-187, 1996.

1) Abbott, C. A., Gorrell, M. D., Levy, M. T. et al.:Molecular analyses of human and rat dipeptidyl peptidase IV. Adv. Exp. Med. Biol. 421:161-169, 1997.

PubMed

1) Fraser, A. and Evan, G.:A license to kill. Cell 85 (6) :781-784, 1996.

PubMed

1) Bellon, T., Corbi, A., Lastres, P. et al.:Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur. J. Immunol. 23 (9) :2340-2345, 1993.

PubMed

1) Lund, F., Solvason, N., Grimaldi, J. C. et al.:Murine CD 38:an immunoregulatory ectoenzyme. Immunol. Today 16 (10) :469-473, 1995.

1) Karlsson, K. A.:Animal glycosphingolipids as membrane attachment sites for. Annu. Rev. Biochem. 58:309-350, 1989.

PubMed

1) Allison, J. P. and Havran, W. L.:The immunobiology of T cells with invariant gamma delta antigen receptors. Annu. Rev. Immunol. 9:679-705, 1991.

PubMed

1) Goyert, S. M.:Leukocyte Typing VI, MC 17/1031.

1) Parkos, C. A.:Molecular events in neutrophil transepithelial migration. Bioessays 19 (10) :865-873, 1997.

1) Backe, E., Schwarting, R., Gerdes, J. et al.:Ber-MAC 3:new monoclonal antibody that defines human monocyte/macrophage differentiation antigen. J. Clin. Pathol. 44 (11) :936-945, 1991.

PubMed

1) Del Prete, G., Maggi, E., Pizzolo, G. et al.:CD 30, Th 2 cytokines and HIV infection:a complex and fascinating link. Immunol. Today 16 (2) :76-80, 1995.

1) Zannetttino, A. C. W. [Leukocyte Typing VI, AS 33/456]

1) Bagot, M., Martinel, I., Charue, D. et al.:CD 101 is expressed by skin dendritic cells. Role in T-lymphocyte activation. Tisszae Antigens 50 (5) :439-448, 1997.

1) Gerard, C. and Gerard, N. P.:C5 A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775-808, 1994.

1) Kuno, K. and Matsushima, K.:The IL-1 receptor signaling pathway. J. Leukoc. Biol. 56 (5) :542-547, 1994.

PubMed

1) Aussel, C., Bernard, G., Breittmayer, J. P. et al.:Monoclonal antibodies directed against the E 2 protein (MIC 2 gene product) induce exposure of phosphatidylserine at the thymocyte cell surface. Biochemistry 32 (38) :10096 10101, 1993.

1) Ali, J., Liao, F., Martens, E. et al.:Vascular endothelial cadherin (VE-cadherin) :cloning and role in endothelial cell-cell adhesion. Microcirculation 4 (2) :267-277, 1997.

PubMed

1) Larson, R. S. and Springer, T. A.:Structure and function of leukocyte integrins. Immunol Rev. 114:181-217, 1990.

PubMed

1) June, C. H., Bluestone, J. A., Nadler, L. M. et al.:The B7 and CD28 receptor families. Immunol. Today 15 (7) :321-331, 1994.

PubMed

1) Kansas G. S., Wood G. S., Tedder T. F. Expression, distribution, and biochemistry of human CD 39. Role in activation-associated homotypic adhesion of lymphocytes. J. Immunol. 146 (7) :2235-2244, 1991.

1) Goyert, S. M.:Leukocyte Typing VI, MC 18/1032.

1) Bobolis, K. A., Moulds, J. J. and Telen, M. J.:Isolation of the JMH antigen on a novel phosphatidylinositol-linked human membrane protein. Blood 79 (6) :1574-1581, 1992.

PubMed

1) Hale, G., Xia, M. Q., Tighe, H. P. et al.:The CAMPATH-1 antigen (CDw 52) . Tissue Antigens 35 (3) :118-127, 1990.

1) Bhattacharya-Chatterjee, M., Pride, M. W., Seon, B. K. et al.:Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes. J. Immunol. 139 (4) :1354 1360, 1987.

1) Wright, M. D. and Tomlinson, M. G.:The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15 (12) :588-594, 1994.

PubMed

1) Aruffo, A., Bowen, M. A., Patel, D. D. et al.:CD 6-ligand interactions:a paradigm for SRCR domain function? Immunol. Today 18 (10) :498-504, 1997.

1) Crocker, P. R., Kelm, S., Hartnell, A. et al.:Sialoadhesin and related cellular recognition molecules of the immunoglobulin superfamily. Biochem. Soc. Trans. 24 (1) :150-156, 1996.

PubMed

1) Goridis, C. and Brunet, J. F.:NCAM:structural diversity, function and regulation of expression. Semin. Cell Biol. 3 (3) :189-197, 1992.

PubMed

1) Foy, T. M., Aruffo, A., Bajorath, J. et al.:Immune regulation by CD 40 and its ligand GP 39. Annu. Rev. Immunol. 14:591-617, 1996.

1) Nagel, G. and Grunert, F.:From genes to proteins:the nonspecific cross-reacting antigens. Tumout Biol. 16 (1) :17-22, 1995.

1) Bougeret, C., Mansur, I. G., Dastot, H. et al.:Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J. Immunol. 148 (2) :318-323, 1992.

1) Candeias, S., Muegge, K. and Durum, S. K.:IL-7 receptor and VDJ recombination:trophic versus mechanistic actions. Immunity 6 (5) :501-508, 1997.

PubMed

1) Fukuda, M.:Lysosomal membrane glycoproteins. Structure, biogsynthesis, and intracellular trafficking. J. Biol. Chem. 266 (32) :21327-21330, 1991.

PubMed

1) Gerlier, D., Varior-Krishnan, G. and Devaux, P.:CD 46-mediated measles virus entry:a first key to host-range specificity. Trends Microbiol. 3 (9) :338-345, 1995.

1) Thompson, J. A., Grunert, F. and Zimmermann, W.:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5 (5) :344-366, 1991.

PubMed

1) Tedder, T. F. and Engel, P.:CD 20 :a regulator of cell-cycle progression of B lymphocytes. Immunol. Today 15 (9) :450-454, 1994.

1) Petty, H. R. and Todd, R. F.:Integrins as promiscuous signal transduction devices. Immunol. Today 17 (5) :209 212, 1996.

1) Baker, S. J. and Reddy, E. P.:Transducers of life and death:TNF receptor superfamily and associated proteins. Oncogene 12 (1) :1-9, 1996.

PubMed

1) Ravetch, J. V. and Kinet, J. P.:Fc receptors. Annu. Rev. Immunol. 9:457-492, 1991.

PubMed

1) Bach, E. A., Aguet, M. and Schreiber, R. D.:The IFN gamma receptor:a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563-591, 1997.

PubMed

1) Davis, S. J. and van der Merwe, P. A.:The structure and ligand interactions of CD 2:implications for T-cell function. Immunol. Today 17 (4) :177-187, 1996.

1) Carroll, M. C. and Prodeus, A. P.:Linkages of innate and adaptive immunity. Curr. Opin. Immunol. 10 (1) :36-40, 1998.

PubMed

1) Obrink, B.:CEA adhesion molecules:multifunctional proteins with signal regulatory properties. Curr. Opin Cell Biol. 9 (5) :616 626, 1997.

1) Arnaout, M. A.:Leukocyte adhesion molecules deficiency :its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol. Rev. 114:145-180, 1990.

PubMed

1) DeLisser, H. M., Newman, P. J. and Albelda, S. M.:Molecular and functional aspects of PECAM-1/CD 31. Immunol. Today 15 (10) :490-495, 1994.

1) Galli, S. J., Zsebo, K. M. and Geissler, E. N.:The kit ligand, stem cell factor. Adv. Immunol. 55:1-96, 1994

PubMed

1) Fearon, D. T. and Carter, R. H.:The CD19/CR2/TAPA-1 complex of B lymphocytes:linking natural to acquired immunity. Annu. Rev. Immunol. 13:127-149, 1995.

1) Armitage, R. J.:Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin Immunol. 6 (3) :407-413, 1994.

PubMed

1) Aruffo, A., Bowen, M. A., Patel, D. D. et al.:CD 6 ligand interactions:a paradigm for SRCR domain function? Immunol. Today 18 (10) :498-504, 1997.

1) Miyajima, A., Mui, A. L., Ogorochi, T. et al.:Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82 (7) :1960-1974, 1993.

PubMed

1) Felding-Habermann, B. and Cheresh, D. A.:Vitronectin and its receptors. Curr. Opin. Cell Biol. 5 (5) :864-868, 1993.

PubMed

1) Bergelson, J. M. and Hemler, M. E.:Integrin-ligand binding. Do integrins use a 'MIDAS touch' to grasp an Asp? Curr. Biol. 5 (6) :615-617, 1995.

PubMed

1) Nanni, L.:Leukocyte Typing VI, NK 8/286.

1) Adgey, A. A.:An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors. Am. Heart J. 135 (4) :S 43-55, 1998.

1) Allison, J. P. and Krummel, M. F.:The Yin and Yang of T cell costimulation. Science 270 (5238) :932-933, 1995.

PubMed

1) Leonard, W. J., Shores, E. W. and Love, P. E.:Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol. Rev. 148:97-114, 1995.

PubMed

1) Hemler, M. E., Mannion, B. A. and Berditchevski, F.:Association of TM4SF proteins with integrins:relevance to cancer. Biochim. Biophys. Acta 1287 (2-3) :67-71, 1996.

1) Del Prete, G., Maggi, E., Pizzolo, G. et al.:CD 30, Th 2 cytokines and HIV infection:a complex and fascinating link. Immunol. Today 16 (2) :76-80, 1995.

1) Maecker, H. T., Todd, S. C. and Levy, S.:The tetraspanin superfamily:molecular facilitators. FASEB J. 11 (6) :428-442, 1997.

1) Cecchini, M. G., Hofstetter, W., Halasy, J. et al.:Role of CSF-1 in bone and bone marrow develompment. Mol. Reprod. Dev. 46 (1) :75-83;discussion-4, 1997.

1) Steinman, R. M., Pack, M. and Inaba, K.:Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:25-37, 1997.

1) Acevedo, A., del Pozo, M. A., Arroyo, A. G. et al.:Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells. Am. J. Pathol. 143 (3) :774-783, 1993.

PubMed

1) LeBien, T. W. and McCormack, R. T.:The common acute lymphoblastic leukemia antigen (CD 10) emancipation from a functional enigma. Blood 73 (3) :625-635, 1989.

1) Hirano, T.:Interleukin 6 and its receptor:ten years later. Int. Rev. Immunol. 16 (3 4) :249 284, 1998.

1) Thompson, J. A., Grunert, F. and Zimmermann, W.:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5 (5) :344-366, 1991.

PubMed

1) de la Fuente, MA:Leukocyte Typing VI, BC 25/193.

1) Pulford, K.:Leukocyte Typing VI, BC 26/196.

1) Davey, F. R., Cordell, J. L., Erber, W. N. et al.:Monoclonal antibody (Y 1/82 A) with specificity towards peripheral blood monocytes and tissue macrophages. J. Clin. Pathol. 41 (7) :753-758, 1988.

1) Maecker, H. T., Todd, S. C. and Levy, S.:The tetraspanin superfamily:molecular facilitators. FASEB J. 11 (6) :428-442, 1997.

1) McKnight, A. J. and Gordon S.:EGF-TM 7:a novel subfamily of seven-transmembrane-region leukocyte surface molecules. Immunol. Today 17 (6) :283-287, 1996.

1) Hathcock, K. S. and Hodes, R. J.:Role of the CD28-B 7 costimulatory pathways in T cell-dependent B cell responses. Adv. Immunol. 62:131-166, 1996.

1) Avalos, B. R.:Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88 (3) :761-777, 1996.

PubMed

1) Lopez, J. A. and Dong, J. F.:Structure and function of the glycoprotein Ib-IX-V complex. Curr. Opin. Hematol. 4 (5) :323-329, 1997.

1) Testi, R., D'Ambrosio, D., De Maria, R. et al.:The CD 69 receptor:a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15 (10) :479-483, 1994

1) Krieger, M. and Herz, J.:Structures and functions of multiligand lipoprotein receptors:macrophage scavenger receptors and LDL receptor-related protein (LRP) . Annu. Rev. Biochem. 63:601-637, 1994.

PubMed

1) Bordin, J. O., Kelton, J. G., Warner, M. N. et al.:Maternal immunization to Gov system alloantigens on human platelets. Transfusion 37 (8) :823-828, 1997.

PubMed

1) Doherty. P. C., Topham, D. J., Tripp, R. A. et al.:Effector CD4' and CD8' T cell mechanisms in the control of respiratory virus infections. Immunol Rev., 159:105 117, 1997.

1) Hakomori, S.:Le (X) and related structures as adhesion molecules. Histochem. J. 24 (11) :771-776, 1992.

1) Altin, J. G. and Sloan, E. K.:The role of CD 45 and CD 45-associated molecules in T cell activation. Immunol. Cell Biol. 75 (5) :430-445, 1997.

1) Hintzen, R. Q., de Jong, R., Lens, S. M. et al.:CD 27:marker and mediator of T-cell activation? Immunol. Today 15 (7) :307-311, 1994.

1) Butcher, E. C. and Picker, L. J.:Lymphocyte homing and homeostasis. Science 272 (5258) :60-66, 1996.

PubMed

1) Fujimura, Y., Kawasaki, T. and Titani, K.:Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb. Haemost. 76 (5) :633-639, 1996.

PubMed

1) Doody, G. M., Dempsey, P. W. and Fearon, D. T.:Activation of B lymphocytes:integrating signals from CD 22 and gamma RIIb1. Curr. Opin. Immunol. 8 (3) :378382, 1996.

1) Bird, M. I., Foster, M. R., Priest, R. et al.:Selectins:physiological and pathophysiological roles. Biochem. Soc. Trans. 25 (4) :1199-1206, 1997.

PubMed

1) Bazil, V., Brandt, J. E. and Hoffman, R.:Resistance of human hematopoietic stem cells to a monoclonal antibody recognizing CD 43. Stem Cells 15 (Suppl. 1) :13 8;discussion 8 9, 1997.

1) Devos, R., Plaetinck, G., Cornelis, S. et al.:Interleukin-5 and its receptor:a drug target for eosinophilia associated with chronic allergic disease. J. Leukoc. Biol. 57 (6) :813-819, 1995.

1) Crispe, I. N. and Mehal, W. Z.:Strange brew:T cells in the liver. Immunol. Today 17 (11) :522-525, 1996.

1) Lopez, J. A. and Dong, J. F.:Structure and function of the glycoprotein Ib-IX-V complex. Curr. Opin. Hematol. 4 (5) :323-329, 1997.

1) Casasnovas, J. M., Springer, T. A., Liu, J. H. et al.:Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature 387 (6630) :312-315, 1997.

PubMed

1) Goodison, S. and Tarin, D.:Current status of CD 44 variant isoforms as cancer diagnostic markers. Histopathology 32 (1) :1-6, 1998.

1) Ben-Aissa, H., Paulie, S., Koho, H. et al.:Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder. Br. J. Cancer 52 (1) :65 72, 1985.

1) Hemler, M. E.:VLA proteins in the integrin family:structures, functions, and their role on leukocytes. Annza. Rev. Immunol. 8:365-400, 1990.

1) Lopez, J. A. and Dong, J. F.:Structure and function of the glycoprotein Ib-IX-V complex. Curr. Opin. Hematol. 4 (5) :323-329, 1997.

1) Armitage, R. J., Maliszewski, C. R., Alderson, M. R. et al.:CD 40 L:a multi-functional ligand. Semin. Immunol. 5 (6) :401-412, 1993.

1) Garrod, D. R.:Desmosomes and hemidesmosomes. Curr. Opin. Cell Biol. 5 (1) :30-40, 1993.

PubMed

1) Binstadt, B. A., Brumbaugh, K. M. and Leibson, P. J.:Signal transduction by human NK cell MHC-recognizing receptors. Immunol. Rev. 155:197-203, 1997.

PubMed

1) Armitage, R. J.:Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6 (3) :407-413, 1994.

PubMed

1) Cheresh, D. A.:Vitronectin and its receptors. Curr. Opin. Cell Biol. 5 (5) :864-868, 1993.

PubMed

1) Baynes, R. D., Shih, Y. J. and Cook, J. D.:Mechanism of production of the serum transferrin receptor. Adv. Exp. Med. Biol. 356:61-68, 1994.

PubMed

1) Kirschfink, M.:Controlling the complement system in inflammation. Immunopharmacology 38 (1-2) :51-62, 1997.

1) Kerr, M. A.:The structure and function of human IgA. Biochem. J. 271 (2) :285-296, 1990.

PubMed

1) Hakomori, S.:Le (X) and related structures as adhesion molecules. Histochem. J. 24 (11) :771-776, 1992.

1) Bardin, N., George, F., Mutin, M. et al.:S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 48 (5) :531-539, 1996.

PubMed

1) Hulett, M. D. and Hogarth, P. M.:Molecular basis of Fc receptor function. Adv. Immunol. 57:1-127, 1994.

PubMed

1) Chomarat, P. and Banchereau, J.:An update on interleukin-4 and its receptor. Eur. Cytokine Netw. 8 (4) :333-344, 1997.

PubMed

1) Crocker, P. R., Hartnell, A., Munday, J. et al.:The potential role of sialoadhesin as a macrophage recognition in health and disease. Glycoconj. J. 14 (5) :601-609, 1997

PubMed

1) Collesi, C., Santoro, M. M., Gaudino, G. et al.:A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol. Cell. Biol. 16 (10) :5518-5526, 1996.

2) Hintzen, R. Q., de Jong, R., Lens, S. M. et al.:CD 27:marker and mediator of T cell activation? Immunol. Today 15 (7) :307-311, 1994.

2) Claesson-Welsh, L.:Platelet-derived growth factor receptor signals. J. Biol. Chem. 269 (51) :32023-32026, 1994.

PubMed

2) Grotjahn, C., Heuring, A., Lohmeyer, J. et al.:Leukocyte Typing VI section B 28. 4/642.

2) Bonnefoy, J. Y., Plater-Zyberk, C., Lecoanet-Henchoz, S. et al.:A new role for CD 23 in inflammation. Immuno. Today 17 (9) :418-420, 1996.

2) Higgs, J. B., Zeldes, W., Kozarsky, K. et al.:A novel pathway of human T lymphocyte activation. Identification by a monoclonal antibody generated against a rheumatoid synovial T cell line. J. Immunol. 140:3758-3765, 1988.

2) Nesheim, M., Wang, W., Boffa, M. et al.:Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb. Haemost. 78 (1) :386-391, 1997.

PubMed

2) Couchman, J. R. and Woods, A.:Syndecans, signaling, and cell adhesion. J. Cell. Biochem. 61 (4) :578-584, 1996.

PubMed

2) Doody, G. M., Dempsey, P. W. and Fearon, D. T.:Activation of B lymphocytes :integrating signals from CD 19, CD 22 and gamma RIIb1. Curr. Opin. Immunol. 8 (3) :378-382, 1996.

2) Bendelac, A., Rivera, M. N., Park, S. H. et al.:Mouse CD 1-specific NK 1 T cells:development, specificity, and function. Annu. Rev. Immunol. 15:535-562, 1997.

2) Resnick, D., Pearson, A. and Krieger, M.:The SRCR superfamily:a family reminiscent of the Ig superfamily. Trends Biochem. Sci. 19 (1) :5-8, 1994.

2) Gearing, A. J. and Newman, W.:Circulating adhesion molecules in disease. Immunol. Today 14 (10) :506-512, 1993.

PubMed

2) Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand super family:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378 3404, 1995.

2) Aigner, S., Sthoeger, Z. M., Fogel, M. et al.:CD 24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89 (9) :3385 3395, 1997.

2) Carlsson, S. R., Roth, J., Piller, F. et al.:Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins polylactosaminoglycan. J. Biol. Chem. 263 (35) :18911-18919, 1988.

2) Osterud, B.:Tissue factor:a complex biological role. Thromb. Haemost. 78 (1) :755-758, 1997.

PubMed

2) Lachmann, P. J.:The control of homologous lysis. Immunol. Today 12 (9) :312-315, 1991.

PubMed

2) Dustin, M. L. and Springer, T. A.:Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu. Rev. Immunol. 9:27-66, 1991.

PubMed

2) Gearing, A. J. and Newman, W.:Circulating adhesion molecules in disease. Immunol. Today 14 (10) :506-512, 1993.

PubMed

2) Gaudino, G., Follenzi, A., Naldini, L. et al.:RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 13 (15) :3524-3532, 1994.

PubMed

2) Lyman, S. D. and Williams, D. E.:Biology and potential clinical applications of flt 3 ligand. Curr. Opin. Hematol. 2 (3) :177-181, 1995.

PubMed

2) Minami, Y. and Taniguchi, T.:IL-2 signaling:recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. Curr. Opin. Cell Biol. 7 (2) :156-162, 1995.

PubMed

2) Wetsel, R. A.:Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 7 (1) :48-53, 1995.

PubMed

2) Schachner, M., Martini, R., Hall, H. et al.:Functions of the L 2/HNK-1 carbohydrate in the nervous system. Prog. Brain Res. 105:183-188, 1995.

2) Corvol, P., Michaud, A., Soubrier, F. et al.:Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. J. Hypertens. Suppl. 13 (Suppl. 3) :S 3-10, 1995.

2) Elhabazi, A., Lang, V., Herold, C. et al.:The human semaphorin-like leukocyte cell surface molecule CD 100 associates with a serine kinase activity. J. Biol. Chem. 272 (38) :23515-23520, 1997.

2) Fearon, D. T.:The CD 19-CR 2-TAPA-1 complex, CD 45 and signaling by the antigen of B lymphocytes. Curr. Opin. Immunol. 5 (3) :341-348, 1993.

2) Fuster, V., Poon, M. and Willerson, J. T.:Learning from the transgenic mouse:endothelium, adhesive molecules, and neointimal formation. Circulation 97 (1) :16-18, 1998.

PubMed

2) Giancotti, F. G.:Signal transduction by the alpha 6 beta 4 integrin :charting the path between laminin binding and nuclear events. J. Cell Sci. 109 (Pt 6) :1165-1172, 1996.

2) Liu, Y. J. and Banchereau, J.:Regulation of B-cell commitment to plasma cells or to memory B cells. Semin. Immunol. 9 (4) :235-240, 1997.

PubMed

2) Adra, C. N., Lelias, J. M., Kobayashi, H. et al.:Cloning of the cDNA for a hematopoietic cell-specific protein related to CD 20 and the beta subunit of the high-affinity IgE receptor :evidence for a family of proteins with four membrane-spanning regions. Proc. Natl. Acad. Sci. USA 91 (21) :10178-52, 1994.

PubMed

2) Fleischer, B.:CD 26:a surface protease involved in T-cell activation. Immunol. Today 15 (4) :180-184, 1994.

2) Goodman, C. S.:Mechanisms and molecules that control growth cone guidance. Annu. Rev. Neourosci. 19:341-377, 1996.

2) Bach, T. L., Barsigian, C., Chalupowicz, D. G. et al.:VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp. Cell. Res. 238 (2) :324-334, 1998.

PubMed

2) Bell, GM. and Imboden, J. B.:CD 2 and the regulation of T cell anergy. J. Immunol. 155 (6) :2805-2807, 1995.

2) Leonard, W. J.:The molecular basis of X-linked severe combined immunodeficiency:defective cytokine receptor signaling. Annu. Rev. Med. 47:229-239, 1996.

PubMed

2) Armitage, R. J.:Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6 (3) :407-413, 1994.

PubMed

2) Wright, M. D. and Tomlinson, M. G.:The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15 (12) :588-594, 1994.

PubMed

2) Ben-Aissa, H., Paulie, S., Koho, H. et al.:Monoclonal antibodies against carcinoma cells of the human urinary bladder:immunohistochemical staining of tissues. Anticancer Res. 6 (2) :165 170, 1986.

2) Liszewski, M. K., Farries, T. C., Lublin, D. M. et al.:Control of the complement system. Adv. Immunol. 61:201-283, 1996.

PubMed

2) Ravetch, J. V. and Kinet, J. P.:Fc receptors. Annu. Rev. Immunol. 9:457-492, 1991.

PubMed

2) Miyajima, A., Mui, A. L., Ogorochi, T. et al.:Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82 (7) :1960-1974, 1993.

PubMed

2) June, C. H., Bluestone, J. A., Nadler, L. M. et al.:The B 7 and CD 28 receptor families. Immunol. Today 15 (7) :321-331, 1994.

2) Kishimoto, T., Akira, S., Narazaki, M. et al.:Interleukin-6 family of cytokines and gp 130. Blood 86 (4) :1243-1254, 1995.

2) Johnson, J. P., Rummel, M. M., Rothbacher, U. et al.:MUC 18:A cell adhesion molecule with a potential role in tumor growth and tumor cell dissemination. Curr. Top. Microbiol. Immunol. 213 (Pt 1) :95-105, 1996.

2) Berditchevski, F., Chang, S., Bodorova, J. et al.:Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha 3 beta l complexes with EMMPRIN/basigin/OX 47/M 6. J. Biol. Chem. 272 (46) :29174-29180, 1997.

2) Fischer, E. H., Charbonneau, H. and Tonks. N. K.:Protein tyrosine phosphatases:a diverse family of intracellular and transmembrane enzymes. Science 253 (5018) :401 406, 1991.

2) Lopez-Botet, M., Perez-Villar, J. J., Carretero, M. et al.:Structure and function of the CD 94 C-type lectin receptor complex involved in recognition of HLA class I molecules Immunol. Rev. 155:165-174, 1997.

2) Doody, G. M., Dempsey, PW. and Fearon, D. T.:Activation of B lymphocytes:integrating signals from CD 19, CD 22 and gamma R II b 1. Curr. Opin. Immunol. 8 (3) :378-382, 1996.

2) Kniep, B., Peter-Katalinic, J., Muthing, J. et al.:The CDw 65 monoclonal antibodies VIM-8 and VIM-11 bind to the neutral glycolipid V3FucnLc8Cer. J. Biochem. (Tokyo) 119 (3) :456-62, 1996.

2) Janssen, J. L. W. D., Borkhardt, A., Spadinger, U. et al.:Pre-pre-B acute lymphoblastic leukemia:high frequency of alternatively spliced ALL 1-AF 4 transcripts and absence of minimal residual disease during complete remission. Blood 84 (11) :3835-3842, 1994.

2) Thompson, J. A., Grunert, F. and Zimmermann, W.:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5 (5) :344-366, 1991.

PubMed

2) Hemler, M. E.:VLA proteins in the integrin family:structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8:365-400, 1990.

PubMed

2) Larson, R. S. and Springer, T. A.:Structure and function of leukocyte integrins. Immunol. Rev. 114:181-217, 1990.

PubMed

2) Gearing, A. J. and Newman, W.:Circulating adhesion molecules in disease. Immunol. Today 14 (10) :506-512, 1993.

PubMed

2) Amiot, M.:Identification and analysis of cDNA clones encoding CD 53. A pan-leukocyte antigen related to membrane transport proteins. J. Immunol. 145 (12) :4322-4325, 1990.

2) Banting, G. S., Pym, B., Darling, S. M. et al.:The MIC 2 gene product:epitope mapping and structural prediction analysis define all integral membrane protein. Mol. Immunol. 26 (2) :181-188, 1989.

2) Bates, P.:Chemokine receptors and HIV-1:an attractive pair? Cell 86 (1) :1-3, 1996.

PubMed

2) Thompson, J. A., Grunert, F. and Zimmermann, W.:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5 (5) :344-366, 1991.

PubMed

2) Komschlies, K. L., Grzegorzewski, K. J. and Wiltrout, R. H.:Diverse immunological and hematological effects of interleukin 7:implications for clinical application. J. Leukoc. Biol. 58 (6) :623-633, 1995.

PubMed

2) Fureder, W., Agis, H., Sperr, W. R. et al.:The surface membrane antigen phenotype of human blood basophils. Allergy 49 (10) :861-865, 1994.

PubMed

2) Arnaiz-Villena, A., Rodriguez-Gallego, C., Timon, M. et al.:Diseases involving the T-cell receptor/CD 3 complex. Crit. Rev. Oncol. Hematol. 19 (2) :131-147, 1995.

2) Falini, B., Pileri, S., Pizzolo, G. et al.:CD 30 (Ki-1) molecule:a new cytokine receptor of the tumor necrosis. Blood 85 (1) :1-14, 1995.

2) Aversa, G., Chang, C. C., Carballido, J. M. et al.:Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J. Immunol. 158 (9) :4036-4044, 1997.

PubMed

2) Hale, G. and Phillips, J. M.:Clinical trials with CAMPATH-I and other monoclonal antibodies. Biochem. Soc. Trans. 23 (4) :1057-1063, 1995.

PubMed

2) Ashman, L. K., Aylett, GW., Mehrabani, P. A. et al.:The murine monoclonal antibody, 14A2. H1, identifies a novel platelet surface antigen. Br. J. Haematol. 79 (2) :263-270, 1991.

PubMed

2) Ginsberg, M. H., Xiaoping, D., O'Toole, T. E. et al.:Platelet integrins. Thromb. Haemost. 70 (1) :87-93, 1993.

PubMed

2) Thompson, J. A., Grunert, F. and Zimmermann, W.:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5 (5) :344-366, 1991.

PubMed

2) Sehgal, P. B.:Inlterleukin 6 type cytokines in vivo :regulated bioavailability. Proc. Soc. Exp. Biol. Med. 213 (3) :238 247, 1996.

2) Cerboni, C., Gismondi, A., Palmieri, G. et al.:CD 16-mediated activation of phosphatidylinositol-3 kinase (PI-3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb 2, Shc, pp 36 and p 85 PI 3 K subunit. Eur. J. Immunol. 28 (3) :1005-1015, 1998.

2) Nagel, G. and Grunert, F.:From genes to proteins:the nonspecific cross-reacting antigens. Tumour Biol. 16 (1) :17-22, 1995.

PubMed

2) Newman, P. J.:The biology of PECAM-1. J. Clin. Invest. 99 (1) :3-8, 1997.

PubMed

2) Shively, J. E. and Beatty, J. D.:CEA related antigens:molecular biology and clinical significance. Crit. Rev. Oncol. Heinatol. 2 (4) :355-399, 1985.

PubMed

2) Linsley, P. S.:Distinct roles for CD 28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J. Exp. Med. 182 (2) :289-292, 1995.

2) Bossy, D., Mattei, M. G. and Simmons, D. L.:The human intercellular adhesion molecule 3 (ICAM 3) gene is located in the 19 p 13. 2-p 13. 3 region, close to the ICAM 1 gene. Genomics 23 (3) :712-713, 1994.

2) Barnett, T. R., Pickle, WD. and Elting, J. J.:Characterization of two new members of the pregnancy-specific beta 1-glycoprotein family from the myeloid cell line KG-1 and suggestion of two distinct classes of transcription unit. Biochemistry 29 (44) :10213-10218, 1990.

2) Fukuda, M.:Lysosomal membrane glycoproteins. Structure, biosynthesis, and. J. Biol. Chem. 266 (32) :21327-21330, 1991.

2) Moestrup, S. K.:The alpha 2-macroglobulin receptor and epithelial glycoprotein-330:giant receptors mediating endocytosis of multiple ligands. Biochim. Biophys. Acta 1197:197-213, 1994.

PubMed

2) Cebrian, M., Yague, E., Rincon, M. et al.:Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168 (5) :1621-1637, 1988.

PubMed

2) Varki, A.:Selectin ligands. Proc. Natl. Acad. Sci. USA 91 (16) :7390-7397, 1994.

PubMed

2) Koike, M. and Takatsu, K.:IL-5 and its receptor:which role do they play in the immune response? Int. Arch. Allergy Immunol. 104 (1) :1-9, 1994.

PubMed

2) Hulett, M. D. and Hogarth, P. M.:Molecular basis of Fc receptor fuction. Adv. Immunol. 57:1 127, 1994.

2) Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

2) Collo, G., Domanico, S. Z., Klier, G. et al.:Gradient of integrin alpha 6 A distribution in the myocardium during early heart development. Cell Adhes. Commun. 3 (2) :101-113, 1995.

PubMed

2) Banchereau, J., Bazan, F., Blanchard, D. et al.:The CD 40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922, 1994

2) Hynes, R. O.:Integrins:versatility, modulation, and signaling in cell adhesion. Cell 69 (1) :11-25, 1992.

PubMed

2) Ginsberg, M. H., Xiaoping, D., O'Toole, T. E. et al.:Platelet integrins. Thromb. Haemost. 70 (1) :87-93, 1993.

PubMed

2) Hentze,. M. W. and Kuhn, L. C.:Molecular control of vertebrate iron metabolism:mRNA-based circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. USA 93 (16) :8175-8182, 1996.

2) Dodelet, V. C. and Cashman, NR.:Prion protein expression in human leukocyte differentiation. Blood 91 (5) :1556-1561, 1998.

PubMed

2) Keegan, A. D. and Zamorano, J.:Regulation of gene expression, growth, and cell survival by IL-4:contribution of multiple signaling pathways. Cell Res. 8 (1) :1-13, 1998.

PubMed

2) Andrews, R. G., Singer, J. W. and Bernstein, I. D.:Precursors of colony-forming cells in humans can be distinguished colony-forming cells by expression of the CD 33 and CD 34 antigens and light scatter properties. J. Exp. Med. 169 (5) :1721-1731, 1989.

2) Aoki, J., Koike, S., Asou, H. et al.:Mouse homolog of poliovirus receptor-related gene 2 product, mPRR 2, mediates homophilic cell aggregation. Exp. Cell. Res. 235 (2) :374-384, 1997.

2) Wolfsberg, T. G., Primakoff, P., Myles, D. G. et al.:ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain:multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol. 131 (2) :275-278, 1995.

2) Oostendorp, R. A. and Dormer, P.:VLA-4-mediated interactions between normal human hematopoietic progenitors and stromal cells. Leuk. Ly Jzphoma 24 (5-6) :423-435, 1997

2) Gordon, J.:B-cell signalling via the C-type lectins CD 23 and CD 72. Immunol. Today 15 (9) :411-417, 1994.

2) Miyajima, A., Kinoshita, T., Wakao, H. et al.:Signal transduction by the GM-CSF, IL-3 and IL-5 receptors. Leukemia 11 (Suppl. 3) :418-422, 1997.

2) Krause, D. S., Fackler, M. J., Civin, C. J. et al.:CD 34:structure, biology, and clinical utility. Blood 87:1-13, 1996.

2) Goldstein, S. C. and Todd, R. F.:Structural and biosynthetic features of the Mo 5 human myeloid differentiation antigen. Tissue Antigens 41 (4) :214-218, 1993.

2) Berditchevski, F., Zutter, M. M. and Hemler, M. E.:Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM 4 proteins) . Mol. Biol. Cell 7 (2) :193-207, 1996.

2) Kerr, M. A., Stewart, W. W., Bonner, B. C. et al.:The diversity of leucocyte IgA receptors. Contrib. Nephrol. 111:60 64;discussion 5, 1995.

2) Bazil, V. and Strominger, J. L.:Shedding as a mechanism of down-modulation of CD 14 on stimulated monocytes. J. Immunol. 147 (5) :1567-1574, 1991.

2) Fremont, D. H., Rees, W. A. and Kozono, H.:Biophysical studies of T-cell receptors and their ligands. Curr. Opin. Immunol. 8 (1) :93-100, 1996.

PubMed

2) Foster, C. A.:VCAM-1/alpha 4-integrin adhesion pathway :therapeutic target for allergic inflammatory disorders. J. Allergy Clin. Immunol. 98 (6 Pt 2) :S 270-277, 1996.

2) Zimmermann, H.:5' Nucleotidase:molecular structure and functional aspects. Biochem. J. 285 (Pt 2) :345-365, 1992.

2) Minami, Y., Kono, T., Miyazaki, T. et al.:The IL-2 receptor complex:its structure, function, and target genes. Annu. Rev. Immunol. 11:245-268, 1993.

PubMed

2) Fearon, D. T. and Ahearn, J. M.:Complement receptor type 1 (C 3 b/C 4 b receptor:CD 35) and complement receptor type 2 (C 3 d/Epstein-Barr virus receptor:CD 21) . Curr. Top. Microbiol. Immunol. 153:83-98, 1990.

2) Cresswell, P.:Invariant chain structure and MHC class II function. Cell 84 (4) :505-507, 1996

PubMed

2) Long, E. O. and Wagtmann, N.:Natural killer cell receptors. Curr. Opin. Immunol. 9 (3) :344-350, 1997.

PubMed

2) Bergelson, J. M., Shepley, M. P., Chan, B. M. et al.:Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255 (5052) :1718-1720, 1992.

PubMed

2) Long, E. O. and Wagtmann, N.:Natural killer cell receptors. Curr. Opin. Immunol. 9 (3) :344-350, 1997.

PubMed

2) Kuno, K. and Matsushima, K.:The IL-1 receptor signaling pathway. J. Leukoc. Biol. 56 (5) :542-547, 1994.

PubMed

2) Gross, H. J., Merling, A., Moldenhauer, G. et al.:Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid. Blood 87 (12) :5113-5126, 1996.

2) Gross, H. J., Merling, A., Moldenhauer, G. et al.:Ecto-sialyltransferase of human B lymphocytes reconstitutes neuraminic acid. Blood 87 (12) :5113-5126, 1996.

2) Semenza, G.:Anchoring and biosynthesis of stalked brush border membrane proteins:glycosidases and peptidases of enterocytes and renal tubuli. Annu. Rev. Cell Biol. 2:255-313, 1986.

PubMed

2) Husten, L.:Receptor offers clues to how 'good' cholesterol works. Science 278 (5341) :1228, 1997.

PubMed

2) Miwa, H., Nakase, K. and Kita, K.:Biological characteristics of CD 7 (+) acute leukemia. Leuk. Lymphoma 21 (3-4) :239-244, 1996.

2) Akari, H., Yagita, H., Nishida, T. et al.:Selective expression of beta 7 integrin on lymphocytes undergoing apoptosis in lymphoid tissues. Biochem. Biophys. Res. Commun. 244 (2) :578-582, 1998.

PubMed

2) Belkin, V. M., Belkin, A. M. and Koteliansky, V. E.:Human smooth muscle VLA-1 integrin:purification, substrate specificity, localization in aorta, and expression during development. J. Cell Biol. 111 (5 Pt 1) :2159-2170, 1990.

2) Poggi, A., Tomasello, E. and Costa, P.:NKRP 1 A and p 40 molecules are involved in regulation of activation and maturation of human NK cells. Res. Immunol. 148 (3) :179-184, 1997.

2) Krammer, P. H., Dhein, J., Walczak, H. et al.:The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142:175-191, 1994.

PubMed

2) Pui, C. H., Behm, FG., Singh, B. et al:Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 75 (1) :198-202, 1990.

PubMed

2) Cresswell, P.:Proteases, processing, and thymic selection. Science 280 (5362) :394-395, 1998.

PubMed

2) Blair, A., Hogge, D. E., Ailles, L. E. et al.:Lack of expression of Thy-1 (CD 90) on acute myeloid leukemia cells long-term proliferative ability in vitro and in vivo. Blood 89 (9) :3104-3112, 1997.

2) O'Brien, A. D., Tesh, V. L., Donohue-Rolfe, A. et al.:Shiga toxin:biochemistry, genetics, mode of action, and role in pathogensis. Curr. Top. Microbiol. Immunol. 180:65-94, 1992

2) Kikutani, H., Kimura, R., Nakamura, H. et al.:Expression and function of an early activation marker restricted to human B cells. J. Immunol. 136:4019-4026, 1986.

2) Wright, M. D. and Tomlinson, M. G.:The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15 (12) :588-594, 1994.

PubMed

2) DeFranco, A. L.:Transmembrane signaling by antigen receptors of B and T lymphocytes. Curr. Opin. Cell Biol. 7 (2) :163-175, 1995.

2) Baorto, D. M., Gao, Z., Malaviya, R. et al.:Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 389 (6651) :636-639, 1997.

PubMed

2) Furie, B. and Furie, B. C.:Leukocyte crosstalk at the vascular wall. Thromb. Haemost. 78 (1) :306-309, 1997.

PubMed

2) Malavasi, F., Funaro, A., Roggero, S. et al.:Human CD 38:a glycoprotein in search of a function. Immunol. Today 15 (3) :95-97, 1994.

2) Carlsson, S. R., Roth, J., Piller, F. et al.:Isolation and characterization of human lysosomal membrane glycoproteins, h lamp-1 and h-lamp 2. Major sialoglycoproteins polylactosaminoglycan. J. Biol. Chem. 263 (35) :18911 18919, 1988.

2) Abi, Abitorabi, M., Pachynski, R. K., Ferrando, R. E. et al.:Presentation of integrins on leukocyte microvilli:a role for the extracellular domain in determining membrane localization. J. Cell Biol. 139 (2) :563-571, 1997.

2) Law, S. K., Micklem, K. J., Shaw, J. M. et al.:A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur. J. Immunol. 23 (9) :2320-2325, 1993.

PubMed

2) O'Neill, L. A. and Greene, C.:Signal transduction pathways activated by the IL-1 receptor family:ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63 (6) :650-657, 1998.

2) Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

2) Patarroyo, M. . Prieto, J., Rincon, J. et al.:Leukocyte cell adhesion:a molecular process fundamental in leukocyte physiology. Immunol. Rev. 114:67 108, 1990

2) Clifford, E. E., Martin, K. A., Dalal, P. et al.:Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5'-nucleotidase in myeloid leukocytes. Am. J. Physiol. 273 (3 Pt 1) :C 973-987, 1997.

2) Masuzawa, Y., Miyauchi, T., Hamanoue, M. et al.:A novel core protein ag. well as polymorphic epithelial mucin carry peanut agglutinin binding sites in human gastric carcinoma cells:sequence analysis and examination of gene expression. J. Biochem. (Tokyo) 112 (5) :609-615, 1992.

2) Bruggers, C. S., Patel, D. D., Scearce, R. M. et al.:AD 2, a human molecule involved in the interaction of T cells with epidermal keratinocytes and thymic epithelial cells. J. Immunol. 154:2012-2022, 1995.

2) Bajorath, J., Bowen, M. A. and Aruffo, A.:Molecular model of the N-terminal receptor-binding domain of the human CD 6 ligand ALCAM. Protein Sci. 4 (8) :1644-1647, 1995.

2) Bagot, M., Martinel, I., Charue, D. et al.:Functional role of CD 1010n skin dendritic cells. Adv. Exp. Med. Biol. 417:227-232, 1997.

2) Gordon, J., Katira, A., Holder, M. et al.:Central role of CD 40 and its ligand in B lymphocyte responses to T-dependent antigens. Cell. Mol. Biol. 40 Suppl 1:1-13, 1994.

2) Behrendt, N., Ronne, E., Ploug, M. et al.:The human receptor for urokinase plasminogen activator. NH 2-terminal amino acid sequence and glycosylation variants. J. Biol. Chem. 265 (11) :6453-6460, 1990.

2) Linsley, P. S. and Ledbetter, J. A.:The role of the CD28 receptor during T cell responses to antigen. Annu. Dev. Immunol. 11:191-212, 1993.

2) Kirschfink, M.:Controlling the complement system in inflammation. Immunopharmacology 38 (1-2) :51-62, 1997.

2) Kantor, A. B. and Herzenberg, L. A.:Origin of murine B cell lineages. Annu. Rev. Immunol. 11:501-538, 1993.

PubMed

2) Cheifetz, S., Bellon, T., Cales, C. et al.:Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J. Biol. Chem. 267 (27) :19027-19030, 1992.

PubMed

2) Farrar, M. A. and Schreiber, R. D.:The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571-611, 1993.

PubMed

2) Adachi, S., Ebi, Y., Nishikawa, S. et al.:Necessity of extracellular domain of W (c-kit) receptors for of murine cultured mast cells to fibroblasts. Blood 79 (3) :650 656, 1992.

2) Larson, R. S. and Springer, T. A.:Structure and function of leukocyte integrins. Immunol. Rev. 114:181-217, 1990.

PubMed

2) Broer, A. and Hamprecht, B.:Expression of the surface antigen 4F2 hc affects system-L-like neutral-amino-acid-transport activity in mammalian cells. Biochem. J. 324 (Pt 2) :535-541, 1997.

2) Maecker, H. T., Todd, S. C. and Levy, S.:The tetraspanin superfamily:molecular facilitators. FASEB J. 11 (6) :428-442, 1997.

2) Miyajima, A., Kinoshita, T., Wakao, H. et al.:Signal transduction by the GM-CSF, IL-3 and IL-5 receptors. Leukemia 11 (Suppl. 3) :418-422, 1997.

2) Larson, R. S. and Springer, T. A.:Structure and function of leukocyte integrins. Immunol. Rev. 114:181-217, 1990.

PubMed

2) Calvete, J. J.:Clues for understanding the structure and function of a prototypic human integrin:the platelet glycoprotein IIb/IIIa complex. Thromb. Haemost. 72 (1) :1-15, 1994.

PubMed

2) Daniels, G. L. and Knowles, R. W.:A monoclonal antibody to the high frequency red cell antigen JMH. J. Immunogenet. 9 (1) :57-59, 1982.

2) Maecker, H. T., Todd, S. C. and Levy, S.:The tetraspanin superfamily:molecular facilitators. FASEB J. II (6) :428-442, 1997.

2) Hamilton, J. A.:CSF-1 signal transduction. J. Leukoc. Biol 62 (2) :145-155, 1997.

PubMed

2) Shipp, M. A. and Look, A. T.:Hematopoietic differentiation antigens that are membrane-associated enzymes:cutting is the key! Blood 82 (4) :1052-1070, 1993.

PubMed

2) Wang, P. L., O'Farrell, S., Clayberger, C. et al.:Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily. J. Immunol. 148 (8) :2600-2608, 1992.

2) Bondanza, A., Leone, B. E., Manici, S. et al.:CD 14+CD 34+peripheral blood mononuclear cells migrate across endothelium and give rise to immunostimulatory dendritic cells. J. Immunol. 160 (6) :2675-2683, 1998.

2) de la Fuente, M. A., Pizcueta, P., Nadal, M. et al.:CD 84 leukocyte antigen is a new member of the Ig superfamily. Blood 90 (6) :2398-2405, 1997.

2) Hirohashi, N., Nakao, M., Kubo, K. et al.:A novel antigen (H47 Ag) on human lymphocytes involved in Tcell activation. Cell. Immunol. 152 (2) :371-382, 1993.

2) Rubinstein, E., Boucheix, C., Worthington, R. E. et al.:Anti-platelet antibody interactions with Fc gamma receptor. Semin. Thromb. Hemost. 21 (1) :10-22, 1995.

PubMed

2) June, C. H., Bluestone, J. A., Nadler, L. M. et al.:The B7 and CD28 receptor families. Immunol. Today 15:321-331, 1994.

PubMed

2) Ware, J.:Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb. Haemost. 79 (3) :466-478, 1998.

PubMed

2) Eichler, W., Aust, G. and Hamann, D.:Characterization of an early activation-dependent antigen on lymphocytes defined by the monoclonal antibody BL-Ac (F 2) . Scand. J. Immunol. 39 (1) :111-115, 1994.

2) Brashem-Stein, C., Nugent, D. and Bernstein, I. D.:Characterization of an antigen expressed on activated human T cells platelets. J. Immunol. 140 (7) :2330-2333, 1988.

2) Kay, T. W., Chaplin, HL., Parker, J. L. et al.:CD4' and CD8' T lymphocytes:clarification of their pathogellic roles ill diabetes in the NOD mouse. Ress. Immunol. 148 (5) :320327, 1997.

2) Bell, EB., Sparshott, SM. and Bunce, C.:CD4+ T-cell memory, CD 45 R subsets and the persistence of antigen-a unifying concept. Immunol. Today 19 (2) :60-64, 1998.

2) Haynes, B. F., Liao, H. X. and Patton, K. L.:The transmembrane hyaluronate receptor (CD 44) :multiple functions, multiple forms. Cancer Cells 3 (9) :347-350, 1991.

2) Jandrot-Perrus, M., Bouton, M. C., Lanza, F. et al.:Thrombin interaction with platelet membrane glyco-protein Ib. Semin. Thromb. Hemost. 22 (2) :151-156, 1996.

2) Timens, W. and Kamps, W. A.:Hemopoiesis in hurman fetal and embryonic liver. Microsc. Res. Tech. 39 (5) :387 397, 1997.

2) Cowan,. P. J., Tsang, D., Pedic, C. M. et al.:The human ICAM-2 promoter is endothelial cell-specific in vitro and in vivo and contains critical Sp1 and GATA binding sites. J. Biol. Chem. 273 (19) :11737-11744, 1998.

2) Ware, J.:Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb. Haemost. 79 (3) :466-478, 1998.

PubMed

2) Haynes, B. F., Liao, H. X. and Patton, K. L.:The transmembrane hyaluronate receptor (CD 44) :multiple functions, multiple forms. Cancer Cells 3 (9) :347-350, 1991.

2) Ware, J.:Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb. Haemost. 79 (3) :466-478, 1998.

PubMed

3) Bowen, M. A., Patel, D. D., Li, X. et al.:Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM) , a CD 6 ligand. J. Exp. Med. 181 (6) :2213-2220, 1995.

3) Kipps, T. J.:The CD 5 B cell. Adv. Immunol. 47:117-185, 1989.

3) Aruffo, A., Melnick, MB., Linsley, P. S. et al.:The lymphocyte glycoprotein CD 6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins. J. Exp. Med. 174 (4) :949-952, 1991.

3) Eichler, W., Hamann, J. and Aust, G.:Expression characteristics of the human CD 97 antigen. Tissue Antigens 50 (5) :429-438, 1997.

3) Aruffo, A. and Seed, B.:Molecular cloning of two CD 7 (T-cell leukemia antigen) cDNAs by a COS cell expression system. EMBO J. 6 (11) :3313-3316, 1987.

3) Ku, C. C., Kotzin, B., Kappler, J. et al. CD8' T cell clones in old mice. Immunol. Rev., 160, 139-144, 1997.

PubMed

3) Wright, M. D. and Tomlinson, M. G.:The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15 (12) :588-594, 1994.

PubMed

3) D'Adamio, L., Shipp, M. A., Masteller, E. L. et al.:Organization of the gene encoding common acute lymphoblastic 5'untranslated regions. Proc. Natl. Acad. Sci. USA 86 (18) :7103-7107, 1989.

PubMed

3) Lub, M., van Kooyk, Y. and Figdor, CG.:Ins and outs of LFA-1. Immunol. Today 16 (10) :479-483, 1995.

PubMed

3) Petty, H. R. and Todd, R. F.:Integrins as promiscuous signal transduction devices. Immunol. Today 17 (5) :209-212, 1996.

PubMed

3) Diaz, L. A. Jr., Friedman, A. W., He, X. et al.:Monocyte-dependent regulation of T lymphocyte activation through CD 98. Int. Immunol. 9 (9) :1221-1231, 1997.

3) Petty, H. R. and Todd, R. F.:Integrins as promiscuous signal transduction devices. Immunol. Today 5:209-212, 1996.

PubMed

3) Gaubin, M., Autiero, M., Houlgatte, R. et al.:Molecular basis of T lymphocyte CD 4 antigen functions. Eur. J. Clin. Chem. Clin. Biochem. 34 (9) :723-728, 1996.

3) Stain, C., Stockinger, H., Scharf, M. et al.:Human blood basophils display a unique phenotype including activation linked membrane structures. Blood 70 (6) :1872-1879, 1987.

PubMed

3) Shipp, M. A. and Look, A. T.:Hematopoietic differentiation antigens that are membrane-associated enzymes:cutting is the key! Blood 82 (4) :1052-1070, 1993.

PubMed

3) Wange, R. L. and Samelson, LE.:Complex complexes:signaling at the TCR. Immunity 5 (3) :197-205, 1996

PubMed

3) Bufler, P., Stiegler, G., Schuchmann, M. et al.:Soluble lipopolysaccharide receptor (CD 14) is released via two different mechanisms from human monocytes and CD 14 transfectants. Eur. J. Immunol. 25 (2) :604-610, 1995.

3) Eggens, I., Fenderson, B., Toyokuni, T. et al.:Specific interaction between Lex and Lex determinants. A possible for cell recognition in preimplantation embryos and in embryonal carcinoma cells. J. Biol. Chem. 264 (16) :9476-9484, 1989.

PubMed

3) Bochner, B. S., Sterbinsky, S. A., Briskin, M. et al.:Counter-receptors on human basophils for endothelial cell adhesion molecules. J. Immunol. 157 (2) :844-850, 1996.

PubMed

3) Huang, M. T.:T cell development in CD 3-zeta mutant mice. Int. Rev. Immunol. 13 (1) :29-41, 1995.

3) Farber, D. L. and Sears, D. W.:Rat CD 16 is defined by a family of class III Fc gamma receptors requiring co-expression of heteroprotein subunits. J. Immunol. 146 (12) :43524361, 1991.

3) Kojima, N. and Hakomori, S.:Cell adhesion, spreading, and motility of GM 3-expressing cells based on glycolipid-glycolipid interaction. J. Biol. Chem. 266:17552-17558, 1991.

3) Patarroyo, M., Prieto, J., Rincon, J. et al.:Leukocyte-cell adhesion:a molecular process fundamental in leukocyte physiology. Immunol Rev. 114:67-108, 1990.

PubMed

3) Bernard, A., Aubrit, F., Raynal, B. et al.:A T cell surface molecule different from CD 2 is involved in spontaneous rosette formation with erythrocytes. J. Immunol. 140 (6) :1802 1807, 1988.

3) Tedder, T. F., Zhou, L. J. and Engel, P.:The CD 19/CD 21 signal transduction complex of B lymphocytes. Immunol. Today 15 (9) :437-442, 1994.

3) Holter, W., Schwarz, M., Cerwenka, A. et al.:The role of CD 2 as a regulator of human T-cell cytokine production. Immunol. Rev. 153:107-122, 1996.

3) Bubien, J. K., Kirk, K. L., Rado, T. A. et al.:Cell cycle dependence of chloride permeability in normal and cystic fibrosis lymphocytes. Science 248 (4961) :1416-1419, 1990.

PubMed

3) Doody, G. M., Dempsey, P. W. and Fearon, D. T.:Activation of B lymphocytes :integrating signals from CD 19, CD 22 and gamma RIIb1. Curr. Opin. Immunol. 8 (3) :378-382, 1996.

3) Craig, W., Kay, R., Cutler, R. L. et al.:Expression of Thy-1 on human hematopoietic progenitor cells. J. Exp. Med. 177 (5) :1331-1342, 1993.

PubMed

3) Maher, J. K. and Kronenberg, M.:The role of CD 1 molecules in immune responses to infection. Curr. Opin. Immunol. 9 (4) :456-461, 1997.

3) Law, C. L., Sidorenko, S. P. and Clark, E. A.:Regulation of lymphocyte activation by the cell-surface molecule. Immunol. Today 15 (9) :442-449, 1994.

PubMed

3) Mudde, G. C., Bheekha, R. and Bruijnzeel-Koomen, C. A.:Consequences of IgE/CD 23-mediated antigen presentation in allergy. Immunol Today 16 (8) :380-383, 1995.

3) Chappel, M. S., Hough, M. R., Mittel, A. et al.:Cross-linking the murine heat stable antigen induces apoptosis in B cell precursors and Lsuppresses the anti-CD 40 induced proliferation of mature resting B lymphocytes. J. Exp. Med. 184 (5) :1638 1649, 1996.

3) Sondel, P. M., Voss, S. D. and Hong, R.:Addendum to SCID, interleukin-2, and the interleukin-2 receptor review. Blood 84 (2) :667-668, 1994.

PubMed

3) Franco, R., Valenzuela, A., Lluis, C. et al.:Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol. Rev. 161:27-42, 1998.

PubMed

3) Hall, K. T., Boumsell, L., Schultze, J. L. et al.:Human CD 100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc. Natl. Acad. Sci. USA 93 (21) :11780-11785, 1996.

3) Bigler, R. D., Bushkin, Y. and Chiorazzi, N.:S 152 (CD 27) . A modulating disulfide-linked T cell activation antigen. J. Immunol. 141 (1) :21-28, 1988.

3) Ledbetter, J. A:The role of the CD 28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-212, 1993.

3) Hynes, R. O.:Integrins:versatility, modulation, and signaling in cell adhesion. Cell 69 (1) :11-25, 1992.

PubMed

3) Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

3) Watt, S. M., Gschmeissner, S. E. and Bates, P. A.:PECAM-1:its expression and function as a cell adhesion molecule on hemopoietic and endothelial cells. Leuk. Lymphoma 17 (3-4) :229-244, 1995.

3) Scharenberg, A. M. and Kinet, J. P.:The emerging field of receptor mediated inhibitory signaling:SHP or SHIP? Cell 87 (6) :961 964, 1996.

PubMed

3) Caron, P. C., Jurcic, J. G., Scott, A. M. et al.:Aphase 1 B trial of humanized monoclonal antibody M195 (anti-CD 33) myeloid leukerpia:specific targeting without immunogenicity. Blood 83 (7) :1760-1768, 1994.

3) Link, H. and Arseniev, L.:CD 34 positive blood cells for allogeneic progenitor and stem cell transplantation. Leuk. Lymphoma 26 (5-6) :451-465, 1997.

3) Hourcade, D., Holers, V. M. and Atkinson, J. P.:The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 45:381-416, 1989.

PubMed

3) Lynch, D. H., Ramsdell, F. and Alderson, M. R.:Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16 (12) :569-574, 1995.

PubMed

3) Krieger, M. and Herz, J.:Structures and functions of multiligand lipoprotein receptors:macrophagescavenger receptors and LDL receptor-related protein (LRP) . Annu. Rev. Biochem. 63:60-637, 1994.

3) Angelisova, P., Hilgert, I. and Horejsi, V.:Association of four antigens of the tetraspans family (CD 37, CD 53, 1, and R 2/C 33) with MHC class II glycoproteins. Immunogenetics 39 (4) :249-256, 1994.

3) Mehta, K., Shahid, U. and Malavasi, F.:Human CD 38, a cell surface protein with multiple functions. FASEB J. 10 (12) :1408-1417, 1996.

3) Gayle, R. B., Maliszewski, C. R., Gimpel, S. D. et al.:Inhibition of platelet function by recombinant soluble ecto-ADPase/CD 39. J. Clin. In vest. 101 (9) :1851-1859, 1998.

3) Gordon, J.:CD 40 and its ligand:central players in B lymphocyte survival, growth, and differentiation. Blood Rev. 9 (1) :53-56, 1995.

3) Gouttefangeas, C., Jacquot, S., Meffre, E. et al.:Differential proliferative responses in subsets of human CD 28+ cells delineated by BB 27 mAb. Int. Immunol. 6 (3) :423-430, 1994.

3) Cines, D. B.:Glycoprotein IIb/IIIa antagonists:potential induction and detection of drug-dependent anti-platelet antibodies. Am. Heart J. 135 (5 Pt 2 Su) :S 152-159, 1998.

3) Bastian, L. S., Yagi, M., Chan, C. et al.:Analysis of the megakaryocyte glycoprotein IX promoter identifies positive and negative regulatory domains and functional GATA and Ets sites. J. Biol. Chem. 271 (31) :18554-18560, 1996.

3) Lopez, J. A. and Dong, J. F.:Structure and function of the glycoprotein Ib-IX-V complex. Curr. Opin. Haemostl. 4 (5) :323-329, 1997.

3) Clemetson, K. J., McGregor, J. L., James, E. et al.:Characterization of the platelet membrane glycoprotein abnormalities Bernard-Soulier syndrome and comparison with normal by surface-techniques and high-resolution two-dimensional gel electrophoresis. J. Clin. Invest. 70 (2) :304-311, 1982.

PubMed

3) Dong, J. F., Sae-Tung, G. and Lopez, J. A.:Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site. Blood 89 (12) :4 355-4363, 1997.

3) Alvarado, M., Klassen, C., Cerny, J. et al.:MEM 59 momclonal antibody detects a CD 43 epitope involved in lymphocyte activation. Eur. J. Immunol. 25 (4) :1051-1055, 1995.

3) Damle, N. K., Klussman, K. and Aruffo, A.:Intercellular adhesion molecule-2, a second counter-receptor for CD 11a/CD 18 (leukocyte function-associated antigen-1) , provides a costimulatory signal for T-cell receptor-initiated activation of human T cells. J. Immunol. 148 (3) :665-671, 1992.

3) Lesley, J., Hyman, R. and Kincade, P. W.:CD 44 and its interaction with extracellular matrix. Adv. Immunol. 54:271-335, 1993.

3) Lesley, J., Hyman, R. and Kincade, PW.:CD 44 and its interaction with extracellular matrix. Adv. Immunol. 54:271 335, 1993.

3) Barclay, A. N. and McCall, M. N.:CD 45;from alloantigen to mapping of restricted epitopes using recombinant soluble CD 45 isoforms. Biochem. Soc. Trans. 20 (1) :161-164, 1992.

3) Liszewski, M. K., Post, T. W. and Atkinson, J. P.:Membrane cofactor protein (MCP or CD 46) :newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431-455, 1991.

3) Hara, H. and Seon, B. K.:Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins:nude mouse models. Proc. Natl. Acad. Sci. USA 84 (10) :3390-3394, 1987.

PubMed

3) Pulford, K., Micklem, K., McCarthy, S. et al.:A monocyte/macrophage antigen recognized by the four antibodies Ber-MAC 3, Ki M 8 and SM 4. Immunology 75 (4) :588 595, 1992.

3) Brown, E., Hooper, L., Ho, T. et al.:Integrin-associated protein:a 50-kD plasma membrane antigen physically and functionally associated with integrins. J. Cell Biol. 111 (6 Pt 1) :2785-2794, 1990.

3) McEver, R. P. and Cummings, R. D.:Perspectives series:cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J. Clin. Invest. 100 (3) :485-491, 1997.

PubMed

3) Griscelli-Bennaceur, A., Gluckman, E., Scrobohaci, M. L. et al.:A plastic anemia and paroxysmal nocturnalhemoglobinuria:search for a pathogenetic link. Blood 85 (5) :1354-1363, 1995.

3) See, D. M., Khemka, P., Sahl, L. et al.:The role of natural killer cells in viral infections. Scand. J. Immunol. 46 (3) :217-224, 1997.

PubMed

3) Briesewitz, R., Epstein, M. R. and Marcantonio, E. E.:Expression of native and truncated forms of the human integrin alpha 1 subunit. J. Biol. Chem. 268 (4) :2989-2996, 1993.

PubMed

3) Mingari, M. C., Moretta, A. and Moretta, L.:Regulation of KIR expression in human T cells:a safety mechanism that may impair protective T-cell responses. Immunol. Today 19 (4) :153-157, 1998.

3) Chan, B. M., Matsuura, N., Takada, Y. et al.:In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 251 (5001) :1600-1602, 1991.

PubMed

3) Benmerah, A., Badrichani, A., Ngohou, K. et al.:Homotypic aggregation of CD 103 (alpha E beta 7) + lymphocytes by an anti CD 103 antibody, HML-4. Eur. J. Immunol. 24 (9) :2243-2249, 1994.

3) Mingari, M. C., Moretta, A. and Moretta, L.:Regulation of KIR expression in human T cells:a safety mechanism that may impair protective T cell responses. Immunol Today 19 (4) :153-157, 1998.

3) Carter, W. G., Wayner, E. A., Bouchard, T. S. et al.:The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell. substrate adhesion of human epidermal cells. J. Cell Biol. 110 (4) :1387 1404, 1990.

3) Hirata, Y., Kimura, N., Sato, K. et al.:ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1. FEBS Lett. 356 (2-3) :244-248, 1994.

3) Alon, R., Kassner, P. D., Carr, MW. et al.:The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128 (6) :1243-1253, 1995.

PubMed

3) Wolfsberg, T. G. and White, J. M.:ADAMs in fertilization and development. Dev. Biol. 180 (2) :389-401, 1996.

PubMed

3) Bernhardt, G., Harber, J., Zibert, A. et al.:The poliovirus receptor:identification of domains and amino acid residues critical for virus binding. Virology 203 (2) :344-356, 1994.

PubMed

3) Argraves, W. S., Suzuki, S., Arai, H. et al.:Amino acid sequence of the human fibronectin receptor. J. Cell Biol. 105 (3) :1183-1190, 1987.

PubMed

3) Callard, R. E., Armitage, R. J., Fanslow, W. C. et al.:CD 40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14 (11) :559-564, 1993.

3) Delwel, G. O., Kuikman, I. and Sonnenberg, A.:An alternatively spliced exon in the extracellular domain of the human alpha 6 integrin subunit-functional analysis of the alpha 6 integrin variants. Cell Adhes. Commun. 3 (2) :143-161, 1995.

PubMed

3) Amakawa, R., Hakem, A., Kundig, T. M. et al.:Impaired negative selection of T cells in Hodgkin's disease antigen CD 30-deficient mice. Cell 84 (4) :551-562, 1996.

3) Campanero, M. R., del Pozo, M. A., Arroyo, A. G. et al.:ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J. Cell Biol. 123 (4) :1007-1016, 1993.

PubMed

3) Linsley, P. S. and Golstein, P.:Lymphocyte activation:T-cell regulation by CTLA-4. Curr. Biol. 6 (4) :398-400, 1996.

PubMed

3) Hynes, R. O.:Integrins:versatility, modulation, and signaling in cell adhesion. Cell 69 (1) :11-25, 1992.

PubMed

3) Fitter, S., Tetaz, T. J., Berndt, M. C. et al.:Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3. Blood 86 (4) :1348-1355, 1995.

PubMed

3) Kirchhoff, C. and Hale, G.:Cell-to-cell transfer of glycosylphosphatidylinositol-anchored membrane proteins during sperm maturation. Mol. Hum. Reprod. 2 (3) :177-184, 1996.

PubMed

3) Cocks, B. G., Chang, C. C., Carballido, J. M. et al.:A novel receptor involved in T-cell activation. Nature 376 (6537) :260-263, 1995.

3) Bell, G. M., Seaman, W. E., Niemi, E. C. et al.:The OX-44 molecule couples to signaling pathways and is associated with CD 2 on rat T lymphocytes and a natural killer cell line. J. Exp. Med. 175 (2) :527-536, 1992.

3) Long, E. O. and Wagtmann, N.:Natural killer cell receptors. Curr. Opin. Immunol. 9 (3) :344-350, 1997.

PubMed

3) de la Fuente Garcia, M. A., Nicolas, J. M., Freed, J. P. E. et al.:CD 148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 91 (8) :2800-2809, 1998.

3) Ohh, M. and Takei, F.:New insights into the regulation of ICAM-1 gene expression. Leuk. Lymphoma 20 (3-4) :223-228, 1996.

3) Biswas, C.:Tumor cell stimulation of collagenase production by fibroblasts. Biochem. Biophys. Res. Commun. 109 (3) :1026-1034, 1982.

PubMed

3) Bardin, N., Frances, V., Combes, V. et al.:CD 146:biosynthesis and production of a soluble form in human cultured endothelial cells. FEBS Lett. 421 (1) :12-14, 1998.

3) Nicholson-Weller, A. and Wang, C. E.:Structure and function of decay accelerating factor CD 55. J. Lab. Clin. Med. 123 (4) :485-491, 1994.

3) Koho, H., Paulie, S., Ben-Aissa, H. et al.:Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence. Cancer Immunol. Immunother. 17 (3) :165-172, 1984.

PubMed

3) Breier, G., Breviario, F., Caveda, L. et al.:Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood 87 (2) :630-641, 1996.

PubMed

3) Baldwin, T. J., Fazeli, M. S., Doherty, P. et al.:Elucidation of the molecular actions of NCAM and structurally related cell adhesion molecules. J. Cell. Biochem. 61 (4) :502-513, 1996.

PubMed

3) Singer, D. R., Missouris, C. G. and Jeffery, S.:Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion. Circulation 94 (3) :236-239, 1996.

3) Abo, T., Cooper, M. D. and Balch, C. M.:Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J. Immunol. 129 (4) :1752-1757, 1982.

PubMed

3) Arulanandam, A. R., Kister, A., McGregor, M. J. et al.:Interaction between human CD 2 and CD 58 involves the major beta sheet surface of each of their respective adhesion domains. J. Exp. Med. 180 (5) :1861-1871, 1994.

3) Ruf, W. and Mueller, B. M.:Tissue factor in cancer angiogenesis and metastasis. Curr. Opin. Hematol. 3 (5) :379-384, 1996.

PubMed

3) Liszewski, M. K., Farries, T. C., Lublin, D. M. et al.:Control of the complement system. Adv. Immunol. 61:201-283, 1996.

PubMed

3) Ohlin, A. K., Norlund, L. and Marlar, R. A.:Thrombomodulin gene variations and thromboembolic disease. Thromb. Haemost. 78 (1) :396-400, 1997.

PubMed

3) Kniep, B., Flegel, W. A., Northoff, H. et al.:CDw 60 glycolipid antigens of human leukocytes:structural characterization and cellular distribution. Blood 82 (6) :1776-1786, 1993.

3) Kieffer, N. and Phillips, D. R.:Platelet membrane glycoproteins:functions in cellular interactions. Annu. Rev. Cell. Biol. 6:329-357, 1990.

PubMed

3) Claesson-Welsh, L.:Mechanism of action of platelet-derived growth factor. Int. J. Biochem. Cell Biol. 28 (4) :373-385, 1996.

PubMed

3) Hardie, D. L., Hill, D. S., Casamayor, M. et al.:Leukocyte Typing VI section B 28. 4/642.

3) Elenius, K. and Jalkanen, M.:Function of the syndecans-a family of cell surface proteoglycans. J. Cell Sci. 107 (Pt 11) :2975-2982, 1994.

3) Tedder, T. F., Steeber, D. A., Chen, A. et al.:The selectins:vascular adhesion molecules. FASEB J. 9 (10) :866-873, 1995.

PubMed

3) Alderson, M. R., Smith, C. A., Tough, T. W. et al.:Molecular and biological characterization of human 4-1 BB and its ligand. Eur. J. Immunol. 24 (9) :2219-2227, 1994.

3) Lasky, L. A.:Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu. Rev. Biochem. 64:113-139, 1995.

PubMed

3) Gaudino, G., Avantaggiato, V., Follenzi, A. et al.:The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 11 (12) :2627-2637, 1995.

PubMed

3) Lyman, S. D. and Jacobsen, S. E.:c-kit ligand and Flt 3 ligand:stem/progenitor cell factors with overlapping yet distinct activities. Blood 91 (4) :1101-1134, 1998.

PubMed

3) Lasky, L. A.:Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu. Rev. Biochem. 64:113-139, 1995.

PubMed

3) Weinberg, A. D.:Antibodies to OX-40 (CD 134) can identify and eliminate autoreactive T cells:implications for human autoimmune disease. Mol. Med. Today 4 (2) :76-83, 1998.

3) Sugamura, K., Asao, H., Kondo, M. et al.:The common gamma-chain for multiple cytokine receptors. Adv. Immunol. 59:225-277, 1995.

PubMed

3) Berditchevski, F., Bazzoni, G. and Hemler, M. E:Specific association of CD 63 with the VLA-3 and VLA-6 integrins. J. Biol. Chem. 270 (30) :17784-17790, 1995.

3) van de Winkel, J. G. and Capel, P. J.:Human IgG Fc receptor heterogeneity:molecular aspects and clinical implications. Immunol. Today 14 (5) :215 221, 1993.

3) Dirksen, U., Nishinakamura, R., Groneck, P. et al.:Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J. Clin. Invest. 100 (9) :2211-2217, 1997.

PubMed

3) Taga, T. and Kishimoto, T.:Gp 130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:797-819, 1997.

3) Knapp, W., Strobl, H. and Majdic, O.:Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry 18 (4) :187-198, 1994.

PubMed

3) Chen, T., Grunert, F., Medina-Marino, A. et al.:Several carcinoembryonic antigens (CD 66) serve as receptors for gonococcal opacity proteins. J. Exp. Med. 185 (9) :1557-1564, 1997.

3) Harada, A., Sekido, N., Akahoshi, T. et al.:Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol. 56 (5) :559-564, 1994.

PubMed

3) Arakawa, F., Kuroki, M., Misumi, Y. et al.:Characterization of a cDNA clone encoding a new species of the nonspecific cross-reacting antigen (NCA) , a member of the CEA gene family. Biochem. Biophys. Res. Commun. 166 (3) :1063-1071, 1990.

PubMed

3) Adachi, S., Yoshida, H., Honda, K. et al.:Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage. Int. Immunol. 10 (1) :1-6, 1998.

PubMed

3) Chen, T., Grunert, F., Medina-Marino, A. et al.:Several carcinoembryonic antigens (CD 66) serve as receptors for gonococcal opacity proteins. J. Exp. Med. 185 (9) :1557-1564, 1997.

3) Simpson, R. J., Hammacher, A., Smith, D. K. et al.:Interleukin 6:structure function relationships. Protein. Sci. 6 (5) :929-955, 1997.

PubMed

3) Chen, T. and Gotschlich, E. C.:CGMla antigen of neutrophils, a receptor of gonococcal opacity proteins. Proc. Natl. Acad. Sci. USA 93 (25) :14851-14856, 1996.

PubMed

3) Thompson, J. A., Grunert, F. and Zimmermann, W.:Carcinoembryonic antigen gene family:molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5 (5) :344-366, 1991.

PubMed

3) Moestrup, S. K., van den Berg, B. M., Pannekoek, H. et al.:Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library. J. Biol. Chem. 270 (20) :11770-11775, 1995.

3) Oikawa, S., Inuzuka, C., Kuroki, M. et al.:A pregnancy-specific beta 1-glycoprotein, a CEA gene family member, expressed in a human promyelocytic leukemia cell line, HL-60:structures of protein, mRNA and gene. Biochem. Biophys. Res. Commun. 163 (2) :1021-1031, 1989.

3) Holness, C. L. and Simmons, D. L.:Molecular cloning of CD 68, a human macrophage marker related to lysosomal glycoproteins. Blood 81 (6) :1607-1613, 1993.

3) Corrales, J. J., Lopez, A., Ciudad, J. et al.:Methimazole therapy in Graves' disease influences the abnormal expression of CD 69 (early activation antigen) on T cells. J. Endocrinol. 155 (3) :491-500, 1997.

3) Miyajima, A., Kinoshita, T., Wakao, H. et al.:Signal transduction by the GM-CSF, IL-3 and IL-5 receptors. Leukemia 11 (Suppl. 3) :418-422, 1997.

3) Hintzen, R. Q., Lens, S. M., Koopman, G. et al.:CD 70 represents the human ligand for CD 27. Int. Immunol. 6 (3) :477-480, 1994.

3) Biffo, S., Sanvito, F., Costa, S. et al.:Isolation of a novel beta 4 integrin-binding protein (p 27 (BBP)) highly expressed in epithelial cells. J. Biol. Chem. 272 (48) :30314-30321, 1997.

3) Testa, U., Pelosi, E. and Peschle, C. . The transferrin receptor. Crit. Rev. Oncog. 4 (3) :241-276, 1993.

PubMed

3) Yanagihara, Y., Ikizawa, K., Kajiwara, K. et al.:Functional significance of IL-4 receptor on B cells in IL-4-induced human IgE production. J. Allergy Clin. Immunol. 96 (6 Pt 2) :1145-1151, 1995.

3) Beavil, A. J., Edmeades, R. L., Gould, H. J. et al.:Alpha-helical coiled-coil stalks in the low-affinity receptor for IgE (Fc epsilon RII/CD 23) and related C-type lectins. Pro. Natl. Acad. Sci. USA 89 (2) :753-757, 1992.

3) Bagley, C. J., Phillips, J., Cambareri, B. et al.:A discontinuous eight-amino acid epitope in human interleukin-3 binds the alpha-chain of its receptor. J. Biol. Chem. 271 (50) :31922-31928, 1996.

3) Airas, L., Hellman, J., Salmi, M. et al.:CD 73 is involved in lymphocyte binding to the endothelium:characterization of lymphocyte vascular adhesion protein 2 identifies it as CD 73. J. Exp. Med. 182 (5) :1603-1608, 1995.

3) Minami, Y. and Taniguchi, T.:IL-2 signaling:recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. Curr. Opin. Cell Biol. 7 (2) :156-162, 1995.

PubMed

3) Bakke, O. and Dobberstein, B.:MHC class II-associated invariant chain contains a sorting signal fo endosomal compartments. Cell 63 (4) :707-716, 1990.

3) O'Neill, L. A. and Greene, C.:Signal transduction pathways activated by the IL-1 receptor family:ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63 (6) :650-657, 1998.

3) Keppler, O. T., Moldenhauer, G., Oppenlander, M. et al.:Human Golgi beta-galactoside alpha-2, 6-sialyltransferase generates a group of sialylated B lymphocyte differentiation antigens. Eur. J. Immunol. 22 (11) :2777-2781, 1992.

PubMed

3) Brodin, N. T., Dahmen, J., Nilsson, B. et al.:Monoclonal antibodies produced by immunization with neoglycoproteins containing Gal alpha 1-4 Gal beta 1-4 Glc beta-O and Gal alpha 1-4 Gal beta 1-4 GlcNAc beta-O residues:useful immunochemical and reagents for blood group P antigens and a differentiation marker in Burkitt lymphoma and other B-cell malignancies. Int. J. Cancer 42 (2) :185-194, 1988.

3) Sims, J. E., Giri, J. G. and Dower, S. K.:The two interleukin-1 receptors play different roles in IL-1 actions. Clin. Immunol. Immunopathol. 72 (1) :9-14, 1994.

PubMed

3) Kikutani, H., Nakamura, H., Sato, R. et al.:Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody. J. Immunol. 136:4027-4034, 1986.

3) Desiderio, S.:The B cell antigen receptor in B-cell development. Curr. Exp. Immunol. 6 (2) :248-256, 1994.

3) Smith, C. A., Farrah, T. and Goodwin, R. G.:The TNF receptor superfamily of cellular and viral proteins:activation, costimulation, and death. Cell 76 (6) :959-962, 1994.

PubMed

3) Lenschow, D. J., Walunas, T. L. and Bluestone, J. A.:CD28/B7 system of T cell costimulation. Annu. Dev. Immunol. 14:233-258, 1996.

3) Jouanguy, E., Altare, F., Lamhamedi-Cherradi, S. et al.:Infections in IFNγR-1-deficient children. J. Interferon Cytokine Res. 17 (10) 6:583-587, 1997.

3) Akashi, K., Kondo, M. and Weissman, I. L.:Two distinct pathways of positive selection for thymocytes. Proc. Natl. Acad. Sci. USA 95 (5) :2486 2491, 1998.

3) Wright, M. D. and Tomlinson, M. G.:The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15 (12) :588-594, 1994.

PubMed

3) Gallione, C. J., Klaus, D. J., Yeh, E. Y. et al.:Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum. Mutat. 11 (4) :286-294, 1998.

PubMed

3) Crosier, K. E., Wong, G. G., Mathey-Prevot, B. et al.:A functional isoform of the human granulocyte/macrophage colony-stimulating factor receptor has an unusual cytoplasmic domain. Proc. Natl. Acad. Sci. USA 88 (17) :7744-7748, 1991.

PubMed

3) Wright, M. D. and Tomlinson, M. G.:The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15 (12) :588-594, 1994.

PubMed

3) Sherr, C. J.:Colony-stimulating factor-1 receptor. Blood 75 (1) :1-12, 1990.

PubMed

3) Kozlow, E. J., Wilson, G. L., Fox, C. H. et al.:Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes. Blood 81 (2) :454-461, 1993.

PubMed

3) Pulford, K., Micklem, K., Thomas, J. et al.:A 72-kD B cell-associated surface glycoprotein expressed at high levels in hairy cell leukaemia and plasma cell neoplasms. Clin. Exp. Immunol. 85 (3) :429-435, 1991.

3) Lenschow, D. J., Walunas, T. L. and Bluestone, J. A.:CD 28/B 7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258, 1996.

3) Tidow, N. and Welte, K.:Advances in understanding postreceptor signaling in response to granulocyte colony-stimulating factor. Curr. Opin. Hematol. 4 (3) :171-175, 1997.

PubMed

3) Haregewoin, A., Solomon, K., Hom, R. C. et al.:Cellular expression of a GPI-linked T cell activation protein. Cell Immunol. 156 (2) :357-370, 1994.

PubMed

3) Daniels, G. L. and Knowles, R. W.:Further analysis of the monoclonal antibody H8 demonstrating a JMH-related specificity. J. Immunogenet. 10 (3) :257-258, 1983.

PubMed

3) Bianchi, E., Cohen, R. L., Thor, A. T. et al.:The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res. 54 (4) :861-866, 1994.

3) Carlsson, S. R., Lycksell, P. O. and Fukuda, M.:Assignment of O glycan attachment sites to the hinge-like regions of human lysosomal membrane glycoproteins lamp-1 and lamp-2. Arch. Biochem. Biophys. 304 (1) :65-73, 1993.

3) Ye, R. D. and Boulay, F.:Structure and function of leukocyte chemoattractant receptors. Adv. Pharmacol. 39:221-289, 1997.

PubMed

3) Carlsson, S. R., Lycksell, P. O. and Fukuda, M.:Assignment of O-glycan attachment sites to the hinge-like regions of human lysosomal membrane glycoproteins lamp-1 and lamp-2. Arch. Biochem. Biophys. 304 (1) :65-73, 1993.

3) Morton, H. C., van Egmond, M. and van de Winkel, J. G.:Structure and function of human lgA Fc receptors (Fc alpha R) . Crit. Rev. Immumol. 16 (4) :423 440, 1996.

3) Gearing, A. J. and Newman, W.:Circulating adhesion molecules in disease. Immunol. Today 14 (10) :506-512, 1993.

PubMed

4) Tracey, K. J. and Cerami, A.:Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9:317-343, 1993.

PubMed

4) Rosen, S. D. and Bertozzi, C. R.:Two selectins converge on sulphate. Leukocyte adhesion. Curr. Biol. 6 (3) :261-264, 1996.

PubMed

4) Guerin, S., Mari, B., Maulon, L. et al.:CD 10 plays a specific role in early thymic development. FASEB J. 11 (5) :376-381, 1997.

4) Giancotti, F. G. and Ruoslahti, E.:Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 60 (5) :849-859, 1990.

PubMed

4) al-Shamkhani, A., Birkeland, M. L., Puklavec, M. et al.:OX 40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX 40 ligand. Eur. J. Immunol. 26 (8) :1695-1699, 1996.

4) Fisher, R. C. and Thorley-Lawson, D. A.:Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD 48) . Mol. Cell. Biol. 11 (3) :1614-1623, 1991.

4) Bellacosa, A., Lazo, P. B. S. E. and Tsichlis, P. N.:The rat leukocyte antigen MRC OX-44 is a member of a new family of cell surface proteins which appear to be involved in growth regulation. Mol. Cell. Biol. 11 (5) :2864-2872, 1991.

4) Classon, B. J., Williams, A. F., Willis, A. C. et al.:The primary structure of the human leukocyte antigen CD 37, a species homologue of the rat MRC OX-44 antigen. J. Ejep. Med. 169 (4) :1497-1502, 1989.

4) Chen, T., Grunert, F., Medina-Marino, A. et al.:Several carcinoembryonic antigens (CD 66) serve as receptors for gonococcal opacity proteins. J. Exp. Med. 185 (9) :1557-1564, 1997.

4) Reth, M.:Antigen receptors on B lymphocytes. Annu. Rev. Immunol. 10:97-121, 1992.

4) Hamann, J., Eichler, W., Hamann, D. et al.:Expression cloning and chromosomal mapping of the leukocyte antigen CD 97, a new seven-span transmembrane molecule of the receptor superfamily with an unusual extracellular domain. J. Immunol. 155 (4) :1942-1950, 1995.

4) Mudad, R., Rao, N., Angelisova, P. et al.:Evidence that CDw108 membrane protein bears the JMH blood group. Transfusion 35 (7) :566-570, 1995.

PubMed

4) Moretta, A., Bottino, C., Vitale, M. et al.:Receptors for HLA class I molecules in human natural killer cells. Annu. Rev. Immunol. 14:619 648, 1996.

4) Ware, J.:Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb. Haemost. 79 (3) :466-478, 1998.

PubMed

4) Honda, H., Inazawa, J., Nishida, J. et al.:Molecular cloning, characterization, and chromosomal localization of a novel protein-tyrosine phosphatase, HPTP eta. Blood 84 (12) :4186-4194, 1994.

PubMed

4) Berditchevski, F., Zutter, M. M. and Hemler, M. E.:Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM 4 proteins) . Mol. Biol. Cell 7 (2) :193-207, 1996.

4) Bubien, J. K., Zhou, L. J., Bell, P. D. et al.:Transfection of the CD 20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes. J. Cell Biol. 121 (5) :1121-1132, 1993.

4) Schwartz, M. A., Schaller, M. D. and Ginsberg, M. H.:Integrins:emerging paradigms of signal transduction. Annu. Rev. Cell. Dev. Biol. 11:549-599, 1995.

PubMed

4) Rosen, S. D. and Bertozzi, C. R.:Two selectins converge on sulphate. Leukocyte adhesion. Curr. Biol. 6 (3) :261-264, 1996.

PubMed

4) van de Stolpe, A. and van der Saag, P. T.:Intercellular adhesion molecule-1. J. Mol. Med. 74 (1) :13-33, 1996.

PubMed

4) Rivas, A., Ruegg, C. L., Zeitung, J. et al.:V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies. J. Immunol. 154 (9) :4423-4433, 1995.

4) Foy, T. M., Aruffo, A., Balorath, J. et al.:Immune regulation by CD 40 and its ligand GP 39. Annu. Rev. Immunol. 14:591-617, 1996.

4) Freidman, A. W., Diaz, L. A. Jr., Moore, S. et al.:The human 4F2 antigen:evidence for cryptic and noncryptic epitopes and for a role of 4F2 in human T lymphocyte activation. Cell. Immunol. 154 (1) :253-263, 1994.

4) Bajorath, J., Bowen, M. A. and Aruffo, A.:Molecular model of the N-terminal receptor-binding domain of the CD 6 ligand ALCAM. Protein Sci. 4 (8) :1644-1647, 1995.

4) Zbar, A. P., Lemoine, N. R., Wadhwa, M. et al.:Biological therapy:approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target. Br. J. Cancer 77 (5) :683-693, 1998.

PubMed

4) Akeson, A. L., Woods, C. W., Hsieh, L. C. et al.:AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL) -1 receptor and blocks in vivo responses to IL-1. J. Biol. Chem. 271 (48) :30517-30523, 1996.

PubMed

4) Lynch, D. H.:Induction of dendritic cells (DC) by Flt 3 Ligand (FL) promotes the generation of tumor specific immune responses in vivo. Crit. Rev. Immunol. 18 (1-2) :99-107, 1998.

4) Naor, D., Sionov, R. V., Zahalka, M. et al.:Organ specific requirements for cell adhesion molecules during cell dissemination. Curr. Top. Microbiol. Immunol. 231:143 166, 1998.

4) Fyfe, G., Cebra-Thomas, J. A., Mustain, E. et al.:Subpopulations of B lymphocytes in germinal centers. J. Immunol. 139 (7) :2187-2194, 1987.

PubMed

4) Moore, F. D. Jr.:Therapeutic regulation of the complement system in acute injury. Adv. Immunol. 56:267-299, 1994.

PubMed

4) Fox, J. E., Aggerbeck, L. P. and Berndt, M. C.:Structure of the glycoprotein Ib. IX complex from platelet membranes. J. Biol. Chem. 263 (10) :4882-4890, 1988.

PubMed

4) Biswas, C., Zhang, Y., DeCastro, R. et al.:The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 55 (2) :434-439, 1995.

PubMed

4) Sugamura, K., Asao, H., Kondo, M. et al.:The interleukin-2 receptor gamma chain:its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 14:179-205, 1996.

4) Nagata, S. and Golstein, P.:The Fas death factor. Science 267 (5203) :1449-1456, 1995.

PubMed

4) Berling, B., Kolbinger, F., Grunert, F. et al.:Cloning of a carcinoembryonic antigen gene family member expressed leukocytes of chronic myeloid leukemia patients and bone marrow. Cancer Res. 50 (20) :6534-6539, 1990.

PubMed

4) Moretta, A., Bottino, C., Vitale, M. et al.:Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14:619-648, 1996.

4) Kisielow, P. and von Boehmer, H.:Development and selection of T cells:facts and puzzles. Adv. Immunol. 58:87-209, 1995.

PubMed

4) Gouttefangeas, C., Mansur, I., Schmid, M. et al.:The CD 39 molecule defines distinct cytotoxic subsets within alloactivated human CD 8-positive cells. Eur. J. Immunol. 22 (10) :2681-2685, 1992.

4) Hemler, M. E., Crouse, C., Takada, Y. et al.:Multiple very late antigen (VLA) heterodimers on platelets. Evidence for distinct VLA-2, VLA-5 (fibronectin receptor) , and VLA-6 structures. J. Biol. Chem. 263:7660-7665, 1988.

PubMed

4) George, F., Brouqui, P., Boffa, M. C. et al.:Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 82 (7) :2109-2116, 1993.

PubMed

4) Kniep, B., Muhlradt, P. F., Dorken, B. et al.:Monoclonal antibodies against the human lymphocyte differentiation antigen CD76 bind to gallgliosides. FEBS Lett. 261 (2) :347-349, 1990.

PubMed

4) Lenschow, D. J., Walunas, T. L. and Bluestone, J. A.:CD 28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258, 1996.

4) Herold, C., Bismuth, G., Bensussan, A. et al.:Activation signals are delivered through two distinct epitopes of CD 100, a unique 150 kDa human lymphocyte surface structure previously defined by BB 18 mAb. Int. Immunol. 7 (1) :1-8, 1995.

4) Moingeon, P., Chang, H. C., Sayre, P. H. et al.:The structural biology of CD 2. Immunol. Rev. 111:111-144, 1989.

4) Chen, H., Kinzer, C. A. and Paul, W. E.:p 161, a murine membrane protein expressed on mast cells and some macrophages, is mouse CD 13/aminopeptidase N. J. Immunol. 157 (6) :2593-2600, 1996.

4) Ahmad, M., Theofanidis, P. and Medford, R. M.:Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J. Biol. Chem. 273 (8) :4616-4621, 1998.

PubMed

4) Schmoeckel, M., Bhatti, F. N., Zaidi, A. et al.:Xenotransplantation of pig organs transgenic for human DAF:an update. Transplant. Proc. 29 (7) :3157-3158, 1997.

PubMed

4) Gougos, A. and Letarte, M.:Primary structure of endoglin, an RGD containing glycoprotein of human endothelial cells. J. Biol. Chem. 265 (15) :8361-8364, 1990.

PubMed

4) Hickey, M. J., Hagen, F. S., Yagi, M. et al.:Human platelet glycoprotein V:characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins. Proc. Natl. Acad. Sci. USA 90 (18) :8327-8331, 1993.

PubMed

4) Taga, T. and Kishimoto, T.:Gp 130 and the interleukin 6 family of cytokines. Annu. Rev. Immunol. 15:797-819, 1997.

4) Sgroi, D., Aruffo, A., Sy, M. S. et al.:The B lymphocyte adhesion molecule CD22 interacts with leukocyte, antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell 66 (6) :1133-1144, 1991.

4) Babina, M., Weber, S., Mammeri, K. at al.:Signal transduction via CD 43 (leukosialin, sialophorin) and associated biological effects in human mast cell line (HMC-1) . Biochem. Biophys. Res. Commun. 243 (1) :163 169, 1998.

4) Paulie, S., Koho, H., Ben-Aissa, H. et al.:Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. II. Identification of the cellular target structures by immunoprecipitation and SDS-PAGE. Cancer Immunol. Immunother. 17 (3) :173-179, 1984.

PubMed

4) Lu, P., Wang, Y. L. and Linsley, P. S.:Regulation of self-tolerance by CD 80/CD 86 interactions. Curr. Opin. Immunol. 9 (6) :858-862, 1997.

4) Eberle, F., Dubreuil, P., Mattei, M. G. et al.:The human PRR 2 gene, related to the human poliovirus receptor gene (PVR) , is the true homolog of the murine MPH gene. Gene 159 (2) :267-272, 1995.

4) Camerini, D., Walz, G., Loenen, W. A. et al.:The T cell activation antigen CD 27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 147 (9) :3165-3169, 1991.

4) Chen, J. W., Cha, Y., Yuksel, K. U. et al.:Isolation and sequencing of a cDNA clone encoding lysosomal membrane glycoprotein mouse LAMP-1. Sequence similarity to proteins bearing differentiation antigens. J. Biol. Chem. 263 (18) :8754-8758, 1988.

PubMed

4) Freemont, P. S., Foulkes, W. and Trowsdale, J.:An ovarian tumor marker with homology to vaccinia virus contains an like region and multiple transmembrane domains. Cancer Res. 52 (19) :5416-5420, 1992.

4) Carter, W. G., Ryan, M. C. and Gahr, P. J.:Epiligrin, a new cell adhesion ligand for integrhn alpha 3 beta 1 in epithelial basement membranes. CE, J. 65 (4) :599 610, 1991.

4) Bernard, G., Zoccola, D., Deckert, M. et al.:The E2 molecule (CD 99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes. J. Immunol. 154 (1) :26 32, 1995.

4) Caveda, L., Martin-Padura, I., Navarro, P. et al.:Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin) . J. Clin. Invest. 98 (4) :886-893, 1996.

PubMed

4) Croager, E. J. and Abraham, L. J.:Characterisation of the human CD 30 ligand gene structure. Biochim. Biophys. Acta 1353 (3) :231-235, 1997.

4) Schnorr, J. J., Xanthakos, S., Keikavoussi, P. et al.:Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc. Natl. Acad. Sci. USA 94 (10) :5326-5331, 1997.

PubMed

4) Sims, J. E., Giri, J. G. and Dower, S. K.:The two interleukin-1 receptors play different roles in IL-1 actions. Clin. Immunol. Immunopathol. 72 (1) :9-14, 1994.

PubMed

4) van de Winkel, J. G. and Capel, P. J.:Human IgG Fc receptor heterogeneity:molecular aspects and clinical implications. Immunol. Today 14 (5) :215 221, 1993.

4) Naor, D., Sionov, R. V., Zahalka, M. et al.:Organ-specific requirements for cell adhesion molecules during cell dissemination. Curr. Top. Microbiol. Immunol. 231:143-166, 1998.

PubMed

4) Barton, C. H., Dickson, G., Gower, H. J. et al.:Complete sequence and in vitro expression of a tissue-specific phosphatidylinositol-linked N-CAM isoform from skeletal muscle. Development 104 (1) :165-173, 1988.

PubMed

4) de Fougerolles, A. R., Stacker, S. A., Schwarting, R. et al.:Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J. Exp. Med. 174 (1) :253-267, 1991.

PubMed

4) Seon, B. K., Negoro, S., Barcos, M. P. et al.:Monoclonal antibody SN 2 defining a human T cell leukemia-associated cell surface glycoprotein. J. Immunol. 132 (4) :2089-2095, 1984.

4) Bohuslav, J., Horejsi, V., Hansmann, C. et al.:Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med. 181 (4) :1381-1390, 1995.

PubMed

4) de Fougerolles, A. R. and Springer, T. A.:Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J. Exp. Med. 175 (1) :185-190, 1992.

PubMed

4) Hegen, M., Kameoka, J., Dong, R. P. et al.:Structure of CD 26 (dipeptidyl peptidase IV) and function in human T cell activation. Adv. Exp. Med. Biol. 421:109-116, 1997.

4) Claesson, L., Larhammar, D., Rask, L. et al.:cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure. Proc. Natl. Acad. Sci. USA 80 (24) :7395-7399, 1983.

PubMed

4) Sugamura, K., Asao, H., Kondo, M. et al.:The common gamma-chain for multiple cytokine receptors. Adv. Immunol. 59:225-277, 1995.

PubMed

4) Adachi, M., Taki, T., Konishi, T. et al.:Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD 9 and KAI1/CD 82 gene expression. J. Clin. Oncol. 16 (4) :1397-1406, 1998.

4) Ahearn, J. M. and Fearon, D. T.:Structure and function of the complement receptors, CR 1 (CD 35) and (CD 21) . Adv. Immunol. 46:183-219, 1989.

4) Agerholm-Larsen, B., Nordestgaard, B. G., Steffensen, R. et al.:ACE gene polymorphism:ischemic heart disease and longevity in 10, 150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 95 (10) :2358-2367, 1997.

PubMed

4) Parsons, J. T.:Integrin-mediated signalling :regulation by protein tyrosine kinases and small GTP-binding proteins. Curr. Opin. Cell. Biol. 8 (2) :146-152, 1996.

PubMed

4) Arch, R. H. and Thompson, CB.:4-1 BB and Ox 40 are members of a tumor necrosis factor (TNF) nerve growth factor receptor subfamily that bind TNF receptor associated factors and activate nuclear factor kappa B. Mol. Cell. Biol. 18 (1) :558-565, 1998.

4) Airas, L. and Jalkanen, S.:CD 73 mediates adhesion of B cells to follicular dendritic cells. Blood 88 (5) :1755-1764, 1996.

4) Cepek, K. L., Parker, C. M., Madara, J. L. et al.:Integrin alpha E beta 7 mediates adhesion of T lymphocytes to epithelial cells. J. Immunol. 150 (8 Pt 1) :34593470, 1993.

4) Dahlgren, C., Carlsson, S. R., Karlsson, A. et al.:The lysosomal membrane glycoproteills Lamp-1 and Lamp-2 are present mobilizable organelles, but are absent from the azurophil granules of human neutrophils. Biochem. J. 311 (Pt 2) :667-674, 1995.

4) Crosier, K. E., Hall, L. R., Vitas, M. R et al.:Expression and functional analysis of two isoforms of the human GM-CSF receptor alpha chain in myeloid development and leukaemia. Br. J. Haematol. 98 (3) :540-548, 1997.

PubMed

4) Bakker, H., Friedmann, I., Oka, S. et al.:Expression cloning of a cDNA encoding a sulfotransferase involved in the biosynthesis of the HNK-1 carbohydrate epitope. J. Biol. Chem. 272 (47) :29942-29946, 1997.

PubMed

4) Strickland, D. K., Kounnas, M. Z. and Argraves, W. S.:LDL receptor-related protein:a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 9 (10) :890-898, 1995.

PubMed

4) Mackey, M. F., Barth, R. J. Jr. and Noelle, R. J.:The role of CD 40/CD 154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukoc. Biol. 63 (4) :418-428, 1998.

4) Stanley, E. R., Berg, K. L., Einstein, D. B. et al.:Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46 (1) :4-10, 1997.

PubMed

4) Sugamura, K., Asao, H., Kondo, M. et al.:The common gamma-chain for multiple cytokine receptors. Adv. Immunol. 59:225-277, 1995.

PubMed

4) Del Porto, P., Bruno, L., Mattei, M. G. et al.:Cloning and comparative analysis of the human pre-T-cell receptor chain gene. Proc. Natl. Acad. Sci. USA 92 (26) :12105-12109, 1995.

PubMed

4) Devitt, A., Moffatt, O. D., Raykundalia, C. et al.:Human CD 14 mediates recognition and phagocytosis of apoptotic cells. Nature 392 (6675) :505-509, 1998.

4) Dustin, M. L., Selvaraj, P., Mattaliano, R. J. et al.:Anchoring mechanisms for LFA-3 cell adhesion glyco-protein at membrane surface. Nature 329 (6142) :846-848, 1987.

4) Horuk, R.:The interleukin-8-receptor family:from chemokines to malaria. Immunol. Today 15 (4) :169-174, 1994.

PubMed

4) Bowen, M. A., Bajorath, J., Siadak, A. W. et al.:The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD 6 with a 1:1 stoichiometry. J. Biol. Chem. 271 (29) :17390-17396, 1996.

4) Azuma, M., Ito, D., Yagita, H. et al.:B70 antigen is a second ligand for CTLA-4 and CD 28. Nature 366 (6450) :76-79, 1993.

4) Barry, S. C., Korpelainen, E., Sun, Q. et al.:Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function. Blood 89 (3) :842-852, 1997.

4) Chen, FA., Repasky, EA. and Bankert, R. B.:Human lung tumor-associated antigen identified as an extracellular matrix adhesion molecule. J. Exp. Med. 173 (5) :1111-1119, 1991.

PubMed

4) Malissen, B. and Malissen, M.:Functions of TCR and pre-TCR subunits:lessons from gene ablation. Curr. Opin. Immunol. 8 (3) :383-393, 1996.

PubMed

4) Howard, L. M. and Reen, D. J.:CD72 ligation regulates defective naive newborn B cell responses. Cell. Immunol. 175 (2) :179-188, 1997.

PubMed

4) Gray-Owen,. S. D., Dehio, C., Haude, A. et al.:CD 66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes. EMBO J. 16 (12) :3435-3445, 1997.

4) Mannel, D. N. and Grau, G. E.:Role of platelet adhesion in homeostasis and immunopathology. Mol. Pathol. 50 (4) :175-185, 1997.

PubMed

4) Semeraro, N. and Colucci, M.:Tissue factor in health and disease. Thromb. Haemost. 78 (1) :759-764, 1997.

PubMed

4) Asano, Y., Yokoyama, T., Shibata, S. et al.:Effect of the chimeric soluble granulocyte colony-stimulating factor receptor on the proliferation of leukemic blast cells from patients with acute myeloblastic leukemia. Cancer Res. 57 (16) :3395-3397, 1997.

PubMed

4) Andria, M. L., Hsieh, C. L., Oren, R. et al.:Genomic organization and chromosomal localization of the TAPA-1 gene. J. Immunol. 147 (3) :1030-1036, 1991.

4) Baldwin, H. S., Shen, H. M., Yan, H. C. et al.:Platelet endothelial cell adhesion molecule-1 (PECAM-1/ CD 31) :alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120 (9) :2539-2553, 1994.

4) Alberola-Ila, J., Places, L., Cantrell, D. A. et al.:Intracellular events involved in CD 5-induced human T cell activation and proliferation. J. Immunol. 148 (5) :1287-1293, 1992.

4) Rudd, P. M., Morgan, B. P., Wormald, M. R. et al.:The glycosylation of the complement regulatory protein, human erythrocyte CD 59. Adv. Exp. Med. Biol. 435:153-162, 1998.

4) Springer, T. A.:Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep paradigm. Cell 76 (2) :301-314, 1994.

PubMed

4) Ishihara, K., Kobune, Y., Okuyama, Y. et al.:Stage-specific expression of mouse BST1/BP3 on the early B and T progenitors prior to gene rearrangement of antigen receptor. Int. Immunol. 8 (9) :1395-1404, 1996.

4) Springer, T. A.:Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep paradigm. Cell 76 (2) :301-314, 1994.

PubMed

4) Borradori, L., Koch, P. J., Niessen, C. M. et al.:The localization of bullous pemphigoid antigen 180 (BP 180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the beta 4 integrin subunit. J. Cell Biol. 136 (6) :1333-1347, 1997.

4) Varner, J. A., Brooks, P. C. and Cheresh, D. A.:REVIEW:the integrin alpha V beta 3:angiogenesis andapoptosis. Cell Adhes. Commun. 3 (4) :367-374, 1995.

4) Enk, A. H. and Katz, S. J.:Heat stable antigen is an important costimulatory molecule on Langerhans' cells. J. Immunol. 152 (7) :3264 3270, 1994.

4) Lund-Johansen, F., Olweus, J., Horejsi, V. et al.:Activation of human phagocytes through carbohydrate antigens (CD 15, sialyl-CD 15, CDw 17, and CDw 65) . J. Immunol. 148:3221-3229, 1992.

4) Theil, E. C., McKenzie, R. A. and Sierzputowska-Gracz, H.:Structure and function of IREs, the noncoding mRNA sequences regulating synthesis of ferritin, transferrin receptor and (erythroid) 5-aminolevulinate synthase. Adv. Exp. Med. Biol. 356:111-118, 1994

PubMed

4) McEver, R. P., Moore, K. L. and Cummings, R. D.:Leukocyte trafficking mediated by selectin-carbohydrate interactions. J. Biol. Chem. 270 (19) :11025-11028, 1995.

4) Gardner, H., Kreidberg, J., Koteliansky, V. et al.:Deletion of integrin alpha 1 by homologous recombination permits murine development but gives rise to a specific deficit in cell adhesion. Dev. Biol. 175 (2) :301-313, 1996.

PubMed

4) Besmer, P., Murphy, J. E., George, P. C. et al.:A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320 (6061) :415-421, 1986.

PubMed

4) Sadler, J. E.:Thrombomodulin structure and function. Thromb. Haemost. 78 (1) :392-395, 1997.

PubMed

4) Ahlin, A., Elinder, G. and Palmblad, J.:Dose-dependent enhancements by interferon gamma on functional of neutrophils from chronic granulomatous disease patients. Blood 89 (9) :3396-3401, 1997.

PubMed

4) Forsyth, K. D., Simpson, A. C. and Levinsky, R. J.:CD 15 antibodies increase neutrophil adhesion to endothelium by an dependent mechanism. Eur. J. Immunol. 19 (7) :1331-1334, 1989.

4) Fleit, H. B., Wright, S. D. and Unkeless, J. C.:Human neutrophil Fc gamma receptor distribution and structure. Proc. Natl. Acad. Sci. USA 79 (10) :3275 3279, 1982.

4) Nasert, S., Millner, M., Herz, U. et al.:Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL 4 R) in allergic diseases. Behring Inst. Mitt. 96:118-130, 1995.

4) Deterre, P., Gelman, L., Gary-Gouy, H. et al.:Coordinated regulation in human T cells of nucleotide-hydrolyzing enzymatic activities, including CD 38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites. J. Immunol. 157 (4) :1381-1388, 1996.

4) Liszewski, M. K., Farries, T. C., Lublin, D. M. et al.:Control of the complement system. Adv. Immunnol. 61:201-283, 1996.

PubMed

4) Sutherland, D. R. and Keating, A.:The CD 34 antigen:structure, biology, and potential clinical. J. Hematother. 1 (2) :115-129, 1992.

4) Clemetson, K. J., McGregor, J. L., James, E. et al.:Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J. Clin. Invest. 70 (2) :304-311, 1982.

PubMed

4) Hasegawa, H., Utsunomiya, Y., Kishimoto, K. et al.:SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily. J. Virol. 70 (5) :3258-3263, 1996.

PubMed

4) Rieber, E. P. and Rank, G.:CDw 60:a marker for human CD 8+ T helper cells. J. Exp. Med. 179 (4) :1385-1390, 1994.

4) Akashi, K., Kondo, M. and Weissman, I. L.:Two distinct pathways of positive selection for thymocytes. Proc. Natl. Acad. Sci. USA 95 (5) :2486-2491, 1998.

PubMed

4) Shen, L.:Receptors for IgA on phagocytic cells. Immunol. Res. 11 (34) :273 282, 1992.

4) Sutton, B. J. and Gould, H. J.:The human IgE network. Nature 366 (6454) :421-428, 1993.

PubMed

4) Bock, D., Martin, U., Gartner, S. et al.:The C terminus of the human C5a receptor (CD 88) is required for ligand-dependent receptor internalization. Eur. J. Immunol. 27 (6) :1522-1529, 1997.

4) Pestka, S.:The interferon receptors. Semin. Oncol. 24 (3 Suppl. 9) :S9-18-S 9-40, 1997.

4) Phillips, D. R., Charo, I. F. and Scarborough, R. M.:GP IIb-IIIa:the responsive integrin. Cell 65 (3) :359-362, 1991.

4) Lowe, J. B., Kukowska-Latallo, J. F., Nair, R. P. et al.:Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1-dependent cell adhesion. J. Biol. Chem. 266 (26) :17467-17477, 1991.

4) Arroyo, A. G., Yang, J. T., Rayburn, H. et al.:Differential requirements for alpha 4 integrins during fetal and adult hematopoiesis. Cell 85 (7) :997-1008, 1996.

4) Tedder, T. F., Inaoki, M. and Sato, S.:The CD 19-CD 21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6 (2) :107-118, 1997.

4) Brugnoni, D., Airo, P., Marino, R. et al.:CD 70 expression on T-cell subpopulations:study of normal individuals and patients with chronic immune activation. Immunol. Lett. 55 (2) :99-104, 1997.

4) Takatsu, K., Takaki, S. and Hitoshi, Y.:Interleukin-5 and its receptor system:implications in the immune system and inflammation. Adv. Immunol. 57:145-190, 1994.

PubMed

4) Sivakumar, P. V., Puzanov, I., Williams, N. S. et al.:Ontogeny and differentiation of murine natural killer cells and their receptors. Curr. Top. Microbiol. Immunol. 230:161-190, 1998.

PubMed

4) Lindahl, P. and Betsholtz, C.:Not all myofibroblasts are alike:revisiting the role of PDGF-A and PDGF-B using PDGF-targeted mice. Curr. Opin. Nephrol. Hypertens. 7 (1) :21-26, 1998.

PubMed

4) Kelton, J. G., Smith, J. W., Horsewood, P. et al.:Gova/b alloantigen system on human platelets. Blood 75 (11) :2172-2176, 1990.

PubMed

4) Hiraiwa, N., Dohi, T., Kawakami-Kimura, N. et al.:Suppression of sialyl Lewis X expression and E-selectin-mediated cell adhesion in cultured human lymphoid cells by transfection of antisense cDNA of an alpha 1→3 fucosyltransferase (Fuc-T VII) . J. Biol. Chem. 271:31556-31561, 1996.

4) Gale, R. E., Freeburn, R. W., Khwaja, A. et al.:A truncated isoform of the human beta chain common to the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3) , and IL-5 with increased mRNA expression in some patients with acute leukemia. Blood 91 (1) :54-63, 1998.

4) Craston, R., Koh, M., Mc Dermott, A. et al.:Temporal dynamics of CD 69 expression on lymphoid cells. J. Immunol. Methods 209 (1) :37-45, 1997.

4) Feng, H., Zhao, WQ., Bernard, C. C. et al.:Purified antichick Thy-1 IgG abolishes intermediate and long-term memory. Physiol. Behav. 53 (2) :215-219, 1993.

PubMed

4) Chan, A. C., Desai, D. M. and Weiss, A.:The role of protein tyrosine kinases and protein tyrosine in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:555-592, 1994.

4) Lu, P., Wang, Y. L. and Linsley, P. S.:Regulation of self-tolerance by CD80/CD86 interactions. Curr. Opin. Immunol. 9 (6) :858-862, 1997.

PubMed

4) Ellerbrock, K., Pera, I., Hartung, S. et al.:Gene expression in the dog epididymis:a model for human epididymal function. Int. J. Androl. 17 (6) :314-323, 1994.

4) Freeman, S. D., Kelm, S., Barber, E. K. et al.:Characterization of CD 33 as a new member of the sialoadhesin family cellular interaction molecules. Blood 85 (8) :2005-2012, 1995.

4) Han, S., Stuart, L. A. and Degen, S. J.:Characterization of the DNF 15 S 2 locus on human chromosome 3:identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 30 (40) :9768-9780, 1991.

4) Inki, P. and Jalkanen, M.:The role of syndecan-1 in malignancies. Ann. Med. 28 (1) :63-67, 1996.

PubMed

4) Wollert, K. C. and Chien, K. R.:Cardiotrophin-1 and the role of gp 130-dependent signaling pathways in cardiac growth and development. J. Mol. Med. 75 (7) :492-501, 1997

4) Powell, L. D. and Varki, A.:I-type lectins. J. Biol. Chem. 270 (24) :14243-14246, 1995.

PubMed

4) Melian, A., Beckman, E. M., Porcelli, S. A. et al.:Antigen presentation by CD 1 and MHC-encoded class I-like molecules. Curr Opin. Immunol. 8 (1) :82-88, 1996.

4) Blobel, C. P., Wolfsberg, T. G., Turck, C. W. et al.:A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 356 (6366) :248-252, 1992.

4) Moretta, A., Bottino, C., Vitale, M. et al.:Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14:619-648, 1996.

4) Pames, J. R.:Molecular biology and functioll of CD 4 and CD 8. Adv. Immunol. 44:265-311, 1989.

4) Varki, A.:Selectin ligands. Proc. Natl. Acad. Sci. USA 91 (16) :7390-7397, 1994.

PubMed

4) Ferrante, P., Fusi, M. L., Saresella, M. et al.:Cytokine production and surface marker expression in acute and stable multiple sclerosis:altered IL-12 production and augmented signaling Lymphocytic activation molecule (SLAM) -expressing lymphocytes in acute multiple sclerosis. J. Immunol. 160 (3) :1514-1521, 1998.

PubMed

4) Ginsberg, M. H., Xiaoping, D., O'Toole, T. E. et al.:Platelet integrins. Th romb. Haemost. 70 (1) :87-93, 1993.

4) Pulford, K. A., Rigney, E. M., Micklem, K. J. et al.:KP 1:a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J. Clin. Pathol. 42 (4) :414-421, 1989.

4) Springer, T. A.:Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep paradigm. Cell 76 (2) :301-314, 1994.

PubMed

4) Tatarinov, Y. S.:Trophoblast-specific beta 1-glycoprotein as a marker for pregnancy and malignancies. Gynecol. Obstet. Invest. 9 (2-3) :65-97, 1978.

4) Bonilla, FA., Kokron, C. M., Swinton, P. et al.:Targeted gene disruption of murine CD 7. Int. Immunol. 9 (12) :1875-1883, 1997.

4) Agrawal, B., Reddish, M. and Longenecker, B. M.:CD 30 expression on human CD 8+Tcells isolated from peripheral blood lymphocytes of normal donors. J. Immunol. 157 (8) :3229-3234, 1996.

4) Radzun, H. J., Kreipe, H., Bodewadt, S. et al.:Ki-M 8 monoclonal antibody reactive with all intracytoplasmic antigen monocyte/macrophage lineage. Blood 69 (5) :1320-1327, 1987.

5) Cornelis, S., Plaetinck, G., Devos, R. et al.:Detailed analysis of the IL-5-IL-5R alpha interaction:characterization of crucial residues on the ligand and the receptor. EMBO J. 14 (14) :3395-3402, 1995.

PubMed

5) Cepek, K. L., Shaw, S. K., Parker, C. M. et al.:Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372 (6502) :190-193, 1994.

5) DeBenedette, M. A., Chu, N. R., Pollok, K. E. et al.:Role of 4 1 BB ligand in costimulation of T lymphocyte growth and its upregulation on M 12 B lymphomas by cAMP. J. Exp. Med. 181 (3) :985992, 1995.

5) Mudad, R., Rao, N., Issitt, P. D. et al.:JMH variants:serologic, clinical, and biochemical analyses in two cases. Transfusion 35 (11) :925-930, 1995.

PubMed

5) Benchimol, S., Fuks, A., Jothy, S. et al.:Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57 (2) :327-334, 1989.

PubMed

5) Tanaka, Y., Ardouin, L., Gillet, A. et al.:Early T-cell development in CD 3-deficient mice. Immunol. Rev. 148:171-199, 1995.

5) Gray-Owen, S. D., Dehio, C., Haude, A. et al.:CD 66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes. EMBO J. 16 (12) :3435-3445, 1997.

5) Jennings, L. K. and White, M. M.:Expression of ligand-induced binding sites on glycoprotein IIb/IIIa complexes and the effect of various inhibitors. Am. Heart J. 135 (5 Pt 2 Su) :S 179-183, 1998.

5) Tedder, T. F., Steeber, D. A., Chen, A. et al.:The selectins:vascular adhesion molecules. FASEB J. 9 (10) :866-873, 1995.

PubMed

5) Emi, M., Katagiri, T., Harada, Y. et al.:A novel metalloprotease/disintegrin-like gene at 17q21. 3 is somatically rearranged in two primary breast cancers. Nat. Genet. 5 (2) :151-157, 1993.

PubMed

5) Iwama, A., Okano, K., Sudo, T. et al.:Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 83 (11) :3160-3169, 1994.

PubMed

5) Ahearn, J. M., Fischer, M. B., Croix, D. et al.:Disruption of the Cr 2 locus results in a reduction in B-1 a cells and in an impaired B cell response to T-dependent antigen. Immunity 4 (3) :251-262, 1996.

5) Hibbs, M. L., Selvaraj, P., Carpen, O. et al.:Mechanisms for regulating expression of membrane isoforms of FcRIII (CD 16) .

5) Fukuda, M., Viitala, J., Matteson, J. et al.:Cloning of cDNAs encoding human lysosomal membrane glycoproteins, lamp-1 and h-lamp 2. Comparison of their deduced amino acid. J. Biol. Chem. 263 (35) :18920 18928, 1988.

5) Gaffney, P. M., Lund, J. and Miller, J. S.:FLT-3 ligand and marrow stroma-derived factors promote CD 3 gamma, CD 3 delta, CD 3 zeta, and RAG-2 gene expression in primary human CD 34+LIN-DR-marrow progenitors. Blood 91 (5) :1662-1670, 1998.

5) Bernard, G., Breittmayer, J. P., de Matteis, M. et al.:Apoptosis of immature thymocytes mediated by E 2/ CD 99. J. Immunol. 158 (6) :2543-2550, 1997.

5) De Benedetti, F., Alonzi, T., Moretta, A. et al.:Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin like growth factor I. A model for stunted growth in children with chronic inflammation. J. Clin Invest. 99 (4) :643-650, 1997.

5) Grunert, F., Daniel, S., Nagel, G. et al.:CD 66 b, CD 66 c and carcinoembryonic antigen (CEA) are independently regulated markers in sera of tumor patients. Int. J. Cancer 63 (3) :349-355, 1995.

5) Rosen, S. D. and Bertozzi, C. R.:Two selectins converge on sulphate. Leukocyte adhesion. Curr. Biol. 6 (3) :261-264, 1996.

PubMed

5) Akashi, K., Kondo, M., von Freeden-Jeffry, U. et al.:Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89 (7) :1033-1041, 1997.

PubMed

5) Donner, M., Karpman, D., Kristoffersson, A. C. et al.:Recurrent mutation Asn45→Ser of glycoprotein IX in Bernard-Soulier syndrome [letter]. Eur. J. Haematol. 57 (2) :178-179, 1996.

5) Justement, L. B.:The role of CD 45 in signal transduction. Adv. Immunol. 66:1-65, 1997.

5) Al-Shamkhani, A., Mallett, S., Brown, M. H. et al.:Affinity and kinetics of the interaction between soluble trimeric OX 40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX 40 on activated T cells. J. Biol. Chem. 272 (8) :5275-5282, 1997.

5) Borges, E., Pendl, G., Eytner, R. et al.:The binding of T cell-expressed P-selectin glycoprotein ligand-1 to E-and P-selectin is differentially regulated. J. Biol. Chem. 272 (45) :28786-28792, 1997.

5) Clark, E. A. and Shu, G.:Activation of human B cell proliferation through surface Bp 35 (CD 20) polypeptides or immunoglobulin receptors. J. Immunol. 138 (3) :720-725, 1987.

PubMed

5) Herz, J., Hamann, U., Rogne, S. et al.:Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7 (13) :4119-4127, 1988.

5) Eades-Perner, A. M., Thompson, J., van der Putten, H. et al.:Mice transgenic for the human CGM 6 gene express its product, the granulocyte marker CD 66 b, exclusively in granulocytes. Blood 91 (2) :663-672, 1998.

5) Freistadt, M. S., Fleit, H. B. and Wimmer, E.:Poliovirus receptor on human blood cells:a possible extraneural site of poliovirus replication. Virology 195 (2) :798-803, 1993;

PubMed

5) Voss, S. D., Hong, R. and Sondel, P. M.:Severe combined immunodeficiency, interleukin-2 (IL-2) , and the IL-2 receptor:experiments of nature continue to point the way. Blood 83 (3) :626-635, 1994.

PubMed

5) Schad, V., Greenstein, J. L., Giovino-Barry, V. et al.:An anti-CD 2 monoclonal antibody that elicits alloantigen-specific hyporesponsiveness. Transplant. Proc. 28 (4) :2051-2053, 1996

5) Carmo, A. M. and Wright, M. D.:Association of the transmembrane 4 superfamily molecule CD 53 with a tyrosine phosphatase activity. Eur. J. Immunol. 25 (7) :2090-2095, 1995.

5) Bernard, T., Gale, R. E., Evans, J. P. et al.:Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloidleukaemia and may be a bystander phenomenon. Br. J. Haematol. 101 (1) :141-149, 1998.

PubMed

5) Symington, F. W., Hedges, D. L. and Hakomori, S.:Glycolipid antigens of human polymorphonuclear neutrophils and the inducible HL-60 myeloid leukemia line. J. Immunol. 134 (4) :2498-2506, 1985.

5) Carrel, S., Salvi, S., Rafti, F. et al.:Direct involvement of CD 7 (gp 40) in activation of TcR gamma/delta+ Tcells. Eur. J. Immunol. 21 (5) :1195-1200, 1991.

5) Mackay, C. R.:Chemokine receptors and T cell chemotaxis. J. Exp. Med. 184 (3) :799-802, 1996.

5) Hauck, W., Nedellec, P., Turbide, C. et al.:Transcriptional control of the human biliary glycoprotein gene, a CEA gene family member down-regulated in colorectal carcinomas. Eur. J. Biochem. 223 (2) :529-541, 1994.

PubMed

5) Bauer, T. R., Schwartz, B. R., Conrad, Liles, W. et al.:Retroviral-mediated gene transfer of the leukocyte integrin CD 18 into peripheral blood CD 34+cells derived from a patient with leukocyte adhesion deficiency type 1. Blood 91 (5) :1520-1526, 1998.

5) Burgle, M., Koppitz, M., Riemer, C. et al.:Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides. Biol. Chem. 378 (3-4) :231-237, 1997.

5) Allen, J. M. and Seed, B.:Isolation and expression of functional high affinity Fc receptor complementary DNAs. Science 243 (4889) :378-381, 1989.

PubMed

5) Hahn, G., Jores, R. and Mocarski, E. S.:Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 95 (7) :3937-3942, 1998.

5) Lund-Johansen, F., Olweus, J., Horejsi, V. et al.:Activation of human phagocytes through carbohydrate antigens (CD 15, sialyl-CD 15, CDw 17, and CDw 65) . J. Immunol. 148 (10) :3221-3229, 1992.

5) Gorman, D. M., Itoh, N., Kitamura, T. et al.:Cloning and expression of a gene encoding an interleukin 3 receptor-like protein:identification of another member of the cytokine receptor gene family. Proc. Natl. Acad. Sci. USA 87 (14) :5459-5463, 1990.

PubMed

5) Bradbury, L. E., Kansas, GS., Levy, S. et al.:The CD 19/CD 21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149 (9) :2841, 2850, 1992.

5) Bravo, J., Staunton, D., Heath, J. K. et al.:Crystal structure of a cytokine-binding region of gp 130. EMBO J. 17 (6) :1665-1674, 1998.

5) Gao, A. G., Lindberg, F. P., Finn, M. B. et al.:Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271 (1) :21-24, 1996.

5) Holers, V. M., Ruff, T. G., Parks, D. L. et al.:Molecular cloning of a murine fibronectin receptor and its expression during inflammation. Expression of VLA 5 is increased in activated peritoneal macrophages in amanner discordant from major histocompatibility complex class II. J. Exp. Med. 169 (5) :1589-1605, 1989.

PubMed

5) Alford, P. B., Xue, Y. and Shackelford, R. E.:Tumor necrosis factor-alpha induces c-fms RNA expression in murine tissue macrophages. Biochem. Biophys. Res. Commun. 240 (2) :442-445, 1997.

PubMed

5) Ruegg, C. L., Rivas, A., Madani, N. D. et al.:V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V 7 gene. J. Immunol. 154 (9) :4434-4443, 1995.

5) Afshar Kharghan, V. and Lopez, J. A.:Bernard-Soulier syndrome caused by a dinucleotide deletion and reading frameshift in the region encoding the glycoprotein Ib alpha transmembralle domain. Blood 90 (7) :2634 2643, 1997.

5) Moretta, A., Biassoni, R., Bottino, C. et al.:Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155:105-117, 1997.

5) Grewal, I. S., Borrow, P., Pamer, E. G. et al.:The CD 40-CD 154 system in anti-infective host defense. Curr. Opin. Immunol. 9 (4) :491-497, 1997.

5) Gahmberg, C. G., Nortamo, P., Zimmermann, D. et al.:The human leukocyte-adhesion ligand, intercellular-adhesion molecule 2. Expression and characterization of the protein. Eur. J. Biochem. 195 (1) :177-182, 1991.

PubMed

5) Bartolazzi, A., Nocks, A., Aruffo, A. et al.:Glycosylation of CD 44 is implicated in CD 44 mediated cell adhesion to hyaluronan. J. Cell Biol. 132 (6) :1199 1208, 1996.

5) Kelly, M. D., Essex, D. W., Shapiro, S. S. et al.:Complementary DNA cloning of the alternatively expressed endothelial cell glycoprotein Ib beta (GP Ib beta) and localization of the GP Ib beta gene to chromosome 22. J. Clin. Invest. 93 (6) :2417-2424, 1994.

5) Brooks, D. G., Qiu, W. Q., Luster, A. D. et al.:Structure and expression of human IgG FcRII (CD 32) . Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J. Exp. Med. 170 (4) :1369-1385, 1989.

5) Hemler, M. E., Crouse, C. and Sonnenberg, A.:Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA beta 1 subunit on certain cell lines. J. Biol. Chem. 264 (11) :6529-6535, 1989.

5) Calverley, D. C., Yagi, M., Stray, S. M. et al.:Human platelet glycoprotein V:its role in enhancing expression of the glycoprotein Ib receptor. Blood 86 (4) :1361-1367, 1995.

PubMed

5) Baeckstrom, D.:Post-translational fate of a mucin-like leukocyte sialoglycoprotein (CD 43) aberrantly expressed in a colon carcinoma cell line. J. Biol. Chem. 272 (17) :11503-11509, 1997.

5) Del Prete, G., De Carli, M., D'Elios, M. M. et al.:CD 30-mediated signaling promotes the development of human T helper 2-like T cells. J. Exp. Med. 182 (6) :1655-1661, 1995.

5) Weissman, D., Li, Y., Ananworanich, J. et al.:Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92 (3) :826-830, 1995.

PubMed

5) de Fougerolles, A. R., Klickstein, L. B. and Springer, T. A.:Cloning and expression of intercellular adhesion molecule 3 reveals strong homology to other immunoglobulin family counter-receptors for lymphocyte function-associated antigen 1. J. Exp. Med. 177 (4) :1187-1192, 1993.

PubMed

5) Aruffo, A., Stamenkovic, I., Melnick, M. et al.:CD 44 is the principal cell surface receptor for hyaluronate. Cell 61 (7) :1303-1313, 1990.

5) Link, M. P., Bindl, J., Meeker, T. C. et al.:A unique antigen on mature B cells defined by a monoclonal antibody. J. Immunol. 137 (9) :3013-3018, 1986.

PubMed

5) Sanchez-Mateos, P., Cabanas, C. and Sanchez-Madrid, F.:Regulation of integrin function. Semin. Cancer Biol. 7 (3) :99-109, 1996.

PubMed

5) Gearing, D. P., King, J. A., Gough, N. M. et al.:Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J. 8 (12) :3667-3376, 1989.

PubMed

5) Bradshaw, J. D., Lu, P., Leytze, G. et al.:Interaction of the cytoplasmic tail of CTLA-4 (CD 152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochemistry 36 (50) :15975-15982, 1997.

5) Elices, M. J. and Hemler, M. E.:The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc. Natl. Acad. Sci. USA 86 (24) :9906-9910, 1989.

5) Behar, E., Chao, N. J., Hiraki, D. D. et al.:Polymorphism of adhesion molecule CD 31 and its role in acute graft-versus-host disease. N. Engl. J. Med. 334 (5) :286-291, 1996.

5) Behr, S. and Schriever, F.:Engaging CD19 or target of an antiproliferative antibody 1 on human B lymphocytes induces binding of B cells to the interfollicular stroma of human tonsils via integrin alpha 4/beta 1 and fibronectin. J. Exp. Med. 182 (5) :1191-1199, 1995.

PubMed

5) Bracke, M., Dubois, GR., Bolt, K. et al.:Differential effects of the T helper cell type 2 derived cytokines IL 4 and IL 5 on ligand binding to IgG and IgA receptors expressed by human eosiinophils. J. Immunol. 159 (3) :1459 1465, 1997.

5) Varner, J. A. and Cheresh, D. A.:Integrins and cancer. Curr. Opin. Cell Biol. 8 (5) :724-730, 1996.

PubMed

5) Horejsi, V., Ansotegui, I. J., Knapp, W. et al.:GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254 (5034) :1016-1019, 1991.

PubMed

5) Bischoff, S. C. and Dahinden, C. A.:c-kit ligand:a unique potentiator of mediator release by human lung mast cells. J. Exp. Med. 175 (1) :237-244, 1992.

PubMed

5) Moretta, A., Biassoni, R., Bottino, C. et al.:Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155:105-117, 1997.

5) Hasegawa, H., Watanabe, H., Nomura, T. et al.:Molecular cloning and expression of mouse homologue of SFA-1/PETA-3 (CD 151) , a member of the transmembrane 4 superfamily. Biochim. Biophys. Acta 1353 (2) :125-130, 1997.

5) Stewart, M., Thiel, M. and Hogg, N.:Leukocyte integrins. Curr. Opin Cell Biol. 7 (5) :690-696, 1995.

PubMed

5) Aguet, M., Dembic, Z. and Merlin, G.:Molecular cloning and expression of the human interferon-gamma. Cell 55 (2) :273-280, 1988.

PubMed

5) Daniel, P. T., Kroidl, A., Cayeux, S. et al.:Costimulatory signals through B7. 1/CD28 prevent T cell apoptosis during target cell lysis. J. Immunol. 159 (8) :3808-3815, 1997.

PubMed

5) Harada, N., Santos-Argumedo, L., Chang, R. et al.:Expression cloning of a cDNA encoding a novel murine B cell activation marker. Homology to human CD 38. J. Immunol. 151 (6) :3111-3118, 1993.

5) Pinchouk, V. G., Sidorenko, S. P., Gluzman, D. F. et al.:Monoclonal antibodies IPO-3 and IPO-10 against human B cell differentiation antigens. Anticancer Res. 8 (6) :1377-1264, 1988.

5) Aizawa, S., Nakano, H., Ishida, T. et al.:Tumor necrosis factor receptor-associated factor (TRAF) 5and TRAF 2 involved in CD 30-mediated NFkappaB activation. J. Biol. Chem. 272 (4) :2042-2045, 1997.

5) Hale, G. and Users, H. W. C.:Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. Blood 91 (8) :3079-3083, 1998.

5) Fischer, M. B., Goerg, S., Shen, L. et al.:Dependence of germinal center B cells on expression of CD 21/ CD 35 for survival. Science 280 (5363) :582585, 1998.

5) Alberola-Ila, J., Places, L., Lozano, F. et al.:Association of an activation inducible serine kinase activity with CD 5. J. Immunol. 151 (9) :4423-4430, 1993.

5) Hamann, J., Vogel, B., van Schijndel, G. M. et al.:The seven-span transmembrane receptor CD 97 has a cellular ligand DAF. J. Exp. Med. 184 (3) :1185-1189, 1996.

5) Abraham, E., Glauser, M. P., Butler, T. et al.:p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 277 (19) :1531-1538, 1997.

5) Stewart, M., Thiel, M. and Hogg, N.:Leukocyte integrins. Curr. Opin. Cell Biol. 7 (5) :690 696, 1995.

5) Reth, M.:The B-cell antigen receptor complex and co-receptors. Immunol. Today 16 (7) :310-313, 1995.

5) Wijngaard, P. L., Metzelaar, M. J., Macllugh, N. D. et al.:Molecular characterization of the WC 1 antigen expressed specifically bovine CD 4 CD 8 gamma delta T lymphocytes. J. Immunol. 149 (10) :3273-3277, 1992.

5) Bosca, L., Lazo, P. A.:Induction of nitricoxide release by MRC OX 44 (anti-CD 53) through a protein kinase C dependent pathway in rat macrophages. J. Exp. Med. 179 (4) :1119 1126, 1994.

5) Moretta, A., Biassoni, R., Bottino, C. et al.:Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155:105-117, 1997.

5) Boucheix, C., Benoit, P., Frachet, P. et al.:Molecular cloning of the CD 9 antigen. A new family of cell surface proteins. J. Biol. Chem. 266 (1) :117-122, 1991.

5) Hundt, M. and Schmidt, R. E.:Functional characterization of receptor-type protein tyrosine transduction of human neutrophils. Eur. J. Immunol. 27 (12) :3532 3535, 1997.

5) Argraves, W. S., Suzuki, S., Thompson, K. et al.:Amino acid sequence of the human fibronectin receptor. J. Cell Biol. 105 (3) :1183-1190, 1987.

PubMed

5) Allen, S., Khan, S., Al-Mohanna, F. et al.:Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J. Clin. Invest. 101 (5) :1064-1075, 1998.

5) Bella, J., Kolatkar, P. R., Marlor, C. W. et al.:The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc. Natl. Acad. Sci. USA 95 (8) :4140-4145, 1998.

PubMed

5) Yokoyama, W. M. and Seaman, W. E.:The Ly-49 and NKR-P1 gene families encoding lectin like receptors on natural killer cells:the NK gene complex. Annu. Rev. Immunol. 11:613-635, 1993.

PubMed

5) Herold, C., Elhabazi, A., Bismuth, G. et al.:CD 100 is associated with CD 45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J. Immunol. 157 (12) :5262-5268, 1996.

5) Bergers, G., Reikerstorfer, A., Braselmann, S. et al.:Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 13 (5) :1176-1188, 1994.

PubMed

5) Gregory, C. D., Tursz, T., Edwards, C. F. et al.:Identification of a subset of normal B cells with a Burkitt's lymphoma (BL) -like phenotype. J. Immunol. 139 (1) :313-318, 1987.

PubMed

5) Fadool, J. M. and Linser, P. J.:5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina. Dev. Dyn. 196 (4) :252-262, 1993.

PubMed

5) Bowen, M. A., Patel, D. D., Li, X. et al.:Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM) , a CD 6 ligand. J. Exp. Med. 181 (6) :2213-2220, 1995.

5) Aruffo, A. and Seed, B.:Molecular cloning of a CD 28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 84 (23) :8573-8577, 1987.

5) Lemoli, R. F., Raspadori, D., Ventura, M. A. et al.:Selection and transplantation of autologous hematopoietic CD 34+cells for patients with multiple myeloma. Leuk. Lymphoma 26 (Suppl. 1) :1-11, 1997.

5) Hsu, M. Y., Palazzo, J. P. and Herlyn, M.:The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. Am. J. Pathol. 151 (3) :745-751, 1997.

PubMed

5) Lastres, P., Bellon, T., Cabanas, C. et al.:Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur. J. Immunol. 22 (2) :393397, 1992.

5) Vanderpuye, O. A., Labarrere, C. A. and Mclntyre, J. A.:The complement system in human reproduction. Am. J. Reprod. Immunol. 27 (3-4) :145-155, 1992.

5) Handa, M. and Guidotti, G.:Purification and cloning of a soluble ATP-diphosphohydrolase (apyrase) from potato tubers (Solanum tuberosum) . Biochem. Biop hys. Res. Commun. 218 (3) :916-923, 1996.

5) Delmas, B., Gelfi, J., Kut, E. et al.:Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site. J. Virol. 68 (8) :5216-5224, 1994.

5) Haouas, H., Morello, D., Lavenu, A. et al.:Characterization of the 5'region of the CD 10/neutral endopeptidase 24. 11 gene. Biochem. Biophys. Res. Coomun. 207 (3) :933-942, 1995.

5) de Jong, R., Loenen, W. A., Brouwer, M. et al.:Regulation of expression of CD 27, a T cell-specific member of a novel family of membrane receptors. J. Immunol. 146 (8) :2488-2494, 1991.

5) Gottesdiener, K. M., Karpinski, B. A., Lindsten, T. et al.:Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation. Mol. Cell. Biol. 8 (9) :3809-3819, 1988.

5) Dejana, E., Corada, M. and Lampugnani, M. G.:Endothelial cell-to-cell junctions. Faseb J. 9 (10) :910-918, 1995.

PubMed

5) Townsend, S. E., Su, F. W., Atherton, J. M. et al.:Specificity and longevity of antitumor immune responses induced by B 7-transfected tumors. Cancer Res. 54 (24) :6477-6483, 1994.

5) Dahlgren, C., Carlsson, S. R., Karlsson, A. et al.:The lysosomal membrane glycoproteins Lamp-1 and Lamp-2 are present mobilizable organelles, but are absent from the azurophil granules of human neutrophils. Biochem. J. 311 (Pt 2) :667-674, 1995.

5) Elices, M. J., Urry, L. A. and Hemler, M. E.:Receptor functions for the integrin VLA 3:fibronectin, collagen, and laminin binding are differentially influenced by Arg Gly Asp peptide and by divalent cations. J. Cell Biol. 112 (1) :169 181, 1991.

5) Savill, J., Fadok, V., Henson, P. et al.:Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14 (3) :131-136, 1993.

5) Cremer, H., Lange, R., Christoph, A. et al.:Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature 367 (6462) :455-459, 1994.

5) Colotta, F., Re, F., Muzio, M. et al.:Interleukin-1 type II receptor:a decoy target for IL-1 that is regulated by IL-4. Science 261 (5120) :472-475, 1993.

PubMed

5) Freisewinkel, I. M., Schenck, K. and Koch, N.:The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl. Acad. Sci. USA 90 (20) :9703-9706, 1993.

PubMed

5) Naider, F.:Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28 (1) :31-81, 1993.

PubMed

5) Seon, B. K., Fukukawa, T., Jackson, A. L. et al.:Human T-Cell leukemia-associated cell surface glycoprotein GP 37:studies with three monoclonal antibodies and a rabbit antiserum. Mol. Immunol. 23 (6) :569-580, 1986.

5) Cambien, F., Poirier, O., Lecerf, L. et al.:Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359 (6396) :641-644, 1992.

PubMed

5) Taniguchi, T., Miyazaki, T., Minami, Y. et al.:IL-2 signaling involves recruitment and activation of multiple protein tyrosine kinases by the IL-2 receptor. Ann. N. Y. Acad. Sci. 766:235-244, 1995.

PubMed

5) Airas, L., Niemela, J., Salmi, M. et al.:Differential regulation and function of CD 73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes endothelial cells. J. Cell Biol. 136 (2) :421-431, 1997.

5) Taniguchi, T. and Minami, Y.:The IL-2/IL-2 receptor system:a current overview. Cell 73 (1) :5-8, 1993.

PubMed

5) Geba, G. P., Wegner, C. D., Wolyniec, W. W. et al.:Nonatopic asthma:in vivo airway hyperreactivity adoptively transferred to naive mice by THY-1 (+) and B 220 (+) antigen-specific cells that lack surface expression of CD 3. J. Clin. Invest. 100 (3) :629-638, 1997.

5) Hoffman, S. and Edelman, G. M.:A proteoglycan with HNK-1 antigenic determinants is a neuron-associated ligand for cytotactin. Proc. Natl. J. Acad. Sci. USA 84 (8) :2523-2527, 1987.

5) Garcia, K. C., Degano, M., Stanfield, R. L. et al.:An alphabeta T cell receptor structure at 2. 5 A and its orientation in the TCR-MHC complex. Science 274 (5285) :209-219, 1996.

PubMed

5) Dustin, M. L., Ferguson, L. M., Chan, P. Y. et al.:Visualization of CD 2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area. J. Cell Biol. 132 (3) :465-474, 1996.

5) Fearns, C., Kravchenko, V. V., Ulevitch, R. J. et al.:Murine CD 14 gene expression in vivo:extramyeloid synthesis and regulation by lipopolysaccharide. J. Exp. Med. 181 (3) :857-866, 1995.

5) Clarke, AS., Lotz, M. M., Chao, C. et al.:Activation of the p21 pathway of growth arrest and apoptosis by the beta 4 integrin cytoplasmic domain. J. Biol. Chem. 270 (39) :22673-22676, 1995.

PubMed

5) Kamal, M., Katira, A. and Gordon, J.:Stimulation of B lymphocytes via CD 72 (human Lyb-2) . Eur. J. Immunol. 21 (6) :1419-1424, 1991.

5) Angelisova, P., Hilgert, I. and Horejsi, V.:Association of four antigens of the tetraspans family (CD 37, CD 53, 1, and R 2/C 33) with MIIC class II glycoproteins. Immunogentics 39 (4) :249-256, 1994.

5) Taubman, M. B., Fallon, J. T., Schecter, A. D. et al.:Tissue factor in the pathogenesis of atherosclerosis. Thromb. Haemost. 78 (1) :200-204, 1997.

PubMed

5) Itoh, M., Ishihara, K., Tomizawa, H. et al.:Molecular cloning of murine BST 1 having homology with CD 38 and ADP-ribosyl cyclase. Biochem. Biophys. Res Commun. 203 (2) :1309, 1317, 1994.

5) Fischer, G. F., Majdic, O., Gadd, S. et al.:Signal transduction in lymphocytic and myeloid cells via CD 24, a new member of phosphoinositol anchored membrane molecules. J. Immunol. 144 (2) :638-641, 1990.

5) Venneker, G. T. and Asghar, S. S.:CD 59:a molecule involved in antigen presentation as well as downregulation of membrane attack complex. Exp. Clin. Immunogenet. 9 (1) :33-47, 1992.

5) Hara, T. and Miyajima, A.:Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3) . EMBO J. 11 (5) :1875-1884, 1992.

PubMed

5) Seya, T.:CD 46, a complement regulatory protein/measles virus receptor, and its relation to hematological disorders. Int. J. Hematol. 64 (2) :101-109, 1996.

5) Trowbridge, I. S., Collawn, J. F. and Hopkins, C. R.:Signal-dependent membrane protein trafficking in the endocytic pathway. Annua. Rev. Cell Biol. 9:129-161, 1993

5) Boulay, F., Mery, L., Tardif, M. et al.:Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 30 (12) :2993-2999, 1991.

PubMed

5) Bajzar, L., Morser, J. and Nesheim, M.:TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271 (28) :16603-16608, 1996.

5) Baumheter, S., Singer, M. S., Henzel, W. et al.:Binding of L-selectin to the vascular sialomucin CD 34. Science 262 (5132) :436-438, 1993.

5) Goelz, S. E., Hession, C., Goff, D. et al.:ELFT:a gene that directs the expression of an ELAM-1 ligand. Cell 63 (6) :1349-1356, 1990.

PubMed

5) Bonder, C. S., Dickensheets, H. L., Finlay-Jones, J. J. et al.:Involvement of the IL-2 receptor gamma-chain (gammac) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production. J. Immunol. 160 (8) :4048-4056, 1998.

PubMed

5) Armant, M., Ishihara, H., Rubio, M. et al.:Regulation of cytokine production by soluble CD 23 :costimulation of interferon gamma secretion and triggering of tumor necrosis factor alpha release. J. Exp. Med. 180 (3) :1005-1011, 1994.

5) Van Parijs, L. and Abbas, A. K.:Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8 (3) :355-361, 1996.

PubMed

5) Vater, M., Kniep, B., Gross, H. J. et al.:The 9-O-acetylated disialosyl carbohydrate sequence of CDw 60 is a marker on activated human B lymphocytes. Immunol. Lett. 59 (3) :151-157, 1997.

5) Noelle, R. J.:CD 40 and its ligand in host defense. Immunity 4 (5) :415-419, 1996.

5) Smith, J. W., Hayward, C. P., Horsewood, P. et al.:Characterization and localization of the Gova/b alloantigens to the glycosylphosphatidylinositol-anchored protein CDw109 on human platelets. Blood 86 (7) :2807-2814, 1995.

5) Shattil, S. J.:Function and regulation of the beta 3 integrins in hemostasis and vascular biology. Thromb. Haemost. 74 (1) :149-155, 1995.

PubMed

5) Goodwin, R. G., Alderson, M. R., Smith, C. A. et al.:Molecular and biological characterization of a ligand for CD 27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73 (3) :447-456, 1993.

5) Showalter, H. D. and Kraker, A. J.:Small molecule inhibitors of the platelet-derived growth factor receptor, the fibroblast growth factor receptor, and Src family tyrosine kinases. Pharmacol. Ther. 76 (1-3) :55-71, 1997.

5) Gumperz, J. E. and Parham, P.:The enigma of the natural killer cell. Nature 378 (6554) :245-248, 1995.

PubMed

5) Beekhuizen, H., van de Gevel, J. S., Olsson, B. et al.:Infection of human vascular endothelial cells with Staphylococcus azareus induces hyperadhesiveness for human monocytes and granulocytes. J. Immunol. 158 (2) :774-782, 1997.

PubMed

5) Tedder, T. F., Tuscano, J., Sato, S. et al.:CD 22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Ann. Rev. Immunol. 15:481-504, 1997.

5) Koch, A. E., Halloran, M. M., Haskell, C. J. et al.:Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376 (6540) :517-519, 1995.

PubMed

5) Pulford, K. A., Sipos, A., Cordell, J. L. et al.:Distribution of the CD 68 macrophage/myeloid associated antigen. Int. Immunol. 2 (10) :973-980, 1990.

5) Goldman, R., Harvey, J. and Hogg, N.:VLA-2 is the integrin used as a collagen receptor by leukocytes. Eur. J. Immunol 22 (5) :1109-1114, 1992.

PubMed

5) Asundi, V. K. and Carey, D. J.:Self-association of N-syndecan (syndecan-3) core protein is mediated a novel structural motif in the transmembrane domain and ectodomain flanking region. J. Biol. Chem. 270 (44) :26404-26410, 1995.

5) Zamoyska, R.:The CD 8 coreceptor revisited:One chain good, two chains better. Immunity (4) :243-246, 1994

5) Porcelli, S. A.:The CD 1 family:a third lineage of antigen-presenting molecules. Adv. Immunol. 59:1-98, 1995.

5) Bowen, M. A., Bajorath, J., D'Egidio, M. et al.:Characterization of mouse ALCAM (CD 166) :the CD6-binding domain is conserved in different homologs and mediates cross-species binding. Eur. J. Immunol. 27 (6) :1469-1478, 1997.

5) Teglund, S., Olsen, A., Khan, W. N. et al.:The pregnancy-specific glycoprotein (PSG) gene cluster on human chromosome 19:fine structure of the 11 PSG genes and identification of 6 new genes forming a third subgroup within the carcinoembryonic antigen (CEA) family. Genomics 23 (3) :669-684, 1994.

6) D'Ambrosio, D., Hippen, K. L., Minskoff, S. A. et al.:Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science 268 (5208) :293-297, 1995.

PubMed

6) Al Aoukaty, A., Rolstad, B. and Maghazachi, A. A.:Functional coupling of NKR P 1 receptors to various heterotrilneric G proteins in rat interleukin 2 activated natural killer cells. J. Biol. Chem. 272 (50) :31604-31608, 1997.

6) Armesilla, A. L. and Vega, M. A.:Structural organization of the gene for human CD 36 glycoprotein. J. Biol. Chem. 269 (29) :18985-18991, 1994.

6) Hall, D. E., Reichardt, L. F., Crowley, E. et al.:The alpha 1/beta 1 and alpha 6/beta 1 integrin heterodimers mediate cell attachment to distinct sites on laminin. J. Cell Biol. 110 (6) :2175-2184, 1990.

PubMed

6) Moretta, A. and Moretta, L.:HLA class I specific inhibitory receptors. Curr. Opin. Immunol. 9 (5) :694-701, 1997.

6) Hourcade, D., Garcia, A. D., Post, T. W. et al.:Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs) . Gienomics 12 (2) :289-300, 1992.

PubMed

6) Hemler, M. E., Jacobson, J. G. and Strominger, J. L.:Biochemical characterization of VLA-1 and VLA-2. Cell surface heterodimers on activated T cells. J. Biol. Chem. 260 (28) :15246-15252, 1985.

PubMed

6) Moretta, A. and Moretta, L.:HLA class I specific inhibitory receptors. Curr. Opin. Immunol. 9 (5) :694-701, 1997.

6) Hofman, P., Selva, E., Le Negrate, G. et al.:CD 10 inhibitors increase f Met-Leu-Phe-induced neutrophil transmigration. J. Leukoc. Biol. 63 (3) :312 320, 1998.

6) Gehlsen, K. R., Dickerson, K., Argraves, W. S. et al.:Subtmit structure of a laminin binding integrin and localization of its binding site on laminin. J. Biol. Chem 264 (32) :19034 19038, 1989.

6) Kaisho, T., Ishikawa, J., Oritani, K. et al.:BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth. Proc. Natl. Acad. Sci. USA 91 (12) :5325 5329, 1994.

6) Cheng, J., Baumhueter, S., Cacalano, G. et al.:Hematopoietic defects in mice lacking the sialomucin CD 34. Blood 87 (2) :479-490, 1996.

6) Berlin, C., Berg, E. L., Briskin, M. J. et al.:Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74 (1) :185-5, 1993.

6) Kataoka, M., Yoshiyama, K., Matsuura, K. et al.:Structure of the murine CD 156 gene, characterization of its promoter, and chromosomal location. J. Biol. Chem. 272 (29) :18209-18215, 1997

6) Bussolino, F., Wang, J. M., Defilippi, P. et al.:Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337 (6206) :471-473, 1989.

PubMed

6) Geraghty, R. J., Krummenacher, C., Cohen, G. H. et al.:Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280 (5369) :1618-1620, 1998.

PubMed

6) Peiper, S. C., Ashmun, R. A. and Look, A. T.:Molecular cloning, expression, and chromosomal localization of a gene encoding the CD 33 myeloid differentiation antigen. Blood 72 (1) :314-321, 1988.

6) Bauer, M. K. A., Vogt, M., Los, M. et al.:Role of reactive oxygen intermediates in activation-induced CD 95 (APO-1/Fas) ligand expression. J. Biol. Chem 273 (14) :8048-8055, 1998.

6) Isberg, R. R. and Leong, J. M.:Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 60 (5) :861-871, 1990.

PubMed

6) Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

6) Berlin, C., Berg, E. L., Briskin, M. J. et al.:Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74 (1) :185-5, 1993.

6) Hogervorst, F., Kuikman, I., van Kessel, A. G. et al.:Molecular cloning of the human alpha 6 integrin subunit. Alternative splicing of alpha 6 mRNA and chromosomal localization of the alpha 6 and beta 4 genes. Eur. J. Biochem. 199 (2) :425-433, 1991.

PubMed

6) Gattei, V., Degan, M., Gloghini, A. et al.:CD 30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood 89 (6) :2048-2059, 1997.

6) de Fougerolles, A. R., Qin, X. and Springer, T. A.:Characterization of the function of intercellular adhesion molecule (ICAM) -3 and comparison with ICAM-1 and ICAM-2 in immune responses. . Z Exp. Med. 179 (2) :619-629, 1994.

6) Moretta, A. and Moretta, L.:HLA class I specific inhibitory receptors. Curr. Opin. Immunol. 9 (5) :694-701, 1997.

6) Brunet, J. F., Denizot, F., Luciani, M. F. et al.:A new member of the immunoglobulin superfamily-CTLA-4. Nature 328 (6127) :267-270, 1987.

PubMed

6) Zhou, L. J., Schwarting, R., Smith, H. M. et al.:Anovel cell-surface molecule expressed by human interdigitating member of the Ig superfamily. J. Immunol. 149 (2) :735-742, 1992.

6) DeLisser, H. M., Yan, H. C., Newman, P. J. et al.:Platelet/endothelial cell adhesion molecule-1 (CD 31) -mediated aggregation involves cell surface glycosaminoglycans. J. Biol. Chem. 268 (21) :16037-16046, 1993.

6) Asakura, S., Niwa, K., Tomozawa, T. et al.:Fibroblasts spread on immobilized fibrin monomer by mobilizing a beta 1-class integrin, together with a vitronectin receptor alpha v beta 3 on their surface. J. Biol. Chem. 272 (13) :8824-8829, 1997.

6) Hasegawa, H., Kishimoto, K., Yanagisawa, K. et al.:Assignment of SFA-1 (PETA-3) , a member of the transmembrane 4 superfamily, to human chromosome 11p15. 5 by fluorescence in situ. Genomics 40 (1) :193-196, 1997.

PubMed

6) Polacino, P. S., Pinchuk, L. M., Sidorenko, S. P. et al.:Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells. J. Med. Primatol. 25 (3) :201-209, 1996.

6) Alzona, M., Jack, H. M., Fisher, R. J. et al.:IL-12 activates IFN-gamma production through the preferential activation of CD 30+T cells. J. Immunol. 154 (1) :9-16, 1995.

6) Kirchhoff, C., Pera, I., Derr, P. et al.:The molecular biology of the sperm surface. Post-testicular membrane remodelling. Adv. Exp. Med. Biol. 424:221-232, 1997.

PubMed

6) Yamada, T., Endo, R., Gotoh, M. et al.:Identification of semaphorin E as a non-MDR drug resistance gene of human cancers. Proc. Natl. Acad. Sci. USA 94 (26) :14713-14718, 1997.

PubMed

6) Balzac, F., Belkin, A. M., Koteliansky, V. E. et al.:Expression and functional analysis of a cytoplasmic domain variant of the beta 1 integrin subunit. J. Cell Biol. 121 (1) :171-178, 1993.

PubMed

6) de Parseval, A., Lerner, D. L., Borrow, P. et al.:Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD 9 is via inhibition of virus release rather than interference with receptor binding. J. Virol. 71 (8) :5742-5749, 1997.

6) Korinek, V. and Horejsi, V.:Genomic structure of the human CD53 gene. Immunogenetics 38 (4) :272-279, 1993.

PubMed

6) Jallal, B., Mossie, K., Vasiloudis, G. et al.:The receptor-like protein-tyrosine phosphatase DEP-1 is constitutively associated with a 64-kDa protein serine/threonine kinase. J. Biol. Chem. 272 (18) :12158-12163, 1997.

PubMed

6) Berendt, A. R., McDowall, A., Craig, A. G. et al.:The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site. Cell 68 (1) :71-81, 1992.

PubMed

6) Fadool, J. M. and Linser, P. J.:Evidence for the formation of multimeric forms of the 5A11/HT7 antigen. Biochem. Biophys. Res. Commun. 229 (1) :280-286, 1996.

PubMed

6) Buonavista, N., Balzano, C., Pontarotti, P. et al.:Molecular linkage of the human CTLA 4 and CD 281g-superfamily genes yeast artificial chromosomes. Genomics 13 (3) :856-861, 1992.

6) Lehmann, J. M., Riethmuller, G. and Johnson, J. P.:MUC 18, a marker of tumor progression in human melanoma, shows similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc. Natl. Acad. Sci. USA 86 (24) :9891-9895, 1989.

6) Brodbeck, W. G., Liu, D., Sperry, J. et al.:Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. J. Immunol. 156 (7) :2528-2533, 1996.

PubMed

6) Gravestein, L. A., Blom, B., Nolten, L. A. et al.:Cloning and expression of murine CD 27:comparison with 4-IBB, lymphocyte-specific member of the nerve growth factor receptor. Eur. J. Immunol. 23 (4) :943-950, 1993.

6) Gotsch, U., Borges, E., Bosse, R. et al.:VE-cadherin antibody accelerates neutrophil recruitment in vivo. J. Cell Sci. 110 (Pt 5) :583-588, 1997.

6) Abbott, C. A., Baker, E., Sutherland, G. R. et al.:Genomic organization, exact localization, and tissue expression of the human CD 26 (dipeptidyl peptidase IV) gene. Immunogenetics 40 (5) :331-338, 1994.

6) Azuma, M., Ito, D., Yagita, H. et al.:B70 antigen is a second ligand for CTLA-4 and CD 28. Nature 366 (6450) :76-79, 1993.

6) Cunningham, B. A., Hemperly, J. J., Murray, B. A. et al.:Neural cell adhesion molecule:structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science 236 (4803) :799-806, 1987.

PubMed

6) Cambien, F., Costerousse, O., Tiret, L. et al.:Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90 (2) :669-676, 1994.

PubMed

6) Waldmann, T. A.:The interleukin-2 receptor. J. Biol. Chem. 266 (5) :2681-2684, 1991.

PubMed

6) Lanier, L. L., Le, A. M., Phillips, J. H. et al.:Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immunol. 131:1789-1796, 1983.

PubMed

6) Freudenthal, P. S. and Steinman, R. M.:The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc. Natl. Acad. Sci. USA 87 (19) :7698-7702, 1990.

6) Albrecht, S., Luther, T., Grossmann, H. et al.:An ELISA for tissue factor using monoclonal antibodies. Blood Coagul. Fibrinolysis 3 (3) :263-270, 1992.

PubMed

6) Hahne, M., Wenger, R. H., Vestweber, D. et al.:The heat stable antigen can alter very late antigen 4-mediated. J. Exp. Med. 179 (4) :1391 1395, 1994.

6) Walsh, L. A., Tone, M., Thiru, S. et al.:The CD 59 antigen-a multifunctional molecule. Tissue Antigens 40 (5) :213-220, 1992.

6) Cerf-Bensussan, N. Jarry, A., Brousse, N. et al.:A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur. J. Immunol. 17 (9) -12791285, 1987.

6) Bajzar, L., Nesheim, M., Morser, J. et al.:Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 273 (5) :2792-2798, 1998.

PubMed

6) Classon, B. J., Brown, M. H., Garnett, D. et al.:The hinge region of the CD 8 alpha chain:structure, antigenicity, and utility in expression of immunoglobulin superfamily domains. Int. Immunol. 4 (2) :215-225, 1992.

PubMed

6) Claesson Welsh, L., Eriksson, A., Westermark, B. et al.:cDNA cloning and expression of the human A-type platelet. derived growth factor (PDGF) receptor establishes structural similarity to the B type PDGF receptor. Proc. Natl. Acad. Sci. USA 86 (13) :4917 4921, 1989.

6) Aubry, J. P., Pochon, S., Graber, P. et al.:CD 21 is a ligand for CD 23 and regulates IgE production. Nature 358 (6386) :505-507, 1992.

6) Sutherland, D. R., Yeo, E., Ryan, A. et al.:Identification of a cell-surface antigen associated with activated T lymphoblasts and activated platelets. Blood 77 (1) :84-93, 1991.

PubMed

6) Skov, L., Chan, L. S., Fox, D. A. et al.:Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw 60 on normal keratinocytes. Am. J. Pathol. 150 (2) :675-683, 1997.

6) Valentin, N. and Newman, P. J.:Human platelet alloantigens. Curr. Opin. Hematol. 1 (5) :381-387, 1994.

PubMed

6) Campbell, M. A. and Klinman, N. R.:Phosphotyrosine-dependent association between CD 22 and protein phosphatase 1 C. Eur. J. Immunol. 25 (6) :1573-1579, 1995.

6) Aviezer, D., Hecht, D., Safran, M. et al.:Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79 (6) :1005-1013, 1994.

PubMed

6) Balk, S. P., Burke, S., Polischuk, J. E. et al.:Beta 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science 265 (5169) :259262, 1994.

6) Andreassen, A. K., Nordoy, I., Simonsen, S. et al.:Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation. Am. J. Cardiol. 81 (5) :604-608, 1998.

PubMed

6) Garni-Wagner, B. A., Lee, Z. H., Kim, Y. J. et al.:4-1 BB is expressed on CD45RAhiROhi transitional T cell in humans. Cell. Immunol. 169 (1) :91-98, 1996.

6) Iwama, A., Yamaguchi, N. and Suda, T.:STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J. 15 (21) :5866-5875, 1996.

PubMed

6) Ellis, N. A., Tippett, P., Petty, A. et al.:PBDX is the XG blood group gene. Nat. Genet. 8 (3) :285-290, 1994.

PubMed

6) Varki, A.:Selectin ligands. Proc. Natl. Acad. Sci. USA 91 (16) :7390-7397, 1994.

PubMed

6) Beyers, A. D., Spruyt, L. L. and Williams, AF.:Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD 2, CD 4, or CD 8 and CD 5. Proc. Natl. A cad. Sci. USA 89 (7) :2945-2949, 1992.

6) Aubry, J. P., Pochon, S., Graber, P. et al.:CD 21 is a ligand for CD 23 and regulates IgE production. Nature 358 (6386) :505-507, 1992.

6) Gotze, K. S., Ramirez, M., Tabor, K. et al.:Flt 3 high and Flt 3 low CD 34+ progenitor cells isolated from human bone marrow are functionally distinct. Blood 91 (6) :1947-1958, 1998.

6) Tedder, T. F., Steeber, D. A., Chen, A. et al.:The selectins:vascular adhesion molecules. FASEB J. 9 (10) :866-873, 1995.

PubMed

6) Deans, J. P., Schieven, G. L., Shu, G. L. et al.:Association of tyrosine and serine kinases with the B cell surface antigen CD 20. Induction via CD 20 of tyrosine phosphorylation and activation of phospholipase C-gamma 1 and PLC phospholipase C-gamma. J. Immunol. 151 (9) :4494-4504, 1993.

6) Arch, R. H. and Thompson, C. B.:4-1 BB and OX 40 are members of a tumor necrosis factor (TNF) -nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappa B. Mol. Cell. Biol. 18 (1) :558-565, 1998.

6) Carrera, A. C., Rincon, M., Sanchez-Madrid, F. et al.:Triggering of comitogenic signals in T cell proliferation by anti-LFA-1 (CD 18, CD 11a) , LFA-3, and CD 7 monoclonal antibodies. J. Immunol. 141 (6) :1919-1924, 1988.

6) Bani, L., David, D., Fevrier, M. et al.:Interleukin-2 receptor beta and gamma chain dysregulation during the inhibition of CD 4 T cell activation by human immunodeficiency virus-1 gp120. Eur. J. Immunol. 27 (9) :2188-2194, 1997.

6) Bell, G. M., Fargnoli, J., Bolen, J. B. et al.:The SH 3 domain of p 56 lck binds to proline-rich sequences in the cytoplasmic domain of CD 2. J. Exp. Med. 183 (1) :169-178, 1996.

6) Hotta, H., Ross, A. H., Huebner, K. et al.:Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res. 48 (11) :2955-2962, 1988.

PubMed

6) Hara, T. and Miyajima, A.:Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3) . EMBO J. 11 (5) :1875-1884, 1992.

PubMed

6) Ernst, L. K., van de Winkel, J. G., Chiu, I. M. et al.:Three genes for the human high affinity Fc receptor for IgG (Fc gamma RI) encode four distinct transcription products. J. Biol. Chem. 267 (22) :15692-15700, 1992.

PubMed

6) Casey, J. R., Petranka, J. G., Kottra, J. et al.:The structure of the urokinase-type plasminogen activator receptor. Blood 84 (4) :1151-1156, 1994.

PubMed

6) Carter, R. H. and Fearon, D. T.:CD 19:lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256 (5053) :1 5107, 1992.

6) Fujio, Y., Kunisada, K., Hirota, H. et al.:Signals through gp 130 upregulate bcl-x gene expression via STAT 1-binding cis-element in cardiac myocytes. J. Clin. Invest. 99 (12) :2898-2905, 1997.

6) Gunn, M. D., Tangemann, K., Tam, C. et al.:A chemokine expressed in lymphoid high endothelial venules promotes adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95 (1) :258-263, 1998.

6) Macher, B. A., Buehler, J., Scudder, P. et al.:Anovel carbohydrate, differentiation antigen on fucogangliosides of human myeloid cells recognized by monoclonal antibody VIM-2. J. Biol. Chem. 263 (21) :10186-10191, 1988.

6) Hueber, A. O., Raposo, G., Pierres, M. et al.:Thy-1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism. J. Exp. Med. 179 (3) :785-796, 1994.

PubMed

6) Hauck, C. R., Meyer, T. F., Lang, F. et al.:CD 66-mediated phagocytosis of Opa 52 Neisseria gonorrhoeae requires Src-like tyrosine kinase-and Rac 1-dependent signalling pathway. EMBO J. 17 (2) :443-454, 1998.

6) Herz, J., Kowal, R. C., Goldstein, J. L. et al.:Proteolytic processing of the 600 kd low density lipoprotein receptor-related protein (LRP) occurs in a trans-Golgi compartment. EMBO J. 9 (6) :1769-1776, 1990.

6) Matsumoto, T., Yokoi, K., Mukaida, N. et al.:Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury. J. Leukoc Biol. 62 (5) :581-587, 1997.

PubMed

6) Symington, F. W., Bernstein, I. D. and Hakomori, S.:Monoclonal antibody specific for lactosylceramide. J. Biol. Chem. 259 (9) :6008-6012, 1984.

PubMed

6) Grunert, F., Daniel, S., Nagel, G. et al.:CD 66 b, CD 66 c and carcinoembryonic antigen (CEA) are independently regulated markers in sera of tumor patients. Int. J. Cancer 63 (3) :349-355, 1995.

6) Corcoran, A. E., Riddell, A., Krooshoop, D. et al.:Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391 (6670) :904-907, 1998.

PubMed

6) Gough, N. R. and Fambrough, D. M.:Different steady state subcellular distributions of the three splice variants of lysosome-associated membrane protein LAMP-2 are determined largely by the COOH-terminal alnino acid residue. J. Cell Biol. 137 (5) :1161 1169, 1997.

6) Kinugasa, T., Kuroki, M., Takeo, H. et al.:Expression of four CEA family antigens (CEA, NCA, BGP and CGM 2) in CGM 2 in carcinomas. Int. J. Cancer 76 (1) :148-153, 1998.

6) Huizinga, T. W., van der Schoot, C. E., Jost, C. et al.:The PI linked receptor FcRIII is released on stimulation of neutrophils. Nature 333 (6174) :667 669, 1988.

6) Hirata, Y., Taga, T., Hibi, M. et al.:Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J. Immunol. 143 (9) :2900-2906, 1989.

PubMed

6) Kuroki, M., Arakawa, F., Matsuo, Y. et al.:Molecular cloning of nonspecific cross-reacting antigens in human granulocytes. J. Biol. Chem. 266 (18) :11810-11817, 1991.

PubMed

6) Biassoni, R., Ferrini, S., Prigione, I. et al.:CD 3-negative lymphokine-activated cytotoxic cells express the CD 3 epsilon gene. J. Immunol. 140 (5) :1685-1689, 1988.

6) Chen, C. J., Li, L. J., Maruya, A. et al.:In vitro and in vivo footprint analysis of the promoter of carcinoembryonic antigen in colon carcinoma cells:effects of interferon gamma treatment. Cancer Res. 55 (17) :3873-3882, 1995.

PubMed

6) Edgerton, M. D., Graber, P., Willard, D. et al.:Spatial orientation of the alpha and betac receptor chain binding sites on monomeric human interleukin-5 constructs. J. Biol. Chem. 272 (33) :20611-20618, 1997.

PubMed

6) Watanabe, S. and Chou, J. Y.:Human pregnancy-specific beta 1-glycoprotein:a new member of the carcinoembryonic antigen gene family. Biochem. Biophys. Res. Commun. 152 (2) :762-768, 1988.

PubMed

6) Rabinowitz, S. S. and Gordon, S.:Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J. Exp. Med. 174 (4) :827-836, 1991.

PubMed

6) Lowe, J. B., Stoolman, L. M., Nair, R. P. et al.:ELAM-1-dependent cell adhesion to vascular endothelium determined transfected human fucosyltransferase cDNA. Cell 63 (3) :475-484, 1990.

PubMed

6) Hamann, J., Fiebig, H. and Strauss, M.:Expression cloning of the early activation antigen CD 69, a type II integral membrane protein with a C-type lectin domain. J. Immunol. 150 (11) :4920-4927, 1993.

6) Bowen, M. A., Whitney, G. S., Neubauer, M. et al.:Structure and chromosomal location of the human CD 6 gene:detection five human CD 6 isoforms. J. Immunol. 158 (3) :1149-1156, 1997.

6) Lowe, J. B., Kukowska-Latallo, J. F., Nair, R. P. et al.:Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1-dependent cell adhesion. J. Biol. Chem. 266 (26) :17467-14777, 1991.

6) Lastres, P., Martin Perez, J., Langa, C. et al.:Phosphorylation of the human-transforming-growth-factor-beta binding protein endoglin. Biochem. J. 301 (Pt 3) :765 768, 1994.

6) Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

6) Doucet, C., Brouty-Boye, D., Pottin-Clemenceau, C. et al.:Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest. 101 (10) :2129-2139, 1998.

PubMed

6) Bitter, W., Gerrits, H., Kieft, R. et al.:The role of transferrin-receptor variation in the host range of Trypanosoma brucei. Nature 391 (6666) :499-502, 1998.

PubMed

6) Chen, Z., Zhang, X., Gonnella, NC. et al.:Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin. J. Biol. Chem. 273 (17) :10411-10419, 1998.

PubMed

6) Karpinski, B. A., Yang, L. H., Cacheris, P. et al.:The first intron of the 4F2 heavy-chain gene contains a transcriptional enhancer element that binds multiple nuclear proteins. Mol. Cell. Biol. 9 (6) :2588-2597, 1989.

PubMed

6) Hara, T., Ichihara, M., Takagi, M. et al.:Interleukin-3 (IL-3) poor-responsive inbred mouse strains carry the identical deletion of a branch point in the IL-3 receptor alpha subunit gene. Blood 85 (9) :2331-2336, 1995.

PubMed

6) Ferrero, E. and Goyert, S. M.:Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD 14. Nucleic Acids Res. 16 (9) :4173, 1988.

6) Kamal, M., Knox, K., Finney, M. et al.:Stimulation of tyrosine phosphorylation without inositol lipid hydrolysis in human B lymphocytes on engaging CD72. FEBS Lett. 319 (3) :212-216, 1993.

6) Beck, F. W., Kaplan, J., Fine, N. et al.:Decreased expression of CD 73 (ecto-5'-nucleotidase) in the CD 8+ is associated with zinc deficiency in human patients. J. Lab. Clin. Med. 130 (2) :147-156, 1997.

6) Dowling, J., Yu, Q. C. and Fuchs, E.:Beta 4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J. Cell Biol. 134 (2) :559-572, 1996.

PubMed

6) Ascherman, D. P., Migone, T. S., Friedmann, M. C. et al.:Interleukin-2 (IL2) -mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat 5 activation. J. Biol. Chem. 272 (13) :8704-8709, 1997.

6) Garboczi, D. N., Ghosh, P., Utz, U. et al.:Structure of the complex between human T-cell receptor, viral viral peptide and HLA-A 2. Natzare 384 (6605) :134-141, 1996.

6) Hamann, J., Hartmann, E. and van Lier, R. A.:Structure of the human CD 97 gene:exon shuffling has generated a new type of seven-span transmembrane molecule related to the secretin receptor superfamily. Genomics 32 (1) :144-147, 1996.

6) Fukuda, M., Viitala, J., Matteson, J. et al.:Cloning of cDNAs encoding human lysosomal membrane glycoproteins, lamp-1 and h-lamp-2. Comparison of their deduced amino acid. J. Biol. Chem. 263 (35) :18920-18928, 1988.

6) Ghosh, P., Amaya, M., Mellins, E. et al.:The structure of an intermediate in class II MHC maturation:CLIP bound to HLA-DR 3. Nature 378 (6556) :457-462, 1995.

6) Colotta, F., Saccani, S., Giri, J. G. et al.:Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 156 (7) :2534-2541, 1996.

PubMed

6) Giugni, T. D., Soderberg, C., Ham, D. J. et al.:Neutralization of human cytomegalovirus by human CD 13-specific antibodies. J. Infect. Dis. 173 (5) :1062-1071, 1996.

6) Ito, M., Suzuki, E., Naiki, M. et al.:Carbohydrates as antigenic determinants of tumor associated antigens recognized by monoclonal anti-tumor antibodies produced in a syngeneic system. Int. J. Cancer 34 (5) :689-697, 1984.

6) Cohen, P. E. and Pollard, J. W.:Normal sexual function in male mice lacking a functional type I interleukin-1 (IL-1) receptor. Endocrinology 139 (2) :815-818, 1998.

PubMed

6) Littman, D. R.:The CD 4 molecule. Roles in T lymphocytes and in HIV disease. Introduction. Curr. Top. Microbiol. Immunol. 205:v-x, 1996.

6) Ha, H. J., Kubagawa, H. and Burrows, P. D.:Molecular cloning and expression pattern of a human gene homologous to the murine mb-1 gene. J. Immunol. 148 (5) :1526-1531, 1992.

6) Bauer, T. R., Schwartz, B. R., Conrad, Liles, W. et al.:Retroviral mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD 34+cells derived from a patient with leukocyte adhesion deficiency type 1. Blood 91 (5) :1520-1526, 1998.

6) Banner, D. W., D'Arcy, A., Janes, W. et al.:Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex:implications for TNF receptor activation. Cell 73 (3) :431-445, 1993.

PubMed

6) Dunussi-Joannopoulos, K., Dranoff, G., Weinstein, H. J. et al.:Gene immunotherapy in murine acute myeloid leukemia:granulocyte-potent antitumor immunity compared with B7 family and other cytokine vaccines. Blood 91 (1) :222-230, 1998.

PubMed

6) Bach, E. A., Tanner, J. W., Marsters, S. et al.:Ligand-induced assembly and activation of the gamma interferon in intact cells. Mol. Cell. Biol. 16 (6) :3214-3221, 1996.

PubMed

6) Annenkov, A., Ortlepp, S. and Hogg, N.:The beta 2 integrin Mac-1 but not p 150, 95 associates with Fc gamma. Eur. J. Immunol. 26 (1) :207-212, 1996.

PubMed

6) Blume-Jensen, P., Wernstedt, C., Heldin, C. H. et al.:Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cells. J. Biol. Chem. 270 (23) :14192-14200, 1995.

6) Springer, T. A.:Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep paradigm. Cell 76 (2) :301-314, 1994.

PubMed

6) Carayannopoulos, L., Hexham, J. M. and Capra, J. D.:Localization of the binding site for the monocyte immonoglobulin (Ig) A-Fc receptor (CD 89) to the domain boundary between Cα2 and Cα3. J. Exp. Med. 183 (4) :1579 1586, 1996.

6) Berditchevski, F., Zutter, M. M. and Hemler, M. E.:Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM 4 proteins) . Mol. Biol. Cell 7 (2) :193-207, 1996.

6) Hayashida, K., Kitamura, T., Gorman, D. M. et al.:Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF) :reconstitution of a high-affinity GM-CSF receptor. Proc. Natl. Acad. Sci. USA 87 (24) :9655-9659, 1990.

PubMed

6) Bartolazzi, A., Nocks, A., Aruffo, A. et al.:Glycosylation of CD 44 is implicated in CD 44-mediated cell adhesion to hyaluronan. J. Cell Biol. 132:1199-1208, 1996.

6) Bazil, V., Brandt, J., Tsukamoto, A. et al.:Apoptosis of human hematopoietic progenitor cells induced by crosslinking of surface CD 43, the major sialoglycoprotein of. Blood 86 (2) :502-511, 1995.

6) Lanza, F., Morales, M., de La Salle, C. et al.:Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation. J. Biol. Chem. 268 (28) :20801-20807, 1993.

6) Lopez, J. A., Chung, D. W., Fujikawa, K. et al.:The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc. Natl. A cad. Sci. USA 85 (7) :2135-2139, 1988.

6) Ashmun, R. A., Look, A. T., Roberts, W. M. et al.:Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal monorluclear phagocytes and on human myeloid leukemic blast cells. Blood 73 (3) :827-837, 1989.

6) Bennett, K. L., Jackson, D. G., Simon, J. C. et al.:CD 44 isoforms containing exon V 3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128 (4) :687 698, 1995.

6) Russell, G. J., Parker, C. M., Sood, A. et al.:p126 (CDw 101) , a costimulatory molecule preferentially expressed on mucosal T lymphocytes. J. Immunol. 157 (8) :3366-3374, 1996.

6) Asazuma, N., Ozaki, Y., Satoh, K. et al.:Glycoprotein Ib von Willebrand factor interactions activate tyrosille kinases in human platelets. Blood 90 (12) :4789 4798, 1997.

6) Trowbridge, I. S. and Thomas, M. L.:CD 45:an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12:85-116, 1994.

6) Heiska, L., Kantor, C., Parr, T. et al.:Binding of the cytoplasmic domain of intercellular adhesion molecule-2 (ICAM-2) to alpha-actinin. J. Biol. Chem. 271 (42) :26214-26219, 1996.

PubMed

6) Fox, J. E., Aggerbeck, L. P. and Berndt, M. C.:Structure of the glycoprotein Ib. IX complex from platelet membranes. J. Biol. Chem. 263 (10) :4882-4890, 1988.

PubMed

6) Lefkovits, J., Plow, E. F. and Topol, E. J.:Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N. Engl. J. Med. 332 (23) :1553-1559, 1995.

PubMed

6) Burns, F. R., von Kannen, S., Guy, L. et al.:DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension. Neuron 7 (2) :209-220, 1991.

PubMed

6) Van Kooten, C. and Banchereau, J.:CD 40-CD 40 ligand:a multifunctional receptor-ligand pair. Adv. Immunol. 61:1-77, 1996.

6) Vanderpuye, O. A., Labarrere, C. A. and McIntyre, J. A.:The complement system in human reproduction. Am. J. Reprod. Immunol. 27 (3-4) :145-155, 1992.

6) Seon, B. K.:Similarity of TALLA-1, a T-cell acute lymphoblastic leukemia antigen, to GP 37 [letter]. Int. J. Cancer 63 (3) :474, 1995.

6) Maliszewski, C. R., Delespesse, G. J., Schoenborn, M. A. et al.:The CD 391ymphoid cell activation antigen. Molecular cloning and structural characterization. J. Immunol. 153 (8) :3574-3583, 1994.

PubMed

6) Hoshino, S., Kukimoto, I., Kontani, K. et al.:Mapping of the catalytic and epitopic sites of human CD 38/ NAD+glycohydrolase to a functional domain in the carboxyl terminus. J. Immunol. 158 (2) :741-747, 1997.

6) Cooper, D., Lindberg, F. P., Gamble, J. R. et al.:Transendothelial migration of neutrophils involves integrin-associated protein (CD 47) . Proc. Natl. Acad. Sci. US4 92 (9) :3978-3982, 1995.

6) Fuhlbrigge, R. C., Kieffer, J. D., Armerding, D. et al.:Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389 (6654) :978-981, 1997.

PubMed

6) Schwartz Albiez, R., Dorken, B., Hofmann, W. et al.:The B cell associated CD 37 antigen (gp 40-52) . Structure and expression of an extensively glycosylated glycoprotein. J. Immunol. 140 (3) :905-914, 1988.

6) Dong, J. T., Lamb, P. W., Rinker Schaeffer, C. W. et al.:KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11. 2. Science 268 (5212) :884-886, 1995.

PubMed

6) Kingsmore, S. F., Souryal, C. A., Watson, M. L. et al.:Physical and genetic linkage of the genes encoding Ly-9 and CD 48 on mouse and human chromosomes 1. Immunogenetics 42 (1) :59-62, 1995.

7) Berlin, C., Bargatze, R. F., Campbell, J. J. et al.:alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80 (3) :413-422, 1995.

PubMed

7) Punnonen, J., Cocks, B. G., Carballido, J. M. et al.:Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185 (6) :993-1004, 1997.

7) Ferrag, F., Pezet, A., Chiarenza, A. et al.:Homodimerization of IL-2 receptor beta chain is necessary and sufficient to activate Jak 2 and downstream signaling pathways. FEBS Lett. 421 (1) :32-36, 1998.

PubMed

7) Emtage, P. C., Wan, Y., Bramson, J. L. et al.:Adouble recombinant adenovirus expressing the costimulatory molecule B 7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model. J. Immunol. 160 (5) :2531-2538, 1998.

7) Myles, D. G., Kimmel, L. H., Blobel, C. P. et al.:Identification of a binding site in the disintegrin domain of fertilin required for sperm-egg fusion. Proc. Natl. Acad. Sci. USA 91 (10) :4195-4198, 1994.

PubMed

7) Riopelle, R. J., McGarry, R. C. and Roder, J. C.:Adhesion properties of a neuronal epitope recognized by the monoclonal antibody HNK-1. Brain Res. 367 (1-2) :20-25, 1986.

7) Arnaout, M. A., Gupta, S. K., Pierce, M. W. et al.:Amino acid sequence of the alpha subunit of human leukocyte adhesion receptor Mo 1 (complement receptor type 3) . J. Cell Biol. 106 (6) :2153-2158, 1988.

7) Bajt, M. L., Ginsberg, M. H., Frelinger, ALd, et al.:A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site. J. Biol. Chem. 267 (6) :3789-3794, 1992.

7) Cook, J. R., Jung, V., Schwartz, B. et al.:Structural analysis of the human interferon gamma receptor:a small segment of the intracellular domain is specifically required for class I major histocompatibility complex antigen induction and antiviral activity. Proc. Natl. Acad. Sci. USA 89 (23) :11317-11321, 1992.

7) Cybulsky, M. I., Fries, J. W., Williams, A. J. et al.:Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM 1 gene. Proc. Natl. Acad. Sci. USA 88 (17) :7859-7863, 1991.

PubMed

7) Ascherman, D. P., Migone, T. S., Friedmann, M. C. et al.:Interleukin-2 (IL-2) -mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat 5 activation. J. Biol. Chem. 272 (13) :8704-8709, 1997.

7) Amakawa, R., Hakem, A., Kundig, T. M. et al.:Impaired negative selection of T cells in Hodgkin's disease antigen CD 30-deficient mice. Cell 84 (4) :551-562, 1996.

7) Maly, P., Thall, A., Petryniak, B. et al.:The alpha (1, 3) fucosyltransferase Fuc-T VII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 86 (4) :643-653, 1996.

7) Howard, M., Grimaldi, J. C., Bazan, J. F. et al.:Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD 38. Science 262 (5136) :1056-1059, 1993.

7) Helander, T. S., Carpen, O., Turunen, O. et al.:ICAM-2 redistributed by ezrin as a target for killer cells. Nature 382 (6588) :265-268, 1996.

PubMed

7) Gutensohn, W., Resta, R., Misumi, Y. et al.:Ecto-5'-nucleotidase activity is not required for T cell activation through CD 73. Cell. Immunol. 161 (2) :213-217, 1995.

PubMed

7) Broudy, V. C., Lin, N. L., Buhring, H. J. et al.:Analysis of c-kit receptor dimerization by fluorescence resonance energy transfer. Blood 91 (3) :898-906, 1998.

PubMed

7) Hintzen, R. Q., Lens, S. M., Beckmann, M. P. et al.:Characterization of the human CD 27 ligand, a novel member of the TNF gene family. J. Immunol. 152 (4) :1762-1773, 1994.

7) Lee, B. O., Ishihara, K., Denno, K. et al.:Elevated levels of the soluble form of bone marrow stromal cell 1 in the sera of patients with severe rheumatoid arthritis. Arthritis Rheum. 39 (4) :629 637, 1996.

7) Buckley, C. D., Doyonnas, R., Newton, J. P. et al.:Identification of alpha v beta 3 as a heterotypic ligand for CD 31/PECAM-1. J. Cell Sci. 109 (Pt 2) :437-445, 1996.

7) Zhou, L. J. and Tedder, T. F.:A distinct pattern of cytokine gene expression by human CD83+blood dendritic cells. Blood 86 (9) :3295-3301, 1995.

PubMed

7) Goldstein, M. D. and Watts, T. H.:Identification of distinct domains in CD 40 involved in B 7-1 induction or growth inhibition. J. Immunol. 157 (7) :2837-2843, 1996.

PubMed

7) Dunussi-Joannopoulos, K., Dranoff, G., Weinstein, HJ. et al.:Gene immunotherapy in murine acute myeloid leukemia:granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B 7 family and other cytokine vaccines. Blood 91 (1) :222-230, 1998.

7) Chuang, L. M., Chiu, K. C., Chiang, F. T. et al.:Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolism 46 (10) :1211-1214, 1997.

PubMed

7) Stewart, M., Thiel, M. and Hogg, N.:Leukocyte integrins. Curr. Opin. Cell. Biol. 7 (5) :690-696, 1995.

PubMed

7) Howe, C. L., Granger, B. L., Hull, M. et al.:Derived protein sequence, oligosaccharides, and membrane insertion of the 120-kDa lysosomal membrane glycoprotein (lgp 120) :identification a highly conserved family of lysosomal membrane glycoproteins. Proc. Natl. Acad. Sci. USA 85 (20) :7577-7581, 1988.

7) Kalb, R., Walka, M., Kiefel, V. et al.:The human platelet alloantigens Br (a) and Brb are associated with asingle amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2) . J. Clin. Invest. 92 (5) :2427-2432, 1993.

7) Roberts, J. J., Rodgers, S. E., J. D., Ashman, L. K et al.:Platelet activation induced by a murine monoclonal antibody directed against a novel tetra-span antigen. Br. J. Haematol. 89 (4) :853-860, 1995.

7) Ellis, N. A., Ye, T. Z., Patton, S. et al.:Cloning of PBDX, an MIC 2 related gene that spans the pseudoautosomal boundary on chromosome Xp. Nat. Genet. 6 (4) :394 400, 1994.

7) Kalli, K. R., Hsu, P. H., Bartow, T. J. et al.:Mapping of the C 3 b-binding site of CR 1 and construction of a (CR 1) 2-F (ab') 2 chimeric complement inhibitor. J. Exp. Med. 174 (6) :1451-1460, 1991.

7) Berditchevski, F., Tolias, K. F., Wong, K. et al.:A novel link between integrins, transmembrane-4 super-family proteins (CD 63 and CD 81) , and phosphatidylinositol 4-kinase. J. Biol. Chem. 272 (5) :2595-2598, 1997.

7) Lefranc, MP., Chuchana, P., Dariavach, P. et al.:Molecular mapping of the human T cell receptor gamma (TRG) genes linkage of the variable and constant regions. Ezar. J. Immunol. 19 (6) :989-994, 1989.

7) de Wit, T. P., Morton, H. C., Capel, P. J. et al.:Structure of the gene for the human myeloid lgA Fc receptor (CD 89) . J. Immunol. 155 (3) :1203 1209, 1995.

7) Heaney, M. L., Vera, J. C., Raines, M. A. et al.:Membrane-associated and soluble granulocyte/macrophage-colony-stimulating factor receptor alpha subunits are independently regulated in HL-60 cells. Proc. Natl. Acad. Sci. USA 92 (6) :2365-2369, 1995.

PubMed

7) de Koning, J. P., Soede-Bobok, A. A., Schelen, A. M. et al.:Proliferation signaling and activation of Shc, p 21 Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood 91 (6) :1924-1933, 1998.

7) Chai, J. G., Bartok, I., Scott, D. et al.:T:T antigen presentation by activated murine CD 8+T cells induces anergy and apoptosis. J. Immunol. 160 (8) :3655-3665, 1998.

7) Marcus, A. J., Broekman, M. J., Drosopoulos, J. H. et al.:The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD 39. J. Clin. Invest. 99 (6) :1351-1360, 1997.

7) Yokota, S., Hara, H., Luo, Y. et al.:Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin. Cancer Res. 50 (1) :32-37, 1990.

7) Fawcett, J., Buckley, C., Holness, C. L. et al.:Mapping the homotypic binding sites in CD 31 and the role of CD 31 adhesion in the formation of interendothelial cell contacts. J. Cell Biol. 128 (6) :1229-1241, 1995.

7) Crosby, J. R., Seifert, R. A., Soriano, P. et al.:Chimaeric analysis reveals role of Pdgf receptors in all muscle lineages. Nat. Genet. 18 (4) :385 388, 1998.

7) Chan, A. C., Iwashima, M., Turck, CW. et al.:ZAP-70:a 70 kd protein-tyrosine kinase that associates with the zeta chain. Cell 71:649-662, 1992.

PubMed

7) Baker, D. A., Celetti, A. and Dibb, N. J.:Selection of activating mutations of c-fms in FDC-P 1 cells. Oncogene 11 (7) :1347-1356, 1995.

7) del Pozo, M. A., Sanchez-Mateos, P., Nieto, M. et al.:Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J. Cell Biol. 131 (2) :495-508, 1995.

PubMed

7) Biassoni, R., Cantoni, C., Falco, M. et al.:The human leukocyte antigen (HLA) -C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183 (2) :645-650, 1996.

PubMed

7) Bennett, K. L., Jackson, D. G., Simon, J. C. et al.:CD 44 isoforms containing exon V 3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128 (4) :687-698, 1995.

7) Delespesse, G., Sarfati, M., Wu, C. Y. et al.:The low-affinity receptor for IgE. Immunol. Rev. 125:77-97, 1992.

PubMed

7) Koch, N., Moldenhauer, G., Hofmann, WJ. et al.:Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD 74) . J. Immunol. 147 (8) :2643-2651, 1991.

7) Cleveland, J. L. and Ihle, J. N.:Contenders in FasL/TNF death signaling. Cell 81 (4) :479-482, 1995.

PubMed

7) Degen, W. G., van Kempen, L. C., Gijzen, E. G. et al.:MEMD, a new cell adhesion molecule in metastasizing human melanoma lines, is identical to ALCAM (activated leukocyte cell adhesion molecule) . Am. J. Pathol. 152 (3) :805-813, 1998.

PubMed

7) Cyster, J. G., Shotton, D. M. and Williams, A. F.:The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J. 10 (4) :893 902, 1991.

7) Ianelli, C. J., Edson, C. M. and Thorley-Lawson, D. A.:A ligand for human CD 48 on epithelial cells. J. Immunol. 159 (8) :3910-3920, 1997.

7) Gruss, H. J., Pinto, A., Gloghini, A. et al.:CD 30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. Am. J. Pathol. 149 (2) :469-481, 1996.

7) Ryan, J. C. and Seaman, W. E.:Divergent functions of lectin-like receptors on NK cells. Immunol Rev. 155:79-89, 1997.

PubMed

7) Hogervorst, F., Kuikman, I., von dem Borne, A. E. et al.:Cloning and sequence analysis of beta-4 cDNA:an integrin subunit that contains a unique 118 kd cytoplasmic domain. EMBO J. 9 (3) :765-770, 1990.

PubMed

7) Lopez, J. A., Leung, B., Reynolds, C. C. et al.:Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IX complex requires the presence of its three subunits. J. Biol. Chem. 267 (18) :12851-12859, 1992.

PubMed

7) Lindberg, F. P., Gresham, H. D., Schwarz, E. et al.:Molecular cloning of integrin-associated protein:an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding. J. Cell Biol. 123:485-496, 1993.

7) Conway, E. M., Pollefeyt, S., Collen, D. et al.:The amino terminal lectin-like domain of thrombomodulin is required constitutive endocytosis. Blood 89 (2) :652-661, 1997.

PubMed

7) Kajiji, S., Tamura, RN. and Quaranta, V.:A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. EMBO J. 8 (3) :673-680, 1989.

7) Deyerle, K. L., Sims, J. E., Dower, S. K. et al.:Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J. Immunol. 149 (5) :1657-1665, 1992.

PubMed

7) Lopez, J. A., Weisman, S., Sanan, D. A. et al.:Glycoprotein (GP) Ib beta is the critical subunit linking GP Ib alpha and GP IX in the GP Ib-IX complex. Analysis of partial complexes. J. Biol. Chem. 269 (38) :23716-23721, 1994.

PubMed

7) Biancone, L., Bowen, M. A., Lim, A. et al.:Identification of a novel inducible cell-surface ligand of CD 5 on activated lymphocytes. J. Exp. Med. 184 (3) :811-819, 1996.

7) Arase, N., Arase, H., Park, S. Y. et al.:Association with FcRgamma is essential for activation signal through NKR-P1 (CD 161) in natural killer (NK) cells and NK1. 1+ T cells. J. Exp. Med. 186 (12) :1957 1963, 1997.

7) Feizi, T.:Evidence for carbohydrate-mediated interactions between the neural-cell-adhesion molecules NCAM and L 1. Trends Biochem. Sci. 19 (6) :233-234, 1994.

7) Bernard, A. M., Vivier, I., Darmoul, D. et al.:cDNA cloning for mouse thymocyte-activating molecule. A ecto-dipeptidyl peptidase IV (CD 26) included in a subgroup of serine proteases. J. Biol. Chem. 267 (4) :2200-2208, 1992.

7) Engelhardt, W., Geerds, C. and Frey, J.:Distribution, inducibility and biological function of the cloned and expressed human beta Fc receptor II. Eur. J. Immunol. 20 (6) :1367-1377, 1990.

PubMed

7) Doody, G. M., Justement, L. B., Delibrias, C. C. et al.:A role in B cell activation for CD 22 and the protein tyrosine phosphatase SHP. Science 269 (5221) :242-244, 1995.

7) Herren, B., Levkau, B., Raines, E. W. et al.:Cleavage of beta catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis:evidence for a role for caspases and metalloproteinases. Mol. Biol. Cell 9 (6) :1589 1601, 1998.

7) Gunthert, U., Hofmann, M., Rudy, W. et al.:A new variant of glycoprotein CD 44 confers metastatic potential to rat carcinoma cells. Cell 65 (1) :13-24, 1991.

7) Kikuchi, Y., Yasue, T., Miyake, K. et al.:CD 38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain:synergistic effects with interleukin 5. Proc. Natl. Acad. Sci. USA 92 (25) :11814-11818, 1995.

7) Coppolino, M., Migliorini, M., Argraves, W. S. et al.:Identification of a novel form of the alpha 3 integrin subunit:covalent association with transferrin receptor. Biochem. J. 306 (Pt 1) :129-134, 1995.

7) Hidari, K. I., Weyrich, A. S., Zimmerman, G. A. et al.:Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J. Biol. Chem. 272 (45) :28750-28756, 1997.

PubMed

7) Larsen, S. L., Pedersen, LO., Buus, S. et al.:T cell responses affected by aminopeptidase N (CD 13) -mediated of major histocompatibility complex class II-bound peptides. J. Exp. Med. 184 (1) :183-189, 1996.

7) Emsley, J., Cnlz, M., Handin, R. et al.:Crystal structure of the von Willebrand Factor A 1 domaill and implications for the binding of platelet glycoprotein Ib. J. Biol. Chem. 273 (17) :1 (1396 10401, 1998.

7) Isberg, R. R., M. L. J.:Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 60 (5) :861 871, 1990.

7) Liu, Y. J. and Banchereau, J.:Regulation of B-cell commitment to plasma cells or to memory B cells. Semin. Immunol. 9 (4) :235-240, 1997.

PubMed

7) Lopez-Cabrera, M., Santis, A. G., Fernandez-Ruiz, E. et al.:Molecular cloning, expression, andchromosomal localization of the human earliest lymphocyte activation antigen AIM/CD 69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178 (2) :537-547, 1993.

7) Berg, E. L., Yoshino, T., Rott, L. S. et al.:The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J. Exp. Med. 174 (6) :1461-1466, 1991

PubMed

7) Gearing, D. P., Comeau, M. R., Friend, D. J. et al.:The IL-6 signal transducer, gp 130:an oncostatin M receptor and affinity converter for the LIF receptor. Science 255 (5050) :1434-1437, 1992.

7) Brodsky, R. A., Vala, M. S., Barber, J. P. et al.:Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc. Natl. Acad. Sci. USA 94 (16) :8756-8760, 1997.

PubMed

7) Ellis, V., Behrendt, N. and Dano, K.:Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 266 (19) :12752-12758, 1991.

7) Kristensen, T., Moestrup, S. K., Gliemann, J. et al.:Evidence that the newly cloned low-density-lipoprotein receptor protein (LRP) is the alpha 2-macroglobulin receptor. FEBS Lett. 276 (1-2) :151-155, 1990.

PubMed

7) Davis, S. J. and van der Merwe, P. A.:CD 2:an exception to the immunoglobulin superfamily concept? Science 273 (5279) :1241-1242, 1996.

7) Gravestein, L. A., van Ewijk, W., Ossendorp, F. et al.:CD 27 cooperates with the pre-T cell receptor in the regulation of murine T cell development. J. Exp. Med. 184 (2) :675-685, 1996.

7) Carbone, A., Gaidano, G., Gloghini, A. et al.:Differential expression of BCL-6, CD 138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related Hodgkin's lymphomas. Blood 91 (3) :747-755, 1998.

7) Doherty, P. C.:The numbers game for virus specific CD 8+Tcells. Scrience 280 (5361) :227, 1998.

7) Kishimoto, T. K., Hollander, N., Roberts, T. M. et al.:Heterogeneous mutations in the beta subunit common to the LFA-1, and p 150, 95 glycoproteins cause leukocyte adhesion deficiency. Cell 50 (2) :193-202, 1987.

7) Majdic, O., Fischer, G. F., Petzelbauer, P. et al.:MUC 18/MCAM (CD 146) , an activation antigen of human T lymphocytes. J. Immunol. 158 (5) :2107-2115, 1997.

7) Hadley, G. A., Bartlett, S. T., Via, C. S. et al.:The epithelial cell specific integrin, CD 103 (alpha E integrin) , defines a novel subset of alloreactive CD 8+ CTL. J. Immunol. 159 (8) :3748-3756, 1997.

7) Corbel, C., Pourquie, O., Cormier, F. et al.:BEN/SC 1/DM-GRASP, a homophilic adhesion molecule, is required for in vitro myeloid colony formation by avian hemopoietic progenitors. Proc. Natl. Acad. Sci. USA 93 (7) :2844-2849, 1996.

7) Ernst, L. K., Duchemin, A. M. and Anderson, C. L.:Association of the high affinity receptor for IgG (Fc gamma RI) with the gamma subunit of the IgE receptor. Proc. Natl. Acad. Sci. USA 90 (13) :6023-6027, 1993.

PubMed

7) Meredith, J. E. Jr., Fazeli, B. and Schwartz, M. A.:The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4 (9) :953-961, 1993.

PubMed

7) Engel, P., Zhou, L. J., Ord, D. C. et al.:Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD 19 signal transduction molecule. Immunity 3 (1) :3950, 1995.

PubMed

7) Felzmann, T., Gadd, S., Majdic, O. et al.:Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis. J. Clin. Immunol. 11 (4) :205-212, 1991.

PubMed

7) Leiden, J. M, Yang, L. H., Morle, G. D. et al.:The 4F2 heavy chain gene:a molecular model of inducible gene expression in human T cells. J. Autoimmun. (2 Suppl.) :67-79, 1989.

7) Hayashida, K., Kitamura, T., Gorman, D. M. et al.:Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF) :reconstitution of a high-affinity GM-CSF receptor. Proc. Natl. Acad. Sci. USA 87 (24) :9655-9659, 1990.

PubMed

7) Gromeier, M., Lu, H. H., Bernhardt, G. et al.:The human poliovirus receptor. Receptor-virus interaction and parameters of disease specificity. Ann. N. Y. Acad. Sci. 753:19-36, 1995.

7) Kinugasa, T., Kuroki, M., Takeo, H. et al.:Expression of four CEA family antigens (CEA, NCA, BGP and CGM 2) in CGM 2 in carcinomas. Int. J. Cancer 76 (1) :148-153, 1998.

7) Ishimaru, F. and Shipp, M. A.:Analysis of the human CD 10/neutral endopeptidase 2. 11 promoter two separate regulatory elements. Blood 85 (11) :3199 3207, 1995.

7) Maloney, M. D. and Lingwood, C. A.:CD19 has a potential CD77 (globotriaosyl ceramide) binding site with sequence similarity to verotoxin B-subunits:implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis. J. Exp. Med. 180 (1) :191-201, 1994.

7) Ahuja, S. K., Ozcelik, T., Milatovitch, A. et al.:Molecular evolution of the human interleukin-8 receptor gene cluster. Nat. Genet. 2 (1) :31-36, 1992.

PubMed

7) Arendt, C. W. and Ostergaard, H. L.:CD 45 protein-tyrosine phosphatase is specifically associated with a 116-kDa tyrosine-phosphorylated glycoprotein. J. Biol. Chem. 270 (5) :2313-2319, 1995.

7) Ichihara, M., Hara, T., Takagi, M. et al.:Impaired interleukin 3 (IL-3) response of the A/J mouse is caused by a branch point deletion in the IL-3 receptor alpha subunit gene. EMBO J. 14 (5) :939-950, 1995.

7) Fukudome, K., Furuse, M., Imai, T. et al.:Identification of membrane antigen C 33 recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1 (HTLV 1) . induced syncytium formation:altered glycosylation of C 33 antigen in HTLV-1-positive T cells. J. Virol. 66 (3) :1394-1401, 1992.

7) Cao, Z., Henzel, W. J. and Gao, X.:IRAK:a kinase associated with the interleukin-1 receptor. Science 271 (5252) :1128-1131, 1996.

7) Asch, A. S., Liu, I., Briccetti, F. M. et al.:Analysis of CD 36 binding domains:ligand specificity controlled by dephosphorylation of an ectodomain. Science 262 (5138) :1436-1440, 1993.

7) Symington, F. W., Murray, W. A., Bearman, S. J. et al.:Intracellular localization of lactosylceramide, the major human neutrophil glycosphingolipid. J. Biol. Chem. 262 (23) :11356-11363, 1987.

PubMed

7) Clark, G. J. and Dallman, M. J.:Identification of a cDNA encoding the rat CD 28 homologue. Immumogenetics 35 (1) :54-57, 1992.

7) Crompton, T., Outram, S. V., Buckland, J. et al.:Distinct roles of the interleukin-7 receptor alpha chain in fetal and adult thymocyte development revealed by analysis of interleukin-7 receptor alpha-deficient mice. Eur. J. Immunol. 28 (6) :1859-1866, 1998.

PubMed

7) Bessler, M., Mason, P. J., Hillmen, P. et al.:Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 13 (1) :110-117, 1994.

PubMed

7) Hotta, H., Miyamoto, H., Hara, I. et al.:Genomic structure of the ME 491/CD 63 antigen gene and functional analysis of the 5'-flanking regulatory sequences. Biochem. Biolphys. Res. Commun. 185 (1) :436-442, 1992.

7) Ferrero, E., Hsieh, C. L., Francke, U. et al.:CD 14 is a member of the family of leucine rich proteins and is encoded by a gene syntenic with multiple receptor genes. J. Immunol. 145 (1) :331336, 1990.

7) Conneally, E., Eaves, C. J. and Humphries, R. K.:Efficient retroviral-mediated gene transfer to human cordblood stem cells with in vivo repopulating potential. Blood 91 (9) :3487-3493, 1998.

7) Boesteanu, A., Silva, A. D. D., Nakajima, H. et al.:Distinct roles for signals relayed through the common cytokine receptor gamma chain and interleukin 7 receptor alpha chain in natural T cell development. J. Exp. Med. 186 (2) :331-336, 1997.

7) Hemler, M. E., Sanchez-Madrid, F., Flotte, T. J. et al.:Glycoproteins of 210, 000 and 130, 000 m. w. on activated T cells:cell distribution and antigenic relation to components on resting cells and T cell lines. J. Immunol 132 (6) :3011-3018, 1984.

7) Hoijer, M. A., de Groot, R., van Lieshout, L. et al.:Differences in N-acetylmuramyl-L-alanine amidase and lysozyme in and cerebrospinal fluid of patients with bacterial meningitis. J. Infected 177 (1) :102-106, 1998

7) Mazerolles, F., Auffray, C. and Fischer, A.:Down regulation of T-cell adhesion by CD 4. Hum. Immunol. 31 (1) :40-46. 1991.

7) Bomstein, Y. and Fishelson, Z.:Enhanced sensitivity of P-glycoprotein-positive multidrug resistant tumor cells to complement-mediated lysis. Eur. J. Immunol. 27 (9) :2204-2211, 1997.

PubMed

7) Hickey, M. J., Williams, S. A. and Roth, G. J.:Human platelet glycoprotein IX:an adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures. Proc. Natl. Acad. Sci. USA 86 (17) :6773-6777, 1989.

PubMed

7) Caras, I. W., Davitz, M. A., Rhee, L. et al.:Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325 (6104) :545-549, 1987.

PubMed

7) Varki, A.:Selectin ligands. Proc. Natl. Acad. Sci. USA 91 (16) :7390-7397, 1994.

PubMed

7) Chan, A. S., Mobley, J. L., Fields, G. B. et al.:CD 7-mediated regulation of integrin adhesiveness on human Tcells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase. J. Immunol. 159 (2) :934-942, 1997.

7) Gasque, P., Singhrao, S. K., Neal, J. W. et al.:Expression of the receptor for complement C5a (CD 88) is up-regulated reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150 (1) :31-41, 1997.

7) Kurosaki, T., Gander, I., Wirthmueller, U. et al.:The beta subunit of the Fc epsilon RI is associated with the Fc gamma RIII on mast cells. J. Exp. Med. 175 (2) :447451, 1992.

7) Cadroy, Y., Dupouy, D. and Boneu, B.:Arachidonic acid enhances the tissue factor expression of mononuclear cells by the cyclo-oxygenase-1 pathway:beneficial effect of n-3 fatty acids. J. Immunol. 160 (12) :6145-6150, 1998.

7) Deans, J. P., Kalt, L., Ledbetter, J. A. et al.:Association of 75/80-kDa phosphoproteins and the tyrosine kinases Fyn, and Lck with the B cell molecule CD 20. Evidence against involvement of the cytoplasmic regions of CD 20. J. Biol. Chem. 270 (38) :22632-22638, 1995.

7) Mannion, B. A., Berditchevski, F., Kraeft, S. K. et al.:Transmembrane 4 superfamily proteins CD 81 (TAPA 1) , CD 82, CD 63, and CD 53 specifically associated with integrin alpha 4 beta 1 (CD 49 d/CD 29) . J. Immunol. 157 (5) :2039 2047, 1996.

7) Belkin, A. M., Zhidkova, N. I., Balzac, F. et al.:Beta 1 D integrin displaces the beta 1 A isoform in striated muscles:localization at junctional structures and signaling potential in nonmuscle cells. J. Cell Biol. 132 (1-2) :211-226, 1996.

7) Kleist, S. V., Chavanel, G. and Burtin, P.:Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc. Natl. Acad. Sci. USA 69 (9) :2492-2494, 1972.

7) McKnight, A. J. and Gordon, S.:The EGF-TM 7 family:unusual structures at the leukocyte surface. J. Leukoc. Biol. 63 (3) :271-280, 1998.

7) Baum, P. R., Gayle, R. Br., Ramsdell, F. et al.:Molecular characterization of murine and human OX 40/ OX 40 ligand systems:identification of a human OX 40 ligand as the HTLV-1-regulated protein gp 34. EMBO J. 13 (17) :3992-4001, 1994.

7) Robertson, M. J., Soiffer, R. J., Freedman, A. S. et al.:Human bone marrow depleted of CD 33-positive cells mediates delayed durable reconstitution of hematopoiesis:clinical trial of MY 9 monoclonal antibody purged autografts for the treatment of acute. Blood 79 (9) :2229-2236, 1992.

7) Hashimoto, S., Mohrenweiser, H. W., Gregersen, P. K. et al.:Chromosomal localization, genomic structure, and allelic polymorphism of the human CD 79 alpha (Ig-alpha/mb-1) gene. Immunogenetics 40 (4) :287-295, 1994.

7) Horsten, U., Muller Newen, G., Gerhartz, C. et al.:Molecular modeling-guided mutagenesis of the extracellular part of gp 130 leads to the identification of contact sites in the interleukin-6 (IL-6) /IL-6 receptor/gp 130 complex. J. Biol. Chem. 272 (38) :23748-23757, 1997.

7) Ramprasad, M. P., Fischer, W., Witztum, J. L. et al.:The 94-to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD 68. Proc. Natl. Acad. Sci. USA 92 (21) :9580-9584, 1995.

7) Blackford, J., Reid, H. W., Pappin, D. J. et al.:A monoclonal antibody, 3/22, to rabbit CD 11c which induces homotypic cell aggregation:evidence that ICAM 1 is a ligand for CD 11c/CD 18. Eur. J. Immunol. 26 (3) :525-531, 1996.

7) Myers, D. E. and Uckun, F. M.:An anti-CD 72 immunotoxin against therapy-refractory B-lineage acute. Leuk. Lymphoma 18 (1-2) :119-122, 1995.

7) Hannum, C., Culpepper, J., Campbell, D. et al.:Ligand for FLT 3/FLK 2 receptor tyrosine kinase regulate growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368 (6472) :643-648, 1994.

7) Keane, M. M., Lowrey, G. A., Ettenberg, S. A. et al.:The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res. 56 (18) :4236-4243, 1996.

PubMed

7) Carel, J. C., Myones, B. L., Frazier, B. et al.:Structural requirements for C 3 dg/Epstein-Barr virus receptor (CR 2/CD 21) ligand binding, internalization, and viral infection. J. Biol. Chem. 265 (21) :12293-12299, 1990.

7) Fujiwara, H., Hanissian, S. H., Tsytsykova, A. et al.:Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA 94 (11) :5866-5871, 1997.

7) Boyle, J. S., Brady, J. L. and Lew, A. M.:Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392 (6674) :408-411, 1998.

PubMed

7) Boldin, M. P., Mett, I., Varfolomeev, E. E. et al.:Self-association of the "death domains" of the p 55 tumor necrosis factor (TNF) receptor and Fas/APO 1 prompts signaling for TNF and Fas/APO 1 effects. J. Biol. Chem. 270 (1) :387-391, 1995.

7) Li, B. Q., Wang, M. H., Kung, H. F. et al.:Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor. Biochem. Biophys. Res. Commun. 216 (1) :110-118, 1995.

PubMed

7) Biassoni, R., Pessino, A., Malaspina, A. et al.:Role of amino acid position 70 in the binding affinity of p50. 1 and p58. 1 receptors for HLA-Cw4 molecules. Eur. J. Immunol. 27 (12) :3095-3099, 1997.

PubMed

7) Nagel, G., Grunert, F., Kuijpers, T. W. et al.:Genomic organization, splice variants and expression of CGMl, a CD 66-related member of the carcinoembryonic antigen gene family. Eur. J. Biochem. 214 (1) :27 35, 1993.

7) Hardy, R. R., Carmack, C. E., Shinton, S. A. et al.:Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173 (5) :1213 1225, 1991.

7) Martin-Satue, M., Marrugat, R., Cancelas, J. A. et al.:Enhanced expression of alpha (1, 3) -fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells. Cancer Res. 58 (7) :1544-1550, 1998.

7) Moliterno, D. J. and Topol, E. J.:Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction. Thromb. Haemost 78 (1) :214-219, 1997.

PubMed

7) Lastres, P., Letamendia, A., Zhang, H. et al.:Endoglin modulates cellular responses to TGF beta 1. J. Cell Biol. 133 (5) :1109 1121, 1996.

7) Sidorenko, S. P., Vetrova, E. P., Yurchenko, O. V. et al.:Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping. Neoplasima 39 (1) :3-9, 1992.

PubMed

7) Bendelac, A., Lantz, O., Quimby, M. E. et al.:CD 1 recognition by mouse NK 1+T lymphocytes. Science 268 (5212) :863-865, 1995.

7) Gleich, G. J. and Kita, H.:Roles of CD 9 molecules in survival and activation of human eosinophils. J. Immunol. 159 (2) :926-933, 1997.

7) Gangopadhyay, A., Bajenova, O., Kelly, T. M. et al.:Carcinoembryonic antigen induces cytokine expression in Kuppfer cells:implications for hepatic metastasis from colorectal cancer. Cancer Res. 56 (20) 4805-4810, 1996.

PubMed

7) Hurtado, J. C., Kim, S. H., Pollok, K. E. et al.:Potential role of 4-1 BB in T cell activation. Comparison with the costimulatory molecule CD 28. J. Immunol. 155 (7) :3360-3367, 1995.

7) Mitchell, E. L., Jones, D., White, G. R. et al.:Determination of the gene order of the three loci CD 2, NGFB, and NRAS at human chromosome band 1 p13 and refinement of their localisation at the subband level by fluorescence in situ hybridisation. Cytogenet. Cell Genet. 70 (3-4) :183-185, 1995.

7) Jeng, C. J., McCarroll, S. A., Martin, T. F. et al.:Thy-1 is a component common to multiple populations of synaptic vesicles. J. Cell Biol. 140 (3) :685-698, 1998.

PubMed

7) Kubota, H., Okazaki, H., Onuma, M. et al.:Identification and gene cloning of a new phosphatidylinositol-linked antigen expressed on mature lymphocytes. Down-regulation by lymphocyte activation. J. Immunol. 145 (11) :3924-3931, 1990.

PubMed

8) Grunert, F., Daniel, S., Nagel, G. et al.:CD 66 b, CD 66 c and carcinoembryonic antigen (CEA) are independently regulated markers in sera of tumor patients. Int. J. Cancer 63 (3) :349-355, 1995.

8) Li, J., Cook, R., Doyle, M. L. et al.:Monomeric isomers of human interleukin 5 show that 1:1 receptor recruitment is sufficient for function. Proc. Natl. Acad. Sci. USA 94 (13) :6694-6699, 1997.

PubMed

8) Jang, I. K., Lee, Z. J., Kim, Y. J. et al.:Human 4-1 BB (CD 137) signals are mediated by TRAF 2 and activate nuclear factor-kappa B. Biochem. Biophys. Res. Commun. 242 (3) :613-620, 1998.

8) Clevers, H. C., Dunlap, S., Wileman, T. E. et al.:Human CD 3-epsilon gene contains three miniexons and is transcribed a non-TATA promoter. Proc. Natl. Acad. Sci. US. 85 (21) :8156-8160, 1988.

8) Gangemi, R. M., Swack, J. A., Gaviria, D. M. et al.:Anti-T 12, an anti-CD 6 monoclonal antibody, can activate human T lymphocytes. J. Immunol. 143 (8) :2439-2447, 1989.

8) Hanninen, A., Salmi, M., Simell, O. et al.:Recirculation and homing of lymphocyte subsets :dual homing specificity of beta 7-integrin (high) -lymphocytes in nonobese diabetic mice. Blood 88 (3) :934-944, 1996.

PubMed

8) Bevilacqua, M. P., Pober, J. S., Mendrick, D. L. et al.:Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA 84 (24) :9238-9242, 1987.

PubMed

8) Chabot, S., Williams, G. and Yong, V. W.:Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b. J. Clin. Invest. 100 (3) :604-612, 1997.

PubMed

8) Lindsten, T., June, C. H., Thompson, C. B. et al.:Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms. Mol. Cell. Biol. 8 (9) :3820-3826, 1988.

8) Munro, J. M., Lo, S. K., Corless, C. et al.:Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am. J. Pathol. 141 (6) :1397-1408, 1992.

8) Lippincott-Schwartz, J. and Fambrough, D. M.:Lysosomal membrane dynamics :structure and interorganellar a major lysosomal membrane glycoprotein. J. Cell Biol. 102 (5) :1593-1605, 1986.

8) Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

8) Strobl, H., Scheinecker, C., Csmarits, B. et al.:Flow cytometric analysis of intracellular CD 68 molecule expression in normal and malignant haemopoiesis. Br. J. Haematol. 90 (4) :774-782, 1995.

8) Carey, D. J., Bendt, K. M. and Stahl, R. C.:The cytoplasmic domain of syndecan-1 is required for cyto-skeleton association but not detergent insolubility. Identification of essential cytoplasmic domain residues. J. Biol. Chem. 271 (25) :15253-15260, 1996.

8) DeBernardo, A. P. and Chang, S.:Heterophilic interactions of DM-GRASP:GRASP-NgCAM interactions involved in neurite extension. J. Cell. Biol. 133 (3) :657-666, 1996.

8) Lopez-Cabrera, M., Munoz, E., Blazquez, M. V. et al.:Transcriptional regulation of the gene encoding thehuman C-type lectin leukocyte receptor AIM/CD 69 and functional characterization of its tumor necrosisfactor-alpha-responsive elements. J. Biol. Chem. 270 (37) :21545-21551, 1995.

8) Dorken, B., Moldenhauer, G., Pezzutto, A. et al.:HD 39 (B 3) , a B lineage-restricted antigen whose cell surface is limited to resting and activated human B lymphocytes. J. Immunol. 136 (12) :4470-4479, 1986.

8) Nimgaonkar, M., Kemp, A., Lancia, J. et al.:A combination of CD 34 selection and complement-mediated (anti-CD 15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells. J. Hematother. 5 (1) :39-48, 1996.

8) Gavett, S. H., O'Hearn, D. J., Karp, C. L. et al.:Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am. J. Physiol. 272 (2 Pt 1) :L253-261, 1997.

8) Bray, P. F.:Inherited diseases of platelet glycoproteins:considerations for rapid molecular characterization. Thromb. Haemost. 72 (4) :492-502, 1994.

PubMed

8) Baruch, D. I., Gormely, J. A., Ma, C. et al.:Plasmodium falciparum erythrocyte membrane protein l is a erythrocyte receptor for adherence to CD 36, thrombospondin, and intercellular adhesion molecule J. Proc. Natl. Acad. Sci. USA 93 (8) :3497-3502, 1996.

8) Jacquot, S., Kobata, T., Iwata, S. et al.:CD 154/CD 40 and CD 70/CD 27 interactions have different and sequential functions in T cell-dependent B cell responses:enhancement of plasma cell differentiation by CD 27 signaling. J. Immunol. 159 (6) :2652-1657, 1997.

8) Gelderloos, J. A., Rosenkranz, S., Bazenet, C. et al.:A role for Src in signal relay by the platelet derived growth factor alpha receptor. J. Biol. Chem. 273 (10) :5908 5915, 1998.

8) Dugas, B., Mossalayi, M. D., Damais, C. et al.:Nitric oxide production by human monocytes :evidence for a role of. Immunol. Today 16 (12) :574-580, 1995.

PubMed

8) Healy, A. M., Rayburn, H. B., Rosenberg, R. D. et al.:Absence of the blood-clotting regulator throm-bomodulin causes lethality in mice before development of a functional cardiovascular system. Proc. Natl. Acad. Sci. USA 92 (3) :850-854, 1995.

8) Gelin, C., Aubrit, F., Phalipon, A. et al.:The E 2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC 2 gene product. EMBO J. 8 (11) :3253-3259, 1989.

8) Ishimaru, F., Mari, B. and Shipp, M. A.:The type 2 CD 10/neutral endopeptidase 24. 11 promoter:functional characterization and tissue specific regulation by CBF/NF Y isoforms. Blood 89 (11) :4136-4145, 1997.

8) Israeli, R. S., Powell, C. T., Fair, W. R. et al.:Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res. 53 (2) :227-230, 1993.

PubMed

8) Bickmore, W. A., Longbottom, D., Oghene, K. et al.:Colocalization of the human CD59 gene to 11p13 with the MIC 11 cell surface antigen. Genomics 17 (1) :129-135, 1993.

08) Wolfsberg, T. G., Bazan, J. F., Blobel, C. P. et al.:The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain:structural, functional, and evolutionary implications. Proc. Natl. Acad. Sci. USA 90 (22) :10783-10787, 1993.

8) Dong, F., Brynes, R. K., Tidow, N. et al.:Mutations in the gene for the granulocyte colony-stimulatingfactor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N. Engl. J. Med. 333 (8) :487-493, 1995.

8) Ferrero, E. . Jiao, D., Tsuberi, B. Z. et al.:Transgenic mice expressing human CD 14 are hypersensitive to lipopolysaccharide. Proc Natl. Acad. Sci. USA 90 (6) :2380 2384, 1993.

8) Kitamura, T., Sato, N., Arai, K. et al.:Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL 3 and GM-CSF receptors. Cell 66 (6) :1165-1174, 1991.

PubMed

8) Fan, Z., Larson, P. J., Bognacki, J. et al.:Tissue factor regulates plasminogen binding and activation. Blood 91 (6) :1987-1998, 1998.

PubMed

8) Cozzi, E. and White, D. J.:The generation of transgenic pigs as potential organ donors for humans. Nat. Med. 1:964-966, 1995.

PubMed

8) Nakayama, E., von Hoegen, I. and Parnes, J. R.:Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation. Proc. Natl. Acad. Sci. USA 86 (4) :1352-1356, 1989.

PubMed

8) Osborn, L., Day, E. S., Miller, G. T. et al.:Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD 58) to its counter receptor CD 2. J. Exp. Med. 181 (1) :429-434, 1995.

8) Gerard, N. P. and Gerard, C.:The chemotactic receptor for human C5a anaphylatoxin. Nature 349 (6310) :614-617, 1991.

PubMed

8) Giri, J. G., Ahdieh, M., Eisenman, J. et al.:Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13 (12) :2822-2830, 1994.

PubMed

8) Hough, M. R., Takei, F., Humphries, R. K. et al.:Defective development of thymocytes overexpressing the molecule, heat-stable antigen. J. Exp. med. 179 (1) :177-184, 1994.

PubMed

8) Fernandez-Ruiz, E., Somoza, C., Sanchez-Madrid, F. et al.:CD 28/CTLA-4 ligands:the gene encoding CD 86 (B70/B 7. 2) maps to the region as CD 80 (B 7/B 7. 1) gene in human chromosome 3q13-q23. Eur. Immunol. 25 (5) :1453-1456, 1995.

8) Cosman, D., Cerretti, D. P., Larsen, A. et al.:Cloning, sequence and expression of human interleukin-2 receptor. Nature 312 (5996) :768-771, 1984.

PubMed

8) Kroll, K.:Downregulation of 5'-nucleotidase in rabbit heart during coronary underperfusion. Am. J. Physiol. 274 (2 Pt 2) :H529-538, 1998.

8) McNagny, K. M., Cazenave, P. A. and Cooper, M. D.:BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice. J. Immunol. 141 (8) :2551 2556, 1988.

8) Wang, T. F. and Guidotti, G.:CD 39 is an ecto-(Ca2+, Mg2+) -apyrase. J. Biol. Chem. 271 (17) :9898-9901, 1996.

8) Rowen, L., Koop, B. F. and Hood, L.:The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science 272 (5269) :1755-1762, 1996.

8) Danilov, S., Jaspard, E., Churakova, T. et al.:Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site. J. Biol. Chem. 269 (43) :26806-26814, 1994.

PubMed

8) Friedlander, D. R., Milev, P., Karthikeyan, L. et al.:The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J. Cell Biol. 125 (3) :669-680, 1994.

8) Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N. et al.:Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4 (1) :77-85, 1996.

PubMed

8) Lamb, C. A., Yewdell, J. W., Bennink, J. R. et al.:Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc. Natl. Acad. Sci. USA 88 (14) :5998-6002, 1991.

PubMed

8) Giri, J. G., Wells, J., Dower, S. K. et al.:Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153 (12) :5802-5809, 1994.

PubMed

8) Kaufmalm, R., Frosch, D., Westphal, C. et al.:Integrin VLA 3:ultrastructural localization at cell-cell contact sites of hunnan cell cultures. J. Cell Biol. 109 (4 Pt 1) :1807 1815, 1989.

8) Bohm, S. K., Gum, J. R. Jr., Erickson, R. H. et al.:Human dipeptidyl peptidase IV gene promoter:tissue-specific from a TATA-less GC-rich sequence characteristic of a housekeeping. Biochem. J. 311 (Pt 3) :835-843, 1995.

8) Look, A. T., Peiper, S. C., Rebentisch, M. B. et al.:Molecular cloning, expression, and chromosomal localization of the encoding a human myeloid membrane antigen (gp 150) . J. Clin. Invest. 78 (4) :914-921, 1986.

8) Guo, C., Dower, S. K., Holowka, D. et al.:Fluorescence resonance energy transfer reveals interleukin (IL) -1-dependent aggregation of IL-1 type I receptors that correlates with receptor activation. J. Biol. Chem. 270 (46) :27562-27568, 1995.

PubMed

8) Huber, P., Dalmon, J., Engiles, J. et al.:Genomic structure and chromosomal mapping of the mouse VE-cadherin (Cdh 5) . Genomics 32 (1) :21 28, 1996.

8) Caras, I. W., Davitz, M. A., Rhee, L. et al.:Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325 (6104) :545-549, 1987.

PubMed

8) Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378-3404, 1995.

PubMed

8) Rummel, M. M., Sers, C. and Johnson, J. P.:Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC 18/MCAM. Cancer Res. 56 (9) :2218-2223, 1996.

8) Fung-Leung, W. P., Schilham, M. W., Rahemtulla, A. et al.:CD 8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65 (3) :443449, 1991.

8) Fossum, S., Mallett, S. and Barclay, A. N.:The MRC OX-47 antigen is a member of the immunoglobulin superfamily with an unusual transmembrane sequence. Eur. J. Immunol. 21 (3) :671-679, 1991.

PubMed

8) Mangeney, M., Richard, Y., Coulaud, D. et al.:CD77:an antigen of germinal center B cells entering apoptosis. Eur. Immunol. 21 (5) :1131-1140, 1991.

PubMed

8) Hogervorst, F., Jaspars, L. H., de Melker, A. A. et al.:The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin. Exp. Cell Res. 211 (2) :360-367, 1994.

PubMed

8) Greene, J. L., Leytze, G. M., Emswiler, J. et al.:Covalent dimerization of CD 28/CTLA-4 and oligomerization of CD 80/CD 86 regulate T cell costimulatory interactions. J. Biol. Chem. 271 (43) :26762-26771, 1996.

8) Casasnovas, J. M., Stehle, T., Liu, J. et al.:A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1. Proc. Natl. Acad. Sci. USA 95 (8) :4134-4139, 1998.

8) De Cesaris, P., Starace, D., Riccioli, A. et al.:Tumor necrosis factor-alpha induces interleukin-6 production and integrin ligand expression by distinct transduction pathways. J. Biol. Chem. 273 (13) :7566-7571, 1998.

PubMed

8) Corbi, A. L., Miller, L. J., O'Connor, K. et al.:cDNA cloning and complete primary structure of the alpha subunit of a leukocyte adhesion glycoprotein, p 150, 95. EMBO J. 6 (13) :4023 4028, 1987.

8) Mitnacht, R., Tacke, M. and Hunig, T.:Expressio n of cell interaction molecules by immature rat thymocytes during passage through the CD4+8+ compartment:developmental regulation and induction by T cell receptor engagement of CD 2, CD 5, CD 28, CD 11 a, CD 44 and CD 53. Eur. J. Immunol. 25 (2) :328-332, 1995.

8) Fackler, M. J., Krause, D. S., Smith, O. M. et al.:Full-length but not truncated CD 34 inhibits hematopoieticcell differentiation of M 1 cells. Blood 85 (11) :3040-3047, 1995.

8) Hashimoto, S., Chiorazzi. N. and Gregersen. P. K.:The complete sequence of the human CD79b (Ig beta/B29) gene:identification of a conserved exon/intron organization, immunoglobulin-like regulatory regions, and allelic polymorphism. Immunogenetics 40 (2) :145-149, 1994.

PubMed

8) Jackson, D. G. and Bell, J. I.:Isolation of a cDNA encoding the human CD 38 (T 10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J. Immunol. 14 (7) :2811-2815, 1990.

8) Brockhaus, M., Schoenfeld, H. J., Schlaeger, E. J. et al.:Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87 (8) :3127-3131, 1990.

PubMed

8) Kuramochi, S., Matsuda, S., Matsuda, Y. et al.:Molecular cloning and characterization of Byp, a murine receptor-type tyrosine phosphatase similar to human DEP-1. FEBS Lett. 378 (1) :7-14, 1996.

PubMed

8) Bossy, B., Bossy-Wetzel, E. and Reichardt, L. F.:Characterization of the integrin alpha 8 subunit:a new integrin beta 1-associated subunit, which is prominently expressed on axons and on cells in contact with basal laminae in chick embryos. EMBO J. 10 (9) :2375-2385, 1991.

PubMed

8) Calvo, J., Sole, J., Simarro, M. et al.:Evolutionarily conserved transcription regulatory elements within the 5'-flanking region of the human CD 5 gene. Tissue Antigens 47 (3) :257-261, 1996.

8) Sakihama, T., Smolyar, A. and Reinherz, EL.:Molecular recognition of antigen involves lattice formation between CD 4, MHC class II and TCR molecules. Immunol. Today 16 (12) :581-587, 1995.

8) Osterborg, A., Fassas, A. S., Anagnostopoulos, A. et al.:Humanized CD 52 monoclonal antibody Campath-1 H as first-line treatment in chronic lymphocytic leukaemia. Br. J. Haematol. 93 (1) :151-153, 1996.

8) Lancki, D. W., Qian, D., Fields, P. et al.:Differential requirement for protein tyrosine kinase Fyn in the functional activation of antigen-specific T lymphocyte clones through the TCR or Thy-1. J. Immunol. 154 (9) :4363-4370, 1995.

8) Frohn, C., Schlenke, P. and Kirchner, H.:The repertoire of HLA-Cw-specific NK cell receptors CD158a/ b (EB 6 GL 183) in individuals with different HLA phenotypes. Immunology 92 (4) :567-570, 1997.

8) Freeman, G. J., Freedman, A. S., Segil, J. M. et al.:B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143 (8) :2714-2722, 1989.

PubMed

8) Corbi, A. L., Kishimoto, T. K., Miller, L. J. et al.:The human leukocyte adhesion glycoprotein Mac-1 (complement type 3, CD 11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J. Biol. Chem. 263:12403-12411, 1988.

8) Dai, W. J., Bartens, W., Kohler, G. et al.:Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-gamma receptor-deficient mice. J. Immunol. 158 (11) :5297-5304, 1997.

PubMed

8) Sidorenko, S. P., Vetrova, EP., Yurchenko, O. V. et al.:Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping. Neoplasma 39 (1) :3-9, 1992.

PubMed

8) Biswas, P., Smith, C. A., Goletti, D. et al.:Cross-linking of CD 30 induces HIV expression in chronically infected T cells. Immunity 2 (6) :587-596, 1995.

8) Zhou, L. J. and Tedder, T. F.:Human blood dendritic cells selectively express CD 83, a member of the immunoglobulin superfamily. J. Immunol. 154 (8) :3821-3835, 1995.

8) Crosier, P. S., Ricciardi, S. T., Hall, L. R. et al.:Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 82:1151-1158, 1993.

PubMed

8) Bezouska, K., Yuen, C. T., O'Brien, J. et al.:Oligosaccharide ligands. for NKR P 1 protein activate NK cells and cytotoxicity. Nature 372 (6502) :150 157, 1994.

8) Busk, M., Pytela, R. and Sheppard, D.:Characterization of the integrin alpha v beta 6 as a fibronectin-binding Protein. J. Biol. Chem. 267 (9) :5790-5796, 1992.

PubMed

8) Cock, J. G., Tepper, AD., de Vries, E. et al.:CD 95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J. Biol. Chem. 273 (13) :7560-7565, 1998.

8) Bauer, T. R., Schwartz, B. R., Conrad, Liles, W. et al.:Retroviral-mediated gene transfer of the leukocyte integrin CD 18 into peripheral blood CD 34+ cells derived from a patient with leukocyte adhesion deficiency type 1. Blood 91 (5) :1520-1526, 1998.

8) Iversen, P. O., Hercus, T. R., Zacharakis, B. et al.:The apoptosis-inducing granulocyte-macrophage colony-stimulating factor (GM-CSF) analog E21R functions through specific regions of the heterodimeric GM-CSF receptor and requires interleukin-1 beta-converting enzyme-like proteases. J. Biol. Chem. 272 (15) :9877-9883, 1997.

PubMed

8) Kamata, T. and Takada, Y.:Direct binding of collagen to the I domain of integrin alpha 2 beta 1 (VLA-2, CD 49 b/CD 29) in a divalent cation-independent manner. J. Biol. Chem. 269 (42) :26006-26010, 1994.

8) Sincock, P. M., Mayrhofer, G. and Ashman, L. K.:Localization of the transmembrane 4 superfamily (TM 4 SF) member PETA-3 (CD 151) in normal human tissues:comparison with CD 9, CD 63, and alpha 5 beta 1 integrin. J. Histochem. Cytochem. 45 (4) :515-525, 1997.

8) Boismenu, R., Rhein, M., Fischer, W. H. et al.:A role for CD81 in early T cell development. Science 271 (5246) :198-200, 1996.

8) Kinoshita, T., Molina, H., Hourcade, D. et al.:Mouse complement regulatory protein Crry/p 65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181 (1) :151-159, 1995.

8) Chambers, C. A., Sullivan, T. J. and Allison, J. P.:Lymphoproliferation in CTLA 4 deficient mice is mediated by costimulation dependent activation of CD 4+T cells. Immunity 7 (6) :885 895, 1997.

8) Deo, Y. M., Sundarapandiyan, K., Keler, T. et al.:Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI CD 89) and tumor antigens efficiently promote cell mediated cytotoxicity of tumor targets in whole blood. J. Immunol. 160 (4) :1677 1686, 1998.

8) Fawcett, J., Holness, C. L., Needham, L. A. et al.:Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 360 (6403) :481-484, 1992.

PubMed

8) Bourette, R. P., Myles, G. M., Choi, J. L. et al.:Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma 2 by the M-CSF receptor is necessary for differentiation signaling. EMBO J. 16 (19) :5880-5893, 1997.

8) DeGrendele, H. C., Estess, P., Picker, L. J. et al.:CD 44 and its ligand hyaluronate mediate rolling under physiologic flow:a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 183 (3) :1119-1130, 1996.

8) Kirschbaum, N. E., Gumina, R. J. and Newman, P. J.:Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain. Blood 84 (12) :4028-4037, 1994.

8) Fanales Belasio, E., Zambruno, G., Cavani, A. et al.:Antibodies agains t sialophorin (CD 43) enhance the capacity of dendritic cells to cluster and activate T lymphocytes. J. Immunol. 159 (5) :2203-2211, 1997.

8) Mayer, J. L. and Beardsley, D. S.:Varicella-associated thrombocytopenia:autoantibodies against platelet surface glycoprotein V. Pediatr. Res. 40 (4) :615-619, 1996.

PubMed

8) Natali, P. G., Nicotra, M. R., Bigotti, A. et al.:Localization of the alpha 6 and beta 4 integrin subunits in normal human non-lymphoid tissues. J. Cell Sci. 103 (Pt 4) :1243-1247, 1992.

8) Muszbek, L. and Laposata, M:Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages. J. Biol. Chem. 264 (17) :9716-9719, 1989.

PubMed

8) Lindberg, F. P., Lublin, D. M., Telen, M. J. et al.:Rh-related antigen CD 47 is the signal-transducer integrin-associated protein. J. Biol. Chem. 269 (3) :1567-1570, 1994.

8) Lee, S. Y., Park, C. G. and Choi, Y.:T cell receptor-dependent cell death of T cell hybridomas mediated by the CD 30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183 (2) :669-674, 1996.

8) Li, R., Nortamo, P., Kantor, C. et al.:A leukocyte integrin binding peptide from intercellular adhesion molecule-2 stimulates T cell adhesion and natural killer cell activity. J. Biol. Chem. 268 (29) :21474-21477, 1993.

PubMed

8) Ierino, F. L., Powell, M. S., McKenzie, I. F. et al.:Recombinant soluble human Fc gamma RII:production, characterization, and inhibition of the arthus reaction. J. Exp. Med. 178 (5) :1617-1628, 1993.

PubMed

8) Hirose, M., Kawashima, H. and Miyasaka, M.:A functional epitope on P-selectin that supports binding of P-selectin to P-selectin glycoprotein ligand-1 but not to sialyl Lewis X oligosaccharides. Int. Immunol. 10 (5) :639-649, 1998.

8) Hirata, T., Fukuse, T., Naiki, H. et al.:Expression of CD 44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor. Cancer Res. 58 (6) :1108-1110, 1998.

8) Ikeyama, S., Koyama, M., Yamaoko, M. et al.:Suppression of cell motility and metastasis by transfection with motility-related protein (MRP-1/CD 9) DNA. J. Exp. Med. 177 (5) :1231-1237, 1993.

8) Fox, J. E., Aggerbeck, L. P. and Berndt, M. C.:Structure of the glycoprotein Ib. IX complex from platelet membranes. J. Biol. Chem. 263 (10) :4882 4890, 1988.

8) Mami-Chouaib, F., Bruneau, J. M., Jitsukawa, S. et al.:TCT. 1, a target molecule for gamma/delta T cells, is encoded by an immunoglobulin superfamily gene (Blast-1) located in the CD 1 region of human chromosome 1. J. Exp. Med. 173 (6) :1339-1344, 1991.

PubMed

8) Aramburu, J., Balboa, M. A., Izquierdo, M. et al.:A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J. Immunol. 147 (2) :714-721, 1991.

8) Nermut. M. V., Green, N. M., Eason, P. et al.:Electron microscopy and structural model of human fibronectin receptor. EMBO J. 7 (13) :4093 4099, 1988.

8) Hibi, M., Murakami, M., Saito, M. et al.:Molecular cloning and expression of an IL-6 signal transducer, gp 130. Cell 63 (6) :1149-1157, 1990.

8) Boisvert, W. A., Santiago, R., Curtiss, L. K. et al.:A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor deficient mice. J. Clin. Invest. 101 (2) :353 363, 1998.

8) Dustin, M. L., Sanders, M. E., Shaw, S. et al.:Purified lymphocyte function-associated antigen 3 binds to CD 2 and mediates T lymphocyte adhesion. J. Exp. Med. 165 (3) :677-692, 1987.

8) Kishimoto, T. K., O'connor, K., Lee, A. et al.:Cloning of the beta subunit of the leukocyte adhesion proteins:homology to an extracellular matrix receptor defines a novel supergene family. Cell 48 (4) :681-690, 1987.

8) Muszbek, L. and Laposata, M.:Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages. J. Biol. Chem. 264 (17) :9716-9719, 1989.

PubMed

8) Fazioli, F., Resnati, M., Sidenius, N. et al.:A urokinase-sensitive region of the human urokinase receptoris responsible for its chemotactic activity. EMBO J. 16 (24) :7279-7286, 1997.

8) Fanger, N. A., Wardwell, K., Shen, L. et al.:Type I (CD 64) and type II (CD 32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J. Immunol. 157 (2) :541-548, 1996.

8) Fearon, D. T. and Carter, R. H.:The CD19/CR 2/TAPA-1 complex of B lymphocytes:linking natural to acquired immunity. Annu. Rev. Immunol. 13:127149, 1995.

8) Noelle, R. J.:CD 40 and its ligand in host defense. Immunity 4:415-419, 1996.

8) Kuijpers, T. W., Hoogerwerf, M., van der Laan, L. J. et al.:CD 66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. J. Cell Biol. 118 (2) :457-466, 1992.

8) Hemler, M. E., Glass, D., Coblyn, J. S. et al.:Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation. J. Clin. Invest. 78 (3) :696-702, 1986.

PubMed

8) Itoh, N., Yonehara, S., Schreurs, J. et al.:loning of an interleukin-3 receptor gene:a member of a distinct receptor gene family. Science 247 (4940) :324-327, 1990.

8) Moestrup, S. K., Gliemann, J. and Pallesen, G.:Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 269 (3) :375-382, 1992.

PubMed

8) Mannion, B. A., Berditchevski, F., Kraeft, S. K. et al.:Transmembrane-4 superfamily proteins CD 81 (TAPA-1) , CD 82, CD 63, and CD 53 specifically associated with integrin alpha 4 beta 1 (CD 49 d/CD 29) . J. Immunol. 157 (5) :2039-2047, 1996.

8) Symington, F. W.:CDw 17:a neutrophil glycolipid antigen regulated by activation. J. Immunol. 142 (8) :2784-2790, 1989.

8) Fujihashi, K., McGhee, J. R., Yamamoto, M. et al.:An interleukin-7 internet for intestinal intraepithelial T cell development:knockout of ligand or receptor reveal differences in the immunodeficient state. Eur. J. Immunol. 27 (9) :2133-2138, 1997.

PubMed

8) Basadonna, G. P., Auersvald, L., Khuong, C. Q. et al.:Antibody-mediated targeting of CD 45 isoforms:A novel strategy. Proc. Natl. Acad. Sci. USA 95 (7) :3821-3826, 1998.

8) Israels, S. J., McMillan, EM., Robertson, C. el al.:The lysosomal granule membrane protein, LAMP-2, is also present in platelet dense granule membranes. Thromb. Haemost. 75 (4) :623-629, 1996.

8) McAllister, K. A., Grogg, K. M., Johnson, D. W. et al.:Endoglin, a TGF beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8 (4) :345351, 1994.

8) Kuijpers, T. W., van der Schoot, C. E., Hoogerwerf, M. et al.:Cross-linking of the carcinoembryonicantigen-like glycoproteins CD 66 and CD 67 induces neutrophil aggregation. J. Immunol. 151 (9) :4934-4940, 1993.

8) Chen, M., Cheng, A., Chen, Y. Q. et al.:The amino terminus of JAK 3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. Proc. Natl. Acad. Sci. USA 94 (13) :6910-6915, 1997.

8) Blagoveshchenskaya, A. D., Norcott, J. P. and Cutler, D. F.:Lysosomal targeting of P-selectin is mediated by a novel sequence within its cytoplasmic tail. J. Biol. Chem. 273 (5) :2729-2737, 1998.

PubMed

8) Lanier, L. L., Yu, G. and Phillips, J. H.:Co association of CD 3 zeta with a receptor (CD 16) for IgG Fc on human natural killer cells. Nature 342 (6251) :803-805, 1989.

8) Imai, T., Fukudome, K., Takagi, S. et al.:C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1 induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD 53, and CD 63. J. Immunol. 149 (9) :2879 2886, 1992.

8) Himmelmann, A., Riva, A., Wilson, G. L. et al.:PU. 1/Pip and basic helix loop helix zipper transcription factors and stage-specific expression of CD 20 in B lymphocytes. Blood 90 (10) :3984-3995, 1997.

8) Horie, H., Koike, S., Kurata, T. et al.:Transgenic mice carrying the human poliovirus receptor:new animal models for study of poliovirus neurovirulence. J. Virol. 68 (2) :681-688, 1994.

PubMed

8) Jelinek, D. F., Aagaard-Tillery, K. M., Arendt, B. K. et al.:Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression. J. Clin. Invest. 99 (3) :447-456, 1997.

PubMed

8) Simmons, D. and Seed, B.:Isolation of a cDNA encoding CD 33, a differentiation antigen of myeloid progenitor cells. J. Immunol. 141 (8) :2797-2800, 1988.

8) Duerkop, H., Latza, U., Himmelreich, P. et al.:Expression of the human OX 40 (hOX 40) antigen in normal and neoplastic tissues. Br. J. Haematol. 91 (4) :927-931, 1995.

8) Jung, L. K., Fu, S. M., Hara, T. et al.:Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency. J. Clin. Invest. 77 (3) :940-946, 1986.

PubMed

8) Juan, T. S., McNiece, I. K., Van, G. et al.:Chronic expression of murine flt 3 ligand in mice results in increased circulating white blood cell levels and abnormal cellular infiltrates associated with splenic fibrosis. Blood 90 (1) :76-84, 1997.

PubMed

8) Butcher, E. C. and Picker, L. J.:Lymphocyte homing and homeostasis. Science 272 (5258) :60-66, 1996.

PubMed

8) Delcayre, A. X., Salas, F., Mathur, S. et al.:Epstein Barr virus/complement C 3 d receptor is an interferon alpha receptor. EMBO J. 10 (4) :919-926, 1991.

8) Theroux, P.:Glycoprotein II b/III a inhibitors in unstable angina. Curr. Opin. Cardiol. 12 (5) :447-452, 1997.

8) Skubitz, K. M., Campbell, K. D. and Skubitz, A. P.:CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. J. Leukoc. Biol. 60 (1) :106-117, 1996.

PubMed

8) Medico, E., Mongiovi, A. M., Huff, J. et al.:The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro. Mol. Biol. Cell 7 (4) :495-504, 1996.

PubMed

8) Bendelac, A.:Positive selection of mouse NK 1+T cells by CD 1 expressing cortical thymocytes. J. Exp. Med. 182 (6) :2091, 2096, 1995.

8) Tomlinson, M. G. and Wright, M. D.:Characterisation of mouse CD 37:cDNA and genomic cloning. Mol. Immunol. 33 (10) :867 872, 1996.

9) Mangeney, M., Lingwood, C. A., Taga, S. et al.:Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD 77, a glycolipid antigen. Cancer Res. 53 (21) :5314-5319, 1993.

9) Blumberg, R. S.:Current collcepts in mucosal immunity. II. One size fits all:nonclassical MHC molecules fulfill multiple roles in epithelial cell function. Am. J. Pysiol. 274 (2 Pt 1) :G 227 231, 1998.

9) Dustin, M. L., Ferguson, L. M., Chan, P. Y. et al.:Visualization of CD 2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area. J. Cell. Biol. 132 (3) :465-474, 1996.

9) Exley, M., Varticovski, L., Peter, M. et al.:Association of phosphatidylinositol 3-kinase with a specific of the T cell receptor zeta chain is dependent on T cell activation. J. Biol. Chem. 269 (21) :15140-15146, 1994.

9) Satyanarayana, K., Hata, S., Devlin, P. et al.:Genomic organization of the human T-cell antigen-receptor alpha/delta locus. Proc. Natl. Acad. Sci. USA 85:8166-8170, 1988.

9) Autiero, M., Cammarota, G., Friedlein, A. et al.:A 17-kDa CD 4-binding glycoprotein present in human seminal plasma in breast tumor cells. Euz J. Immunol. 25 (5) :1461-1464, 1995.

9) Davies, A. A., Ley, S. C. and Crumpton, M. J.:CD 5 is phosphorylatedn tyrosine after stimulation of the T-cell antigen receptor complex. Proc. Natl. Acad. Sci. USA 89 (14) :63686372, 1992.

9) Patel, D. D., Wee, S. F., Whichard, LP. et al.:Identification and characterization of a 100-kD ligand for CD 60n thymic epithelial cells. J. Exp. Med. 181 (4) :1563-1568, 1995.

9) Ledbetter, J. A., June, C. H., Grosmaire, L. S. et al.:Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes. Proc. Natl. Acad. Sci. USA 84 (5) :1384-1388, 1987.

9) Garcia, K. C., Scott, C. A., Brunmark, A. et al.:CD 8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384 (6609) :577581, 1996.

9) Iwamoto, R., Higashiyama, S., Mitamura, T. et al.:Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP 27/CD 9, up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 13 (10) :2322-2330, 1994.

9) Letarte, M. Vera, S., Tran, R. et al.:Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J. Exp. Med. 168 (4) :1247-1253, 1988.

PubMed

9) Dustin, M. L. and Springer, T. A.:T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341 (6243) :619-624, 1989.

PubMed

9) Coxon, A., Rieu, P., Barkalow, F. J. et al.:A novel role for the beta 2 integrin CD 11b/CD 18 in neutrophil apoptosis:a homeostatic mechanism in inflammation. Immunity 5 (6) :653-666, 1996.

9) de Fougerolles, A. R., Diamond, M. S. and Springer, T. A.:Heterogenous glycosylation of ICAM-3 and lack of interaction with and p 150, 95. Eur. J. Immunol. 25 (4) :1008-1012, 1995.

9) Look, A. T., Ashmun, R. A., Shapiro, L. H. et al.:Human myeloid plasma membrane glycoprotein CD 13 (gp 150) is aminopeptidase N. J. Clin. Invest. 83 (4) :1299-1307, 1989.

9) Ferrero, E., Kontgen, F., Hijiya, N. at al.:Resistance to endotoxin shock and reduced dissemination of gram negative bacteria in CD 14 deficient mice. Immunity 4 (4) :407 414, 1996.

9) Stocks, S. C., Albrechtsen, M. and Kerr, M. A.:Expression of the CD 15 differentiation antigen (3-fucosyl-N-acetyl-lactosamine, LeX) on putative neutrophil adhesion molecules CR 3 and 160. Biochem. J. 268:275-280, 1990.

9) Martin-Satue, M., Marrugat, R., Cancelas, J. A. et al.:Enhanced expression of alpha (1, 3) -fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells. Cancer Res. 58 (7) :1544-1550, 1998.

9) Trinchieri, G., Jackson, A., Warner, N. L. et al.:The Fc receptor for IgG on human natural killer cells:phenotypic, functional, and comparative studies with monoclonal antibodies. J. Immunol. 133 (1) :180-189, 1984.

PubMed

9) Willheim, M., Agis, H., Sperr, W. R. et al.:Purification of human basophils and mast cells by multistep separation technique and mAb to CDw 17 and CD 117/c-kit. J. Immunol. Methods 182 (1) :115-129, 1995.

9) Kolanus, W., Nagel, W., Schiller, B. et al.:Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-a cytoplasmic regulatory molecule. Cell 86 (2) :233-242, 1996.

PubMed

9) Kitanaka, A., Mano, H., Conley, M. E. et al.:Expression and activation of the nonrecept or tyrosine kinase Tec in human B cells. Blood 91 (3) :940-948, 1998.

PubMed

9) Kanzaki, M., Shibata, H., Mogami, H. et al.:Expression of calcium-permeable cation channel CD 20 accelerates progression through the G 1 phase in Balb/c 3 T 3 cells. J. Biol. Chem. 270 (22) :13099-13104, 1995.

9) Dempsey, P. W., Allison, M. E., Akkaraju, S. et al.:C 3 d of complement as a molecular adjuvant :bridging innate and immunity. Science 271 (5247) :348-350, 1996.

9) Engel, P., Nojima, Y., Rothstein, D. et al.:The same epitope on CD 22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. J. Immunol. 150 (11) :4719-4732, 1993.

9) Flores-Romo, L., Shields, J., Humbert, Y. et al.:Inhibition of an in vivo antigen-specific IgE response by antibodies to CD 23. Science 261 (5124) :1038-1041, 1993.

9) Hough, M. R., Rosten, P. M., Sexton, T. L. et al.:Mapping of CD 24 and homologous sequences to multiple chromosomal loci. Genoinics 22 (1) :154-161, 1994.

9) John, S., Robbins, CM. and Leonard, WJ.:An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat 5, Elf-1, HMG-1 (Y) and a GATA family protein. EMBO J. 15 (20) :5627-5635, 1996.

9) Dalgleish, A.:HIV and CD 26. Nat. Med. 1 (9) :881-882, 1995.

9) Kobata, T., Jacquot, S., Kozlowski, S. et al.:CD 27-CD 70 interactions regulate B-cell activation by T cells. Proc. Natl. Acad. Sci. USA 92 (24) :11249-11253, 1995.

9) Gross, J. A., St. John, T. and Allison, J. P.:The murine homologue of the T lymphocyte antigen CD 28. Molecular cloning and cell surface expression. J. Immunol. 144 (8) :3201-3210, 1990.

9) Holers, V. M., Ruff, T. G., Parks, D. L. et al.:Molecular cloning of a murine fibronectin receptor and its expression during inflammation. Expression of VLA-5 is increased in activated peritoneal macrophages in a manner discordant from major histocompatibility complex class II. J. Exp. Med. 169 (5) :1589, 1605, 1989.

9) Bowen, M. A., Lee, R. K., Miragliotta, G. et al.:Structure and expression of murine CD 30 and its role in cytokine production. J. Immunol. 156 (2) :442-449, 1996.

9) Muller, W. A., Ratti, C. M., McDonnell, S. L. et al.:A human endothelial cell-restricted, externally disposed protein enriched in intercellular junctions. J. Exp. Med. 170 (2) :399-414, 1989.

PubMed

9) Koch, T., Plutner, H. and Mellman, I.:A complementary DNA clone for a macrophage-lymphocyte Fc receptor. Nature 324 (6095) :372-375, 1986.

PubMed

9) Sobol, R. E., Mick, R., Royston, I. et al.:Clinical importance of myeloid antigen expression in adult lymphoblastic leukemia. N. Engl. J. Med. 316 (18) :1111-1117, 1987.

PubMed

9) Huyhn, A., Dommergues, M., Izac, B. et al.:Characterization of hematopoietic progenitors from humanyolk sacs embryos. Blood 86 (12) :4474-4485, 1995.

PubMed

9) Krych, M., Clemenza, L., Howdeshell, D. et al.:Analysis of the functional domains of complement receptor type 1 (C 3 b/C 4 b receptor;CD 35) by substitution mutagenesis. J. Biol. Chem. 269 (18) :13273-13278, 1994.

9) Calvo, D., Gomez. Coronado, D., Suarez, Y. et al.:Human CD 36 is a high affinity receptor for the native lipoproteins HDL., LDL., and VLDL. J. Lipid Res. 39 (4) :777-788, 1998.

9) Virtaneva, K. L., Angelisova, P., Baumruker, T. et al.:The gelles for CD 37, CI) 53, and R 2, all members of a novel gene family, are located on different chromosomes. Immunogenetics 37 (6) :461465, 1993.

9) Kikuchi, Y., Yasue, T., Miyake, K. et al.:CD 38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain:synergistic effects with interleukin 5. Proc. Natl. Acad. Sci. USA 92 (25) :11814-11818, 1995.

9) Wang, T. F., Rosenberg, P. A. and Guidotti, G.:Characterization of brain ecto-apyrase:evidence for only one ecto-apyrase (CD 39) gene. Brain. Res. Mol. Brain Res. 47 (1-2) :295-302, 1997.

9) Hartwig, U. F., Karlsson, L., Peterson, P. A. et al.:CD 40 and IL-4 regulate murine CD 27 L expression. J. Immunol. 159 (12) :6000-6008, 1997.

9) Quinn, M. and Fitzgerald, D. J.:Long-term administration of glycoprotein IIb/IIIa antagonists. Am. Heart J. 135 (5Pt 2 Su) :S 113-118, 1998

9) Schick, P. K. and Walker, J.:The acylation of megakaryocyte proteins:glycoprotein IX is primarily myristoylated while glycoprotein Ib is palmitoylated. Blood 87 (4) :1377-1384, 1996.

9) Greco, N. J., Tandon, N. N., Jolles, G. D. et al.:Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by alpha thrombin. Biochemistry 35 (3) :906 914, 1996.

9) Nurden, A. T., Dupuis, D., Kunicki, T. J. et al.:Analysis of the glycoprotein and protein composition of Bernard-platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Clin. Invest. 67:1431, 1981.

PubMed

9) Meyer, S. C. and Fox, J. E.:Interaction of platelet glycoprotein V with glycoprotein Ib-IX regulates expression of the glycoproteins and binding of von Willebrand factor to glycoprotein Ib-IX in transfected cells. J. Biol. Chem. 270 (24) :14693-14699, 1995.

9) Kudo, S. and Fukuda, M.:Tissue-specific transcriptional regulation of human leukosialin (CD 43) gene is achieved by DNA methylation. J. Biol. Chem. 270 (22) :13298-13302, 1995.

9) Goldstein, L. A., Zhou, D. F. H., Picker, L. J. et al.:A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56 (6) :1063-1072, 1989.

9) Jackson D. G., Bell J. I., Dickinson R., Timans J., Shields J., Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD 44 are alternatively spliced variants containing the v 3 exon. J. Cell Biol. 128 (4) :673-685, 1995.

9) Bruyns, E., Hendricks-Taylor, L. R., Meuer, S. et al.:Identification of the sites of interaction between lymphocyte phosphatase-associated phosphoprotein (LPAP) and CD 45. J. Biol. Chem. 270 (52) :31372-31376, 1995.

9) Doi, Y., Kurita, M., Matsumoto, M. et al.:Moesin is not a receptor for measles virus entry into mouse embryonic stem cells. J. Virol. 72 (2) :1586-1592, 1998.

9) Lindberg, F. P., Bullard, D. C., Caver, T. E. et al.:Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 274 (5288) :795-798, 1996.

PubMed

9) Mathew, P. A., Garni-Wagner, B. A., Land, K. et al.:Cloning and characterization of the 2 B 4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J. Immunol. 151 (10) :5328-5337, 1993.

9) Ignatius, M. J. and Reichardt, L. F.:Identification of a neuronal laminin receptor:an Mr 200 K/120 K heterodimer that binds laminin in a divalent cation-dependent manner. Neuron 1:713-725, 1988.

9) Kamata, T., Puzon, W. and Takada, Y.:Identification of putative ligand binding sites within I domain of integrin alpha 2 beta 1 (VLA-2, CD 49 b/CD 29) . J. Biol. Chem. 269 (13) :9659-9663, 1994.

9) Kornberg, L. J., Earp, H. S., Turner, C. E. et al.:Signal transduction by integrins:increas ed protein tyrosine phosphorylation caused by clustering of beta 1 integrins. Proc. Natl. Acad. Sci. USA 88 (19) :8392-8396, 1991.

9) Ennis, E., Isberg, R. R. and Shimizu, Y.:Very late antigen 4-dependent adhesion and costimulation of resting human T cells by the bacterial beta 1 integrin ligand invasin. J. Exp. Med. 177 (1) :207-212, 1993.

9) Pacifici, R., Roman, J., Kimble, R. et al.:Ligand binding to monocyte alpha 5 beta 1 integrin activates the alpha 2 beta 1 receptor via the alpha 5 subunit cytoplasmic domain and protein kinase C. J. Immunol. 153 (5) :2222 2233, 1994.

9) Shimizu, Y., van Seventer, GA., Horgan, K. J. et al.:Costimulation of proliferative responses of resting CD 4+T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J. Immunol. 145 (1) :59-67, 1990.

PubMed

9) Hernandez-Caselles, T., Rubio, G., Campanero, M. R. et al.:ICAM-3, the third LFA-1 counterreceptor, is aco-stimulatory molecule for both resting and activated T lymphocytes. Eur. J. Immunol. 23 (11) :2799-2806, 1993.

9) Chappel, J., Alvarez, J. I., Sander, D. et al.:Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J. Biol. Chem. 268 (13) :9901-9907, 1993.

PubMed

9) Osterborg, A., Dyer, M. J., Bunjes, D. et al.:Phase II multicenter study of human CD 52 antibody in previously treated treatment in chronic lymphocytic leukemia. J. Clin. Oncol. 15 (4) :1567-1574, 1997.

9) Mollinedo, F., Fontan, G., Barasoain, I. et al.:Recurrent infectious diseases in human CD 53 deficiency. Clin. Diagn. Lab. Immunol. 4 (2) :229-231, 1997.

9) Casasnovas, J. M., Bickford, J. K. and Springer, T. A.:The domain structure of ICAM-1 and the kinetics of binding to rhinovirus. J. Virol. 72 (7) :6244-6246, 1998.

PubMed

9) Clarkson, N. A., Kaufman, R., Lublin, D. M. et al.:Characterization of the echovirus 7 receptor:domains of CD 55 critical for virus binding. J. Virol. 69:5497-5501, 1995.

9) Grenningloh, G., Rehm, E. J. and Goodman, C. S.:Genetic analysis of growth cone guidance in Drosophila:fasciclin II functions as a neuronal recognition molecule. Cell 67 (1) :45-57, 1991.

PubMed

9) Plunkett, M. L., Sanders, M. E., Selvaraj, P. et al.:Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD 2 and lymphocyte function-associated antigen 3 (LFA-3) . J. Exp. Med. 165 (3) :664-676, 1987.

9) Brodsky, R. A., Vala, M. S., Barber, J. P. et al.:Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc. Natl. Acad. Sci. USA 94 (16) :8756-8760, 1997.

PubMed

9) Calvete, J. J., Henschen, A. and Gonzalez-Rodriguez, J.:Assignment of disulphide bonds in human platelet GP IIIa. A disulphide pattern for the beta-subunits of the integrin family. Biochem. J. 274 (Pt 1) :63-71, 1991.

9) Bevilacqua, M. P., Stengelin, S., Gimbrone, M. A. Jr. et al.:Endothelial leukocyte adhesion molecule 1:an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243 (4895) :1160-1165, 1989.

PubMed

9) Clark, R. A., Fuhlbrigge, R. C. and Springer, T. A.:L-Selectin ligands that are O-glycoprotease resistant and distinct from MECA-79 antigen are sufficient for tethering and rolling of lymphocytes on human high endothelial venules. J. Cell Biol. 140 (3) :721-731, 1998.

PubMed

9) Bossavy, J. P., Sakariassen, K. S., Barret, A. et al.:A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis. Thromb. Haemost. 79 (1) :162-168, 1998.

9) Miyamoto, H., Homma, M. and Hotta, H.:Molecular cloning of the murine homologue of CD 63/ME 491 and detection of its strong expression in the kidney and activated macrophages. Biochim. Biophys. Acta 1217 (3) :312-316, 1994.

9) Fanger, N. A., Voigtlaender, D., Liu, C. et al.:Characterization of expression, cytokine regulation, and effector function of the high affinity lgG receptor Fc gamma RI (CD 64) expressed on human blood dendritic cells. J. Immunol. 158 (7) :3090-3098, 1997.

9) Moeller, M. J., Kammerer, R., Grunert, F. et al.:Biliary glycoprotein (BGP) expression on T cells and on a natural-killer-cell sub-population. Int. J. Cancer 65 (6) :740-745, 1996.

9) Lund-Johansen, F., Olweus, J., Symington, F. W. et al.:Activation of human monocytes and granulocytesby monoclonal to glycosylphosphatidylinositol-anchored antigens. Eur. J. Immunol. 23 (11) :2782-2791, 1993.

PubMed

9) Leusch, H. G., Hefta, S. A., Drzeniek, Z. et al.:Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA) . FEBS Lett. 261 (2) :405-409, 1990.

PubMed

9) Gray-Owen, S. D., Dehio, C., Haude, A. et al.:CD 66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes. EMBO J. 16 (12) :3435-3445, 1997.

9) van der Kooij, M. A., von der Mark, E. M., Kruijt, J. K. et al.:Human monocyte-derived macrophages express an approximately 120-kD LDL binding protein with strong identity to CD 68. Arterioscler Thromb. Vasc. Biol. 17 (11) :3107-3116, 1997.

9) Moretta, A., Poggi, A., Pende, D. et al.:CD 69-mediated pathway of lymphocyte activation:anti-CD 69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J. Exp. Med. 174 (6) :1393-1398, 1991.

9) Kobata, T., Jacquot, S., Kozlowski, S. et al.:CD 27-CD 70 interactions regulate B-cell activation by T cells. Proc. Natl. Acad. Sci. USA 92 (24) :11249-11253, 1995.

9) Kuhn, L. C., McClelland, A. and Ruddle, F. H.:Gene transfer, expression, and molecular cloning of the human transferrin receptor gene. Cell 37 (1) :95-103, 1984.

PubMed

9) Robinson, W. H., Ying, H., Miceli, M. C. et al.:Extensive polymorphism in the extracellular domain of the mouse B cell differentiation antigen Lyb-2/CD 72. J. Immunol. 149 (3) :880-886, 1992.

9) Minamino, T., Kitakaze, M., Node, K. et al.:Inhibition of nitric oxide synthesis increases adenosine production via an extracellular pathway through activation of protein kinase C. Circulation 96 (5) :1586-1592, 1997

PubMed

9) Lazova, R., Moynes, R., May, D. et al.:LN-2 (CD 74) . A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer 79 (11) :2115-2124, 1997.

9) Hermanson, G. G., Eisenberg, D., Kincade, P. W. et al.:B29:a member of the immunoglobulin gene superfamily exclusively expressed on beta-lineage cells. Proc. Natl. Acad. Sci. USA 85 (18) :6890-6894, 1988.

PubMed

9) Freeman, G. J., Gray, G. S., Gimmi, C. D. et al.:Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174 (3) :625-631, 1991.

9) Bradbury, LE., Kansas, G. S., Levy, S. et al.:The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149 (9) :2841-2850, 1992.

9) Imai, T. and Yoshie, O.:C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate each other and with CD4 or CD 8 in T cells. J. Immunol. 151 (11) :6470-6481, 1993.

PubMed

9) Zhou, L. J. and Tedder, T. F.:CDI4+blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 93 (6) :2588-2592, 1996.

9) Freeman, G. J., Gribben, J. G., Boussiotis, V. A. et al.:Cloning of B 7-2:a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262 (5135) :909-911, 1993.

9) Gyetko, M. R., Sitrin, R. G., Fuller, J. A. et al.:Function of the urokinase receptor (CD 87) in neutrophil chemotaxis. J. Leukoc. Biol. 58 (5) :533-538, 1995.

9) Gerard, C., Bao, L., Orozco, O. et al.:Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor. J. Immunol. 149 (8) :2600-2606, 1992.

PubMed

9) Maliszewski, C. R., March, C. J., Schoenborn, M. A. et al.:Expression cloning of a human Fc receptor for IgA. J. Exp. Med. 172 (6) :1665-1672, 1990.

9) Lee, W. S., Jain, M. K., Arkonac, B. M. et al.:Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ. Res. 82 (8) :845-851, 1998.

PubMed

9) Morrot, A., Strickland, D. K., Higuchi, M. et al.:Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi:role of the multifunctional alpha 2 macroglobulin receptor in antigen presentation by monocytes. Int. Immunol. 9 (6) :825-834, 1997.

9) Borrego, F., Ulbrecht, M., Weiss, E. H. et al.:Recognition of human histocompatibility leukocyte antigen (HLA) -E complexed with HLA class I signal sequence-derived peptides by CD 94/NKG 2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187 (5) :813-818, 1998.

9) Felzen, B., Shilkrut, M., Less, H. et al.:Fas (CD 95/Apo-1) -mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perforin-deficient mice:a major role for inositol 1, 4, 5-trisphosphate. Circ. Res. 82 (4) :438-450, 1998.

9) Lumadue, J. A., Glick, A. B. and Ruddle, F. H.:Cloning, sequence analysis, and expression of the large subunit of the human lymphocyte activation antigen 4F2. Proc. Natl. Acad. Sci. USA 84 (24) :9204-9208, 1987.

PubMed

9) Gelin, C., Zoccola, D., Valentin, H. et al.:Isoforms of the E 2 molecule:D44 monoclonal antibody defines an epitope on E 2 and reacts differentially with T cell subsets. Eur. J. Immunol. 21 (3) :715-719, 1991.

9) Li, R., Xie, J., Kantor, C. et al.:A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD 11b/CD 18 and CD 11c/CD 18. J. Cell. Biol. 129 (4) :1143-1153, 1995.

9) Karecla, P. J., Bowden, S. J., Green, S. J. et al.:Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M 290 beta 7 (alpha E beta 7) . Eur. Immunol. 25 (3) :852-856, 1995.

9) Kajiji, S., Tamura, R. N. and Quaranta, V.:Anovel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. EMBO J. 8 (3) :673-680, 1989.

9) Pece, N., Vera, S., Cymerman, U. et al.:Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J. Clin. Invest. 100 (10) :2568-2579, 1997.

9) Elices, M. J., Osborn, L., Takada, Y. et al.:VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60 (4) :577-584, 1990.

9) Sawada, R., Jardine, K. A. and Fukuda, M.:The genes of major lysosomal membrane glycoproteins, lamp-1 and 5'-flanking sequence of lamp-2 gene and comparison of exon in two genes. J. Biol. Chem. 268 (12) :9014-9022, 1993.

9) Konecki, D. S., Foetisch, K., Zimmer, K. P. et al.:An alternatively spliced form of the human lysosome-associated protein-2 gene is expressed in a tissue-specific manner. Biochem. Biophys . Res. Commun. 215 (2) :757-767, 1995.

9) Dong, F., Hoefsloot, L. H., Schelen, A. M. et al.:Identification of a nonsense mutation in the granulocytecolony-stimulating factor receptor in severe congenital neutropenia. Proc. Natl. Acad. Sci. USA 91 (10) :4480-4484, 1994.

9) Carlberg, K. and Rohrschneider, L.:The effect of activating mutations on dimerization, tyrosine phosphorylation and internalization of the macrophage colony stimulating factor receptor. Mol. Biol. Cell 5 (1) :81-95, 1994.

PubMed

9) Jubinsky, P. T., Laurie, A. S., Nathan, D. G. et al.:Expression and function of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit. Blood 84 (12) :4174-4185, 1994.

PubMed

9) Fagioli, F., Garelli, E., Linari, C. et al.:c-kit is expressed in soft tissue sarcoma of neuroectodermic origin:its ligand prevents apoptosis of neoplastic cells. Blood 91 (7) :2397-2405, 1998.

PubMed

9) Farrar, M. A., Campbell, J. D. and Schreiber, R. D.:Identification of a functionally important sequence in the C terminus of the interferon-gamma receptor. Proc. Natl. Acad. Sci. USA 89:11706-11710, 1992.

9) Crowe, P. D., VanArsdale, T. L., Walter, B. N. et al.:A lymphotoxin-beta-specific receptor. Science 264 (5159) :707-710, 1994.

PubMed

9) Glaccum, M. B., Stocking, K. L., Charrier, K. et al.:Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159 (7) :3364-3371, 1997.

PubMed

9) Groves, R. W., Giri, J., Sims, J. et al.:Inducible expression of type 2 1L-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis. J. Immunol. 154 (8) :4065-4072, 1995.

9) Hatakeyama, M., Tsudo, M., Minamoto, S. et al.:Interleukin-2 receptor beta chain gene:generation of three receptor forms by cloned human alpha and beta chain cDNA's. Science 244 (4904) :551-556, 1989.

PubMed

9) Lantz, C. S., Boesiger, J., Song, C. H. et al.:Role for interleukin 3 in mast cell and basophil development and in immunity to parasites. Nature 392 (6671) :90 93, 1998.

9) Idzerda, R. L., March, C. J., Mosley, B. et al.:Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J. Exp. Med. 171 (3) :861-873, 1990.

PubMed

9) Monahan, J., Siegel, N., Keith, R. et al. l Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor. J. Immunol. 159 (8) :4024-4034, 1997.

9) Kopf, M., Baumann, H., Freer, G. et al.:Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368 (6469) :339-342, 1994.

PubMed

9) Goodwin, R. G., Friend, D., Ziegler, S. F. et al.:Cloning of the human and murine interleukin-7 receptors:demonstration of a soluble form and homology to a new receptor superfamily. Cell 60 (6) :94-951, 1990.

9) Broxmeyer, H. E., Cooper, S., Cacalano, G. et al.:Involvement of Interleukin (IL) 8receptor in negative regulation of myeloid progenitor cells in vivo:evidence from mice lacking the murine IL 8 receptor homologue. J. Exp. Med. 184 (5) :1825 1832, 1996.

9) Horsten, U., Muller-Newen, G., Gerhartz, C. et al.:Molecular modeling-guided mutagenesis of the extracellular part of gp 130 leads to the identification of contact sites in the interleukin-6 (IL-6) /IL-6 receptor/gp 130 complex. J. Biol. Chem. 272 (38) :23748-23757, 1997.

9) Itoh, T., Muto, A., Watanabe, S. et al.:Granulocyte-macrophage colony-stimulating factor provokes RAS activation and transcription of c-fos through different modes of signaling. J. Biol. Chem. 271 (13) :7587-7592, 1996.

PubMed

9) Dawson, C. H., Brown, B. L. and Dobson, P. R.:A 70-kDa protein facilitates interleukin-4 signal transduction in the absence of the common gamma receptor chain. Biochem. Biophys. Res. Commun. 233 (1) :279-282, 1997.

PubMed

9) Godfrey, W. R., Fagnoni, F. F., Harara, M. A. et al.:Identification of a human OX-40 ligand, a costimulator of CD 4+T cells with homology to tumor necrosis factor. J. Exp. Med. 180 (2) :757-762, 1994.

9) Lavagna, C., Marchetto, S., Birnbaum, D. et al.:Identification and characterization of a functional murine FLT 3 produced by exon skipping. J. Biol. Chem. J. 270 (7) :3165-3171, 1995.

9) Ronsin, C., Muscatelli, F., Mattei, M. G. et al.:A novel putative receptor protein tyrosine kinase of the met family. Oncogene 8 (5) :1195-1202, 1993.

PubMed

9) Kim, Y. J., Pollok, K. E., Zhou, Z. et al.:Novel T cell antigen 4-1 BB associates with the protein tyrosine kinase p 56 lck 1. J. Immunol. 151 (3) :1255-1262, 1993.

9) Cook, D. M., Hinkes, M. T., Bernfield, M. et al.:Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT 1. Oncogene 13 (8) :1789-1799, 1996.

9) Gronwald, R. G., Grant, F. J., Haldeman, B. A. et al.:Cloning and expression of a cDNA coding for the human platelet derived growth factor receptor:evidence for more than one receptor class. Proc. Natl. Acad. Sci. USA 85 (10) :3435-3439, 1988.

PubMed

9) Ireland, H., Kunz, G., Kyriakoulis, K. et al.:Thrombomodulin gene mutations associated with myocardial infarction. Circulation 96 (1) :15-18, 1997.

PubMed

9) Holschermalm, H., Kohl, O., Maus, U. et al.:Cyclosporin A inhibits monocyte tissue factor activation in cardiac transplant recipients. Circulation 96 (12) :4232 4238, 1997.

9) Hubert, C., Houot, A. M., Corvol, P. et al.:Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J. Biol. Chem. 266 (23) :15377-15383, 1991.

9) Lampugnani, M. G., Resnati, M., Raiteri, M. et al.:A novel endothelial specific membraine protein is a marker of cell cell contacts. J. Cell Biol. 118 (6) :1511 1522, 1992.

9) Sers, C., Kirsch, K., Rothbacher, U. et al.:Genomic organization of the melanoma-associated glycoprotein MUC 18:implications for the evolution of the immunoglobulin domains. Proc. Natl. Acad. Sci. USA 90 (18) :8514-8518, 1993.

9) Igakura, T., Kadomatsu, K., Taguchi, O. et al.:Roles of basigin, a member of the immunoglobulin superfamily, in behavior as to an irritating odor, lymphocyte response, and blood-brain barrier. Biochem. Biophys. Res. Commun. 224 (1) :33-36, 1996.

9) Ostman, A., Yang, Q. and Tonks, N. K.:Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc. Natl. Acad. Sci. USA 91 (21) :9680-9684, 1994.

PubMed

9) Sidorenko, S. P. and Clark, EA.:Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J. Immunol. 151 (9) :4614-4624, 1993.

9) Yanez-Mo, M., Alfranca, A., Cabanas, C. et al.:Regulation of endothelial cell motility by complexes of tetraspan molecules CD 81/TAPA-1 and CD 151/PETA-3 with alpha 3 beta l integrin localized at endothelial lateral junctions. J. Cell. Biol. 141 (3) :791-804, 1998.

9) Freeman, G. J., Borriello, F., Hodes, R. J. et al.:Uncovering of functional alternative CTLA 4 counter-receptor in B7 deficient mice. Science 262 (5135) :907-909, 1993.

PubMed

9) Maggi, E., Annunziato, F., Manetti, R. et al.:Activation of HIV expression by CD 30 triggering in CD 4+T cells from HIV-infected individuals. Immunity 3 (2) :251-255, 1995.

9) Spriggs, M. K., Fanslow, W. C., Armitage, R. J. et al.:The biology of the human ligand for CD 40. J. Clin. Immunol. 13 (6) :373-380, 1993.

9) Koike, S., Horie, H., Ise, I. et al.:The poliovirus receptor protein is produced both as membrane-bound secreted forms. EMBO J. 9 (10) :3217-3224, 1990.

9) Yoshida, S., Setoguchi, M., Higuchi, Y. et al.:Molecular cloning of cDNA encoding MS 2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int. Immunol. 2 (6) :585-591, 1990.

9) McNagny, K. M., Bucy, R. P. and Cooper, M. D:Reticular cells in peripheral lymphoid tissues express the phosphatidylinositol linked BP 3 antigen. Eur. J. Immunol. 21 (2) :509 515, 1991.

9) Mandelboim, O., Pazmany, L., Davis, D. M. et al.:Multiple receptors for HLA-G on human natural killer cells. Proc. Natl. Acad. Sci. USA 94 (26) :14666-14670, 1997.

PubMed

9) Cambiaggi, A., Verthuy, C., Naquet, P. et al.:Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw 3 specific killer cell inhibitory receptor. Proc. Natl. Acad. Sci. USA 94 (15) :8088-8092, 1997.

9) Bezouska, K., Kren, V., Kieburg, C. et al.:GlcNAc-terminated glycodendrimers form defined precipitates with the soluble dimeric receptor of rat natural killer cells, sNKR P 1 A. FEBS Lett. 426 (2) :243-247, 1998.

9) Koenig, A., Norgard-Sumnicht, K., Linhardt, R. et al.:Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J. Clin. Invest. 101 (4) :877-889, 1998.

PubMed

9) Degen, W. G., van Kempen, L. C., Gijzen, E. G. et al.:MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule) . Am. J. Pathol. 152 (3) :805-813, 1998.

PubMed

10) Leusch, H. G., Hefta, S. A., Drzeniek, Z. et al.:Eschenichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA) . FEBS Lett. 261 (2) :405-409, 1990.

PubMed

10) Natsuka, S., Gersten, K. M., Zenita, K. et al.:Molecular cloning of a cDNA encoding a novel human leukocyte alpha-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J. Biol. Chem. 269 (24) :16789-16794, 1994.

PubMed

10) Graves, J. D., Gotoh, Y., Draves, K. E. et al.:Caspase-mediated activation and induction of apoptosis by the Ste 20 like kinase Mst 1. EMBO J. 17 (8) :2224-2234, 1998.

10) Hatakeyama, M., Mori, H., Doi, T. et al.:A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 59 (5) :837-845, 1989.

10) Katoh, S., Zheng, Z., Oritani, K. et al.:Glycosylation of CD 44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182 (2) :419-429, 1995.

10) Habib, A. A., Hognason, T., Ren, J. et al.:The epidermal growth factor receptor associates with and recruits phosphatidylinositol 3-kinase to the platelet derived growth factor beta receptor. J. Biol. Chem. 273 (12) :6885 6891, 1998.

10) Lin, G., Finger, E. and Gutierrez-Ramos, J. C.:Expression of CD 34 in endothelial cells, hematopoieticprogenitors and nervous cells in fetal and adult mouse tissues. Eur. J. Immunol. 25 (6) :1508-1516, 1995.

10) Ip, N. Y., Nye, S. H., Boulton, T. G. et al.:CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69 (7) :1121-1132, 1992.

PubMed

10) Nimpf, J., Stifani, S., Bilous, P. T. et al.:The somatic cell-specific low density lipoprotein receptor-related protein of the chicken. Close kinship to mammalian low density lipoprotein receptor gene family members. J. Biol. Chem. 269 (1) :212 219, 1994.

10) Robinson, W. H., Landolfi, M. M., Schafer, H. et al.:Biochemical identity of the mouse Ly-19. 2 and Ly-32. 2 alloantigens the B cell differentiation antigen Lyb-2/CD 72. J. Immunol. 151 (9) :4764-4772, 1993.

10) Tchilian, E. Z., Beverley, P. C., Young, B. D. et al.:Molecular cloning of two isoforms of the murine homolog of the CD 33 antigen. Blood 83 (11) :3188-3198, 1994.

10) Hemperly, J. J., DeGuglielmo, J. K. and Reid, R. A.:Characterization of cDNA clones defining variant forms of human neural cell adhesion molecule N-CAM. J. Mol. Neurosci. 2 (2) :71-78, 1990.

PubMed

10) Liu, L., Jefferson, A. B., Zhang, X. et al.:A novel phosphatidylinositol 3, 4, 5 trisphosphate 5 phosphatase associates with the interleukin 3 receptor. J. Biol. Chem. 271 (47) :29729 29733, 1996.

10) Loenen, W. A., De Vries, E., Gravestein, L. H. et al.:The CD 27 membrane receptor, a lymphocyte-specific member of the growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur. J. Immunol. 22 (2) :447-455, 1992.

10) Gerard, N. P., Bao, L., Xiao-Ping, H. et al.:Human chemotaxis receptor genes cluster at 19q13. 3-13. 4. Characterization of the human C5a receptor gene. Biochemistry 32 (5) :1243-1250, 1993.

10) Lebron, J. A., Bennett, M. J., Vaughn, D. E. et al.:Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93 (1) :111-123, 1998.

PubMed

10) Skeel, A., Yoshimura, T., Showalter, S. D. et al.:Macrophage stimulating protein:purification, partial amino acid sequence, and cellular activity. J. Exp. Med. 173 (5) :1227-1234, 1991.

PubMed

10) Lens, S. M., Keehnen, R. M., van Oers, M. H. et al.:Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD 70. Eur. J. Immunoll. 26 (5) :1007-1011, 1996.

10) Warren, HS., Altin, J. G., Waldron, J. C. et al.:A carbohydrate structure associated with CD 15 (Lewis x) on myeloid cells is a novel ligand for human CD 2. J. Immunol. 156:2866-2873, 1996.

10) Kondo, M., Takeshita, T., Ishii, N. et al.:Sharing of the interleukin-2 (IL2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262 (5141) :1874-1877, 1993.

PubMed

10) Mantzioris, B. X., Berger, M. F., Sewell, W. et al.:Expression of the Fc receptor for IgG (Fc gamma RII/CDw 32) by human circulating T and B lymphocytes. J. Immunol. 150 (11) :5175-5184, 1993.

10) Dong, R. P., Kameoka, J., Hegen, M. et al.:Characterization of adenosine deaminase binding to human CD 260 on T cells and its biologic role in immune response. J. Immunol. 156 (4) :1349-1355, 1996.

10) Van Kooten, C. and Banchereau, J.:CD 40-CD 40 ligand:a multifunctional receptor-ligand pair. Adv. Immunol. 61:1-77, 1996.

10) Isaac, R. E., Williams, T. A., Sajid, M. et al.:Cleavage of arginyl-arginine and lysyl-arginine from the C-terminus of pro-hormone peptides by human germinal angiotensin I-converting enzyme (ACE) and the C-domain of human somatic ACE. Biochem. J. 328 (Pt 2) :587-591, 1997.

10) Pytela, R., Pierschbacher, M. D. and Ruoslahti, E.:Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40 (1) :191 198, 1985.

10) Levesque, M. C. and Haynes, B. F.:In vitro culture of human peripheral blood monocytes induces binding and up-regulates monocyte variant CD 44 isoform expression. J. Immunol. 156 (4) :1557-1565, 1996.

10) Santis, A. G., Lopez-Cabrera, M., Hamann, J. et al.:Structure of the gene coding for the human early lymphocyte activation antigen CD 69:a C type lectin receptor evolutionarily related with the gene families of natural killer cell specific receptors. Eur. J. Immunol. 24 (7) :1692 1697, 1994.

10) Chuntharapai, A., Lee, J., Hebert, C. A. et al.:Monoclonal antibodies detect different distribution patterns of IL 8 receptor A and IL 8 receptor B on human peripheral blood leukocytes. J. Immunol. 153 (12) :5682-5688, 1994.

PubMed

10) Haks, M. C., Krimpenfort, P., Borst, J. et al.:The CD 3 gamma chain is essential for development of both the TCR alphabeta and TCR gammadelta lineages. EMBO J. 17 (7) :1871-1882, 1998.

10) Murata, Y., Takaki, S., Migita, M. et al.:Molecular cloning and expression of the human interleukin 5 receptor. J. Exp. Med. 175 (2) :341-351, 1992.

PubMed

10) Neumaier, M., Paululat, S., Chan, A. et al.:Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc. Natl. Acad. Sci. USA 90 (22) :10744-10748, 1993.

PubMed

10) Diacovo, T. G., Catalina, M. D., Siegelman, M. H. et al.:Circulating activated platelets reconstitutelymphocyte homing and immunity in L-selectin-deficient mice. J. Exp. Med. 187 (2) :197-204, 1998.

10) Nortamo, P., Li, R., Renkonen, R. et al.:The expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur. J. Immunol. 21 (10) :2629-2632, 1991.

PubMed

10) Luciani, N., Marie-Claire, C., Ruffet, E. et al.:Characterization of Glu 350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3. 4. 11. 2) :insights into its mechanism of action. Biochemistry 37 (2) :686-692, 1998.

10) Juan, M., Vinas, O., Pino-Otin, M. R. et al.:CD 50 (intercellular adhesion molecule 3) stimulation induces calcium mobilization and tyrosine phosphorylation through p59 fyn and p56 lck in Jurkat T cell line. J. Exp. Med. 179 (6) :1747-1756, 1994.

10) Byth, K. F., Conroy, L. A., Howlett, S. et al.:CD 45-null transgenic mice reveal a positive regulatory role for CD 45 in early thymocyte development, in the selection of CD 4+CD 8+ thymocytes, and B cell maturation. J. Exp. Med. 183 (4) :1707-1718, 1996.

10) Kordula, T., Rydel, R. E., Brigham, E. F. et al.:Oncostatin M and the interleukin-6 and soluble interleukin-6receptor complex regulate alpha 1-antichymotrypsin expression in human cortical astrocytes. J. Biol. Chem. 273 (7) :4112-4118, 1998.

10) Sawada, R., Lowe, J. B. and Fukuda, M.:E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysos omal membrane glycoprotein-1 expression levels. J. Biol. Chem. 268 (17) :12675 12681, 1993.

10) Hennet, T., Chui, D., Paulson, J. C. et al.:Immune regulation by the ST6Gal sialyltransferase. Proc. Natl. Acad. Sci. USA 95 (8) :4504-4509, 1998.

PubMed

10) McDonald, P. P., Cassatella, M. A., Bald, A. et al.:CD 30 ligation induces nuclear factor-kappa B activation in human T cell lines. Eur. J. Immunol. 25 (10) :2870-2876, 1995.

10) Kondo, M., Takeshita, T., Higuchi, M. et al.:Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 263 (5152) :1453-1454, 1994.

PubMed

10) Goyert, S. M., Ferrero, E., Rettig, W. J. et al.:The CD 14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 239 (4839) :497 500, 1988.

10) Shimizu, Y., Van Seventer, G. A., Horgan, K. J. et al.:Regulated expression and binding of three VLA (beta 1) integrin receptors on T cells. Nature 345 (6272) :250-253, 1990.

10) Nollau, P., Scheller, H., Kona-Horstmann, M. et al.:Expression of CD 66 a (human C-CAM) and other members of the carcinoembryonic antigen gene family of adhesion molecules in human colorectal adenomas. Cancer Res. 57 (12) :2354-2357, 1997.

10) Oikawa, S., Inuzuka, C., Kuroki, M. et al.:Aspecific heterotypic cell adhesion activity between members of carcinoembryonic antigen family, W 272 and NCA, is mediated by N-domains. J. Biol Chem. 266 (13) :7995-8001, 1991.

10) Weiss, A. and Littman, D. R.:Signal transduction by lymphocyte antigen receptors. Cell 76:263-274, 1994.

PubMed

10) Castano, A. R., Tangri, S., Miller, J. E. et al.:Peptide binding and presentation by mouse CD 1. Science 269 (5221) :223, 226, 1995.

10) Languino, L. R. and Ruoslahti, E.:An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain. J. Biol. Chem. 267 (10) :7116-7120, 1992.

PubMed

10) Kanaji, T., Okamura, T., Kurolwa, M. et al.:Molecular and genetic analysis of two patients with Bernard-Soulier syndrome identification of new mutations in glycoprotein Ib alpha gene. Thromb. Haemost. 77 (6) :1055 1061, 1997.

10) Shan, D., Ledbetter, J. A. and Press, O. W.:Apoptosis of malignant human B cells by ligation of CD 20 with monoclonal antibodies. Blood 91 (5) :1644-1652, 1998.

10) Fearon, D. T. and Locksley, R. M.:The instructive role of innate immunity in the acquired immune. Science 272 (5258) :50-53, 1996.

PubMed

10) Brady, R. L., Dodson, E. J., Dodson, GG. et al.:Crystal structure of domains 3 and 4 of rat CD 4:relation to the NH2-terminal domains. Science 260 (5110) :979-983, 1993.

10) Lippincott-Schwartz, J. and Fambrough, D. M.:Lysosomal membrane dynamics:structure and interor-ganellar a major lysosomal membrane glycoprotein. J. Cell Biol. 102 (5) :1593-1605, 1986.,

10) Dhodapkar, M. V., Abe, E., Theus, A. et al.:Syndecan-1 is a multifunctional regulator of myeloma pathobiology:control of tumor cell survival, growth, and bone cell differentiation. Blood 91 (8) :2679-2688, 1998.

PubMed

10) Kindzelskii, A. L., Laska, Z. O., Todd, R. F. et al.:Urokinase-type plasminogen activator receptor reversiblydissociates from complement receptor type 3 (alpha M beta 2 CD11b/CD18) during neutrophil polarization. J. Immunol. 156 (1) :297-309, 1996.

10) Fujiwara, H., Kikutani, H., Suematsu, S. et al.:The absence of IgE antibody-mediated augmentation of immune in CD 23-deficient mice. Proc. Natl. Acad. Sci. USA 91 (15) :6835-6839, 1994.

10) Connolly, E. S. Jr., Winfree, C. J., Springer, T. A. et al.:Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97 (1) :209-216, 1996.

PubMed

10) Colonna, M. and Samaridis, J.:Cloning of immunoglobulin-superfamily members associated with HLA-HLA-B recognition by human natural killer cells. Science 268 (5209) :405-408, 1995.

PubMed

10) Wright, M. D., Rochelle, J. M., Tomlinson, M. G. et al.:Gene structure, chromosomal localization, and protein sequence of CD 53 (Cd 53) :evidence that the transmembrane 4 superfamily arose by gene duplication. Int. Immunol. 5 (2) :209-216, 1993.

10) Ignatius, M. J., Large, T. H., Houde, M. et al.:Molecular cloning of the rat integrin alpha 1-subunit:a receptor for laminin and collagen. J. Cell Biol. 111 (2) :709-720, 1990.

PubMed

10) Igakura, T., Kadomatsu, K., Kaname, T. et al.:A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev. Biol. 194 (2) :152-165, 1998.

10) Freeman, G. J., Borriello, F., Hodes, R. J. et al.:Murine B 7-2, an alternative CTLA 4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178 (6) :2185-2192, 1993.

10) Lavagna-Sevenier, C., Marchetto, S., Birnbaum, D. et al.:The CBL-related protein CBLB participates in FLT 3 and interleukin-7 receptor signal transduction in pro-B cells. J. Biol. Chem. 273 (24) :14962-14967, 1998.

10) Sullam, P. M., Hyun, W. C., Szollosi, J. et al.:Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fc receptor FcgammaRIIA on the platelet plasma membrane. J. Biol. Chem. 273 (9) :5331-5336, 1998.

PubMed

10) Lindberg, F. P., Gresham, H. D., Reinhold, M. I. et al.:Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding. J. Cell Biol. 134 (5) :1313-1322, 1996.

10) Fukunaga, R., Seto, Y., Mizushima, S. et al.:Three different mRNAs encoding human granulocyte colonystimulating factor receptor. Proc. Natl. Acad. Sci. USA 87 (22) :8702-8706, 1990.

PubMed

10) Gurtner, G. C., Davis, V., Li, H. et al.:Targeted disruption of the murine VCAM 1 gene :essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev. 9 (1) :1-14, 1995.

PubMed

10) Kawaguchi, S., Bergelson, J. M., Finberg, R. W. et al.:Integrin alpha 2 cytoplasmic domain deletion effects:loss of adhesive activity parallels ligand-independent recruitment into focal adhesions. Mol. Biol. Cell 5 (9) :977-988, 1994.

PubMed

10) Olweus, J., Lund Johansen, F. and Horejsi, V.:CD 53, a protein with four membrane spanning domains, mediates signal transduction in human monocytes and B cells. J. Immunol. 151 (2) :707716, 1993.

10) Collard, C. D., Vakeva, A., Bukusoglu, C. et al.:Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation 96 (1) :326-333, 1997.

PubMed

10) Jones, N. H., Clabby, M. L., Dialynas, D. P. et al.:Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T 1/Leu 1. Nature 323 (6086) :346349, 1986.

10) Hough, M. R., Chappel, M. S., Sauvageau, G. et al.:Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat stable antigen. J. Immunol. 156 (2) :479-488, 1996.

10) Schick, P. K. and Walker, J.:The acylation of megakaryocyte proteins:glycoprotein IX is primarily myristoylated while glycoprotein Ib is palmitoylated. Blood 87 (4) :1377-1384, 1996.

10) Nadler, L. M., Anderson, K. C., Marti, G. et al.:B 4, a human B lymphocyte associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J. Immunol. 131 (1) :244-250, 1983.

10) Imai, T., Kakizaki, M., Nishimura, M. et al.:Molecular analyses of the association of CD 4 with two members of the transmembrane 4 superfamily, CD 81 and CD 82. J. Immunol. 155 (3) :1229-1239, 1995.

10) Robinson, W. H., Neuman, de Vegvar, H. E., Prohaska, S. S. et al.:Human CD 6 possesses a large, alternatively spliced cytoplasmic. Eur. J. Immunol. 25 (10) :2765-2769, 1995.

10) Palou, E., de la Fuente-Garcia, M. A. and Nicolas, J. M.:CD 148, a membrane protein tyrosine phosphatase, is able to induce tyrosine phosphorylation on human lymphocytes. Immunol. Lett. 57 (1-3) :101-103, 1997.

10) Fears, S., Gavin, M., Zhang, D. E. et al.:Functional characterization of ETV 6 and ETV 6/CBFA 2 in the regulation of the MCSFR proximal promoter. Proc. Natl. Acad. Sci. USA 94 (5) :1949-1954, 1997.

10) Engel, P., Wagner, N., Miller, A. S. et al.:Identification of the ligand-binding domains of CD 22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand. J. Exp. Med. 181 (4) :1581-1586, 1995.

10) Mingari, M. C., Vitale, C., Cantoni, C. et al.:Interleukin-15-induced maturation of human natural killer cells from early thymic precursors:selective expression of CD 94/NKG 2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27 (6) :1374-1380, 1997.

10) Higashimura, N., Takasawa, N., Tanaka, Y. et al.:Induction of OX 40, a receptor of gp 34, on T cells by trans-acting transcriptional activator, Tax, of human T-cell leukemia virus type I. JPn. J. Cancer Res. 87 (3) :227-231, 1996.

10) Fleming, T. J., Donnadieu, E., Song, C. H. et al.:Negative regulation of Fc epsilon RI-mediated degranulation by CD81. J. Exp. Med. 186 (8) :1307-1314, 1997.

PubMed

10) Kitamura, T., Hayashida, K., Sakamaki, K. et al.:Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF) :evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor. Proc. Natl. Acad. Sci. USA 88 (12) :5082-5086, 1991.

PubMed

10) Mazengera, R. L. and Kerr, M. A.:The specificity of the IgA receptor purified from human nieutrophils. Biochem. J. 272 (1) :159-165, 1990.

PubMed

10) Perry, A. C., Jones, R. and Hall, L.:Identification of an abundant monkey epididymal transcript encoding ahomologue of human CAMPATH-1 antigen precursor. Biochim. Biophys. Acta 1171:122-124, 1992.

PubMed

10) Kwon, B. S. and Weissman, S. M.:cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. USA 86 (6) :1963-1967, 1989.

PubMed

10) Braud, V. M., Allan, D. S., O'Callaghan, C. A. et al.:HLA-E binds to natural killer cell receptors CD 94/NKG2A, B and C. Nature 391 (6669) :795-799, 1998.

10) Crovello, C. S., Furie, B. C. and Furie, B.:Histidine phosphorylation of P-selectin upon stimulation of human platelets:a novel pathway for activation-dependent signal transduction. Cell 82 (2) :279-286, 1995.

PubMed

10) Lee, D. M., Patel, D. D., Pendergast, A. M. et al.:Functional association of CD 7 with phosphatidylinositol 3-kinase:interaction via a YEDM motif. Int. Immunol. 8 (8) :1195-1203, 1996.

10) Jansson, J. H., Boman, K., Brannstrom, M. et al.:High concentration of thrombomodulin in plasma is associated with hemorrhage:a prospective study in patients receiving long-term anticoagulant treatment. Circulation 96 (9) :2938-2943, 1997.

PubMed

10) Bray, P. F., Leung, C. S. L. C. and Shuman, M. A.:Human platelets and megakaryocytes contain alternately spliced glycoprotein IIb mRNAs. J. Biol. Chem. 265 (17) :9587-9590, 1990.

10) Leahy, D. J., Axel, R. and Hendrickson, W. A.:Crystal structure of a soluble form of the human T cell coreceptor CD 8 at 2. 6 A resolution. Cell 68 (6) :11451162, 1992.

10) Bix, M. and Locksley, R. M.:Natural T cells. Cells that co express NKRP 1 and TCR. J. Immunol. 155 (3) :1020 1022, 1995.

10) Gommerman, J. L., Rottapel, R. and Berger, S. A.:Phosphatidylinositol 3-kinase and Ca 2+influx dependence for ligand-stimulated internalization of the c-Kit receptor. J. Biol. Chem. 272 (48) :30519-30525, 1997.

10) Kontani, K., Nishina, H., Ohoka, Y. et al.:NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as. J. Biol. Chem. 268 (23) :16895-16898, 1993.

10) Muraoka, O., Tanaka, H., Itoh, M. et.:Genomic structure of human BST 1. Immunol. Lett. 54 (1) :1-4, 1996.

PubMed

10) Mayani, H. and Lansdorp, P. M.:Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 83 (9) :2410-2417, 1994.

PubMed

10) Nakamura, K., Iwamoto, R. and Mekada, E.:Membrane anchored heparin-binding EGF like growth factor (HB-EGF) diphtheria toxin receptor associated protein (DRAP27) /CD 9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J. Cell Biol. 129 (6) :1691-1705, 1995.

10) Lanza, F., Wolf, D., Fox, C. F. et al.:cDNA cloning and expression of platelet p 24/CD 9. Evidence for a new family of multiple membrane-spanning proteins. J. Biol. Chem. 266 (16) :10638-10645, 1991.

10) Collins, T., Williams, A., Johnston, G. J. et al.:Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1. J. Biol. Chem. 266 (4) :2466-2473, 1991.

10) Hsu, E. C., Dorig, R. E., Sarangi, F. et al.:Artificial mutations and natural variations in the CD 46 molecules from human and monkey cells define regions important for measles virus binding. J. Virol. 71 (8) :6144-6154, 1997.

10) Carter, A. M., Ossei-Gerning, N., Wilson, I. J. et al.:Association of the platelet Pl (A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation 96 (5) :1424-1431, 1997.

PubMed

10) Kondo, M., Takeshita, T., Ishii, N. et al.:Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262 (5141) :1874-1877, 1993.

PubMed

10) Greenlund, A. C., Farrar, M. A., Viviano, B. L. et al.:Ligand-induced IFN gamma receptor tyrosine phosphorylation couples receptor to its signal transduction system (p91) . EMBO J. 13 (7) :1591-1600, 1994.

PubMed

10) Ebeling, O., Duczmal, A., Aigner, S. et al.:L 1 adhesion molecule on human lymphocytes and monocytes:expression involvement in binding to alpha v beta 3 integrin. Eur. J. Immunol. 26 (10) :2508-2516, 1996.

10) Michelson, A. D., Benoit, S. E., Furman, M. J. et al.:The platelet surface expression of glycoprotein V is regulated by two independent mechanisms:proteolysis and a reversible cytoskeletal-mediated redistribution to the surface-connected canalicular system. Blood 87 (4) :1396-1408, 1996.

10) Yagami-Hiromasa, T., Sato, T., Kurisaki, T. et al.:A metalloprotease-disintegrin participating in myoblast fusion. Nature 377 (6550) :652-656, 1995.

PubMed

10) Ohgimoto, S., Tabata, N., Suga, S. et al.:Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp 160-mediated cell fusion. FRP-1 and 4F2/CD 98 are identical molecules. J. Immunol. 155 (7) :3585-3592, 1995.

10) Byrne, G. W., McCurry, K. R., Martin, M. J. et al.:Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63 (1) :149-155, 1997.

PubMed

10) Malfroy, B., Schofield, P. R., Kuang, W. J. et al.:Molecular cloning and amino acid sequence of rat enkephalinase. Biochem. Biophys. Res. Commmun. 144 (1) :59-66, 1987.

PubMed

10) Lampugnani, M. G., Corada, M., Caveda, L. et al.:The molecular organization of endothelial cell to cell junctions:differential association of plakoglobin, beta catenin, and alpha catenin with vascular endothelial cadherin (VE cadherin) . J. Cell Biol. 129 (1) :203 217, 1995.

10) LaRoche, S. M.:Activation of human neutrophils induces an interaction between the integrin beta 2-subunit (CD 18) and the actin binding protein alpha-actinin. J. Immunol. 151 (7) :3795-807, 1993.

10) Freeman, G. J., Disteche, C. M., Gribben, J. G. et al.:The gene for B7, a costimulatory signal for T-cell activation, maps to chromosomal region 3q13. 3 3q21. Blood 79 (2) :489-494, 1992.

10) Erle, D. J., Briski, M. J., Butcher, E. C. et al.:Expression and function of the MAdCAM-1 receptor, integrin alpha 47, On human leukocytes. J. Immunol. 153 (2) :517-528, 1994.

10) Laszik, Z., Jansen, P. J., Cummings, R. D. et al.:P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood 88 (8) :3010-3021, 1996.

PubMed

10) Muller, W. A., Weigl, S. A., Deng, X. et al.:PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178 (2) :449-460, 1993.

PubMed

10) Darnay, B. G., Singh, S., Chaturvedi, M. M. et al.:The p 60 tumor necrosis factor (TNF) receptor-associated kinase (TRAK) signaling. J. Biol. Chem. J. 270 (25) :14867-14870, 1995.

10) Seed, B.:An LFA 3 cDNA encodes a phospholipid linked membrane protein to its receptor CD2. Nature 329 (6142) :840 842, 1987.

10) Manjunath, N., Johnson, R. S., Staunton, D. E. et al.:Targeted disruption of CD 43 gene enhances T lymphocyte adhesion. J. Immunol. 151 (3) :1528-1534, 1993.

10) Pichuantes, S., Vera, S., Bourdeau, A. et al.:Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Tissue Antigens 50 (3) :265-276, 1997.

PubMed

10) Ravetch, J. V. and Perussia, B.:Alternative membrane forms of Fc gamma RIII (CD 16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J. Exp. Med. 170 (2) :481-497, 1989.

10) Kilshaw, P. J. and Murant, S. J.:A new surface antigen on intraepithelial lymphocytes in the intestine. Eur. J. Immunol. 20 (10) :2201-2207, 1990.

PubMed

10) Kaufmann, Y., Tseng, E. and Springer, T. A.:Cloning of the murine lymphocyte function-associated molecule-1 subunit and its expression in COS cells. J. Immunol. 147 (1) :369-374, 1991.

PubMed

10) Kanki, J. P., Chang, S. and Kuwada, J. Y.:The molecular cloning and characterization of potential chick DM-GRASP homologs in zebrafish and mouse. J. Neurobiol. 25 (7) :831-845, 1994.

10) Huang, Z. E., Higuchi, D., Lasky, N. et al.:Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 90 (3) :944 951, 1997.

10) Diamond, M. S., Garcia-Aguilar, J., Bickford, JK. et al.:The I domain is a major recognition site on theleukocyte integrin Mac-1 (CD 11b/CD 18) for four distinct adhesion ligands. J. Cell Biol. 120 (4) :1031-1043, 1993.

10) Koyama, M., Nakamura, T., Higashihara, M. et al.:The novel variants of mb-1 and B29 transcripts generated by alternative mRNA splicing. Immunol. Lett. 47 (3) :151-156, 1995.

PubMed

10) Greene, J. L., Leytze, G. M., Emswiler, J. et al.:Covalent dimerization of CD 28/CTLA 4 and oligomerization of CD 80/CD 86 regulate T cell costimulatory interactions. J. Biol. Chem. 271 (43) :26762 26771, 1996.

10) Nudelman, E., Kannagi, R., Hakomori, S. et al.:A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science 220 (4596) :509-511, 1983.

PubMed

10) Shih, I. M., Elder, D. E., Hsu, M. Y. et al.:Regulation of Mel-CAM/MUC 18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am. J. Pathol. 145 (4) :837-845, 1994.

10) Greenfeder, S. A., Nunes, P., Kwee, L. et al.:Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270 (23) :13757-13765, 1995.

PubMed

10) Hahn, J. H., Kim, M. K., Choi, E. Y. et al.:CD 99 (MIC 2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J. Immunol. 159 (5) :2250-2258, 1997.

10) Leon-Monzon, M. E., Illa, I. and Dalakas, M. C.:Expression of poliovirus receptor in human spinal cord and muscle. Ann. N. Y. Acad. Sci. 753:48-57, 1995.

PubMed

10) Kitamura, T., Sato, N., Arai, K. et al.:Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 66 (6) :1165-1174, 1991.

PubMed

10) Endemann, G., Stanton, L. W., Madden, K. S. et al.:CD 36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268 (16) :11811-11816, 1993.

10) Lopez-Rodriguez, C., Chen, H. M., Tenen, D. G. et al.:Identification of Sp 1-binding sites in the CD 11c (p 150, 95 alpha) and CD 11a (LFA-1 alpha) integrin subunit promoters and their involvement in the tissue-specific expression of CD 11c. Eur. J. Immunol. 25 (12) :3496-3503, 1995.

10) Lafage-Pochitaloff, M., Costello, R., Couez, D. et al.:Human CD 28 and CTLA-4 Ig superfamily genes are located on at bands q 33-q 34. Immunogenetics 31 (3) :198-201, 1990.

10) Radford, K. J., Mallesch, J. and Hersey, P.:Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD 63 (ME 491) . Int. J. Cancer 62 (5) :631-635, 1995.

10) Kennel, S. J., Godfrey, V., Ch'ang, L. Y. et al.:The beta 4 subunit of the integrin family is displayed on a restricted subset of endothelium in mice. J. Cell Sci. 101 (Pt 1) :145-150, 1992.

10) Fortner, K. A., Russell, J. Q. and Budd, R. C.:Down-modulation of CD 2 delays deletion of superantigen-responsive T cells. Eur. J. Immunol. 28 (1) :70-79, 1998.

10) Lotteau, V., Teyton, L., Peleraux, A. et al.:Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348 (6302) :600-605, 1990.

PubMed

10) Horai, R., Asano, M., Sudo, K et al.:Production of mice deficient in genes for interleukin (IL) -1 alpha, IL-lbeta, IL-1 alpha/beta, and IL-1 receptor antagonist shows that IL-1 beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187 (9) :1463-1475, 1998.

10) Del Prete, G., De Carli, M., D'Elios, M. M. et al.:CD 30-mediated signaling promotes the development of human T helper 2-like T cells. J. Exp. Med. 182 (6) :1655-1661, 1995.

10) Keler, T., Graziano, R. F., Mandal, A. et al.:Bispecific antibody-dependent cellular cytotoxicity of HER 2/ neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells. Cancer Res. 57 (18) :4008-4014, 1997.

10) Pierres, A., Benoliel, A. M., Bongrand, P. et al.:Determination of the lifetime and force dependence ofinteractions of single bonds between surface-attached CD 2 and CD 48 adhesion molecules. Proc. Natl. Acad. Sci. USA 93 (26) :15114-15118, 1996.

10) Krych, M., Hauhart, R. and Atkinson, J. P.:Structure-function analysis of the active sites of complement receptor type 1. J. Biol. Chem. 273 (15) :8623-8629, 1998.

PubMed

10) Misumi, Y., Ogata, S., Ohkubo, K. et al.:Primary structure of human placental 5'-nucleotidase and of the glycolipid anchor in the mature form. Eur. J. Biochem. 191 (3) :563-569, 1990.

PubMed

10) Leonard, W. J., Depper, J. M., Crabtree, GR. et al.:Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311 (5987) :626-631, 1984.

PubMed

11) Leung-Hagesteijn, C., Fitz Gibbon, L., Coppolino, M. G. et al.:Regulation of cell adhesion and anchorage-dependent growth by a new beta 1 integrin linked protein kinase. Nature 379 (6560) :91 96, 1996.

11) Morabito, L., Montesinos, M. C., Schreibman, D. M. et al.:Methotrexate and sulfasalazine promote adenosine release by a that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. J. Clin. Invest. 101 (2) :295-300, 1998.

PubMed

11) Gresham, H. D., Graham, I. L., Anderson, D. C. et al.:Leukocyte adhesion-deficient neutrophils fail to amplify phagocytic function in response to stimulation. Evidence for CD 11b/CD 18-dependent and-independent mechanisms of phagocytosis. J. Clin. Invest. 88 (2) :588-597, 1991.

11) Irving, B. A. and Weiss, A.:The cytoplasmic domain of the T cell receptor zeta chain is to couple to receptor-associated signal transduction pathways. Cell 64 (5) :891-901, 1991.

11) Manjunath, N., Correa, M., Ardman, M. et al.:Negative regulation of T-Cell adhesion and activation by CD 43. Nature 377 (6549) :535-538, 1995.

11) Lagaudriere-Gesbert, C., Lebel-Binay, S., Wiertz, E. et al.:The tetraspanin protein CD 82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes. J. Immunol. 158 (6) :2790-2797, 1997.

11) Koyama, M., Ishihara, K., Karasuyama, H. et al.:CD79 alpha/CD79 beta heterodimers are expressed on pro-B cell surfaces without associated heavy chain. Int. Immunol. 9 (11) :1767-1772, 1997.

PubMed

11) Minami, Y., Kono, T., Yamada, K. et al.:Association of p56 lck with IL-2 receptor beta chain is critical for the IL-2-induced activation of p56 lck. EMBO J. 12 (2) :759-768, 1993.

PubMed

11) Meyer, W. K., Reichenbach, P., Schindler, U. et al.:Interaction of STAT 5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription. J. Biol. Chem. 272 (50) :31821-31828, 1997.

11) Marks, M. S., Blum, J. S. and Cresswell, P.:Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J. Cell Biol. 111 (3) :839-855, 1990.

PubMed

11) Robinson, W. H., Prohaska, S. S., Santoro, J. C. et al.:Identification of a mouse protein homologous to the human CD 6 T cell surface protein and sequence of the corresponding cDNA. J. Immunol. 155 (10) :4739-4748, 1995.

11) Nakamura, Y., Komano, H. and Nakauchi, H.:Two alternative forms of cDNA encoding CD 34. Exp. Hematol. 21 (2) :236-242, 1993.

11) Hamann, J., Vogel, B., van Schijndel, G. M. et al.:The seven span transmembrane receptor CD 97 has a cellular ligand (CD55, DAF) . J. Ex. Med. 184 (3) :1185 1189, 1996.

11) Murakami, M., Hibi, M., Nakagawa, N. et al.:IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260 (5115) :1808-1810, 1993.

PubMed

11) Duckett, C. S., Gedrich, R. W., Gilfillan, M. C. et al.:Induction of nuclear factor kappaB by the CD 30 receptor is mediated by TRAF 1 and TRAF 2. Mol. Cell. Biol. 17 (3) :1535-1542, 1997.

11) Brooks, A. G., Posch, P. E., Scorzelli, C. J. et al.:NKG2A complexed with CD 94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 185 (4) :795-800, 1997.

11) Haviland, D. L., McCoy, R. L., Whitehead, W. T. et al.:Cellular expression of the C5a anaphylatoxin receptor (C5aR) :demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154 (4) :1861-1869, 1995.

11) Patel, D. D., Wee, S. F., Whichard, L. P. et al.:Identification and characterization of a 100-kD ligand for CD 6 on human thymic epithelial cells. J. Exp. Med. 181 (4) :1563-1568, 1995.

11) Loenen, W. A., Gravestein, L. A., Beumer, S. et al.:Genomic organization and chromosomal localization of the human CD 27 gene. J. Immunol. 149 (12) :3937-3943, 1992.

11) Van de Velde, H., von Hoegen, I., Luo, W. et al.:The B-cell surface protein CD 72/Lyb-2 is the ligand for CD 5. Nature 351 (6328) :662-665, 1991.

11) Lu, B., Gerard, N. P., Kolakowski, L. F. et al.:Neutral endopeptidase modulation of septic shock. J. Exp. Med. 181 (6) :2271-2275, 1995.

PubMed

11) Thomas, R. and Lipsky, P. E.:Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J. Immunol. 153 (9) :4016-4028, 1994.

PubMed

11) Hofstetter, W., Wetterwald, A., Cecchini, M. C. et al.:Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts. Proc. Natl. Acad. Sci. USA 89 (20) :9637-9641, 1992.

PubMed

11) Kohda, D., Morton, C. J., Parkar, A. A. et al.:Solution structure of the link module:a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 86 (5) :767-775, 1996.

PubMed

11) Newman, P. J., Berndt, M. C., Gorski, J. et al.:PECAM-1 (CD 31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247 (4947) :1219-1222, 1990.

11) Gruss, H. J. and Dower, S. K.:Tumor necrosis factor ligand superfamily:involvement in the pathology of malignant lymphomas. Blood 85 (12) :3378 3404, 1995.

11) Pierres, A., Benoliel, A. M. and Bongrand, P.:The dependence of the association rate of surface-attached adhesion molecules CD 2 and CD 48 on separation distance. FEBS Lett. 403 (3) :239-244, 1997.

11) Miyajima, I., Levitt, L., Hara, T. et al.:The murine interleukin 3 rcceptor alpha subunit gene:chromosomal localization, genomic structure, and promoter function. Blood 85 (5) :1246 1253, 1995.

11) Yagi, M., Edelhoff, S., Disteche, C. M. et al.:Structural characterization and chromosomal location of the gene encoding human platelet glycoprotein Ib beta. J. Biol. Chem. 269 (26) :17424-17427, 1994.

11) Van Leuven, F., Stas, L., Raymakers, L. et al.:Molecular cloning and sequencing of the murine alpha-2-macroglobulin receptor cDNA. Biochim. Biophys. Acta 1173 (1) :71 74, 1993.

11) Wang, M. H., Cox, G. W., Yoshimura, T. et al.:Macrophage-stimulating protein inhibits induction of nitric oxide production by endotoxin-or cytokine-stimulated mouse macrophages. J. Biol. Chem. 269 (19) :14027-14031, 1994.

PubMed

11) Huang, M., Syed, R. Stura, E. A. et al.:The mechaninism of an inhibitory antibody on TF initiated blood coagulation revealed by the crystal structures of human tissue factor FAB 5G9 and TF. G9 complex. J. Mol. Biol. 275 (5) :873 894, 1998.

11) Pytowski, B., Judge, T. W. and McGraw, T. E.:An internalization motif is created in the cytoplasmic domain of the transferrin receptor by substitution of a tyrosine at the first position of a predicted tight turn. J. Biol. Chem. 270 (16) :9067-9073, 1995.

PubMed

11) King, S. L., Kamata, T., Cunningham, J. A. et al.:Echovirus l interaction with the human very late antigen-2 (integrin alpha 2 beta 1) Idomain. Identification of two independent virus contact sites distinct from the metal ion-dependent adhesion site. J. Biol. Chem. 272 (45) :28518-28522, 1997.

11) Imura, A., Hori, T., Imada, K. et al.:The human OX 40/gp34 system directly mediates adhesion of activated cells to vascular endothelial cells. J. Exp. Med. 183 (5) :2185-2195, 1996.

11) Lens, S. M., de Jong, R., Hooibrink, B. et al.:Phenotype and function of human B cells expressing CD 70 (CD 27 ligand) . Eur. J. Immunol. 26 (12) :2964-1971, 1996.

11) Modderman, P. W., Admiraal, L. G., Sonnenberg, A. et al.:Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J. Biol. Chem. 267 (1) :364-369, 1992.

11) Kanekura, T., Miyauchi, T., Tashiro, M. et al.:Basigin, a new member of the immunoglobulin superfamily:genes in different mammalian species, glycosylation changes in the molecule from adult organs and possible variation in the N-terminal sequences. Cell Struct. Funct. 16 (1) :23-30, 1991.

11) Kalled, S. L., Cutler, A. H., Datta, S. K. et al.:Anti-CD 40 ligand antibody treatment of SNF 1 mice with established nephritis:preservation of kidney function. J. Immunol. 160 (5) :2158-2165, 1998.

11) Hart, C. E., Seifert, R. A., Ross, R. et al.:Synthesis, phosphorylation, and degradation of multiple forms of the platelet derived growth factor receptor studied using a monoclonal antibody. J. Biol. Chem. 262 (22) :10780 10785, 1987.

11) Goldrnacher, V. S. and Tedder, T. F.:The CD19 signal transduction complex of B lymphocytes. Deletion of the CD 19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13. J. Immunol. 151 (6) :2915-2927, 1993.

11) Kubo, M., Ransom, J., Webb, D. et al.:T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT 6. EMBO J. 16 (13) :4007-4020, 1997.

11) Krieg, P. A., Sakaguchi, D. S. and Kintner, C. R.:Primary structure and developmental expression of a large cytoplasmic domain form of Xenopus laevis neural cell adhesion molecule (NCAM) . Nucleic Acids Res. 17 (24) :10321-10335, 1989.

PubMed

11) Pascual, V., Liu, Y. J., Magalski, A. et al.:Analysis of somatic mutation in five B cell subsets of humantonsil. J. Exp. Med. 180 (1) :329-339, 1994.

PubMed

11) Metes, D., Ernst, L. K., Chambers, W. H. et al.:Expression of functional CD 32 molecules on human NK cells is by an allelic polymorphism of the Fc gamma RIIC gene. . Blood 91 (7) :2369-2380, 1998.

11) Kontani, K., Kukimoto, I., Nishina, H. et al.:Tyrosine phosphorylation of the c-cbl proto-oncogene product mediated by cell surface antigen CD 38 in HL-60 cells. J. Biol. Chem. 271 (3) :1534-1537, 1996.

11) Allen, R. C., Armitage, R. J., Conley, M. E. et al.:CD 40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259 (5097) :990-993, 1993.

11) Loo, D. T., Chalupny, N. J., Bajorath, J. et al.:Analysis of 4-1 BBL and laminin binding to murine 4-1 BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1 BB. J. Biol. Chem. 272 (10) :6448-6456, 1997.

11) Wright, S. D., Michaelides, K., Johnson, D. J. et al.:Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bernard-Soulier syndrome. Blood 81 (9) :2339-2347, 1993.

PubMed

11) Matsuguchi, T., Zhao, Y., Lilly, M. B. et al.:The cytoplasmic domain of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha subunit is essential for both GM-CSF-mediated growth and differentiation. J. Biol. Chem. 272 (28) :17450-17459, 1997.

PubMed

11) Law, C. L., Torres, R. M., Sundberg, H. A. et al.:Organization of the murine Cd 22 locus. Mapping to chromosome 7 and characterization of two alleles. J. Immunol. 151 (1) :175-187, 1993.

11) Jaspard, E., Wei, L. and Alhenc-Gelas, F.:Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II) . Studies with bradykinin and other natural peptides. J. Biol. Chem. 268 (13) :9496-9503, 1993.

PubMed

11) Santis. A. G., Lopez Cabrera, M., Sanchez Madrid, F. et al.:Expression of the early lymphocyte activation antigen CD69, a C type lectin, is regulated by mRNA degradation associated with AU rich sequence motifs. Eur. J. Immunol. 25 (8) :2142 2146, 1995.

11) Lopez-Rodriguez, C., Kluin-Nelemans, H. C. and Corbi, A. L.:AP-1 regulates the basal and developmentally induced transcription of the CD 11c leukocyte integrin gene. J. Immunol. 156 (10) :3780-3787, 1996.

11) Chuntharapai, A., Lee, J., Burnier, J. et al.:Neutralizing monoclonal antibodies to human IL 8 receptor A map to NH 2 terminal region of the receptor. J. Immunol 152 (4) :1783-1789, 1994.

11) Riechmann, L., Clark, M., Waldmann, H. et al.:Reshaping human antibodies for therapy. Nature 332 (6162) :323-327, 1988.

PubMed

11) Henderson, W. R. Jr., Chi, E. Y., Albert, R. K. et al.:Blockade of CD 49 d (alpha 4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J. Clin. Invest. 100 (12) :3083-3092, 1997.

11) Lou, D. and Kohler, H.:Enhanced molecular mimicry of CEA using photoaffinity crosslinked C3d peptide. Nat. Biotechnol. 16 (5) :458-462, 1998.

PubMed

11) Hailman, E., Lichenstein, H. S., Wurfel, M. M. et al.:Lipopolysaccharide (LPS) binding protein accelerates the binding of to CD 14. J. Exp. Med. 179 (1) :269-277, 1994.

11) Melendez, A., Floto, R. A., Gillooly, D. J. et al.:Fc gamma RI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J. Biol. Chem. 273 (16) :9393-9402, 1998.

PubMed

11) Pereira, E., Goldblatt, J., Rye, P. et al.:Mutation analysis of interleukin-5 in an asthmatic cohort. Hum. Mutat. 11 (1) :51-54, 1998.

11) Szollosi, J., Horejsi, V., Bene, L. et al.:Supramolecular complexes of MHC class I, MHC class II, CD 20, and tetraspan molecules (CD 53, CD 81, and CD 82) at the surface of a B cell line JY. J. Immunol. 157 (7) :2939-2946, 1996.

11) Kato, M., Wang, H., Bernfield, M. et al.:Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. J. Biol. Chem. 269 (29) :18881-18890, 1994.

PubMed

11) Harper, K., Balzano, C., Rouvier, E. et al.:CTLA 4 and CD 28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147 (3) :1037-1044, 1991.

11) Ruppert, M., Aigner, S., Hubbe, M. et al.:The L 1 adhesion molecule is a cellular ligand for VLA-5. J. Cell Biol. 131 (6 Pt 2) :1881-1891, 1995.

11) Semnani, R. T., Nutman, T. B., Hochman, P. et al.:Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4 'T cells. J. Exp. Med. 180 (6) :2125-2135, 1994.

PubMed

11) Neumaier, M., Gopfert, C. and Wagener, C.:Association of pp 60 c-src with biliary glycoprotein (CD 66 a) , an molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas. Oncogene 11 (8) :1649-1655, 1995.

11) Lee, D. M., Staats, H. F., Sundy, J. S. et al.:Immunologic characterization of CD 7-deficient mice. J. Immunol. 160 (12) :5749-5756, 1998.

11) Olsen, J., Cowell, G. M., Konigshofer, E. et al.:Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. FEBS Lett. 238 (2) :307-314, 1988.

PubMed

11) Duke-Cohan, J. S., Morimoto, C., Rocker, J. A. et al.:Serum high molecular weight dipeptidyl peptidase IV (CD 26) is similar to a novel antigen DPPT-L released from activated T cells. J. Immunol. 156 (5) :1714-1721, 1996.

11) Ohmori, K., Takada, A., Ohwaki, I. et al.:A distinct type of sialyl Lewis X antigen defined by a novel monoclonal antibody is selectively expressed on helper memory T cells. Blood 82 (9) :2797-2805, 1993.

PubMed

11) Nortamo, P., Salcedo, R., Timonen, T. et al.:A monoclonal antibody to the human leukocyte adhesion molecule intercellular adhesion molecule-2. Cellular distribution and molecular characterization of the antigen. J. Immunol. 146 (8) :2530-2535, 1991.

11) Liao, H. X., Levesque, M. C., Patton, K. et al.:Regulation of human CD 44 H and CD 44 E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD 44 monoclonal and polyclonal antibodies. J. Immunol. 151 (11) :6490-6499, 1993.

11) Garboczi, D. N., Ghosh, P., Utz, U. et al.:Structure of the complex between human T-cell receptor, viral peptide and HLA-A 2. Nature 384 (6605) :134-141, 1996.

11) Cyster, J. G., Healy, J. I., Kishihara, K. et al.:Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD 45. Nature 381 (6580) :325-328, 1996.

11) Monteiro, R. C., Kubagawa, H. and Cooper, M. D.:Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans. J. Exp. Med. 171 (3) :597-613, 1990.

11) Hwang, S. T., Singer, M. S., Giblin, P. A. et al.:GlyCAM-1, a physiologic ligand for L-selectin, activatesbeta 2 integrins on naive peripheral lymphocytes. J. Exp. Med. 184 (4) :1343-1348, 1996.

11) Ohannesian, D. W., Lotan, D., Thomas, P. et al.:Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res. 55 (10) :2191-2199, 1995.

PubMed

11) Diacovo, T. G., Puri, K. D., Warnock, R. A. et al.:Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273 (5272) :252-255, 1996.

PubMed

11) McMahan, C. J., Slack, J. M. B., Cosman, D. et al.:A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10 (10) :2821-2832, 1991.

11) Krebs, B., Griffin, H., Winter, G. et al.:Recombinant human single chain Fv antibodies recognizing human interleukin-6. Specific targeting of cytokine-secreting cells. J. Biol. Chem. 273 (5) :2858-2865, 1998.

11) Norlund, L., Zoller, B. and Ohlin, A. K.:A novel thrombomodulin gene mutation in a patient suffering from sagittal sinus thrombosis. Thromb. Haemost. 78 (4) :1164-1166, 1997.

11) Kondo, M., Weissman, I. L. and Akashi, K.:Identification of clonogenic common lymphoid progenitors in mouse marrow. Cell 91 (5) :661-672, 1997.

PubMed

11) Okuyama, Y., Ishihara, K., Kimura, N. et al.:Human BST 1 expressed on myeloid cells functions as a receptor. Biochem. Biophys. Res. Common. 228 (3) :838-845, 1996.

11) Nishioka, Y., Davis, L. S., Lipsky, P. E. et al.:Regulation of human B cell function by recombinant CD 40 ligand and other TNF-related ligands. J. Immunol. 155 (5) :2369-2378, 1995.

11) Goltsev, Y. V., Kovalenko, A. V., Arnold, E. et al.:CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272 (32) :19641-19644, 1997.

11) Gong, J. Stenger, S., Zack, J. A. et al:Isolation of mycobacterium reactive CD 1 restricted T cells from patients with human immunodeficiency virus infection. J. Clin. Invest. 101 (2) :383 389, 1998.

11) Luescher, I. F., Vivier, E., Layer, A. et al.:CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 73 (6512) :353-356, 1995.

11) Skubitz, A. P., Bast, R. C. Jr., Wayner, E. A. et al.:Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin. Am. J. Pathol. 148 (5) :1445-1461, 1996.

PubMed

11) Chen, Y. P., Djaffar, I., Pidard, D. et al.:Ser 752→Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc. Natl. Acad. Sci. USA 89 (21) :10169-10173, 1992.

11) Li, F., Wilkins, P. P., Crawley, S. et al.:Post-translational modifications of recombinant P-selectin ligand-1 required for binding to P-and E-selectin. J. Biol. Chem. 271 (6) :3255-3264, 1996.

11) Groves, R. W., Rauschmayr, T., Nakamura, K. et al.:Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J. Clin. Invest. 98 (2) :336-344, 1996.

PubMed

11) Ravetch, J. V., Luster, A. D., Weinshank, R. et al.:Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. Science 234 (4777) :718-725, 1986.

PubMed

11) Skubitz, K. M., Campbell, K. D., Ahmed, K. et al.:CD 66 family members are associated with tyrosine kinase activity in human neutrophils. J. Immunol. 155 (11) :5382-5390, 1995.

11) Tsuboi, S. and Fukuda, M.:Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J. Biol. Chem. 269 (2) :1425, 1431, 1994.

11) Fingeroth, J. D., Benedict, M. A., Levy, D. N. et al.:Identification of murine complement receptor type 2. Proc. Natl. Acad. Sci. USA 86 (1) :242-246, 1989.

PubMed

11) Hemesath, T. J., Price, E. R., Takemoto, C. et al.:MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391 (6664) :298-301, 1998.

11) Miettinen, M., Chatten, J., Paetau, A. et al.:Monoclonal antibody NB 84 in the differential diagnosis of neuroblastoma and other small round cell tumors. Am. J. Surg. Pathol. 22 (3) :327-332, 1998.

11) Law, S. K., Gagnon, J., Hildreth, J. E. et al.:The primary structure of the beta-subunit of the cell surface adhesion glycoproteins LFA-1, CR 3 and p 150, 95 and its relationship to the. EMBO J. 6 (4) :915-919, 1987.

11) Ferrini, S., Cambiaggi, A., Meazza, R. et al.:T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 24 (10) :2294-2298, 1994.

PubMed

11) Kurpakus, M. A., Quaranta, V. and, Jones, J. C.:Surface relocation of alpha 6 beta 4 integrins and assembly of hemidesmosomes in an in vitro model of wound healing. J. Cell Biol. 115 (6) :1737-1750, 1991.

11) Matsuguchi, T., Inhorn, R. C., Carlesso, N. et al.:Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J. 14 (2) :257-265, 1995.

PubMed

11) Bray, P. F.:Inherited diseases of platelet glycoproteins:considerations for rapid molecular characterization. Thromb. Haemost. 72 (4) :492-502, 1994.

PubMed

11) Min, H. Y., Semnani, R., Mizukami, I. F. et al.:cDNA for Mo 3, a monocyte activation antigen, encodes the human for urokinase plasminogen activator. J. Immunol. 148 (11) :3636-3642, 1992.

11) Hsu, E. C., Sarangi, F., Iorio, C. et al.:A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD 46 and reveals another receptor on marmoset B cells. J. Virol. 72 (4) :2905 2916, 1998.

11) Skubitz, K. M., Campbell, K. D., Iida, J. et al.:CD 63 associates with tyrosine kinase activity and CD 11/CD 18, and transmits an activation signal in neutrophils. J. Immunol. 157 (8) :3617-3626, 1996.

11) Sawada, R., Jardine, K. A. and Fukuda, M.:The genes of major lysosomal membrane glycoproteins, lamp-1 and 5'-flanking sequence of lamp-2 gene and comparison of exon in two genes. J. Biol. Chem. 268 (12) :9014-9022, 1993.

11) Ohta, H., Tsurudome, M., Matsumura, H. et al.:Molecular and biological characterization of fusion regulatory proteins (FRPs) :anti-FRP mabs induced HIV mediated cell fusion via an integrin system. EMBO J. 13 (9) :2044-2055, 1994.

PubMed

11) Coyne, K. E., Hall, S. E., Thompson, S. et al.:Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J. Immunol. 149 (9) :2906-2913, 1992.

PubMed

11) Kauhanen, P., Beer, J. H. and Lassila, R.:Defective interaction between von Willebrand factor and platelet glycoprotein Ib a familial study of peripheral arterial occlusive disease. Thromb. J. Haemost. 77 (5) :849-855, 1997.

11) Okamoto, K., Ohgimoto, S., Nishio, M. et al.:Paramyxovirus-induced syncytium cell formation is suppressed by a construct:an important role of FRP-1 in virus-induced cell fusion. J. Gen. Virol. 78 (Pt 4) :775-783, 1997.

11) Itano, A., Salmon, P., Kioussis, D. et al.:The cytoplasmic domain of CD 4 promotes the development of CD 4 cells. J. Exp. Med. 183 (3) :731-741, 1996.

11) Le Naour, F., Prenant, M., Francastel, C. et al.:Transcriptional regulation of the human CD 9 gene:characterization of the 5'-flanking region. Oncogene 13 (3) :481-486, 1996.

11) Lally, E. T., Kieba, I. R., Sato, A. et al.:RTX toxins recognize a beta 2 integrin on the surface of human target cells. J. Biol. Chem. 272 (48) :30463-30469, 1997.

11) Haczku, A., Takeda, K., Hamelmann, E. et al.:CD 23 deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalbumin. Am. J. Respir. Crit. Care Med. 156 (6) :1945-1955, 1997.

11) Brissette Storkus, C., Kaufman, C. L., Pasewicz, L. et al.:Characterization and function of the NKR-P 1 dim/T cell receptor. alpha beta+subset of rat T cells. J. Immunol. 152 (2) :388 396, 1994.

11) Hwang, S. J., Ballantyne, C. M., Sharrett, A. R. et al.:Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases :the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96 (12) :4219-4225, 1997.

11) Nosten-Bertrand, M., Errington, M. L., Murphy, K. P. et al.:Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1. Nature 379 (6568) :826-829, 1996.

PubMed

11) Kessel, J. M., Hayflick, J., Weyrich, A. S. et al.:Coengagement of ICAM-3 and Fc receptors induces chemokine secretion and spreading by myeloid leukocytes. J. Immunol. 160 (11) :5579-5587, 1998.

PubMed

11) Shih, I. M. and Kurman, R. J.:Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab. Invest. 75 (3) :377-388, 1996.

PubMed

11) Lyman, S. D., James, L., Johnson, L. et al.:Cloning of the human homologue of the murine flt 3 ligand:a growth factor for early hematopoietic progenitor cells. Blood 83 (10) :2795-2801, 1994.

11) Kondo, M., Takeshita, T., Higuchi, M. et al.:Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 263 (5152) :1453-1454, 1994.

PubMed

11) Greene, J. L., Leytze, G. M., Emswiler, J. et al.:Covalent dimerization of CD 28/CTLA-4 and oligomerization of CD 80/CD 86 regulate T cell costimulatory interactions. J. Biol. Chem. 271 (43) :26762-26771, 1996.

11) Micklem, K. J., Dong, Y., Willis, A. et al.:HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit. Am. J. Pathol. 139 (6) :1297-1301, 1991.

PubMed

11) Rokhlin, O. W., Cohen, M. B., Kubagawa, H. et al.:Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J. Immunol. 154 (9) :4456 4465, 1995.

11) Kern, A., Briesewitz, R., Bank, I. et al.:The role of the I domain in ligand binding of the human integrin alpha 1 beta 1. J. Biol. Chem. 269 (36) :22811-22816, 1994.

PubMed

11) Matsuyoshi, N., Toda, K., Horiguchi, Y. et al.:In vivo evidence of the critical role of cadherin 5 in murine vascular integrity. Proc. Assoc. Am. Physicians 109 (4) :362-371, 1997.

PubMed

11) Fitzgerald, L. A., Poncz, M., Steiner, B. et al.:Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIb. Biochemistry 26 (25) :8158-8165, 1987.

PubMed

11) Rasmussen, A. M., Blomhoff, H. K., Stokke, T. et al.:Cross linking of CD 53 promotes activation of resting human B lymphocytes. J. Immunol. 153 (11) :4997-507, 1994.

11) Frenette, P. S., Mayadas, T. N., Rayburn, H. et al.:Susceptibility to infection and altered hematopoiesis in mice deficient in both P-and E-selectins. Cell 84 (4) :563-574, 1996.

11) Fukunaga, R., Ishizaka-Ikeda, E., Pan, C. X. et al.:Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 10 (10) :2855-2865, 1991.

PubMed

11) Lee, K. P., Taylor, C., Petryniak, B. et al.:The genomic organization of the CD 28 gene. Implications for the regulation of CD 28 mRNA expression and heterogeneity. J. Immunol. 145 (1) :344-352, 1990.

11) Freeman, G. J., Borriello, F., Hodes, R. J. et al.:Uncovering of functional alternative CTLA 4 counter-receptor in B7 deficient mice. Science 262 (5135) :907-909, 1993.

PubMed

11) Mawby, W. J., Holmes, C. H., Anstee, D. J. et al.:Isolation and characterization of CD 47 glycoprotein:a multispanning membrane protein which is the same as integrin-associated protein and the ovarian tumour marker OA 3. Biochem. Jr. 304 (Pt 2) :525-530, 1994.

11) Yoshiyama, K., Higuchi, Y., Kataoka, M. et al.:CD 156 (human ADAM 8) :expression, primary amino acid sequence, and location. Genomics 41 (1) :56-62, 1997.

11) Kumar, A., Wetzler, E. and Berger, M.:Isolation and characterization of complement receptor type 1 (CR 1) storage vesicles from human neutrophils using antibodies to the cytoplasmic tail of CR 1. Blood 89 (12) :4555-4565, 1997.

11) Haas, C., Ryffel, B. and Le Hir, M.:IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW) F1 mice. J. Immunol. 160 (8) :3713-3718, 1998.

PubMed

11) Cerny, J., Stockinger, H. and Horejsi, V.:Noncovalent associations of T lymphocyte surface proteins. Eur. J. Immunol. 26 (10) :2335-2343, 1996.

PubMed

11) Lankester, A. C., van Schijndel, G. M., Cordell, J. L. et J.:CD 5 is associated with the human B cell antigen receptor complex. Eur. J. Immunol. 24 (4) :812816, 1994.

11) Lopez, M., Eberle, F., Mattei, M. G. et al.:Complementary DNA characterization and chromosomal localization of a human gene related to the poliovirus receptor-encoding gene. Gene 155 (2) :261-265, 1995.

11) Nutt, S. L., Morrison, A. M., Rolink, A. et al.:Identification of BSAP (Pax 5) target genes in early B-cell development by loss-and gain-of-function experiments. EMBO J. 17 (8) :2319-2333, 1998.

11) Konig, H., Pfisterer, P., Corcoran, L. M. et al.:Identification of CD 36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Rev. 9 (13) :1598-1607, 1995.

11) Jackson, D., Waibel, R., Weber, E. et al.:CD 24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res. 52 (19) :5264-5270, 1992.

11) Melero, I., Salmeron, A., Balboa, M. A. et al.:Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J. Immunol. 152 (4) :1662-1673, 1994.

12) Schroter, S., Kirchhoff, C., Yeung, C. H. et al.:Purification and structural analysis of sperm CD 52, a GPI-anchored membrane protein. Adv. Exp. Med. Biol. 424:233-234, 1997.

12) Page, D. M., Tokugawa, Y., Silver, J. et al.:Role of Thy-1 in T cell development. J. Immunol. 159 (11) :5285-5292, 1997.

12) Law, C. L., Sidorenko, S. P., Chandran, K. A. et al.:CD 22 associates with protein tyrosine phosphatase 1 C, Syk, and phospholipase C-gamma (1) upon B cell activation. J. Exp. Med. 183 (2) :547-560, 1996.

12) Shih, I. M., Speicher, D., Hsu, M. Y. et al.:Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM. Cancer Res. 57 (17) :3835-3840, 1997.

PubMed

12) Fitzgerald, L. A., Steiner, B., Rall, S. C. Jr. et al.:Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin". J. Biol. Chem. 262 (9) :3936-3939, 1987.

PubMed

12) Krissansen, GW., Owen, M. J., Verbi, W. et al.:Primary structure of the T 3 gamma subunit of the T 3/T cell antigen receptor complex deduced from cDNA sequences:evolution of the T 3 and delta subunits. EMBO J. 5 (8) :1799-1808, 1986.

12) Loftus, J. C., O'Toole, T. E., Plow, E. F. et al.:A beta 3 integrin mutation abolishes ligand binding and alters divalent cation dependent conformation. Science 249 (4971) :915 918, 1990.

12) Joly, M., Kazlauskas, A., Fay, F. S. et al.:Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science 263 (5147) :684 687, 1994.

12) Lovett-Racke, A. E., Trotter, J. L., Lauber, J. et al.:Decreased dependence of myelin basic protein-reactive Tcells on CD 28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J. Clin. Invest. 101 (4) :725-730, 1998.

12) Hakonarson, H. and Grunstein, M. M.:Autologously up-regulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state. Proc. Natl. J. Acad. Sci. USA 95 (9) :5257-5262, 1998.

12) Kadmon, G., Eckert, M., Sammar, M. et al.:Nectadrin, the heat-stable antigen, is a cell adhesion molecule. J. Cell Biol. 118 (5) :1245-1258, 1992.

PubMed

12) Higgins, P. J., Ko, J. L., Lobell, R. et al.:A soluble chimeric complement inhibitory protein that possesses both decay accelerating and factor I cofactor activities. J. Immunol. 158 (6) :2872 2881, 1997.

12) Holguin, M. H., Martin, C. B., Eggett, T. et al.:Analysis of the gene that encodes the complement regulatory protein, membrane inhibitor of reactive lysis (CD59) . Identification of an alternatively spliced exon and characterization of the transcriptional regulatory regions of the promoter. J. Immunol. 157 (4) :1659-1668, 1996.

PubMed

12) Ohlin, A. K. and Marlar, R. E.:The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease. Blood 85 (2) :330-336, 1995.

12) Navarro, P., Caveda, L., Breviario, F. et al.:Catenin dependent and independent functions of vascular endothelial cadherin. J. Biol. Chem. 270 (52) :30965 30972, 1995.

12) Smith, M. E. and Thomas, J. A.:Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule 1 in normal tissue. J. Clin. Pathol. 43 (11) :893900, 1990.

12) Kemball Cook, G., Johnson, D. J., Takamiya, O. et al.:Coagulation factor VII G1n 100→Arg. Amino acid substitution at the epidermal growth factor 2 protease domain interface results in severely reduced tissue factor binding and procoagulant function. J. Biol. Chem. 273 (14) :85168521, 1998.

12) Hetland, G., Pfeifer, P. H. and Hugli, T. E.:Processing of C5a by human polymorphonuclear leukocytes. J. Leukoc. Biol. 63 (4) :456-462, 1998.

PubMed

12) Sugita, K., Torimoto, Y., Nojima, Y. et al.:The 1 A 4 molecule (CD 27) is involved in T cell activation. J. Immunol. 147 (5) :1477-1483, 1991.

12) Nakajima, H., Liu, X. W., Wynshaw-Boris, A. et al.:An indirect effect of Stat 5 a in IL2-induced proliferation:acritical role for Stat 5 a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity. Exp 7 (5) :691-701, 1997.

12) Lanier, L. L., Chang, C., Azuma, M. et al.:Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD 56) . J. Immunol. 146 (12) :4421-4426, 1991.

12) Kario, K., Kanai, N., Saito, K. et al.:Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 93 (9) :1630-1633, 1996.

PubMed

12) Hegen, M., Camerini, D. and Fleischer, B.:Function of dipeptidyl peptidase IV (CD 26, Tp103) in transfected human T cells. J. Immunol. 146 (2) :249-260, 1993.

12) Woynarowska, B., Skrincosky, D. M., Haag, A. et al.:Inhibition of lectin mediated ovarian tumor cell adhesion by sugar analogs. J. Bio. Chem. 269 (36) :22797 22803, 1994.

12) Frohn, C., Schlenke, P. and Kirchner, H.:The repertoire of HLA-Cw-specific NK cell receptors CD158a/b (EB6 GL183) in individuals with different HLA phenotypes. Immunology 92 (4) :567-570, 1997.

PubMed

12) Mizukami, I. F., Vinjamuri, S. D., Trochelman, R. D. et al.:A structural characterization of the Mo 3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J. Immunol. 144 (5) :1841-1848, 1990.

12) Sawada, R., Lowe, J. B. and Fukuda, M.:E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J. Biol. Chem. 268 (17) :12675-12681, 1993.

12) Moir, S., Perreault, J. and Poulin, L.:Postbinding events mediated by human immunodeficiency virus type 1 sensitive to modifications in the D 4-transmembrane linker region of. J. Virol. 70 (11) :8019-8028, 1996.

12) Kawasaki, T., Fujimura, Y., Usami, Y. et al.:Complete amino acid sequence and identification of the platelet glycoprotein Ib binding site of jararaca GP Ib BP, a snake venom protein isolated froln Bothrops jararaca. J. Biol. Chem. 271 (18) :10635-10639, 1996.

12) Li, F., Erickson, H. P., James, J. A. et al.:Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies. J. Biol. Chem. 271 (11) :6342-6348, 1996.

PubMed

12) Hofer, M. F., Jirapongsananuruk, O., Trumble, A. E. et al.:Upregulation of B7-2, but not B7-1, On B cells from patients with allergic asthma. J. Allergy. Clin. Immunol. 101 (1 Pt 1) :96-102, 1998.

PubMed

12) Kramer, R. H. and Marks, N.:Identification of integrin collagen receptors on human melanoma cells. J. Biol. Chem. 264 (8) :4684-4688, 1989.

12) Hunter, M. G. and Avalos, B. R.:Phosphatidylinositol 3'-kinase and SH 2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocytecolony-stimulating factor receptor. J. Immunol. 160 (10) :4979-4987, 1998.

12) Brumbaugh, K. M., Perez-Villar, J. J., Dick, C. J. et al.:Clonotypic differences in signaling from CD 94 (kp43) on NK cells lead to divergent cellular responses. J. Immunol. 157 (7) :2804-2812, 1996.

12) Majolini, M. B., Galieni, M., Boncristiano, M. et al.:Expression of the T cell specific tyrosine kinase lck in normal B l cells and ill chronic lymphocytic leukemia B cells. Blood 91 (9) :3390-3396, 1998.

12) Moretta, A., Bottino, C., Pende, D. et al.:Identification of four subsets of human CD 3-CD 16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules:correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 172 (6) :1589-1598, 1990.

12) Lebel Binay, S., Gil, M. L., Lagaudriere, C. et al.:Further characterization of CD 82/IA4 antigen (type III surface protein) :an activation differentiation marker of mononuclear cells. J. Immunol. 154 (1) :468-483, 1994.

12) Starling, G. C., Whitney, G. S., Siadak, A. W. et al.:Characterization of mouse CD 6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction. Eur. J. Immunol. 26 (4) :738-746, 1996.

12) Kampgen, E., Koch, F., Heufler, C. et al.:Understanding the dendritic cell lineage through a study of cytokine receptors. J. Exp. Med. 179 (6) :1767-1776, 1994.

PubMed

12) Imai, T., Kakizaki, M., Nishimura, M. et al.:Molecular analyses of the association of CD 4 with two members of the transmembrane 4 superfamily, CD 81 and CD 82. J. Immunol. 155 (3) :1229-1239, 1995.

12) Parkinson, J. E., Sanderson, C. M. and Smith, G. L.:The vaccinia virus A 38 L gene product is a 33-kDa integral membrane glycoprotein. Virology 214 (1) :177-188, 1995.

12) Kunicki, T. J., Nugent, D. J., Staats, S. J. et al.:The human fibroblast class II extracellular matrix receptor mediates platelet adhesion to collagen and is identical to the platelet glycoprotein Ia-IIa complex. J. Biol. Chem. 263 (10) :4516-4519, 1988.

12) Murray, E. W., Pihl, C., Morcos, A. et al.:Ligand-independent cell surface expression of the human soluble granulocyte-macrophage colony-stimulating factor receptor alpha subunit depends on co-expression of the membrane-associated receptor beta subunit. J. Biol. Chem. 271 (26) :15330-15335, 1996.

12) Shovlin, C. L., Hughes, J. M., Scott, J. et al.:Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am. J. Hum. Genet. 61 (1) :68-79, 1997.

PubMed

12) Leta, E., Roy, A. K., Hou, Z. et al.:Production and characterization of the extracellular domain of human CD 7 antigen:further evidence that CD 7 has a role in T cell signaling. Cell. Immunol. 165 (1) :101-109, 1995.

12) Todd, R. F., Roach, J. A. and Arnaout, M. A.:The modulated expression of Mo 5, a human myelomonocytic plasma antigen. Blood 65 (4) :964 973, 1985.

12) Littman, D. R., Thomas, Y., Maddon, P. J. et al.:The isolation and sequence of the gene encoding T 8:a molecule defining functional classes of T lymphocytes. Cell 40 (2) :237-246, 1985.

12) Hirota, S., Isozaki, K., Moriyama, Y. et al.:Gain-of-function mutations of c-kit in human gastrointestinal stromal. Science 279 (5350) :577-580, 1998.

PubMed

12) Iwata, K., Seya, T., Yanagi, Y. et al.:Diversity of sites for measles virus binding and for inactivation of complement C 3 b and C 4 b on membrane cofactor protein CD 46. J. Biol. Chem. 270 (25) :15148-15152, 1995.

12) Loffler, S., Lottspeich, F., Lanza, F. et al.:CD 9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J. Virol. 71 (1) :42-49, 1997.

12) Takada, Y., Strominger, J. L. and Hemler, M. E.:The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis. Proc. Natl. Acad. Sci. USA 84 (10) :3239-3243, 1987.

PubMed

12) Zieger, B., Hashimoto, Y. and Ware, J.:Alternative expression of platelet glycoprotein Ib (beta) mRNA from an adjacent 5'gene with an imperfect polyadenylation signal sequence. J. Clin. Invest. 99 (3) :520-525, 1997.

PubMed

12) Geldhof, A. B., Moser, M., Lespagnard, L. et al.:Interleukin 12 activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Blood 91 (1) :196-206, 1998.

PubMed

12) Jouanguy, E., Altare, F., Lamhamedi, S. et al.:Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335 (26) :1956-1961, 1996.

12) Williams, S. E., Ashcom, J. D., Argraveg., W. S. et al.:A novel mechanism for controlling the activity of alpha 2 macroglobulin receptor/low density lipoprotein receptor related protein. Multiple regulatory sites for 39-kDa receptor associated protein. J. Biol. Chem. 267 (13) :9035 9040, 1992.

12) Salles, G., Chen, C. Y., Reinherz, EL. et al.:CD 10/NEP is expressed on Thy-1 low B 220+ murine B-cell progenitors functions to regulate stromal cell-dependent lymphopoiesis. Blood 80 (8) :2021, 2029, 1992.

12) McCormick, C. J., Craig, A., Roberts, D. et al.:Intercellular adhesion molecule-1 and CD 36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells. J. Clin. Invest. 100 (10) :2521-2529, 1997.

12) Kilger, G., Needham, L. A., Nielsen, P. J. et al.:Differential regulation of alpha 4 integrin-dependent binding to domains 1 and 4 of vascular cell adhesion molecule-1. J. Biol. Chem. 270 (11) :5979-5984, 1995.

PubMed

12) Ravanat, C., Morales, M., Azorsa, D. O. et al.:Gene cloning of rat and mouse platelet glycoprotein V:identification of megakaryocyte-specific promoters and demonstration of functional thrombin cleavage. Blood 89 (9) :3253-3262, 1997.

PubMed

12) Lankester, A. C., van Schijndel, G. M., Cordell, J. L. et al.:CD5 is associated with the human B cell antigen receptor complex. Eur. J. Immunol. 24 (4) :812-816, 1994.

12) Grell, M., Douni, E., Wajant, H. et al.:The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83 (5) :793-802, 1995.

PubMed

12) Landis, R. C., McDowall, A., Holness, C. L. et al.:Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3. J. Cell Biol. 126 (2) :529-537, 1994.

PubMed

12) Mahon, B. P., Katrak, K., Nomoto, A. et al.:Poliovirus-specific CD 4+Th 1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J. Exp. Med. 181 (4) :1285-1292, 1995.

12) Taga, S., Carlier, K., Mishal, Z. et al.:Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells. Blood 90 (7) :2757-2767, 1997.

PubMed

12) Hickstein, D. D., Hickey, M. J., Ozols, J. et al.:cDNA sequence for the alpha M subunit of the human neutrophil receptor indicates homology to integrin alpha subunits. Proc. Natl. Acad. Sci. USA 86 (1) :257-261, 1989.

12) Kanakaraj, P., Schafer, P. H., Cavender, D. E. et al.:Interleukin (IL) -1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 187 (12) :2073-2079, 1998.

PubMed

12) Peduzzi, J. D., Irwin, M. H. and Geisert, E. E. Jr.:Distribution and characteristics of a 90 kDa protein, KG-CAM, in the rat CNS. Brain Res. 640 (1-2) :296-307, 1994.

12) Parker, C. M., Cepek, K. L., Russell, G. J. et al.:A family of beta 7 integrins on human mucosal lymphocytes. Proc. Natl. Acad. Sci. USA 89 (5) :1924-1928, 1992.

PubMed

12) Kurtz, C. B., O'Toole, E., Christensen, S. M. et al.:The murine complement receptor gene family. IV. Alternative splicing Cr 2 gene transcripts predicts two distinct gene products that share homologousdomains with both human CR 2 and CR 1. J. Immunol. 144 (9) :3581-3591, 1990.

12) O'Sullivan, D. M., Larhammar, D., Wilson, M. C. et al.:Structure of the human Ia-associated invariant (gamma) -chain gene:identification of 5' sequences shared with major histocompatibility complex class II genes. Proc. Natl. A cad. Sci. USA 83 (12) :4484-4488, 1986.

12) Orlando, S., Sironi, M., Bianchi, G. et al.:Role of metalloproteases in the release of the IL-1 type II decoyreceptor. J. Biol. Chem. 272 (50) :31764-31769, 1997.

12) Przyklenk, K., Hata, K., Zhao, L. et al.:Disparate effects of preconditioning and MLA on 5'-NT andadenosine levels during coronary occlusion. Am. J. Physiol. 273 (2 Pt 2) :H945-951, 1997.

12) Osawa, M., Hanada, K., Hamada, H. et al.:Long-term lympho hematopoietic reconstitution by a single CD 34-low/negative hematopoietic stem cell. Science 273 (5272) :242-245, 1996.

12) Miyazaki, T., Kawahara, A., Fujii, H. et al.:Functional activation of Jak 1 and Jak 3 by selective association with IL-2 receptor subunits. Science 266 (5187) :1045-1047, 1994.

12) McEvoy, L. M., Jutila, M. A., Tsao, P. S. et al.:Anti-CD 43 inhibits monocyte-endothelial adhesion in inflammation and atherogenesis. Blood 90 (9) :3587-3594, 1997.

12) Lopez-Rodriguez, C. and Corbi, A. L.:PU. 1 negatively regulates the CD 11c integrin gene promoter through recognition of the major transcriptional start site. Eur. J. Immunol. 27 (8) :1843-1847, 1997.

12) Du, X. P., Plow, E. F., Frelinger, A. L. et al.:Ligands "activate" integrin alpha II b beta 3 (platelet GPII b-III a) . Cell 65 (3) :409-416, 1991.

12) Venkataraman, C., Muthusamy, N., Muthukkumar, S. et al.:Activation of lyn, blk, and btk but not syk in CD 72-stimulated B lymphocytes. J. Immunol. 160 (7) :3322 3329, 1998.

PubMed

12) Monteiro, R. C., Cooper, M. D. and Kubagawa, H.:Molecular heterogeneity of Fc alpha receptors detected by receptor specific monoclonal antibodies. J. Immunol. 148 (6) :1764 1770, 1992.

12) Sato, N., Caux, C., Kitamura, T. et al.:Expression and factor dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells. Blood 82 (3) :752 761, 1993.

12) Kato, K., Cantwell, M. J., Sharma, S. et al.:Gene transfer of CD 40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J. Clin. Invest. 101 (5) :1133-1141, 1998.

12) Ruoslahti, E. and Pierschbacher, M. D.:New perspectives in cell adhesion:RGD and integrins. Science 238 (4826) :491-497, 1987.

PubMed

12) Tesselaar, K., Gravestein, L. A., van Schijndel, G. M. et al.:Characterization of murine CD 70, the ligand of the TNF receptor family member CD 27. J. Immunol. 159 (10) :4959-4965, 1997.

12) Itoh, N., Yonehara, S., Ishii, A. et al.:The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66 (2) :233 243, 1991.

12) Kuperman, D., Schofield, B., Wills-Karp, M. et al.:Signal transducer and activator of transcription factor 6 (Stat 6) -deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 187 (6) :939-948, 1998.

12) Armitage, R. J., Fanslow, W. C., Strockbine, L. et al.:Molecular and biological characterization of a murine ligand for CD 40. Nature 357 (6373) :80-82, 1992.

12) Okamoto, K., Tsurudome, M., Ohgimoto, S. et al.:An anti-fusion regulatory protein-1 monoclonal antibody suppresses human parainfluenza virus type 2-induced cell fusion. J. Gen. Virol. 78 (Pt 1) :83-89, 1997.

12) Schnittger, S., Hamann, J., Dannenberg, C. et al.:Regional sublocalization of the human CD69 gene tochromosome bands 12p12. 3 p13. 2, the predicted region of the humam natural killer cell gene complex. Eur. J. Immunol. 23 (10) :2711 2713, 1993.

12) Nair, S. K., Boczkowski, D., Morse, M. et al.:Induction of primary carcinoembryonic antigen (CEA) specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat. Biotechnol. 16 (4) :364-369, 1998.

PubMed

12) Pazdrak, K., Adachi, T. and Alam, R.:Src homology 2 protein tyrosine phosphatase (SHPTP 2) /Src homology 2 phosphatase 2 (SHP 2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival. J. Exp. Med. 186 (4) :561-568, 1997.

12) Czyzyk, J. K., Fernsten, P. D., Brtva, T. R. et al.:CD 45 and Src-related protein tyrosine kinases regulate the T cell response to phorbol esters. Biochem. Biophys. Res. Commun. 243 (2) :444-450, 1998.

12) Shimizu, Y., van Seventer, G. A., Horgan, K. J. et al.:Costimulation of proliferative responses of resting CD 4+T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J. Immunol. 145 (1) :59 67, 1990.

12) Soderberg, C., Giugni, T. D., Zaia, J. A. et al.:CD 13 (human aminopeptidase N) mediates human cytomegalovirus. J. Virol. 67 (11) :6576-6585, 1993.

12) Powell, I. F., Li, T., Jack, H. M. et al.:Construction and expression of a soluble form of human CD 30 ligand with functional activity. J. Leukoc. Biol. 63 (6) :752-757, 1998.

12) Oikawa, S., Inuzuka, C., Kuroki, M. et al.:Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface:homophilic and heterophilic adhesion. Biochem. Biolphys. Res. Commun. 164 (1) :39-45, 1989.

12) Lin, S. C., Yamate, T., Taguchi, Y. et al.:Regulation of the gp 80 and gp 130 subunits of the IL-6 receptoby sex steroids in the murine bone marrow. J. Clin. Invest. 100 (8) :1980-1990, 1997.

12) Skubitz, K. M., Campbell, K. D. and Skubitz, A. P.:CD 66 a, CD 66 b, CD 66 c, and CD 66 d each independently stimulate neutrophils. J. Leukoc. Biol. 60 (1) :106-117, 1996.

12) Ichimiya, S., Kikuchi, K. and Matsuura, A.:Structural analysis of the rat homologue of CD 1. Evidence for evolutionary conservation of the CD1D class and widespread transcription by rat cells. J. Immunol. 153 (3) :1112-1123, 1994.

12) Maeurer, M. J. and Lotze, M. T.:Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity. Int. Rev. Immunol. 16 (3-4) :309-322, 1998.

12) Mackay, C. R., Terpe, H. J., Stauder, R. et al.:Expression and modulation of CD 44 variant isoforms in humans. J. Cell Biol. 124 (1-2) :71-82, 1994.

12) Sonnenberg, A., Modderman, P. W. and Hogervorst, F.:Laminin receptor on platelets is the integrin VLA-6. Nature 336 (6198) :487-489, 1988.

PubMed

12) Nollau, P., Scheller, H., Kona-Horstmann, M. et al.:Expression of CD 66 a (human C-CAM) and other members of the carcinoembryonic antigen gene family of adhesion molecules in human colorectal adenomas. Cancer Res. 57 (12) :2354-2357, 1997.

12) Haziot, A., Chen, S., Ferrero, E. et al.:The monocyte differentiation antigen, CD 14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141 (2) :547552, 1988.

12) Khabar, K. S., Al-Zoghaibi, F., Al-Ahdal, M. N. et al.:The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J. Exp. Med. 186 (7) :1077, 1085, 1997.

12) Muta, T., Kurosaki, T., Misulovin, Z. et al.:A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RII B modulates B-cell receptor signalling. Nature 368 (6466) :70-73, 1994.

PubMed

12) Newman, P. J., Hillery, C. A., Albrecht, R. et al.:Activation-dependent changes in human platelet PECAM-1:phosphorylation, cytoskeletal association, and surface membrane redistribution. J. Cell. Biol. 119 (1) :239-246, 1992.

PubMed

12) Pennica, D., Shaw, K. J., Swanson, T. A. et al.:Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp 130 signaling complex. J. Biol. Chem. 270 (18) :10915-10922, 1995.

12) Chambers, W. H., Vujanovic, N. L., DeLeo, A. B. et al.:Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 169 (4) :1373-1389, 1989.

PubMed

12) Phillips, M. L., Nudelman, E., Gaeta, F. C. et al.:ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 250 (4984) :1130-1132, 1990.

PubMed

12) Lokeshwar, V. B., Fregien, N. and Bourguignon, L. Y.:Ankyrin-binding domain of CD 44 (GP 85) is required for the expression hyaluronic acid-mediated adhesion function. J. Cell Biol. 126 (4) :1099-1109, 1994.

12) Melendez, A. J., Gillooly, D. J., Harnett. M. M. et al.:Aggregation of the human high affinity immunoglobulin G receptor (Fc gamma RI) activates both tyrosine kinase and G protein-coupled phosphoinositide 3-kinase isoforms. Proc. Natl. Acad. Sci. USA 95 (5) :2169-2174, 1998.

12) Takahashi, N., Hotta, H. and Homma, M.:Activation and suppression of a cryptic promoter in the intron of the human melanoma-associated ME 491 antigen gene. Jpn. J. Cancer Res. 82 (11) :1239-1244, 1991.

12) Horspool, J. H., Perrin, P. J., Woodcock, J. B. et al.:Nucleic acid vaccine induced immune responses require CD 28 costimulation and are regulated by CTLA 4. J. Immunol. 160 (6) :2706 2714, 1998.

12) Nishinakamura, R., Nakayama, N., Hirabayashi, Y. et al.:-Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor deficient mice are normal Immunity 2:211 222, 1995.

12) Klickstein, L. B., York, M. R., Fougerolles, A. R. et al.:Localization of the binding site on intercellular adhesion molecule-3 (ICAM-3) for lymphocyte function-associated antigen 1 (LFA-1) . J. Biol. Chem. 271 (39) :23920-23927, 1996.

PubMed

12) Rodewald, H. R., Moingeon, P., Lucich, J. L. et al.:A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells. Cell 69 (1) :139-150, 1992.

PubMed

12) Gonsky, R., Deem, R. L., Hughes, C. C. et al.:Activation of the CD 2 pathway in lamina propria T cells up-regulates functionally active AP-1 binding to the IL-2 promoter, resulting in messenger RNA transcription and IL-2 secretion. J. Immunol. 160 (10) :4914-4922, 1998.

12) Nortamo, P., Valmu, L., Tolvanen, M. et al.:A peptide from ICAM-2 binds to the leukocyte integrin CD 11a/CD 18 and inhibits endothelial cell adhesion. J. Biol. Chem. 268 (23) :17513-17518, 1993.

12) Kondo, M., Akashi, K., Domen, J. et al.:Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity 7 (1) :155-162, 1997.

PubMed

12) Gao, A. G., Lindberg, F. P., Dimitry, J. M. et al.:Thrombospondin modulates alpha v beta 3 function through integrin-associated protein. J. Cell. Biol. 135 (2) :533-544, 1996.

12) Ortlepp, S., Stephens, P. E., Hogg, N. et al.:Antibodies that activate beta 2 integrins can generate different ligand binding states. Eur. J. Immunol. 25 (3) :637-643, 1995.

PubMed

12) Frenette, P. S., Johnson, R. C., Hynes, R. O. et al.:Platelets roll on stimulated endothelium in vivo:an interaction mediated by endothelial P-selectin. Proc. Natl. Acad. Sci. USA 92 (16) :7450-7454, 1995.

PubMed

12) Kawamata, S., Hori, T., Imura, A. et al.:Activation of OX 40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2 and TRAF 5 mediated NF-kappa B activation. J. Biol. Chem. 273 (10) :5808-5814, 1998.

12) Kumagai, M., Coustan-Smith, E., Murray, D. J. et al.:Ligation of CD 38 suppresses human B lymphopoiesis. J. Exp. Med. 181 (3) :1101-1110, 1995.

12) O'Rourke, L. M., Tooze, R., Turner, M. et al.:CD 19 as a membrane-anchored adaptor protein of B lymphocytes:costimulation of lipid and protein kinases by recruitment of Vav. Immunily 8 (5) :635-645, 1998.

12) Sandrin, M. S., Henning, M. M., Lo, M. F. et al.:Isolation and characterization of cDNA clones for Humly 9:the human homologue of mouse Ly 9. Immunogenetics 43 (1-2) :13-19, 1996.

12) Durkop, H., Latza, U., Hummel, M. et al.:Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68 (3) :421-427, 1992.

PubMed

12) Szollosi, J., Horejsi, V., Bene, L. et al.:Supramolecular complexes of MHC class I, MHC class II, CD 20, and tetraspan molecules (CD 53, CD 81, and CD 82) at the surface of a B cell line JY. J. Immunol. 157:2939-2946, 1996.

12) Mackarehtschian, K., Hardin, J. D., Moore, K. A. et al.:Targeted disruption of the flk 2/flt 3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3 (1) :147-161, 1995.

12) Imhof, B. A., Weerasinghe, D., Brown, E. J. et al.:Cross talk between alpha (v) beta 3 and alpha 4 beta lintegrins regulates lymphocyte migration on vascular cell adhesion molecule 1. Eur. J. Immunol. 27 (12) :3242-3252, 1997.

12) Kahn, J., Walcheck, B., Migaki, G. I. et al.:Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism. Cell 92 (6) :809-818, 1998.

PubMed

12) Tedder, T. F., Klejman, G., Disteche, C. M. et al.:Cloning of a complementary DNA encoding a new mouse B lymphocyte differentiation antigen, homologous to the human B 1 (CD 20) antigen, and localization of the gene to chromosome 19. J. Immunol. 141 (12) :4388-4394, 1988.

12) Petty, A. C. and Tippett, P.:Investigation of the biochemical relationship between the blood group antigens Xga and CD 99 (12E7 antigen) on red cells. Vox. Sang. 69 (3) :231-235, 1995.

12) Wang, M. H., Gonias, S. L., Skeel, A. et al.:Proteolytic activation of single-chain precursor macrophage-stimulating protein by nerve growth factor-gamma and epidermal growth factor-binding protein, members of the kallikrein family. J. Biol. Chem. 269 (19) :13806-13810, 1994.

12) Graves, B. J., Crowther, R. L., Chandran, C. et al.:Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. Nature 367 (6463) :532-538, 1994.

PubMed

12) Melero, I., Shuford, W. W., Newby, S. A. et al.:Monoclonal antibodies against the 4-1 BB T-cell activation molecule eradicate established tumors. Nat. Med. 3 (6) :682-685, 1997.

12) Kasinrerk, W., Fiebiger, E., Stefanova, I. et al.:Human leukocyte activation antigen M 6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT 7 molecule. J. Immunol. 149 (3) :847-854, 1992.

12) Mainiero, F., Pepe, A., Wary, K. K. et al.:Signal transduction by the alpha 6 beta 4 integrin :distinct beta 4 subunit sites mediate recruitment of Shc/Grb 2 and association with the cytoskeleton of hemidesmosomes. EMBO J. 14 (18) :4470-4481, 1995.

12) Fischer, M. B., Goerg, S., Shen, L. et al.:Dependence of germinal center B cells on expression of CD 21/CD 35 for survival. Science 280 (5363) :582-585, 1998.

12) Diamond, M. S., Staunton, D. E., Marlin, S. D. et al.:Binding of the integrin Mac-1 (CD 11b/CD 18) to the third immunoglobulin-like domain of ICAM-1 (CD 54) and its regulation by glycosylation. Cell 65 (6) :961-971, 1991.

12) Kato, M., Wang, H., Kainulainen, V. et al.:Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat. Med. 4 (6) :691-697, 1998.

PubMed

13) Krummel, M. F. and Allison, J. P.:CD 28 and CTLA 4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182 (2) :459 465, 1995.

13) Nakamura, Y., Russell, S. M., Mess, S. A. et al.:Heterodimerization of the IL-2 receptor beta-and gamma-chain cytoplasmic domains is required for signalling. Nature 369 (6478) :330-333, 1994.

PubMed

13) Resta, R., Hooker, S. W., Laurent, A. B. et al.:Insights into thymic purine metabolism and adenosinedeaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD 73) . J. Clin. Invest. 99 (4) :676-683, 1997.

13) Khanna, R., Cooper, L., Kienzle, N. et al.:Engagement of CD 40 antigen with soluble CD 40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells. J. Immunol. 159 (12) :5782-5785, 1997.

13) Seki, T., Spurr, N., Obata, F. et al.:The human Thy-1 gene:structure and chromosomal location. Proc. Natl. Acad. Sci. USA 82 (19) :6657-6661, 1985.

13) Phillips, M. L., Schwartz, B. R., Etzioni, A. et al.:Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2. J. Clin. Invest. 96 (6) :2898-2906, 1995.

PubMed

13) Perrotti, D., Bellon, T., Trotta, R. et al.:Acell proliferation-dependent multiprotein complex NC-3 Apositively regulates the CD 34 promoter via a TCATTT-containing element. Blood 88 (9) :3336-3348, 1996.

13) Lee, G. F. and Kelley, R. F.:A novel soluble tissue factor variant with an altered factor VIIa binding interface. J. Biol. Chem. 273 (7) :4149 4154, 1998.

13) Morton, H. C., van den Herik-Oudijk, I. E., Vossebeld, P. et al.:Functional association between the human myeloid immunoglobulin A Fc receptor (CD 89) and FcR gamma chain. Molecular basis for CD 89/FcR gamma chain association. J. Biol. Chem. 270 (50) :29781-29787, 1995.

13) Hopken, U. E., Lu, B., Gerard, N. P. et al.:The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383 (6595) :86-89, 1996.

PubMed

13) Russell, G. J., Parker, C. M., Cepek, K. L. et al.:Distinct structural and functional epitopes of the alpha E beta 7 integrin. Eur. Immunol. 24 (11) :2832-2841, 1994.

PubMed

13) Re, F., Sironi, M., Muzio, M. et al.:Inhibition of interleukin-1 responsiveness by type II receptor gene transfer:a surface "receptor" with anti-interleukin-1 function. J. Exp. Med. 183 (4) :1841-1850, 1996.

PubMed

13) Kirsch, A. H., Diaz, L. A. Jr., Bonish, B. et al.:The pattern of expression of CD 147/neurothelin during human T-cell ontogeny as defined by the monoclonal antibody 8D6. Tissue Antigens 50 (2) :147-152, 1997.

13) O'Sullivan, D. M., Noonan, D. and Quaranta, V.:Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation. J. Exp. Med. 166 (2) :444-460, 1987.

PubMed

13) Molina, H., Holers, V. M., Li, B. et al.:Markedly impaired humoral immune response in mice deficient incomplement receptors l and 2. Proc. Natl. Acad. Sci. USA 93 (8) :3357-3361, 1996.

13) Sultan, P., Schechner, J. S., McNiff, J. M. et al.:Blockade of CD 2 LFA 3 interactions protects human skin allografts in immunodeficient mouse/human chimeras. Nat. Biotechnol. 15 (8) :759-762, 1997.

13) Pesando, J. M., Hoffman, P. and Abed, M.:Antibody-induced antigenic modulation is antigen dependent:characterization of 22 proteins on a malignant human B cell line. J. Immunol. 137:3689-3695, 1986.

13) Labow, M., Shuster, D., Zetterstrom, M. et al.:Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159 (5) :2452-2461, 1997.

PubMed

13) Koch, A. E., Halloran, M. M., Haskell, C. J. et al.:Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376 (6540) :517-519, 1995.

PubMed

13) Nishinakamura, R., Miyajima, A., Mee, P. J. et al.:Hematopoiesis in mice lacking the entire granulocy temacrophage colony stimulating factor/interleukin 3/interleukin 5 functions. Blood 88 (7) :2458-2464, 1996.

13) Mohamadzadeh, M., DeGrendele, H., Arizpe, H. et al.:Proinflammatory stimuli regulate endothelial hyaluronan expression CD 44/HA-dependent primary adhesion. J. Clin. Invest. 101 (1) :97-108, 1998.

13) Lecoanet-Henchoz, S., Gauchat, J. F., Aubry, J. P. et al.:Immunity 3 (1) :119-125, 1995.

PubMed

13) Thorbecke, G. J., Amin, A. R. and Tsiagbe, V. K.:Biology of germinal centers in lymphoid tissue. FASEB J. 8 (11) :832-840, 1994.

PubMed

13) Larson, R. S., Corbi, A. L., Berman, L. et al.:Primary structure of the leukocyte function-associated molecule-1 subunit:an integrin with an embedded domain defining a protein superfamily. J. Cell Biol. 108 (2) :703-712, 1989.

PubMed

13) Feng, Y., Chung, D., Garrard, L. et al.:Peptides derived from the complementarity-determining regions of anti-Mac-1 antibodies block intercellular adhesion molecule-1 interaction with Mac-1. J. Biol. Chem. 273 (10) :5625-5630, 1998.

PubMed

13) Knorr, R. and Dustin, M. L.:The lymphocyte function-associated antigen 1 I domain is a transient binding module for inter Cellular adhesion molecule (ICAM) -1 and ICAM-3 in hydrodynamic flow. J. Exp. Med. 186 (5) :719-730, 1997.

13) Mendelsohn, C. L., Wimmer, E. and Racaniello, V. R.:Cellular receptor for poliovirus:molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56 (5) :855-865, 1989.

PubMed

13) Grell, M., Wajant, H., Zimmermann, G. et al.:The type 1 receptor (CD 120 a) is the high-affinity receptor for soluble tumor necrosis factor. Proc. Natl. Acad. Sci. USA 95 (2) :570-575, 1998.

13) Kay, R., Rosten, P. M. and Humphries, R. K.:CD 24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane. J. Immunol. 147 (4) :1412-1416, 1991.

13) Selvaraj, P., Rosse, W. F., Silber, R. et al.:The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature 333 (6173) :565-567, 1988.

13) Lobb, R. R. and Hemler, M. E.:The pathophysiologic role of alpha 4 integrins in vivo. J. Clin. Invest. 94 (5) :1722-1728, 1994.

PubMed

13) Navarro, P., Ruco, L. and Dejana, E.:Differential localization of VE and N cadherins in human endothelial cells:VE cadherin competes with N cadherin for junctional localization. J. Cell Biol. 140 (6) :1475-1484, 1998.

13) Macardle, P. J., Weedon, H., Fusco, M. et al.:The antigen receptor complex on cord B lymphocytes. Immunology 90 (3) :376-382, 1997.

13) Salles, G., Rodewald, H. R., Chin, B. S. et al.:Inhibition of CD 10/neutral endopeptidase 24. 11 promotes B-cell reconstitution and maturation in vivo. Proc. Natl. Acad. Sci. USA 90 (16) :7618-7622, 1993.

13) Sampoli, Benitez, B. A., Hunter, M. J., Meininger, D. P. et al.:Structure of the fifth EGF-like domain of thrombomodulin:An EGF-like domain with a novel disulfide-bonding pattern. J. Mol. Biol. 273 (4) :913-926, 1997.

PubMed

13) Jouanguy, E., Lamhamedi-Cherradi, S., Altare, F. et al.:Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J. Clin. Invest. 100 (11) :2658-2664, 1997.

13) Greene, J. L., Leytze, G. M., Emswiler, J. et al.:Covalent dimerization of CD 28/CTLA-4 and oligomerization of CD 80/CD 86 regulate T cell costimulatory interactions. J. Biol. Chem. 271 (43) :26762-26771, 1996.

13) Takada, Y., Wayner, E. A., Carter, W. G. et al.:Extracellular matrix receptors, ECMR II and ECMRI, for collagen and fibronectin correspond to VLA 2 and VLA 3 ill the VLA family of heterodimers. J. Cell. Biochem. 37 (4) :385-393, 1988.

13) Williams, S. E., Kounnas, M. Z., Argraves. K. M. et al.:The alpha 2 microglobulin receptor/low density lipoprotein receptor-related protein and the receptor-associated protein. An overview. Ann. N. Y. Acad. Sci. 737:1 13, 1994.

13) Renkonen, R., Paavonen, T., Nortamo, P. et al.:Expression of endothelial adhesion molecules in vivo. Increased endothelial ICAM-2 expression in lymphoid malignancies. Am. J. Pathol. 140 (4) :763-767, 1992.

PubMed

13) Malissen, M., Pereira, P., Gerber, D. J. et al.:The common cytokine receptor gamma chain controls survival of gamma/delta T cells. J. Exp. Med. 186 (8) :1277-1285, 1997.

PubMed

13) Masellis-Smith, A. and Shaw, A. R.:CD 9-regulated adhesion. Anti-CD 9 monoclonal antibody induce preB adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J. Immunol. 152:2768-2777, 1994.

13) Fletcher, C. M., Harrison, R. A., Lachmann, P. J. et al.:Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. Structure 2 (3) :185-199, 1994.

PubMed

13) Gawaz, M., Neumann, F. J., Dickfeld, T. et al.:Vitronectin receptor (alpha (v) beta 3) mediates platelet adhesion to the luminal aspect of endothelial cells:implications for reperfusion in acute myocardial infarction. Circulation 96 (6) :1809-1818, 1997.

13) Navazo, M. D., Daviet, L., Savill, J. et al.:Identification of a domain (155-183) on CD 36 implicated in the phagocytosis of apoptotic neutrophils. J. Biol. Chem. 271 (26) :15381-15385, 1996.

13) Lev, S., Givol, D. and Yarden, Y.:A specific combination of substrates is involved in signal transduction by the kit-encoded receptor. EMBO J. 10 (3) :647-654, 1991.

PubMed

13) Lanza, F., Kieffer, N., Phillips, D. R. et al.:Characterization of the human platelet glycoprotein IIIa gene. Comparison with the fibronectin receptor beta subunit gene. J. Biol. Chem. 265 (30) :18098 18103, 1990.

13) Oxvig, C. and Springer, T. A.:Experimental support for a beta-propeller domain in integrin alpha-subunits and a calcium binding site on its lower surface. Proc. Natl. Acad. Sci. US. 95 (9) :4870-4875, 1998.

13) Karp, C. L., Wysocka, M., Wahl, L. M. et al.:Mechanism of suppression of cell-mediated immunity by measles. Science 273 (5272) :228 231, 1996.

13) Gedrich, R. W., Gilfillan, M. C., Duckett, C. S. et al.:CD 30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor of signal transducing proteins. J. Biol. Chem. 271 (22) :12852-12858, 1996.

13) Malmon, R. B., Kotzin, B. L., Nataraj, C. et al.:Downregulation of T cell receptor expression by CD 8 (+) lymphocytes in kidney allografts. J. Clin. Invest. 101 (11) :2517-2527, 1998.

13) Frenette, P. S., Mayadas, T. N., Rayburn, H. et al.:Susceptibility to infection and altered hematopoiesis in mice deficient in both P-and E-selectins. Cell 84 (4) :563-574, 1996.

13) Melero, I., Bach, N., Hellstrom, K. E. et al.:Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1 BB ligand:synergy with the CD 28 co-stimulatory pathway. Eur. J. Immunol. 28 (3) :1116-1121, 1998.

13) Pauza, M. E., Doumbia, S. O. and Pennell, C. A.:Construction and characterization of human CD 7-specific single-chain Fv immunotoxins. J. Immunol. 158 (7) :3259-3269, 1997.

13) Vicari, A. P., Bean, A. G. and Zlotnik, A.:A role for BP-3/BST 1 antigen in early T cell development. Int. Immunol. 8 (2) :183 191, 1996.

13) Nieuwenhuis, H. K., Akkerman, J. W., Houdijk, W. P. et al.:Human blood platelets showing no response tocollagen fail to express surface glycoprotein Ia. Nature 318 (6045) :470-472, 1985.

PubMed

13) Parkos, C. A., Colgan, S. P., Liang, T. W. et al.:CD 47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia. J. Cell Biol. 132 (3) :437-450, 1996.

13) Nicola, N. A., Wycherley, K., Boyd, A. W. et al.:Neutralizing and nonneutralizing monoclonal antibodies to the human granulocyte-macrophage colony-stimulating factor receptor alpha-chain. Blood 82 (6) :1724-1731, 1993.

13) Mannion, B. A., Berditchevski, F., Kraeft, S. K. et al.:Transmembrane-4 superfamily proteins CD 81 (TAPA-1) , CD 82, CD 63, and CD 53 specifically associated with integrin alpha 4 beta 1 (CD 49 d/CD 29) . J. Immunol. 157 (5) :2039-2047, 1996.

13) Morton, H. C., van den Herik-Oudijk, IE., Vossebeld, P. et al.:Functional association between the human myeloid immunoglobulin A Fc receptor (CD 89) and FcR gamma chain. Molecular basis for CD 89/FcR gamma chain association. J. Biol. Chem. 270 (50) :29781-29787, 1995.

13) Smith, G. M., Biggs, J., Norris, B. et al.:Detection of a soluble form of the leukocyte surface antigen CD 48in plasma and its elevation in patients with lymphoid leukemias and arthritis. J. Clin. Immunol. 17 (6) :502 509, 1997.

13) Latza, U., Durkop, H., Schnittger, S. et al.:The human OX 40 homolog:cDNA structure, expression and chromosomal assignment of the ACT 35 antigen. Eur. J. Immunol. 24 (3) :677-683, 1994.

13) Ross, I. L., Yue, X., Ostrowski, M. C. et al.:Interaction between PU. 1 and another Ets family transcription factor promotes macrophage-specific Basal transcription initiation. J. Biol. Chem. 273 (12) :6662-6669, 1998.

PubMed

13) Leprince, C., Draves, K. E., Geahlen, R. L. et al.:CD 22 associates with the human surface IgM-B-cell antigen receptor complex. Proc. Natl. Acad. Sci. USA 90 (8) :3236-3240, 1993.

13) Treumann, A., Lifely, M. R., Schneider, P. et al.:Primary structure of CD 52. J. Biol. Chem. 270 (11) :6088-6099, 1995.

13) Soiffer, R. J., Fairclough, D., Robertson, M. et al.:CD 6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission. Blood 89 (8) :3039-3047, 1997.

13) Lebel Binay, S., Lagaudriere, C., Fradelizi, D. et al.:CD 82, member of the tetra span transmembrane protein family, is a costimulatory protein for T cell activation. J. Immunol. 155 (1) :101 110, 1995.

13) Muthukkumar, S. and Bondada, S.:Involvement of CD 5 in Th 1 and Th 2 contact. mediated rescue of anti-mu and ionomycin induced growth inhibition in a B cell lymphoma. Int. Immunol. 7 (2) :305315, 1995.

13) Karnauchow, T. M., Tolson, D. L., Harrison, B. A. et al.:The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD 55) . J. Virol. 70 (8) :5143 5152, 1996.

13) Rickert, R. C., Rajewsky, K. and Roes, J.:Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD 19-deficient mice. Nature 376 (6538) :352-355, 1995.

13) Mainiero, F., Pepe, A., Yeon, M. et al.:The intracellular functions of alpha 6 beta 4 integrin are regulated by EGF. J. Cell Biol. 134 (1) :241-253, 1996.

PubMed

13) Mizuguchi, M., Otsuka, N., Sato, M. et al.:Neuronal localization of CD 38 antigen in the human brain. Brain Res. 697 (1-2) :235-240, 1995.

13) Uhrberg, M., Valiante, N. M., Shum, B. P. et al.:Human diversity in killer cell inhibitory receptor genes. Immunity 7 (6) :753-763, 1997.

PubMed

13) Kasper, B., Herbst, A., Pilz, C. et al.:Severe congenital neutropenia patients with point mutations in the granulocyte colony-stimulating factor (G-CSF) receptor mRNA express a normal G-CSF receptor protein. Blood 90 (7) :2839-2841, 1997.

PubMed

13) Perez-Villar, J. J., Melero, I., Gismondi, A. et al.:Functional analysis of alpha 1 beta 1 integrin in human natural killer cells. Eur. Immunol. 26 (9) :2023-2029, 1996.

PubMed

13) Hewitt, C. R., Brown, A. P., Hart, B. J. et al.:A major house dust mite allergen disrupts the immunoglobulin E by selectively cleaving CD 23:innate protection by antiproteases. J. Exp. Med. 182 (5) :1537-1544, 1995.

13) Robertson, P. B., Neiman, R. S., Worapongpaiboon, S. et al.:013 (CD 99) positivity in hematologic proliferations correlates with TdT positivity. Mod. Pathol. 10 (4) :277-282, 1997.

13) Cambiaggi, A., Verthuy, C., Naquet, P. et al.:Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw 3 specific killer cell inhibitory receptor. Proc. Natl. Acad. Sci. USA 94 (15) :8088-8092, 1997.

13) Jellis, C. L., Wang, S. S., Rennert, P. et al.:Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD 86) . Immunogenetics 42 (2) :85-89, 1995.

13) Peach, R. J., Bajorath, J., Brady, W. et al.:Complementarity determining region 1 (CDR 1) -and CDR 3-analogous in CTLA-4 and CD 28 determine the binding to B 7-1. J. Exp. Med. 180 (6) :2049-2058, 1994.

13) Matthews, W., Jordan, C. T., Wiegand, G. W. et al.:A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65 (7) :1143-1152, 1991.

PubMed

13) Kenny, D., Newman, P. J., Morateck, P. A. et al.:A dinucleotide deletion results in defective membrane anchoring and circulating soluble glycoprotein Ib alpha in a novel form of Bernard Soulier syndrome. Blood 90 (7) :2626-2633, 1997.

13) Tomlinson, M. G., Hanke, T., Hughes, D. A. et al.:Characterization of mouse CD 53:epitope mapping, cellular distribution and induction by T cell receptor engagement during repertoire selection. Eur. J. Immunol. 25:2201-2205, 1995.

13) Nakagawa, T., Roth, W., Wong, P. et al.:Cathepsin L:critical role in Ii degradation and CD 4 T cell selection in the thymus. Science 280 (5362) :450-453, 1998.

13) Silverstein, R. L. and Febbraio, M.:Identification of lysosome-associated membrane protein-2 as an activation-dependent platelet surface glycoprotein. Blood 80 (6) :1470-1475, 1992.

PubMed

13) Nykjaer, A., Moller, B., Todd, R. F. et al.:Urokinase receptor. An activation antigen in human T lymphocytes. J. Immunol. 152 (2) :505-516, 1994.

13) Liossis, S. N., Ding, X. Z., Dennis, G. J. et al.:Altered pattern of TCR/CD 3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. In vest. 101 (7) :1448, 1457, 1998.

13) Nicholson, M. W., Barclay, A. N., Singer, M. S. et al.:Affinity and kinetic analysis of L-selectin (CD 62 L) binding to glycosylation-dependent cell adhesion molecule-1. J. Biol. Chem. 273 (2) :763-770, 1998.

13) Luque, A., Gomez, M., Puz W. W. et al.:Activated conformationg. of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355 425) of the common beta 1 chain. J. Biol. Chem. 271 (19) :11067 11075, 1996.

13) Mingari, M. C., Vitale, C., Cantoni, C. et al.:Interleukin-15-induced maturation of human natural killer cells from early thymic precursors:selective expression of CD 94/NKG 2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27 (6) :1374-1380, 1997.

13) Yamaguchi, H., Azuma, H., Shigekiyo, T. et al.:A novel missense mutation in the endoglin gene in hereditary hemorragic telangiectasia. Thromb. Haemost. 77 (2) :243-247, 1997.

13) Tapper, H. and Grinstein, S.:Fc receptor-triggered insertion of secretory granules into the plasma membrane of human neutrophils:selective retrieval during phagocytosis. J. Immunol. 159 (1) :409-418, 1997.

PubMed

13) Okamoto, I., Morisaki, T., Sasaki, J. et al.:Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD 44 variant RNAs. J. Natl. Cancer Inst. 90 (4) :307-315, 1998.

13) Palacin, M.:A new family of proteins (rBAT and 4F2 hc) involved in cationic and zwitterionic amino acid transport:a tale of two proteins in search of a transport function. J. Exp. Biol. 196:123-137, 1994.

PubMed

13) Katsuya, T., Koike, G., Yee, T. W. et al.:Association of angiotensinogen gene T 235 variant with increased risk of coronary heart disease. Lancet 345 (8965) :1600-1603, 1995.

13) Liu, W., Ramachandran, V., Kang, J. et al.:Identification of N-terminal residues on P-selectin glycoprotein ligand-1 required for binding to P-selectin. J. Biol. Chem. 273 (12) :7078-7087, 1998.

13) Soderberg, C., Larsson, S., Rozell, B. L. et al.:Cytomegalovirus-induced CD 13-specific autoimmunity-a possible chronic graft-vs-host disease. Transplantation 61 (4) :600-609, 1996.

13) Liu, F., Poursine-Laurent, J., Wu, H. Y. et al.:Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood 90 (7) :2583-2590, 1997.

PubMed

13) Fujisaku, A., Harley, J. B., Frank, M. B. et al.:Genomic organization and polymorphisms of the human C3d/Epstein-virus receptor. J. Biol. Chem. 264 (4) :2118-2125, 1989.

PubMed

13) Namen, A. E., Lupton, S., Hjerrild, K. et al.:Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 333 (6173) :571-573, 1988.

PubMed

13) Tedder, T. F., and Schlossman, S. F.:Phosphorylation of the B 1 (CD 20) molecule by normal and malignant B lymphocytes. J. Biol. Chem. 263 (20) :10009-10015, 1988.

13) Jousset, C., Carron, C., Boureux, A. et al.:A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL PDGFR beta onco-protein. EMBO J. 16 (1) :69-82, 1997.

13) Stepp, M. A., Spurr-Michaud, S., Tisdale, A. et al.:Alpha 6 beta 4 integrin heterodimer is a component of. Proc. Natl. A cad. Sci. USA 87 (22) :8970-8974, 1990.

13) Sauter, S. L., Rutherfurd, S. M., Wagener, C. et al.:Identification of the specific oligosaccharide sites recognized by type 1 fimbriae from Escherichia coli on nonspecific cross-reacting antigen, a CD 66 cluster granulocyte glycoprotein. J. Biol. Chem. 268 (21) :15510-15116, 1993.

13) Norris, C. F., Pricop, L., Millard, S. S. et al.:Anaturally occurring mutation in Fc gamma RIIA:a Q to K127 change confers unique IgG binding properties to the R131 allelic form of the receptor. Blood 91 (2) :656-662, 1998.

13) Romagnani, P., Annunziato, F., Manetti, R. et al.:High CD 30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus. Blood 91 (9) :3323-3332, 1998.

13) Prall, F., Nollau, P., Neumaier, M. et al.:CD 66 a (BGP) , an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues. J. Histochem. Cytochem. 44 (1) :35-41, 1996.

13) Mayford, M., Barzilai, A., Keller, F. et al.:Modulation of an NCAM-related adhesion molecule with long-term plasticity in Aplysia. Science 256 (5057) :638-644, 1992.

PubMed

13) Shimizu, Y., Van Seventer, G. A., Horgan, K. J. et al.:Regulated expression and binding of three VLA (beta 1) integrin receptors on T cells. Nature 345 (6272) :250-253, 1990.

13) Takaki, S., Murata, Y., Kitamura, T. et al.:Reconstitution of the functional receptors for murine and human interleukin 5. J. Exp. Med. 177 (6) :1523-1529, 1993.

PubMed

13) Lin, T., Brunner, T., Tietz, B. et al.:Fas ligand mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft versus host disease. J. Clin. Invest. 101 (3) :570 577, 1998.

13) Kameoka, J., Tanaka, T., Nojima, Y. et al.:Direct association of adenosine deaminase with a T cell activation antigen, CD 26. Science 261 (5120) :466-469, 1993.

13) Oikawa, S., Nakazato, H. and Kosaki, G.:Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence. Biochem. Biophys. Res. Commun. 142 (2) :511-518, 1987.

PubMed

13) Felberg, J. and Johnson, P.:Characterization of Recombinant CD 45 Cytoplasmic Domain Proteins. Evidence for intramolecular and intermolecular interactions. J. Biol. Chem. 273 (28) :17839-17845, 1998.

13) Kokenyesi, R. and Bernfield, M.:Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1. J. Biol. Chem. 269 (16) :12304-12309, 1994.

PubMed

13) Ludwig, A., Petersen, F., Zahn, S. et al.:The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin 8 receptors CXCR-1 and CXCR 2. Blood 90 (11) :4588-4597, 1997.

PubMed

13) Testi, R., Pulcinelli, F., Frati, L. et al.:CD 69 is expressed on platelets and mediates platelet activation and aggregation. J. Exp. Med. 172 (3) :701 707, 1990.

13) Wang, M. H., Ronsin, C., Gesnel, M. C. et al.:Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science 266 (5182) :117-119, 1994.

PubMed

13) D'Souza, S. E., Ginsberg, M. H., Matsueda, G. R. et al.:Adiscrete sequence in a platelet integrin is involved in ligand recognition. Nature 350 (6313) :66-68, 1991.

13) Joyce, S., Woods, A. S., Yewdell, J. W. et al.:Natural ligand of mouse CD1d1:cellular glycosylphos-phatidylinositol. Science 279 (5356) :1541, 1544, 1998.

13) Haziot, A., Tsuberi, B. Z. and, Goyert, S. M.:Neutrophil CD 14:biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J. Immunol. 150 (12) :5556-5565, 1993.

13) Giorda, R., Rudert, W. A., Vavassori, C. et al.:NKR-P 1, a signal transduction molecule on natural killer cells. Science 249 (4974) :1298-1300, 1990.

13) Nober-Trauth, N., Shultz, L. D., Brombacher, F. et al.:An interleukin 4 (IL-4) -independent pathway for CD 4+Tcell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 94 (20) :10838-10843, 1997.

13) Piali, L., Hammel, P., Uherek, C. et al.:CD 31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in. J. Cell Biol. 130 (2) :451-460, 1995.

13) Campbell, K. A., Ovendale, P. J., Kennedy, M. K. et al.:CD 40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4 (3) :283-289, 1996.

13) Sun, Q., Woodcock, J. M., Rapoport, A. et al.:Monoclonal antibody 7 G 3 recognizes the N terminal domain of the human interleukin 3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist. Blood 87 (1) :83-92, 1996.

13) Jesse, T. L., LaChance, R., Iademarco, M. F. et al.:Interferon regulatory factor-2 is a transcriptional activator in muscle where it regulates expression of vascular cell adhesion molecule-1. J. Cell Biol. 140 (5) :1265-1276, 1998.

PubMed

13) Rutledge, E. A., Green, F. A. and Enns, C. A.:Generation of the soluble transferrin receptor requires cycling through an endosomal compartment. J. Biol. Chem. 269 (50) :31864-31868, 1994.

PubMed

13) Von Hoegen, I., Nakayama, E. and Parnes, J. R.:I dentification of a human protein homologous to the mouse Lyb 2 B cell differentiation antigen and sequence of the corresponding cDNA. J. Immunol. 144 (12) :4870 4877, 1990.

13) Miller, L. J., Wiebe, M. and Springer, T. A.:Purification and alpha subunit N-terminal sequences of human Mac-1 p 150, 95 leukocyte adhesion proteins. J. Immunol. 138 (8) :2381-2383, 1987.

13) McEvoy, L. M., Sun, H., Frelinger, J. G. et al.:Anti-CD 43 inhibition of T cell homing. J. Exp. Med. 185 (8) :1493-1498, 1997.

13) Nikaido, T., Shimizu, A., Ishida, N. et al.:Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311 (5987) :631-635, 1984.

PubMed

13) Shimon, I., Yan, X., Ray, D. W. et al.:Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J. Clin. Invest. 100 (2) :357-363, 1997.

PubMed

13) van Lier, R. A., Borst, J., Vroom, T. M. et al.:Tissue distribution and biochemical and functional properties of Tp 55 (CD 27) , a novel T cell differentiation antigen. J. Immunol. 139 (5) :1589-1596, 1987.

13) Hahn, W. C., Menu, E., Bothwell, A. L. et al.:Overlapping but nonidentical binding sites on CD 2 for CD 58 and a second ligand CD 59. Science 256 (5065) :1805-1807, 1992.

14) Puri, K. D., Finger, EB., Gaudernack, G. et al.:Sialomucin CD 34 is the major L-selectin ligand in humantonsil high endothelial venules. J. Cell Biol. 131 (1) :261-270, 1995.

14) Grimaldi, C. M., Chen, F., Wu, C. et al.:Glycoprotein IIb Leu 214 Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GP IIb/IIIa. Blood 91 (5) :1562-1571, 1998.

14) Kuijpers, R. W., Ouwehand, W. H., Bleeker, P. M. et al.:Localization of the platelet-specific IIPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Ib alpha. Blood 79 (1) :283-288, 1992.

14) Liszewski, M. K., Tedja, I. and Atkinson, J. P.:Membrane cofactor protein (CD 46) of complement. Processing related to alternatively spliced cytoplasmic domains. J. Biol. Chem. 269 (14) :10776 10779, 1994.

14) Pourquie, O., Corbel, C., Le Caer, J. P et al.:BEN, a surface glycoprotein of the immunoglobulin super-family, is expressed in a variety of developing systems. Proc. Natl. Acad. Sci USA 89 (12) :5261-5265, 1992.

14) Pallant, A., Eskenazi, A., Mattei, M. G. et al.:Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16. Proc. Natl. Acad. Sci. USA 86 (4) :1328-1332, 1989.

PubMed

14) Greer, S. F., Lin, J., Clarke, C. H. et al.:Major histocompatibility class II-mediated signal transduction is regulated by the protein-tyrosine phosphatase CD 45. J. Biol. Chem. 273 (19) :11970-11979, 1998.

14) Terpe, H. J., Koopmann, R., Imhof, B. A. et al.:Expression of integrins and CD 44 isoforms in non-Hodgkin's lymphomas:CD 44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J. Pathol. 174:89-100, 1994.

14) Mikecz, K., Brennan, F. R., Kim, J. H. et al.:Anti-CD 44 treatment abrogates tissue oedema and leukocyte in murine arthritis. Nat. Med. 1 (6) :558-563, 1995.

14) Jones, E. Y., Harlos, K., Bottomley, M. J. et al.:Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1. 8 A resolution. Nature 373 (6514) :539-544, 1995.

PubMed

14) Liu, C. P., Lin, W. J., Huang, M. et al.:Development and function of T cells in T cell antigen receptor/CD 3 zeta knockout mice reconstituted with Fc epsilon R I gamma. Proc. Natl. Acad. USA 94 (2) :616-621, 1997.

14) Hopken, U. E., Lu, B., Gerard, N. P. et al.:Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 186 (5) :749-756, 1997.

PubMed

14) Ploug, M., Kjalke, M., Ronne, E. et al.:Localization of the disulfide bonds in the NH 2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins. J. Biol. Chem. 268 (23) :17539-17546, 1993.

14) Woynarowska, B., Skrincosky, D. M., Haag, A. et al.:Inhibition of lectin-mediated ovarian tumor cell adhesion by sugar analogs. J. Biol. Chem. 269 (36) :22797-22803, 1994.

PubMed

14) Ryu, S. E., Kwong, PD., Truneh, A. et al.:Crystal structure of an HIV-binding recombinant fragment of human. Nature 348 (6300) :419-426, 1990.

PubMed

14) Cantoni, C., Biassoni, R., Pende, D. et al.:The activating form of CD 94 receptor complex:CD 94 covalently associates with the Kp 39 protein that represents the product of the NKG 2-C gene. Eur J. Immunol. 28 (1) :327-338, 1998.

14) Jeannin, P., Delneste, Y., Lecoanet-Henchoz, S. et al.:CD 86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE-and IgG 4-producing cells. J. Biol. Chem. 272 (25) :15613-15619, 1997.

14) Mannion, B. A., Berditchevski, F., Kraeft, S. K. et al.:Transmembrane 4 superfamily proteins CD 81 (TAPA-1) , CD 82, CD 63. J. Immunol. 157 (5) :2039-2047, 1996.

14) Laytoll, J. E., Iaria, J., Smith, D. K. et al.:Identification of a ligand-binding site on the granulocyte colonystimulating factor receptor by molecular modeling and mutagenesis. J. Biol. Chem. 272 (47) :29735-29741, 1997.

14) Nishimura, Y., Bierer, B. E. and Burakoff, S. J.:Expression of CD 5 regulates responsiveness to IL-1. J. Immunol. 141 (10) :3438 3444, 1988.

14) Yamada, M., Suzu, S., Akaiwa, E. et al.:Properties of primary murine stroma induced by macrophage colony-stimulating factor. J. Cell. Physiol. 173 (1) :1-9, 1997.

PubMed

14) Maecker, H. T. and Levy, S.:Normal lymphocyte development but delayed humoral immune response in CD 81-null mice. J. Exp. Med. 185 (8) :1505-1510, 1997.

14) Swack, J. A., Mier, J. W., Romain, P. L. et al.:Biosynthesis and post-translational modification of CD 6, a T cell signal-transducing molecule. J. Biol. Chem. 266 (11) :7137-7143, 1991.

14) Park, L. S., Martin, U., Sorensen, R. et al.:Cloning of the low-affinity murine granulocyte-macrophage stimulating factor receptor and reconstitution of a high-affinity receptor complex. Proc. Natl. Acad. Sci. USA 89 (10) :4295-4299, 1992.

PubMed

14) Rabinowich, H., Pricop, L., Herberman, R. B. et al.:Expression and function of CD 7 molecule on human natural killer cells. J. Immunol. 152 (2) :517-526, 1994.

14) Nakayama, K., Kawachi, Y., Tokito, S. et al.:Recent duplication of the two human CD 8 beta-chain genes. J. Immunol. 148 (6) :1919-1927, 1992.

14) Ogawa, M., Matsuzaki, Y., Nishikawa, S. et al.:Expression and function of c-kit in hemopoietic progenitor cells. J. Exp. Med. 174 (1) :63-71, 1991.

PubMed

14) Willnow, T. E., Armstrong, S. A., Hammer, R. E. et al.:Functional expression of low density lipoprotein receptor related protein is controlled by receptor-associated protein in vivo. Proc. Natl. Acad. Sci. USA 92 (10) :4537-4541, 1995.

PubMed

14) Nakamura, K., Iwamoto, R. and Mekada, E.:Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) diphtheria toxin receptor-associated protein (DRAP 27) /CD 9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J. Cell. Biol. 129 (6) :1691-1705, 1995.

14) Inobe, M., Linsley, P. S., Ledbetter, J. A. et al.:Identification of an alternatively spliced form of the murine homologue of B7. Biochem. Biphys. Res. Commun. 200 (1) :443-449, 1994.

14) Kaplan, D. H., Greenlund, A. C., Tanner, J. W. et al.:Identification of an interferon-gamma receptor alpha chain sequence required for JAK-1 binding. J. Biol. Chem. 271 (1) :9-12, 1996.

14) Shipp, M. A., Richardson, N. E., Sayre, P. H. et J.:Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. Proc. Natl. Acad. Sci. USA 85 (13) :4819-4823, 1988.

14) Nakamura, T., Kubagawa, H. and Cooper, M. D.:Heterogeneity of immunoglobulin-associated molecules on human B cells identified by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 89 (18) :8522-8526, 1992.

14) Kelliher, M. A., Grimm, S., Ishida, Y. et al.:The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8 (3) :297-303, 1998.

PubMed

14) Lee, J. O., Bankston, L. A., Arnaout, M. A. et al.:Two conformations of the integrin A-domain (I-domain) :a pathway for activation? Structure 3 (12) :1333-1340, 1995.

14) Wiels, J., Fellous, M. and Tursz, T.:Monoclonal antibody against a Burkitt lymphoma-associated antigen. Proc. Natl. Acad. Sci. USA. 78 (10) :6485-6488, 1981.

PubMed

14) Martin, M., Bol, G. F., Eriksson, A. et al.:Interleukin-1-induced activation of a protein kinase coprecipitating with the type I interleukin-1 receptor in T cells. Eur. J. Immunol. 24 (7) :1566-1571, 1994.

14) Lee, J. O., Bankston, L. A., Arnaout, M. A. et al.:Two conformations of the integrin A-domain (I-domain) :a pathway for activation? Structure 3 (12) :1333-1340, 1995.

14) Rebmann, V., Dornmair, K. and Grosse-Wilde, H.:Biochemical analysis of plasma-soluble invariant chains and their complex formation with soluble HLA-DR. Tissue Antigens 49 (5) :438-442, 1997.

PubMed

14) Sims, J. E., Gayle, M. A., Slack, J. L. et al.:Interleukin l signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90 (13) :6155-6159, 1993.

14) Salazar-Gonzalez, J. F., Moody, D. J., Giorgi, J. V. et al.:Reduced ecto-5'-nucleotidase activity and enhanced OKT 10 and HLA-DR immune deficiency syndrome:evidence of CD 8 cell immaturity. J. Immunol. 135 (3) :1778-1785, 1985.

14) Von Hoegen, I., Hsieh, C. L., Scharting, R. et al.:Identity of human Lyb 2 and CD72 and localization of the gene to chromosome 9. Eur. J. Immunol. 21 (6) :1425 1431, 1991.

14) Sharon, M., Klausner, R. D., Cullen, B. R. et al.:Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science 234 (4778) :859-863, 1986.

PubMed

14) Sadhu, C., Masinovsky, B. and Staunton, D. E.:Differential regulation of chemoattractant-stimulated beta 2, beta 3, and beta 7 integrin activity. J. Immunol. 160 (11) :5622-5628, 1998.

PubMed

14) Myones, B. L., Dalzell, J. G., Hogg, N. et al.:Neutrophil and monocyte cell surface p 150, 95 has iC 3 b-receptor (CR 4) activity resembling CR 3. J. Clin. Invest. 82 (2) :640-651, 1988.

14) Salmon, D., Geuskens, M., Hanocq, F. et al.:A novel heterodimeric transferrin receptor encoded by a pair of VSG expression site-associated genes in T. brucei. Cell 78 (1) :75-86, 1994.

14) Woodcock, J. M., Bagley, C. J., Zacharakis, B. et al.:A single tyrosine residue in the membrane-proximal domain of the granulocyte macrophage colony stimulating factor, interleukin (IL) 3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands. J. Biol. Chem. 271 (42) :25999 26006, 1996.

14) Vance, B. A., Wu, W., Ribaudo, R. K. et al.:Multiple dimeric forms of human CD69 result from differential addition of N-glycans to typical (Asn X Ser/Thr) and a typical (Asn-X cys) glycosylation motifs. J. Biol. Chem. 272 (37) :23117 23122, 1997.

14) Russell, S. M., Keegan, A. D., Harada, N. et al.:Interleukin-2 receptor gamma chain:a functional component of the interleukin-4 receptor. Science 262 (5141) :1880-1883, 1993.

PubMed

14) Oikawa, S., Inuzuka, C., Kuroki, M. et al.:Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface:homophilic and heterophilic adhesion. Biochem. Biophys. Res. Commun. 164 (1) :39-45, 1989.

14) Tavernier, J., Devos, R., Cornelis, S. et al.:A human high affinity interleukin-5 receptor (IL5R) is composed of an IL 5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66 (6) :1175-1184, 1991.

14) Skubitz, K. M., Campbell, K. D., Ahmed, K. et al.:CD 66 family members are associated with tyrosine kinase activity in human neutrophils. J. Immunol. 155 (11) :5382-5390, 1995.

14) Martin. D. A., Siegel, R. M., Zheng, L. et al.:Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha 1) death signal. J. Biol. Chem. 273 (8) :4345 4349, 1998.

14) Mackiewicz, A., Schooltink, H., Heinrich, P. C. et al.:Complex of soluble human IL-6-receptor/IL-6 upregulates expression of acute-phase proteins. J. Immunol. 149 (6) :2021-2027, 1992.

PubMed

14) Watt, V. M. and Yip, C. C.:Amino acid sequence deduced from a rat kidney cDNA suggests it the Znpeptidase aminopeptidase N. J. Biol. Chem. 264 (10) :5480-5487, 1989.

PubMed

14) Yamanka, T., Kuroki, M., Matsuo, Y. et al.:Analysis of heterophilic cell adhesion mediated by CD 66 b and CD 66 c using their soluble recombinant proteirls. Biochem. Biophys. Res. Commun. 219 (3) :842-847, 1996.

14) Noguchi, M., Nakamura, Y., Russell, S. M. et al.:Interleukin-2 receptor gamma chain:a functionalcomponent of the interleukin-7 receptor. Science 262 (5141) :1877-1880, 1993.

14) Skubitz, K. M., Campbell, K. D., Ahmed, K. et al.:CD66 family members are associated with tyrosine kinase activity in human neutrophils. J. Immunol. 155 (11) :5382-5390, 1995.

PubMed

14) Morohashi, H., Miyawaki, T., Nomura, H et al.:Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J. Leukoc. Biol. 57 (1) :180-187, 1995.

PubMed

14) Haziot, A., Lin, X. Y., Zhang, F. et al.:The induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD 14-independent. J. Immunol. 160 (6) :2570-2572, 1998.

14) Stahl, N., Boulton, T. G., Farruggella, T. et al.:Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 receptor components. Science 263 (5143) :92-95, 1994.

PubMed

14) Jullien, D., Stenger, S., Ernst, W. A. et al.:CD 1 presentation of microbial nonpeptide antigens to T cells. J. Clin. Invest. 99 (9) :2071-2074, 1997.

14) Picker, L. J., Treer, J. R., Ferguson-Darnell, B. et al.:Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition. J. Immunol. 150 (3) :1105-1121, 1993.

14) Olweus, J., Terstappen, L. W., Thompson, P. A. et al.:Expression and function of receptors for stem cell factor and erythropoietin during lineage commitment of human hematopoietic progenitor cells. Blood 88 (5) :1594-1607, 1996.

PubMed

14) Quelle, F. W., Sato, N., Witthuhn, B. A. et al.:JAK 2 associates with the beta c chain of the receptor for granulocyte macrophage colony stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14 (7) :4335-4341, 1994.

14) Simmons, D. and Seed, B.:The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein. Nature 333 (6173) :568-570, 1988.

PubMed

14) Nakajima, H. and Leonard, W. J.:Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain:defective Fas ligand expression in gamma-chain-deficient mice. J. Immunol. 159 (10) :4737-4744, 1997.

PubMed

14) Petruzzelli, L., Maduzia, L. and Springer, T. A.:Activation of lymphocyte function-associated molecule-1 (CD 11 a/CD 18) and Mac-1 (CD 11b/CD 18) mimicked by an antibody directed against. J. Immunol. 155 (2) :854-866, 1995.

14) Fujimoto, T., Stroud, E., Whatley, R. E. et al.:P-selectin is acylated with palmitic acid and stearic acid at cysteine 766 through a thioester linkage. J. Biol. Chem. 268 (15) :11394-11400, 1993.

PubMed

14) Rothermel, A. L. and Altieri, D. C.:High affinity cross-reacting mAb generated by minimal mimicry:implications for the pathogenesis of anti-nuclear autoantibodies and immunosuppression. Proc. Natl. Acad. Sci. USA 95 (7) :3816-3820, 1998.

PubMed

14) Mallett, S., Fossum, S. and Barclay, A. N.:Characterization of the MRC OX 40 antigen of activated CD 4 positive T lymphocytes a molecule related to nerve growth factor receptor. EMBO J. 9 (4) :1063 1068, 1990.

14) Sato, S., Steeber, D. A. and Tedder, T. F.:The CD 19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 92 (25) :11558-11562, 1995.

14) Seki, T., Chang, H. C., Moriuchi, T. et al.:A hydrophobic transmembrane segment at the carboxyl terminus of thy-1. Science 227 (4687) :649-651, 1985.

PubMed

14) Rappold, I., Ziegler, B. L., Kohler, I. et al.:Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT 3 (CD 135) receptor tyrosine kinase. Blood 90 (1) :111-125, 1997.

14) Ord, D. C., Ernst, T. J., Zhou, L. J. et al.:Structure of the gene encoding the human leukocyte adhesion molecule 1 (TQ 1, Leu-8) of lymphocytes and neutrophils. J. Biol. Chem. 265 (14) :7760-7767, 1990.

14) Wang, M. H., Yoshimura, T., Skeel, A. et al.:Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade. J. Biol. Chem. 269 (5) :3436-3440, 1994.

PubMed

14) Koenig, A., Norgard-Sumnicht, K., Linhardt, R. et al.:Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J. Clin. Invest. 101 (4) :877-889, 1998.

PubMed

14) Michel, J., Fritsche, J., Kreutz, M. et al.:CD 137 (ILA/4-1 BB) , a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol. 160 (5) :2488-2494, 1998.

14) Tedder, T. F., Streuli, M., Schlossman, S. F. et al.:Isolation and structure of a cDNA encoding the B 1 (CD 20) cell-surface antigen of human B lymphocytes. Proc. Natl. Acad. Sci. USA 85:208, 1988.

14) Gasque, P., Chan, P., Mauger, C. et al.:Identification and characterization of complement C 3 receptors on astrocytes. J. Immunol. 156 (6) :2247-2255, 1996.

PubMed

14) Larrain, J., Cizmeci-Smith, G., Troncoso, V. et al.:Syndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid. J. Biol. Chem. 272 (29) :18418-18424, 1997.

PubMed

14) Naitoh, Y.:Amino acid sequence of a novel integrin beta 4 subunit and primary expression of the mRNA in epithelial cells. EMBO J. 9 (3) :757-763, 1990.

PubMed

14) Lanza, F., Stierle, A., Fournier, D. et al.:A new variant of Glanzmalm's thrombasthenia (Strasbourg I) . Platelets with functionally defective glycoprotein IIb IIIa complexes and a glycoprotein IIIa 214 Arg-214 Trp mutation. J. Clin. Invest. 89 (6) :1995 2004, 1992.

14) Nitschke, L., Carsetti, R., Ocker, B. et al.:CD 22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7 (2) :133-143, 1997.

14) Kelly, J. D., Haldeman, B. A., Grant, F. J. et al.:Platelet derived growth factor (PDGF) stimulates PDGF receptor subunit. J. Biol. Chem. 266:8987-8992, 1991.

PubMed

14) Ikuta, K., Takami, M., Kim, C. W. et al.:Human lymphocyte Fc receptor for IgE :sequence homology of its cloned cDNA with animal lectins. Proc. Natl. Acad. Sci. USA 84 (3) :819-823, 1987.

PubMed

14) Kroshus, T. J., Bolman, R. M. III, Dalmasso, A. P. et al.:Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 61 (10) :1513-1521, 1996.

14) Teasdale, M. S., Bird, C. H. and Bird, P.:Internalization of the anticoagulant thrombomodulin is constitutive does not require a signal in the cytoplasmic domain. Immunol. Cell Biol. 72 (6) :480-488, 1994.

14) Wallich, R., Bremer, C., Brand, Y. et al.:Gene structure, promoter characterization, and basis for alternative mRNA splicing of the human CD 58 gene. J. Immunol. 160 (6) :2862-2871, 1998.

14) Liu, Y., Jones, B., Aruffo, A. et al.:Heat-stable antigen is a costimulatory molecule for CD 4 T cell growth. J. Exp. Med. 175 (2) :437-445, 1992.

14) Morrissey, J. H., Fair, D. S. and Edgington, T. S.:Monoclonal antibody analysis of purified and cell associated tissue factor. Thromb. Res. 52 (3) :247 261, 1988.

14) Serdobova, I., Pla, M., Reichenbach, P. et al.:Elf-1 contributes to the function of the complex interleukin (IL) -2-responsive enhancer in the mouse IL-2 receptor alpha gene. J. Exp. Med. 185 (7) :1211-1221, 1997.

14) Muller, D., Wang, C., Skibo, G. et al.:PSA-NCAM is required for activity-induced synaptic plasticity. Neuron 17 (3) :413-422, 1996.

PubMed

14) Krege, J. H., John, S. W., Langenbach, L. L. et al.:Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375 (6527) :146-148, 1995.

PubMed

14) Loster, K., Zeilinger, K., Schuppan, D. et al.:The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochem. Biophys. Res. Commun. 217 (1) :341-348, 1995.

PubMed

14) Matsumoto, M., Takeda, J., Inoue, N. et al.:A novel protein that participates in nonself discrimination of malignant cells by homologous complement. Nat. Med. 3 (11) :1266 1270, 1997.

14) Tanihara, H., Kido, M., Obata, S. et al.:Characterization of cadherin 4 and cadherin 5 reveals new aspects of cadherins. J. Cell Sci. 107 (Pt 6) :1697 1704, 1994.

14) Porcu, P., Gaddy, J. and Broxmeyer, H. E.:Alloantigen-induced unresponsiveness in cord blood T lymphocytes is associated with defective activation of Ras. Proc. Natl. Acad. Sci. USA 95 (8) :4538-4543, 1998.

PubMed

14) Rowin, M. E., Whatley, R. E., Yednock, T. et al.:Intracellular calcium requirements for beta 1 integrin activation. J. Cell. Physiol. 175 (2) :193 202, 1998.

14) Gonzalo, J. A., St. Pierre, Y., Williams, I. R. et al.:Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. 180 (1) :95-109, 1994.

PubMed

14) Kuno, N., Kadomatsu, K., Fan, Q. W. et al.:Female sterility in mice lacking the basigin gene, which encodes atransmembrane glycoprotein belonging to the immunoglobulin superfamily. FEBS Lett. 425 (2) :191-194, 1998.

14) Valentin, H., Gelin, C., Coulombel, L., et al.:The distribution of the CDW 52 molecule on blood cells and characterization of its involvement in T cell activation. Transplantation 54 (1) :97-104, 1992.

14) Horie, R., Ito, K., Tatewaki, M. et al.:A variant CD 30 protein lacking extracellular and transmembrane is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages. Blood 88 (7) :2422-2432, 1996.

14) Hendey, B., Lawson, M., Marcantonio, E. E. et al.:Intracellular calcium and calcineurin regulate neutrophil motility on vitronectin through a receptor identified by antibodies to integrins alphav and beta 3. Blood 87 (5) :2038-2048, 1996.

14) Pino-Otin, M. R., Vina, O., de la Fuente, M. A. et al.:Existence of a soluble form of CD 50 (intercellular adhesion molecule. produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of systemic lupus erythematosus patiellts. J. Immunol. 154 (6) :3015-3024, 1995.

14) Quackenbush, E., Clabby, M., Gottesdiener, K. M. et al.:Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen:a type II membrane glycoprotein. Proc. Natl. Acad. Sci. USA 84 (18) :6526 6530, 1987.

14) Leach, D. R., Krummel, M. F. and Allison, J. P.:Enhancement of antitumor immunity by CTLA 4 blockade. Science 271 (5256) :1734-1736, 1996.

PubMed

14) Simmons, D. L., Walker, C., Power, C. et al.:Molecular cloning of CD 31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J. Exp. Med. 171 (6) :2147-2152, 1990.

14) Qiu, W. Q., de Bruin, D., Brownstein, B. H. et al.:Organization of the human and mouse low-affinity Fc gamma R genes:duplication and recombination. Science 248 (4956) :732-735, 1990.

PubMed

14) Tamura, R. N., Rozzo, C., Starr, L. et al.:Epithelial integrin alpha 6 beta 4:complete primary structure of alpha 6 and variant forms of beta 4. J. Cell Biol. 111 (4) :1593-1604, 1990.

PubMed

14) Hsu, H. C., Zhou, T., Yang, P. A. et al.:Increased acute-phase response and renal amyloidosis in aged CD 2-fas-transgenic mice. J. Immunol. 158 (12) :5988-5996, 1997.

14) Smith, C. A., Gruss, HJ., Davis, T. et al.:CD 30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73 (7) :1349-1360, 1993.

14) Sosnoski, D. M., Emanuel, B. S., Hawkins, A. L. et al.:Chromosomal localization of the genes for the vitronectin and fibronectin receptors alpha subunits and for platelet glycoproteins IIb and IIIa. J. Clin. Invest. 81 (6) :1993-1998, 1988.

PubMed

14) Cantwell, M., Hua, T., Pappas, J. et al.:Acquired CD 40-ligand deficiency in chronic lymphocytic leukemia. Nat. Med. 3 (9) :984-989, 1997.

14) Sansom, D., Borrow, J., Solomon, E. et al.:The human ICAM 2 gene maps to 17q23-25. Genomics 11 (2) :462 464, 1991.

14) Morton, H. C., Schiel, A. E., Janssen, S. W. et al.:Alternatively spliced forms of the human myeloid Fc alpha receptor (CD 89) in neutrophils. Immunogenetics 43 (4) :246-247, 1996.

14) Nickells, M. W., Moulds, J. J., Brown, M. C. et al.:The C 3 b/C 4 b receptor is recognized by the Knops, McCoy, Swain-and York blood group antisera. J. Exp. Med. 173 (5) :1159-1163, 1991.

14) Morrison, M. E., He, Y. J., Wien, M. W. et al.:Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J. Virol. 68 (4) :2578-2588, 1994.

PubMed

14) Maguire, J. E., Danahey, K. M., Burkly, L. C. et al.:T cell receptor-and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells. J. Exp. Med. 182 (6) :2079-2090, 1995.

14) Takada, Y., Murphy, E., Pil, P. et al.:Molecular cloning and expression of the cDNA for alpha 3 subunit of human alpha 3 beta 1 (VLA-3) , an integrin receptor for fibronectin, laminin, and collagen. J. Cell Biol. 115 (1) :257-266, 1991.

PubMed

14) Nozaki, S., Kashiwagi, H., Yamashita, S. et al.:Reduced uptake of oxidized low density lipoproteins in monocyte-macrophages from CD 36-deficient subjects. J. Clin. Invest. 96 (4) :1859-1865, 1995.

14) Schiro, J. A., Chan, B. M., Roswit, W. T. et al.:Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and of collagen matrices by human cells. Cell 67 (2) :403-410, 1991.

PubMed

14) Rubio, M. A., Sotillos, M., Jochems, G. et al.:Monocyte activation:rapid induction of alpha 1/beta 1 (VLA-1) integrin. Eur. Immunol. 25 (9) :2701-2705, 1995.

PubMed

14) Mandelboim, O., Pazmany, L., Davis, D. M. et al.:Multiple receptors for HLA-G on human natural killer cells. Proc. Natl. Acad. Sci. USA 94 (26) :14666-14670, 1997.

PubMed

14) Staunton, D. E. and Thorley Lawson, D. A.:Molecular cloning of the lymphocyte activation marker Blast-1. EMBO J. 6 (12) :3695 3701, 1987.

14) States, D. J., Walseth, T. F. and Lee, H. C.:Similarities in amino acid sequences of Aplysia ADP-ribosyl cyclase human lymphocyte antigen CD 38. Trends Biochem. Sci. 17 (12) :495, 1992.

14) Giorda, R., Weisberg, E. P., Ip, T. K. et al.:Genomic structure and strain specific expression of the natural killer cell receptor NKR-P1. J. Immunol. 149 (6) :1957-1963, 1992.

PubMed

14) Reinhold, M. I., Lindberg, F. P., Plas, D. et al.:In vivo expression of alternatively spliced forms of integrin-associated protein (CD 47) . J. Cell Sci. 108 (Pt 11) :3419-3425, 1995.

14) Kilger, E., Kieser, A., Baumann, M. et al.:Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD 40 receptor. EMBO J. 17 (6) :1700-1709, 1998.

14) Mehta, P., Patel, K. D., Laue, T. M. et al.:Soluble monomeric P-selectin containing only the lectin and epidermal growth factor domains binds to P-selectin glycoprotein ligand-1 on leukocytes. Blood 90 (6) :2381-2389, 1997.

15) Kornbluth, R. S., Kee, K. and Richman, D. D.:CD 40 ligand (CD 154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc. Natl. A cad. Sci. USA 95 (9) :5205-5210, 1998.

15) Wang, M. H., Skeel, A. and Leonard, E. J.:Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J. Clin. Invest. 97 (3) :720-727, 1996.

PubMed

15) Rosnet, O., Schiff, C., Pebusque, M. J. et al.:Human FLT 3/FLK 2 gene:cDNA cloning and expression in hematopoietic cells. Blood 82 (4) :1110-1119, 1993.

15) Salminen, H., Ahokas, K., Niemela, R. et al.:Improved enzymatic synthesis of a highly potent oligosaccharide antagonist of L-selectin. FEBS Lett. 419 (2-3) :220-226, 1997.

15) Xia, M. Q., Tone, M., Packman, L. et al.:Characterization of the CAMPATH-1 (CDw 52) antigen:biochemical and cDNA cloning reveal an unusually small peptide backbone. Eur. J. Immunol. 21 (7) :1677-1684, 1991.

15) Sato, S., Ono, N., Steeber, D. A. et al.:CD 19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157 (10) :4371-4378, 1996.

15) Tiveron, M. C., Barboni, E., Pliego, Rivero, F. B. et al.:Selective inhibition of neurite outgrowth on mature astrocytes by Thy-1 glycoprotein. Nature 355 (6362) :745-748, 1992.

PubMed

15) Miyake, K., Underhill, C. B., Lesley, J. et al.:Hyaluronate can function as a cell adhesion molecule and CD 44 participates in hyaluronate recognition. J. Exp. Med. 172 (1) :69-75, 1990.

15) Miura, S., Ohtani, K., Numata, N. et al.:Molecular cloning and characterization of a novel glycoprotein, gp 34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40 tax. Mol. Cell. Biol. 11 (3) :1313-1325, 1991.

15) Sharma, C. P., Ezzell, R. M. and Arnaout, M. A.:Direct interaction of filamin (ABP-280) with the beta 2-integrin subunit CD 18. J. Immunol. 154 (7) :3461-3470, 1995.

15) Ishiwata, N., Takio, K., Katayama, M. et al.:Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J. Biol. Chem. 269 (38) :23708-23715, 1994.

PubMed

15) Lam, S. C., Plow, E. F., D'Souza, S. E. et al.:Isolation and characterization of a platelet membrane protein related to the vitronectin receptor. J. Biol. Chem. 264 (7) :3742-3749, 1989.

15) Nielsen, O. H., Kirman, I., Johnson, K. et al.:The circulating common gamma chain (CD 132) in inflammatory bowel disease. Am. J. Gastroenterol. 93 (3) :323-328, 1998.

15) Sandrin, M. S., Vaughan, H. A., Henning, M. M. et al.:Expression cloning of cDNA clones encoding the human cell surface proteins HuLy-m 6 and FMC 29. Immunogenetics 35 (4) :283-285, 1992.

15) Lee, S. Y., Park, C. G. and Choi, Y.:T cell receptor-dependent cell death of T cell hybridomas mediated by the CD 30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183 (2) :669-674, 1996.

15) Warren, A. P., Patel, K., McConkey, D. J. et al.:CD 98:a type II transmembrane glycoprotein expressed from the beginning of primitie and definitive hematopoiesis may play a critical role in the development of hematopoietic cells. Blood 87 (9) :3676 3687, 1996.

15) Takai, T., Li, M., Sylvestre, D. et al.:FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76 (3) :519-529, 1994.

PubMed

15) Sadhu, C., Lipsky, B., Erickson, H. P. et al.:LFA-1 binding site in ICAM 3 contains a cong. erved motif and non-contiguous amino acids. Cells Adhes. Coomun. 2 (5) :429440, 1994.

15) Park, J. K., Hahn, W. C., Rosen, F. S. et al.:Enhancement of T-cell activation by the CD 43 molecule whose expression is defective in Wiskott-Aldrich syndrome. Nature 354 (6350) :233-235, 1991.

15) Sawada, M., Takada, A., Ohwaki, I. et al.:Specific expression of a complex sialyl Lewis X antigen on high endothelial venules of human lymph nodes:possible candidate for L-selectin ligand. Biochem. Biophys. Res. Commun. 193 (1) :337-347, 1993.

PubMed

15) Kawano, T., Cui, J., Koezuka, Y. et al.:CD I d-restricted and TCR-mediated activation of valpha 14 NKT cells by glycosylceramides. Science 278 (5343) :1626-1629, 1997.

15) Sakamaki, K., Miyajima, I., Kitamura, T. et al.:ritical cytoplasmic domains of the common beta subunit of CSF, IL 3 and IL 5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J. 11 (10) :3541 3549, 1992.

15) Gumperz, J. E. and Parham, P.:The enigma of the natural killer cell. Nature 378 (6554) :245-248, 1995.

PubMed

15) Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R. et al.:Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science 257 (5071) :789 792, 1992.

15) Stahl, N., Farruggella, T. J., Boulton, T. G. et al.:Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267 (5202) :1349-1353, 1995.

PubMed

15) Osman, N., Kozak, C. A., McKenzie, I. F. et al.:Structure and mapping of the gene encoding mouse high affinity Fc gamma RI and chromosomal location of the human Fc gamma RI gene. J. Immunol. 148 (5) :1570-1575, 1992.

15) Stockinger, H., Gadd, S. J., Eher, R. et al.:Molecular characterization and functional analysis of the leukocyte surface protein CD 31. J. Immunol. 145 (11) :3889-3897, 1990.

15) Labeta, M. O., Durieux, J. J., Fernandez, N. et al.:Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD 14. Eur. J. Immunol. 23 (9) :2144-2151, 1993.

15) Sabroe, I., Williams, T. J., Hebert, C. A. et al.:Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J. Immunol. 158 (3) :1361-1369, 1997.

PubMed

15) Skubitz, K. M., Campbell, K. D. and Skubitz, A. P.:CD 66 a, CD66 b, CD 66 c, and CD 66 d each independently stimulate neutrophils. J. Leukoc. Biol. 60 (1) :106 117, 1996.

15) Patry, C., Sibille, Y., Lehuen, A. et al.:Identification of Fc alpha receptor (CD 89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J. Immunol. 156 (11) :4442-4448, 1996.

15) Tamura, R. N., Cooper, H. M., Collo, G. et al.:Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains. Proc. Natl. Acad. Sci. USA 88 (22) :10183-10187, 1991.

PubMed

15) Tohgo, A., Takasawa, S., Noguchi, N. et al.:Essential cysteine residues for cyclic ADP-ribose synthesis and hydrolysis by CD 38. J. Biol. Chem. 269 (46) :28555-28557, 1994.

15) Peschon, J. J., Morrissey, P. J., Grabstein, K. H. et al.:Early lymphocyte expansion is severely impaired ininterleukin 7 receptor-deficient mice. J. Exp. Med. 180 (5) :1955-1960, 1994.

15) Newton, K., Harris, A. W., Bath, M. L. et al.:A dominant interfering mutant of FADD/MORT 1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17 (3) :706 718, 1998.

15) Yu, Q. and Toole, B. P.:A new alternatively spliced exon between v 9 and v 10 provides a molecular basis for synthesis of soluble CD 44. J. Biol. Chem. 271:20603-20607, 1996.

15) Weber, M., Uguccioni, M., Baggiolini, M. et al.:Deletion of the NH 2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J. Exp. Med. 183 (2) :681-685, 1996.

15) Modur, V., Li, Y., Zimmerman, G. A. et al.:Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J. Clin. Invest. 100 (11) :2752-2756, 1997.

PubMed

15) Skubitz, K. M., Campbell, K. D. and Skubitz, A. P.:CD 66 a, CD 66 b, CD 66 c, and CD 66 d each independently stimulate neutrophils. J. Leukoc. Biol. 60 (1) :106-117, 1996.

15) Johnson, P., Ostergaard, H. L., Wasden, C. et al.:Mutational analysis of CD 45. A leukocyte-specific protein tyrosine phosphatase. J. Biol. Chem. 267 (12) :8035-8041, 1992.

15) Wiley, S. R., Goodwin, R. G. and Smith, C. A.:Reverse signaling via CD 30 ligand. J. Immunol. 157 (8) :3635-3639, 1996.

15) Sugahara, H., Kanakura, Y., Furitsu, T. et al.:Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J. Exp. J. Med. 179 (6) :1757-1766, 1994.

15) Tavernier, J., Tuypens, T., Plaetinck, G. et al.:Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. Proc. Natl. Acad. Sci. USA 89 (15) :7041-7045, 1992.

PubMed

15) Stuart, S. G., Simister, N. E., Clarkson, S. B. et al.:Human IgG Fc receptor (hFcRII;CD 32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium. EMBO J. 8 (12) :3657-3666, 1989.

15) Noti, J. D., Reinemann, B. C. and Petrus, M. N.:Sp 1 binds two sites in the CD 11c promoter in vivo specifically in myeloid cells and cooperates with AP 1 to activate transcription. Mol. Cell. Biol. 16 (6) :2940-2950, 1996.

15) Sarnacki, S., Begue, B., Buc, H. et al.:Enhancement of CD 3-induced activation of human intestinal intraepithelial lymphocytes by stimulation of the beta 7-containing integrin defined by HML-1 monoclonal antibody. Eur. J. Immunol. 22 (11) :2887-2892, 1992.

15) Schnarr, B., Ezernieks, J., Sebald, W. et al.:IL-4 receptor complexes containing or lacking the gamma C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins. Int. Immunol. 9 (6) :861-868, 1997.

PubMed

15) Ziegler, S. F., Ramsdell, F., Hjerrild, K. A. et al.:Molecular characterization of the early activation antigen CD69:a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur. J. Immunol. 23 (7) :1643-1648, 1993.

PubMed

15) Dullforce, P., Sutton, D. C. and Heath, A. W.:Enhancement of T cell independent immune responses in vivo by CD 40 antibodies. Nat. Med. 4 (1) :88 91, 1998.

15) Skonier, J. E., Bowen, M. A., Emswiler, J. et al.:Recognition of diverse proteins by members of the immunoglobulin superfamily:delineation of the receptor binding site in the human CD 6 ligand ALCAM. Biochemistry 35 (38) :12287-12291, 1996.

15) Schneider, C., Owen, M. J., Banville, D. et al.:Primary structure of human transferrin receptor deduced from the sequence. Nature 311:675-678, 1984.

PubMed

15) Suminami, Y., Kashii, Y., Law, J. C. et al.:Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells. Oncogene 16 (10) :1309-1317, 1998.

PubMed

15) Ying, H., Chang, J. F. and Pames, J. R.:PU. 1/Spi 1 is es sential for the B cell-specific activity of the mouse CD72 promoter. J. Immunol. 160 (5) :2287 2296, 1998.

15) Strohmeier, G. R., Lencer, W. J., Patapoff, T. W. et al.:Surface expression, polarization, and functional significance of CD 73 in human intestinal epithelia. J. Clin. Invest. 99 (11) :2588-2601, 1997.

15) Ryncarz, R. E. and Anasetti, C.:Expression of CD 860n human marrow CD 34 (+) cells identifies immunocompetent committed precursors of macrophages and dendritic cells. Blood 91 (10) :3892-3900, 1998.

15) Sims, J. E., Painter, S. L. and Gow, I. R.:Genomic organization of the type I and type II IL-1 receptors. Cytokine 7 (6) :483-490, 1995.

PubMed

15) Roche, P. A. and Cresswell, P.:Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345 (6276) :615-618, 1990.

PubMed

15) Reinhold, M. I., Lindberg, F. P., Kersh, G. J. et al.:Costimulation of T cell activation by integrin-associated protein (CD 47) is an adhesion-dependent, CD 28-independent signaling pathway. J. Exp. Med. 185 (1) :1-11, 1997.

15) Quigg, R. J. and Holers, V. M.:Characterization of rat complement receptors and regulatory proteins. CR 2and Crry are conserved, and the C 3 b receptor of neutrophils and platelets is distinct from CR 1. J. Immunol. 155 (3) :1481-1488, 1995.

15) Lee, J. O., Rieu, P., Arnaout, M. A. et al.:Crystal structure of the A domain from the alpha subunit ofintegrin CR 3 (CD 11b/CD 18) . Cell 80 (4) :631-638, 1995.

15) Staunton, D. E., Dustin, M. L. and Springer, T. A.:Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM 1. Nature 339 (6219) :6164, 1989.

15) Schreuder, H., Tardif, C., Trump-Kallmeyer, S. et al.:A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386 (6621) :194-200, 1997.

PubMed

15) Qu, A. and Leahy, D. J.:Crystal structure of the I-domain from the CD 11 a/CD 18 (LFA-1, alpha beta 2) integrin. Proc. Natl. Acad. Sci. USA 92 (22) :10277-10281, 1995.

15) Taffs, R. E., Chernokhvostova, Y. V., Dragunsky, E. M. et al.:Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge. J. Infect. Dis. 175 (2) :441-444, 1997.

PubMed

15) Lewis, M., Tartaglia, L. A., Lee, A. et al.:Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88 (7) :2830-2834, 1991.

PubMed

15) Masumoto, A., Hemler, M. E.:Mutation of putative divalent cation sites in the alpha 4 subunit of the integrin VLA-4:distinct effects on adhesion to CS1/fibronectin, VCAM-1, and invasin. J. Cell Biol. 123 (1) :245-253, 1993.

PubMed

15) Lublin, D. M., Liszewski, M. K., Post, T. W. et al.:Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP) . Evidence for inclusion in the multigene family of complement-regulatory proteins. J. Exp. Med. 168 (1) :181-194, 1988.

PubMed

15) Omori, S. A. and Wall, R.:Multiple motifs regulate the B-cell-specific promoter of the B 29 gene. Proc. Natl. Acad. Sci. USA 90 (24) :11723-11727, 1993.

15) Carretero, M., Cantoni, C., Bellon, T. et al.:The CD 94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27 (2) :563-567, 1997.

15) Siva, N., Stein, H. and Reinherz, E. L.:The distribution of CD 10 (NEP 24. 11, CALLA) in humans and mice is similar in non lymphoid organs but differs within the hematopoietic system:absence on murine T and B lymphoid progenitors. Eur. J. Immunol. 25 (3) :677-687, 1995.

15) Kotenko, S. V., Izotova, L. S., Pollack, B. P. et al.:Other kinases can substitute for Jak 2 in signal transduction by interferon-gamma. J. Biol. Chem. 271 (29) :17174-17182, 1996.

PubMed

15) Khoruts, A., Mondino, A., Pape, K. A. et J.:A natural immunological adjuvant enhances T cell clonal expansion through a CD28 dependent, interleukin (IL) 2-independent mechanism. J. Exp. Med. 187 (2) :225-236, 1998.

15) Tamura, R. N., Cooper, H. M., Collo, G. et al.:Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains. Proc. Natl. Acad. Sci. USA 88 (22) :10183-10187, 1991.

PubMed

15) Oritani, K., Wu, X., Medina, K. et al.:Antibody ligation of CD 9 modifies production of myeloid cells in long-term cultures. Blood 87 (6) :2252-2261, 1996.

15) Nakayama, K., Nakayama, K., Negishi, I. et al.:Requirement for CD 8 beta chain in positive selection of CD 8-lineage T cells. Science 263 (5150) :1131-1133, 1994.

15) Paulson, R. F., Vesely, S., Siminovitch, K. A. et al.:Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp 1. Nat. Genet. 13 (3) :309-315, 1996.

15) Schanberg, LE., Fleenor, D. E., Kurtzberg, J. et al.:Isolation and characterization of the genomic human CD 7 gene:structural similarity with the murine Thy-1 gene. Proc. Natl. Acad. Sci. USA 88 (2) :603-607, 1991.

15) Staatz, W. D., Fok, K. F., Zutter, M. M. et al.:Identification of a tetrapeptide recognition sequence for thealpha 2 beta 1 integrin in collagen. J. Biol. Chem. 266 (12) :7363-7367, 1991.

15) Lopez, J. A., Chung, D. W., Fujikawa, K. et al.:Cloning of the alpha chain of human platelet glycoprotein Ib :a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein. Proc. Natl. Acad. Sci. USA 84 (16) :5615-5619, 1987.

PubMed

15) Rajotte, D., Cadieux, C., Haman, A. et al.:Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition. J. Exp. Med. 185 (11) :1939-1950, 1997.

15) Wee, S., Wang, W. C., Farr, A. G. et al.:Characterization of a CD 6 ligand (s) expressed on human-and murine-derived cell lines and murine lymphoid tissues. Cell. Immunol. 158 (2) :353-364, 1994.

15) Maecker, H. T., Do, M. S. and Levy, S.:CD 81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses. Proc. Natl. Acad. Sci. USA 95 (5) :2458-2462, 1998.

15) Pearce, S. F., Wu, J. and Silverstein, R. L.:Acarboxyl terminal truncation mutant of CD 36 is secreted andbinds thrombospondin:evidence for a single transmembrane domain. Blood 84 (2) :384-389, 1994.

15) Taniguchi, M., Oka, K., Iliasa, A. et al.:De novo CD 5 diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 91 (4) :11451151, 1998.

15) Liu, F., Wu, H. Y., Wesselschmidt, R. et J.:Impaired production and increased apoptosis of neutrophils ingranulocyte colony-stimulating factor receptor deficient mice. Immunity 5 (5) :491 501, 1996.

15) Takada, Y., Strominger, J. L. and Hemler, M. E.:The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis. Proc. Natl. Acad. Sci. USA 84 (10) :3239-3243, 1987.

PubMed

15) Moore, K. L., Stults, N. L., Diaz, S., et al.:Identification of a specific glycoprotein ligand for P-selectin (CD 62) on myeloid cells. J. Cell. Biol. 118 (2) :445-456, 1992.

15) Nojima, Y., Hirose, T., Tachibana, K. et al.:The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion. Cell. Immunol. 152 (1) :249-260, 1993.

15) Kuchroo, V. K., Das, M. P., Brown, J. A. et al.:B7-1 and B7-2 costimulatory molecules activate differentially the Th 1/Th 2 developmental pathways:application to autoimmune disease therapy. Cell 80 (5) :707-718, 1995.

15) Sakihama, T., Smolyar, A. and Reinherz, EL.:Oligomerization of CD 4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp 120. Proc. Natl. Acad. Sci. USA 92 (14) :6444-6448, 1995.

15) Roldan, A. L., Cubellis, M. V., Masucci, M. T. et al.:Cloning and expression of the receptor for human urokinase activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 9 (2) :467-474, 1990.

PubMed

15) Moretta, A., Tambussi, G., Bottino, C. et al.:A novel surface antigen expressed by a subset of human CD 3-CD 16+natural killer cells. Role in cell activation and regulation of cytolytic function. J. Exp. Med. 171:695-714, 1990.

15) Norman, D. J. and Leone, M. R.:The role of OKT 3 in clinical transplantation. Pediatr, Nephrol. 5 (1) :130-136, 1991.

15) Pellas, T. C., Boyar, W., van Oostrum, J. et al.:Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo. J. Immunol. 160 (11) :5616-5621, 1998.

PubMed

15) Lindpaintner, K., Pfeffer, M. A., Kreutz, R. et al.:A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 332 (11) :706-711, 1995.

PubMed

15) Rabinowitz, J. E., Rutishauser, U. and Magnuson, T.:Targeted mutation of Ncam to produce a secreted molecule results in a dominant embryonic lethality. Proc. Natl. Acad. Sci. USA 93 (13) :6421-6424, 1996.

15) Misumi, Y., Hayashi, Y., Arakawa, F. et al.:Molecular cloning and sequence analysis of human dipeptidyl peptidase IV, a serine proteinase on the cell surface. Biochem. Biophys. Acad 1131 (3) :333-336, 1992.

15) Sharfe, N., Dadi, H. K., Shahar, M. et al.:Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 94 (7) :3168-3171, 1997.

PubMed

15) Nielsen, P. J., Lorenz, B., Muller, A. M. et al.:Altered erythrocytes and a leaky block in B-cell development in CD 24/HSA-deficient mice. Blood 89 (3) :1058-1067, 1997.

15) Medof, M. E., Lublin, D. M., Holers, V. M. et al.:Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. USA 84 (7) :2007 2011, 1987.

15) Staunton, D. E., Fisher, R. C., LeBeau, M. M. et al.:Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA 3 and OX-45, and maps to chromosome 1 q 21 23. J. Exp. Med. 169 (3) :1087 1099, 1989.

15) Mueller, B. M. and Ruf, W.:Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J. Clin. Invest. 101 (7) :1372, 1378, 1998.

15) Wallner, B. P., Frey, A. Z., Tizard, R. et al.:Primary structure of lymphocyte function-associated antigen 3 (LFA 3) . The ligand of the T lymphocyte CD 2 glycoprotein. J. Exp. Med. 166 (4) :923-932, 1987.

15) Tomura, S., Deguchi, F., Marumo, F. et al.:Enhanced presence of thrombomodulin in the glomeruli of lupus glomerulonephritis. Clin. Nephrol. 41 (4) :205-210, 1994.

PubMed

15) Haas, T. A. and Plow, E. F.:The cytoplasmic domain of alpha IIb/beta 3. A ternary complex of the integrin alpha and beta subunits and a divalent cation. J. Biol. Chem. 271 (11) :6017-6026, 1996.

15) Kieffer, B., Driscoll, P. C., Campbell, I. D. et al.:Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins. Biochemistry 33 (15) :4471-4482, 1994.

PubMed

15) Kikutani, H., Inui, S., Sato, R. et al.:Molecular structure of human lymphocyte receptor for immunoglobulin. Cell 47 (5) :657-665, 1986.

PubMed

15) Natali, P. G., Nicotra, M. R., Bigotti, A. et al.:Localization of ahe alpha 6 and beta 4 integrin subunits in normal human non-lymphoid tissues. J. Cell Sci. 103 (Pt 4) :1243-1247, 1992.

15) Kwee, L., Baldwin, H. S., Shen, H. M. et al.:Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 121 (2) :489-503, 1995.

PubMed

15) Reedquist, K. A. and Bos, J. L.:Costimulation through CD 28 suppresses T cell receptor-dependent activation of the Ras-like small GTPase Rap 1 in human T lymphocytes. J. Biol. Chem. 273 (9) :4944-4949, 1998.

15) Kitami, Y., Inui, H., Uno, S. et al.:Molecular structure and transcriptional regulation of the gene for the platelet. derived growth factor alpha receptor in cultured vascular smooth muscle cells. J. Clin. Invest. 96 (1) :558 567, 1995.

15) O'Keefe, T. L., Williams, G. T., Davies, S. L. et al.:Hyperresponsive B cells in CD 22-deficient mice. Science 274 (5288) :798-801, 1996.

15) Law, D. A., Nannizzi-Alaimo, L. and Philips, D. R.:Outside-in integrin signal transduction. Alpha IIb beta 3 (GP IIb IIIa) tyrosine phosphorylation induced by platelet aggregation. J. Biol. Chem. 271 (18) :10811-10815, 1996.

15) Kato, K., Koyanagi, M., Okada, H. et al.:CD 48 is a counter-receptor for mouse CD 2 and is involved in T cell activation. J. Exp. Med. 176 (5) :1241-1249, 1992.

15) Lories, V., Cassiman, J. J., Van den Berghe, H. et al.:Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. J. Biol. Chem. 267 (2) :1116-1122, 1992.

PubMed

15) Heron, A., Levesque, J. P., Hatzfeld, A. et al.:Mitogenic effect of fibrinogen on hematopoietic cells:involvement of two distinct specific receptors, MFR and ICAM-1. Biochem. Biophys. Res. Commun. 246 (1) :231-237, 1998.

PubMed

15) Hourcade, D., Garcia, A. D., Post, T. W. et al.:Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs) . Genomics 12 (2) :289-300, 1992.

PubMed

15) Ruegg, C., Ferrando, R., Pytela, R. et al.:Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely dis tributed in epithelia and muscle. J. Cell Biol. 123 (5) :1289-1297, 1993.

15) Tedder, T. F., Klejman, G., Schlossman, S. F. et al.:Structure of the gene encoding the human B lymphocyte differentiation antigen CD 20 (B 1) . J. Immunol. 142 (7) :2560-2568, 1989.

15) Pollok, K. E., Kim, Y. J., Zhou, Z. et al.:Inducible T cell antigen 4-1 BB. Analysis of expression and function. J. Immunol. 150 (3) :771-781, 1993.

15) Lawrence, M. B. and Springer, T. A.:Neutrophils roll on E-selectin. J. Immunol. 151 (11) 6338-6346, 1993.

15) Miyauchi, T., Masuzawa, Y. and Muramatsu, T.:The basigin group of the immunoglobulin superfamily:complete conservation of a segment in and around transmembrane domains of human and mouse basigin and chicken HT 7 antigen. J. Biochem. (Tokyo) 110 (5) :770-774, 1991.

16) Mali, M., Jaakkola, P., Arvilommi, A. M. et al.:Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. J. Biol. Chem. 265 (12) :6884-6889, 1990.

PubMed

16) Suzuki, H., Kundig, T. M., Furlonger, C. et al.:Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268 (5216) :1472-1476, 1995.

PubMed

16) Oren, R., Takahashi, S., Doss, C. et al.:TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10 (8) :4007-4015, 1990.

PubMed

16) Huang, G. T., Eckmann, L., Savidge, T. C. et al.:Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM) -1) expression and neutrophil adhesion. J. Clin. Invest. 98 (2) :572-583, 1996.

PubMed

16) Tarakhovsky, A., Kanner, S. B., Hombach, J. et al.:A role for CD 5 in TCR-mediated signal transduction and thymocyte selection. Science 269 (5223) :535-537, 1995.

16) Vazeux, R., Hoffman, P. A., Tomita, J. K. et al.:Cloning and characterization of a new intercellular adhesion molecule ICAM R. Nature 360 (6403) :485488, 1992.

16) Ling, N. R., Brown, B. and Hardie, D.:Synergy test for recognition of epitopes on soluble proteins;its application in the study of CD 21 and CD 23 antigens and their respective antibodies. J. Immunol. Methods 173 (1) :11-17, 1994.

16) Ranheim, T. S., Edelman, G. M. and Cunningham, B. A.:Homophilic adhesion mediated by the neural cell adhesion molecule involves multiple immunoglobulin domains. Proc. Natl. Acad. Sci. USA 93 (9) :4071-4075, 1996.

PubMed

16) Ticchioni, M., Deckert, M., Mary, F. et al.:Integrin-associated protein (CD 47) is a comitogenic molecule on CD 3-activated human T cells. J. Immunol. 158 (2) :677-684, 1997.

16) Liu, F., Poursine-Laurent, J., Wu, H. Y. et al.:Interleukin 6 and the granulocyte colony stimulating factor receptor are major independent regulators of granulopoises in vivo but are not required for lineage commitment or terminal differentiation. Blood 90 (7) :2583 2590, 1997.

16) Saoulli, K., Lee, S. Y., Cannons, J. L. et al.:CD 28-independent, TRAF 2-dependent costimulation of resting T cells by 4-1 BB ligand. J. Exp. Med. 187 (11) :1849-1862, 1998.

16) Sato, N., Sawada, K., Koizumi, K. et al.:In vitro expansion of human peripheral blood CD 34+cells. Blood 82 (12) :3600-3609, 1993.

16) Slack, J., McMahan, C. J., Waugh, S. et al.:Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors. J. Biol. Chem. 268 (4) :2513-2524, 1993.

PubMed

16) Lam, E. W. F., Choi, M. S. K., van der Sman, J. et al.:Modulation of E 2 F activity via signaling through surface IgM and CD 40 receptors in WEHI-231 B lymphoma cells. J. Biol. Chem. 273 (16) :1005-10057, 1998.

16) Schulz, O., Sewell, H. F. and Shakib, F.:Proteolytic cleavage of CD 25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J. Exp. Med. 187 (2) :271-275, 1998.

16) Nehme, C. L., Cesario, M. M., Myles, D. G. et al.:Breaching the diffusion barrier that compartmentalizes the transmembrane glycoprotein CE 9 to the posterior-tail plasma membrane domain of the rat spermatozoon. J. Cell Biol. 120 (3) :687-694, 1993.

16) Norman, K. E., Anderson, G. P., Kolb, H. C. et al.:Sialyl Lewis (x) (sLe (x)) and an sLe (x) mimetic, CGP 69669 A, disrupt E-selectin-dependent leukocyte rolling in vivo. Blood 91 (2) :475-483, 1998.

16) Shimizu, Y., Mobley, J. L., Finkelstein, L. D. et al.:A role for phosphatidyl inositol 3 kinase in the regulation of beta 1 integrin activity by the CD 2 antigen. J. Cell Biol. 131 (6 Pt 2) :1867 1880, 1995.

16) Wang, M. H., Julian, F. M., Breathnach, R. et al.:Macrophage stimulating protein (MSP) binds to its receptor via the MSP beta chain. J. Biol. Chem. 272 (27) :16999-17004, 1997.

16) Kundra, V., Escobedo, J. A., Kazlauskas, A. et al.:Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 367 (6462) :474-476, 1994.

PubMed

16) Chang, C., Rodriguez, A., Carretero, M. et al.:Molecular characterization of human CD 94:a type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 25 (9) :2433-2437, 1995.

16) Rusten, L. S., Lyman, S. D., Veiby, O. P. et al.:The FLT 3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD 34+ bone marrow progenitor cells in vitro. Blood 87 (4) :1317-1325, 1996.

16) Stockinger, B., Pessara, U., Lin, R. H. et al.:Arole of Ia-associated invariant chains in antigen processing and presentation. Cell 56 (4) :683-689, 1989.

16) Sammar, M., Aigner, S., Hubbe, M. et al.:Heat-stable antigen (CD 24) as ligand for mouse P-selectin. Int. Immunol. 6 (7) :1027-1036, 1994.

16) Snapp, K. R., Ding, H., Atkins, K. et al.:A novel P selectin glycoprotein ligand 1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL 1 and blocks recognition of both P and I, selectin. Blood 91 (1) :154 164, 1998.

16) Tedder, T. F. and Isaacs, C. M.:Isolation of cDNAs encoding the CD 19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J. Immunol. 143 (2) :712-717, 1989.

16) Xia, M. Q., Hale, G. and Waldmann, H.:Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw 52) antigen. Mol. Immunol. 30 (12) :1089-1096, 1993.

16) Shin, J., Doyle, C., Yang, Z. et al.:Structural features of the cytoplasmic region of CD 4 required for internalization. EMBO J. 9 (2) :425-434, 1990.

16) Reist, C. J., Liang, H. Y., Denny, D. et al.:Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur. J. Immunol. 24 (9) :2018-2025, 1994.

PubMed

16) Michishita, M., Videm, V. and Arnaout, M. A.:A novel divalent cation-binding site in the A domain of the beta 2 integrin CR 3 (CD 11b/CD 18) is essential for ligand binding. Cell 72 (6) :857-867, 1993.

16) Schwartz-Albiez, R., Dorken, B., Monner, D. A. et al.:CD 22 antigen :biosynthesis, glycosylation and surface expression of a B lymphocyte protein involved in B cell activation and adhesion. Int. Immunol. 3 (7) :623-633, 1991.

16) Ohshima, Y., Tanaka, Y., Tozawa, H. et al.:Expression and function of OX 40 ligand on human dendritic cells. J. Immunol. 159 (8) :3838-3848, 1997.

16) Rubinstein, E., Le Naour, F., Lagaudriere-Gesbert, C. et al.:CD 9, CD 63, CD 81, and CD 82 are components of a surface tetraspan connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26 (11) :2657-2665, 1996.

16) Schwartz, B. R., Conrad, Liles, W., Ochs, H. D. et al.:Retroviral-mediated gene transfer of the leukocyte integrin CD 18 into peripheral blood CD 34+ cells derived from a patient with leukocyte adhesion deficiency type 1. Blood 91 (5) :1520-1526, 1998.

16) Sims, J. E., March, C. J., Cosman, D. et al.:cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241 (4865) :585-589, 1988.

PubMed

16) Oltrona, L., Speidel, C. M., Recchia, D. et al.:Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation 96 (2) :646 652, 1997.

16) Nottenburg, C., Rees, G. and St. John, T.:Isolation of mouse CD 44 cDNA:structural features are distinct from primate cDNA. Proc. Natl. Acad. Sci. USA 86 (21) :8521-8525, 1989.

16) Tse, A. G., Barclay, A. N., Watts, A. et al.:A glycophospholipid tail at the carboxyl terminus of the Thy-1 glycoprotein of neurons and thymocytes. Science 230 (4729) :1003-1008, 1985.

16) Lindberg, F. P., Gresham, H. D., Reinhold, M. J. et al.:Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding. J. Cell Biol. 134 (5) :1313-1322, 1996.

16) Wells, R. G., Lee, W. S., Kanai, Y. et al.:The 4 F 2 antigen heavy chain induces uptake of neutral and dibasic amino acids in Xenopus oocytes. J. Biol. Chem. 267 (22) :15285 15288, 1992.

16) Qu, A. and Leahy, D. J.:The role of the divalent cation in the structure of the I domain from the CD 11 a/ CD 18 integrin. Structure 4 (8) :931-942, 1996.

16) Pedraza-Alva, G., Merida, L. B., Burakoff, S. J. et al.:T cell activation through the CD 43 molecule leads to vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation. J. Biol. Chem. 273 (23) :14218-14224, 1998.

16) Noguchi, M., Nakamura, Y., Russell, S. M. et al.:Interleukin-2 receptor gamma chain:a functional component of the interleukin-7 receptor. Science 262 (5141) :1877-1880, 1993.

PubMed

16) Rigotti, A., Acton, S. L. and Krieger, M.:The class B scavenger receptors SR-BI and CD 36 are receptorsfor anionic phospholipids. J. Biol. Chem. 270 (27) :16221-16224, 1995.

16) Liu, Z. G., Hsu, H., Goeddel, D. V. et al.:Dissection of TNF receptor 1 effector functions:JNK activationis not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87 (3) :565-576, 1996.

16) Johnston, G. J., Cook, R. G. and McEver, R. P.:Cloning of GMP-140, a granule membrane protein of platelets and endothelium:sequence similarity to proteins involved in cell adhesion and inflammation. Cell 56 (6) :1033-1044, 1989.

16) Norman, K. E., Moore, K. L., McEver, R. P. et al.:Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood 86 (12) :4417-4421, 1995.

PubMed

16) Nawrocki, J. F., Kirsten, E. S. and Fisher, R. J.:Biochemical and structural properties of a Hodgkin's disease-related membrane protein. J. Immunol. 141 (2) :672-680, 1988.

16) Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R. et al.:Long term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science. 257 (5071) :789 792, 1992.

16) Wirthmueller, U., Kurosaki, T., Murakami, M. S. et al.:Signal transduction by Fc gamma RIII (CD 16) is mediated through the gamma chain. J. Exp. Med. 175 (5) :1381-1390, 1992.

16) Yang, W. X., Terasaki, T., Shiroki, K. et al.:Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 229 (2) :421-428, 1997.

16) Skubitz, K. M., Ahmed, K., Campbell, K. D. et al.:CD 50 (ICAM 3) is phosphorylated on tyrosine and is associated with tyrosine kinase activity in human neutrophils. J. Immunol. 154 (6) :28882895, 1995.

16) Nakamura, N., Inoue, N., Watanabe, R. et al.:Expression cloning of PIG-L a candidate N-acetylglucosaminyl phosphatidylinositol deacetylase. J. Biol. Chem. 272 (25) :15834-15840, 1997.

16) Neuhaus, H., Hu, M. C., Hemler, M. E. et al.:Cloning and expression of cDNAs for the alpha subunit of the murine lymphocyte-Peyer's patch adhesion molecule. J. Cell Biol. 115 (4) :1149-1158, 1991.

PubMed

16) Sears, P. and Wong, C. H.:Intervention of carbohydrate recognition by proteins and nucleic acids. Proc. Natl. Acad. Sci. USA 93 (22) :12086-12093, 1996.

16) Rooney, I. A., Heuser, J. E. and Atkinson, J. P.:GPI-anchored complement regulatory proteins in seminal plasma. An analysis of their physical condition and the mechanisms of their binding to exogenous cells. J. Clin. Invest. 97 (7) :1675-1686, 1996.

16) Schaefer, B. M., Stark, H. J., Fusenig, N. E. et al.:Differential expression of urokinase-type plasminogen activator (uPA) , its receptor (uPA-R) , and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system. Exp. Res. 220 (2) :415-423, 1995.

16) Molldoro, T. H., Wall, C. D., White, M. M. et al.:Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor. Blood 88 (10) :3824-3830, 1996.

16) Sato, N. Caux, C., Kitamura, T. et al.:Expression and factor dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells. Blood 82 (3) :752 761, 1993.

16) Solan, N. J., Ward, P. E., Sanders, S. P. et al.:Soluble recombinant neutral endopeptidase (CD 10) as a potential antiinflammatory agent. Inflammation 22 (1) :107-121, 1998.

16) Smith, M. J., Goodfellow, P. J. and Goodfellow, P. N.:The genomic organisation of the human pseudoautosomal gene MIC 2 and detection of a related locus. Hum. Mol. Genet. 2 (4) :417-422, 1993.

16) Starr, R., Novak, U., Willson, T. A. et al.:Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp130 in cell type-specific signal transduction. J. Biol. Chem. 272 (32) :19982-19986, 1997.

PubMed

16) Otsuji, M., Kimura, Y., Aoe, T. et al.:Oxidative stress by tumor derived macrophages suppresses the expression of CD3 zeta chain of T cell receptor coniplex and antigen specific T cell responses. Proc. Natl. Acad. Sci. USA 93 (23) :13119 13124, 1996.

16) Peaker, C. J. and Neuberger, M. S.:Association of CD22 with the B cell antigen receptor. Eur. J. Immunol. 23 (6) :1358-1363, 1993.

16) Linsley, P. S., Brady, W., Urnes, M. et al.:CTLA 4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174 (3) :561-569, 1991.

16) Halloran, C. E., Ginsberg, M. H., Feigen, L. P. et al.:The amino-terminal one-third of alpha IIb defines the ligand recognition specificity of integrin alpha IIb/beta 3. J. Biol. Chem. 271 (4) :2033-2039, 1996.

PubMed

16) Niessen, C. M., van der Raaij-Helmer, M. H., Hulsman, E. H. et al.:Deficiency of the integrin beta 4 subunit in junctional epidermolysis bullosa with pyloric atresia :consequences for hemidesmosome and adhesion properties. J. Cell Sci. 109 (Pt 7) :1695-1706, 1996.

16) Porges, A. J., Redecha, P. B., Doebele, R. et al.:Novel Fc gamma receptor I family gene products in human mononuclear cells. J. Clin. Invest. 90 (5) :2102-2109, 1992.

16) Landmann, R., Zimmerli, W., Sansano, S. et al.:Increased circulating soluble CD 14 is associated with high mortality in gram-negative septic shock. J. Infect. Dis. 171 (3) :639-644, 1995.

PubMed

16) Kung, S. K. and Miller, R. G.:The NK1. 1 antigen in NK-mediated F 1 antiparent killing in vitro. J. Immunol. 154:1624-1633, 1995.

PubMed

16) Mahon, B. P., Sheahan, B. J., Griffin, F. et al.:A typical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chaingenes. J. Exp. Med. 186 (11) :1843-1851, 1997.

16) Sun, Q. H., DeLisser, H. M., Zukowski, M. M. et al.:Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J. Biol. Chem. 271 (19) :11090-11098, 1996.

16) Uhrberg, M., Valiante, N. M., Shum, B. P et al.:Human diversity in killer cell inhibitory receptor genes. Immunity 7 (6) :753-763, 1997.

PubMed

16) Sekido, N., Mukaida, N., Harada, A. et al.:Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365 (6447) :654-657, 1993.

PubMed

16) Rubinstein, E., Benoit, P., Billard, M. et al.:Organization of the human CD 9 gene. Genomics 16 (1) :132-138, 1993.

16) Lecoanet-Henchoz, S., Gauchat, J. F., Aubry, J. P. et al.:CD 23 regulates monocyte activation through a novel interaction with adhesion molecules CD 11 b-CD 18 and CD 11 c-CD 18. Immunity 3 (1) :119-125, 1995.

16) Tsuji, T., Yamamoto, F., Miura, Y. et al.:Characterization through cDNA cloning of galactoprotein b3 (Gap b3) , a cell surface membrane glycoprotein showing enhanced expression on oncogenic transformation. Identification of Gap b3 as a member of the integrin superfamily. J. Biol. Chem. 265 (12) :7016-7021, 1990.

PubMed

16) Stocks, S. C. and Kerr, M. A.:Stimulation of neutrophil adhesion by antibodies recognizing CD15 (Le (X)) and CD 15 expressing carcinoembryonic antigen related glycoprotein NCA 160. Biol J. 288 (Pt 1) :23 27, 1992.

16) Pan, G., O'Rourke, K. and Dixit, V. M.:Caspase-9, Bcl-XL., and Apaf 1 form a ternary complex. J. Biol. Chem. 273 (10) :5841-5845, 1998.

16) Naniche, D., Varior-Krishnan, G., Cervoni, F. et al.:Human membrane cofactor protein (CD 46) acts as a cellular receptor measles virus. J. Virol. 67 (10) :6025-6032, 1993.

16) Watanabe, M., Ueno, Y., Yajima, T. et al.:Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J. Exp. Med. 187 (3) :389-402, 1998.

PubMed

16) Linsley, P. S., Clark, E. A. and Ledbetter, J. A.:T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B 7/BB 1. Proc. Natl. Acad. Sci. USA 87 (13) :5031-5035, 1990.

PubMed

16) Rollins, T. E., Siciliano, S., Kobayashi, S. et al.:Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex. Proc. Natl. Acad. Sci. USA 88 (3) :971-975, 1991.

PubMed

16) van Hal, P. T., Hopstaken-Broos, J. P., Prins, A. et al.:Potential indirect anti-inflammatory effects of IL 4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD 13;EC 3. 4. 11. 2) . J. Immunol. 153:2718-2728, 1994.

16) Norment, A. M. and Littman, D. R.:A second subunit of CD 8 is expressed in human T cells. EMBO J. 7 (11) :3433-3439, 1988.

16) Killeen, N., Stuart, S. G. and Littman, D. R.:Development and function of T cells in mice with a disrupted CD 2 gene. EMBO J. 11 (12) :4329-4336, 1992.

16) Mullberg, J., Schooltink, H., Stoyan, T. et al.:The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23 (2) :473-480, 1993.

PubMed

16) Qiu, F. H., Ray, P., Brown, K. et al.:Primary structure of c-kit:relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J. 7 (4) :1003-1011, 1988.

16) Miyake, K., Medina, K., Ishihara, K. et al.:A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J. Cell Biol. 114 (3) :557-565, 1991.

PubMed

16) Tawaragi, Y., Oikawa, S., Matsuoka, Y. et al.:Primary structure of nonspecific crossreacting antigen (NCA) , a of carcinoembryonic antigen (CEA) gene family, deduced from cDNA sequence. Biochem. Biophys. Res. Commun. 150 (1) :89-96, 1988.

PubMed

16) Schanberg, LE., Lee, D. M., Fleenor, D. E. et al.:Characterization of human CD 7 transgenic mice. J. Immunol. 155 (5) :2407-2418, 1995.

16) Pfefferkorn, L. C. and Yeaman, G. R.:Association of IgA-Fc receptors (Fc alpha R) with Fc epsilon RI gamma 2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of gamma 2. J. Immunol. 153 (7) :3228-3236, 1994.

PubMed

16) Weber, C., Alon, R., Moser, B. et al.:Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes:implications for transendothelial chemotaxis. J. Cell Biol. 134 (4) :1063-1073, 1996.

16) Whitney, G. S., Starling, G. C., Bowen, M. A. et al.:The membrane-proximal scavenger receptor cysteine-rich domain of contains the activated leukocyte cell adhesion molecule binding site. J. Biol. Chem. 270 (31) :18187-18190, 1995.

PubMed

16) Leitenberg, D., Novak, T. J., Farber, D. et al.:The extracellular domain of CD 45 controls association with the CD 4-T cell receptor complex and the response to antigen-specific stimulation. J. Exp. Med. 183 (1) :249-259, 1996.

16) Schieferdecker, H. L., Ullrich, R., Weiss-Breckwoldt, A. N. et al.:The HML-1 antigen of intestinal lymphocytes is an activation antigen. J. Immunol. 144 (7) :2541-2549, 1990.

PubMed

16) Wang, P., Wu, P., Cheewatrakoolpong, B. et al.:Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils. J. Immunol. 160 (9) :4427-4432, 1998.

16) Lopez, J. A., Chung, D. W., Fujikawa, K. et al.:The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc. Natl. Acad. Sci. USA 85 (7) :2135-2139, 1988.

PubMed

16) Postigo, A. A., Corbi, A. L., Sanchez-Madrid, F. et al.:Regulated expression and function of CD 11c/CD 18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD 11c/CD 18. J. Exp. Med. 174 (6) :1313-1322, 1991.

16) Ronco, L. V., Silverman, S. L., Wong, S. G. et al.:Identification of conserved amino acids in the human macrophage colony-stimulating factor receptor alpha subunit for function. Evidence for formation of a heterodimeric receptor complex prior to ligand binding. J. Biol. Chem. 269 (1) :277-283, 1994.

16) Takada, Y. and Hemler, M. E.:The primary structure of the VLA-2/collagen receptor alpha 2 subunit (platelet GPIa) :homology to other integrins and the presence of a possible collagen-binding domain. J. Cell Biol. 109 (1) :397-407, 1989.

PubMed

16) Ludwig, E., Corneli, P. S., Anderson, J. L. et al.:Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 91 (8) :2120-2124, 1995.

16) Takeda, K., Tanaka, T., Shi, W. et al.:Essential role of Stat 6 in IL-4 signalling. Nature 380 (6575) :627-630, 1996.

16) Martin, L. H., Calabi, F. and Milstein, C.:Isolation of CD 1 genes:a family of major histocompatibility complex-related differentiation antigens. Proc. Natl. Acad. Sci. USA 83 (23) :9154-9258, 1986.

16) Weiler-Guettler, H., Christie, P. D., Beeler, D. L. et al.:A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J. Clin. Invest. 101 (9) :1983-1991, 1998.

16) Tanaka, H., Matsui, T., Agata, A. et al.:Molecular cloning and expression of a novel adhesion molecule. SC 1. Neuron 7 (4) :535-545, 1991.

16) Thorley-Lawson, D. A., Ianelli, C., Klaman, L. D. et al.:Function of CD 48 and its regulation by Epstein-Barr virus. Biochem. Soc. Trans. 21 (4) :976-980, 1993.

16) Grewal, I. S., Foellmer, H. G., Grewal, K. D. et al:Requirement for CD 40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273 (5283) :1864 1867, 1996.

16) Shahinian, A., Pfeffer, K., Lee, K. P. et al.:Differential T cell costimulatory requirements in CD 28-deficient mice. Science 261 (5121) :609-612, 1993.

16) Van Den Herik-Oudijk, I. E., Westerdaal, N. A., Henriquez, N. V. et al.:Functional analysis of human Fc gamma RII (CD 32) isoforms expressed B lymphocytes. J. Immunol. 152:574-585, 1994.

16) Mittrucker, H. W., Steeg, C., Malissen, B. et al.:The cytoplasmic tail of the T cell receptor zeta chain is required for signaling via CD 26. Eur. J. Immunol. 25 (1) :295 297, 1995.

16) Roberts, K. P. and Griswold, M. D.:Characterization of rat transferrin receptor cDNA:the regulation of transferrin receptor mRNA in testes and in Sertoli cells in culture. Mol. Endocrinol. 4 (4) :531-542, 1990.

PubMed

17) Thomsen, N. K., Soroka, V., Jensen, P. H. et al.:The three-dimensional structure of the first domain of neural cell adhesion molecule. Nat. Struct. Biol. 3 (7) :581-585, 1996.

PubMed

17) Xie, J., Li, R., Kotovuori, P. et al.:Intercellular adhesion molecule 2 (CD 102) binds to the leukocyte integrin CD 11b/CD18 through the A doniain. J. Immunol. 155 (7) :3619 3628, 1995.

17) Shaw, S. K., Cepek, K. L., Murphy, E. A. et al.:Molecular cloning of the human mucosal lymphocyte integrin alpha E subunit. Unusual structure and restricted RNA distribution. J. Biol. Chem. 269 (8) :6016-6025, 1994.

PubMed

17) Vidal, M., Morris, R., Grosveld, F. et al.:Tissue-specific control elements of the Thy-1 gene. EMBO J. 9 (3) :833-840, 1990.

PubMed

17) Ruzzi, L., Gagnoux-Palacios, L., Pinola, M. et al.:A homozygous mutation in the integrin alpha 6 gene in junctional epidermolysis bullosa with pyloric atresia. J. Clin. Invest. 99 (12) :2826-2831, 1997.

17) Reterink, T. J., van Zandbergen, G., van Egmond, M. et al.:Size-dependent effect of IgA on the IgA Fc receptor (CD 89) . Eur. J. Immunol. 27 (9) :2219-2224, 1997.

17) Gumperz, J. E. and Parham, P.:The enigma of the natural killer cell. Nature 378 (6554) :245-248, 1995.

PubMed

17) Watanabe, H., Kuraya, M., Kasukawa, R. et al.:Analysis of C5a receptor by monoclonal antibody. J. Immunol. Methods 185 (1) :19-29, 1995.

17) Navarro, V. J., Silver, D., Langnas, A. N. et al.:A pilot study of soluble adhesion molecules as surrogate markers for acute liver allograft rejection. Transplantation 65 (1) :126-130, 1998.

PubMed

17) Schmitt, M., Harbeck, N., Thomssen, C. et al.:Clinical impact of the plasminogen activation system intumor invasion and metastasis:prognostic relevance and target for therapy. Thromb. Haemost. 78 (1) :285-296, 1997.

17) Linsley, P. S., Greene, J. L., Brady, W. et al.:Human B7 1 (CD80) and B7 2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity, 1 (9) :793 801, 1994.

17) Szollosi, J., Horejsi, V., Bene, L. et al.:Supramolecular complexes of MHC class I, MHC class II, CD 20, and tetraspan molecules (CD 53, CD 81, and CD 82) at the surface of a B cell line JY. J. Immunol. 157 (7) :2939-2946, 1996.

17) Nicholson, S. E., Oates, A. C., Harpur, A. G. et al.:Tyrosine kinase JAK I is associated with the granulocytecolony stimulating factor receptor and both become tyrosine phosphorylated after receptor activation. Proc. Natl. Acad. Sci. USA 91 (8) :2985 2988, 1994.

17) Schick, M. R., Nguyen, V. Q. and Levy, S.:Anti-TAPA-1 antibodies induce protein tyrosine phosphoryla-tion that is prevented by increasing intracellular thiol levels. J. Immunol. 151 (4) :1918-1925, 1993.

17) Sakamaki, K., Miyajima, I., Kitamura, T. et al.:Critical cytoplasmic domains of the common beta subunit of CSF, IL 3 and IL 5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J. 11 (10) :3541-3549, 1992.

PubMed

17) Spritz, R. A. and Beighton, P.:Piebaldism with deafness:molecular evidence for an expanded. Am. J. Med. Genet. 75 (1) :101-103, 1998.

PubMed

17) Linsley, P. S., Brady, W., Urnes, M. et al.:CTLA 4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174 (3) :561-569, 1991.

17) Manoury-Schwartz, B., Chiocchia, G., Bessis, N. et al.:High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J. Immunol. 158 (11) :5501-5506, 1997.

PubMed

17) Pesando, J. M., Bouchard, L. S. and McMaster, B. E.:CD19 is functionally and physically associated with surface immunoglobulin. J. Exp. Med. 170 (6) :2159-2164, 1989.

PubMed

17) Loetscher, H., Pan, Y. C., Lahm, H. W. et al.:Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61 (2) :351-359, 1990.

PubMed

17) Sims, J. E., Acres, R. B., Grubin, C. E. et al.:Cloning the interleukin l receptor from human T cells. Proc. Natl. Acad. Sci. USA 86 (22) :8946-8950, 1989.

17) Strubin, M., Berte, C. and Mach, B.:Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J. 5 (13) :3483-3488, 1986.

PubMed

17) van Deuren, M., van der Ven-Jongekrijg, J., Vannier, E. et al.:The pattern of interleukin-1 beta (1L-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 90 (3) :1101-1108, 1997.

17) Suzuki, H., Duncan, G. S., Takimoto, H. et al.:Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J. Exp. Med. 185 (3) :499-505, 1997.

17) Wang, H. Y., Zamorano, J. and Keegan, A. D.:A role for the insulin-interleukin (IL) -4 receptor motif ofthe IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis By mutagenesis. J. Biol. Chem. 273 (16) :9898-9905, 1998.

17) Woodcock, J. M., Bagley, C. J., Zacharakis, B. et al.:A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL) -3, and IL-5 receptorcommon beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands. J. Biol. Chem. 271 (42) :25999-26006, 1996.

17) Yamanka, T., Kuroki, M., Matsuo, Y. et al.:Analysis of heterophilic cell adhesion mediated by CD 66 b and CD 66 c using their soluble recombinant proteins. Biochem. Biophys. Res. Commun. 219 (3) :842-847, 1996.

17) Peters, M., Jacobs, S., Ehlers, M. et al.:The function of the soluble interleukin 6 (IL-6) receptor in vivo:sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183 (4) :1399-1406, 1996.

PubMed

17) Teixeira, A. M., Fawcett, J., Simmons, D. L. et al.:The N domain of the biliary glycoprotein (BGP) adhesion molecule mediates homotypic binding:domain interactions and epitope analysis of BGPc. Blood 84 (1) :211 219, 1994.

17) Sprenger, H., Lloyd, A. R. and Kelvin, D. J.:Promoter analysis of the human interleukin-8 receptor genes, IL-8RA IL-8RB. Immunobiology 193 (2-4) :334-340, 1995.

17) Scholl, P. R. and Geha, R. S.:Physical association between the high-affinity IgG receptor (Fc gamma RI) and the gamma subunit of the high-affinity IgE receptor (Fc epsilon RI gamma) . Proc. Natl. Acad. Sci. USA 90 (19) :8847-8850, 1993.

17) Soslow, R. A., Bhargava, V. and Warnke, R. A.:MIC 2, TdT, bcl-2, and CD 34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum. Pathol. 28 (10) :1158-1165, 1997.

17) Sui, X., Tsuji, K., Tajima, S. et al.:Erythropoietin-independent erythrocyte production:signals through gp 130 and c-kit dramatically promote erythropoiesis from human CD 34+cells. J. Exp. Med. 183 (3) :837-845, 1996.

17) Sato, N., Sakamaki, K., Terada, N. et al.:Signal transduction by the high-affinity GM CSF receptor:two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J. 12 (11) :4181 4189, 1993.

17) Johnston, G. J., Bliss, G. A., Newman, P. J. et al.:Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes. J. Biol. Chem. 265 (34) :21381-21385, 1990.

17) Noguchi, M., Yi, H., Rosenblatt, H. M. et al.:Interleukin-2 receptor gamma chain mutation results in X-linked combined immunodeficiency in humans. Cell 73 (1) :147-157, 1993.

17) Stuber, E. and Strober, W.:The T cell-B cell interaction via OX 40-OX 40 L is necessary for the T cell dependent humoral immune response. J. Exp. Med. 183 (3) :979-989, 1996.

17) Pavalko, F. M., Walker, D. M., Graham, L. et al.:The cytoplasmic domain of L selectin interacts with cytoskeletal proteins via alpha actinin:receptor positioning microvilli does not require interaction with alpha actinin. J. Cell. Biol. 129 (4) :1155 1164, 1995.

PubMed

17) Small, D., Levenstein, M., Kim, E. et al.:STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD 34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc. Natl. Acad. Sci. USA 91 (2) :459-463, 1994.

17) Yoshimura, T., Yuhki, N., Wang, M. H. et al.:Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J. Biol. Chem. 268 (21) :15461-15468, 1993

PubMed

17) Patel, T. P., Goelz, S. E., Lobb, R. R. et al.:Isolation and characterization of natural protein-associatedcarbohydrate ligands for E-selectin. Biochemistry 33 (49) :14815-14824, 1994.

17) Schwarz, H., Valbracht, J., Tuckwell, J. et al.:ILA, the human 4-1 BB homologue, is inducible in lymphoid and other cell lineages. Blood 85 (4) :1043-1052, 1995.

17) Saunders, S., Jalkanen, M., O'Farrell, S. et al.:Molecular cloning of syndecan, an integral membrane proteoglycan. J. Cell. Biol. 108 (4) :1547-1556, 1989.

PubMed

17) Nurden, A. T.:Platelet glycoprotein IIIa polymorphism and coronary thrombosis. Lancet 350 (9086) :1189, 1191, 1997.

17) Lokker, N. A O'Hare, J. P., Barsoumian, A. et al.:Functional importance of platelet derived growth factor (PDGF) receptor extracellular immunoglobulin-like domains. Identification of PDGF binding site and neutralizing monoclonal antibodies. J. Biol. Chem. 272 (52) :33037-33044, 1997.

PubMed

17) Solomon, K. R., Rudd, C. E. and Finberg, R. W.:The association between glycosylphosphatidylinositol-anchored and heterotrimeric G protein alpha subunits in lymphocytes. Proc. Natl. Acad. Sci. USA 93 (12) :6053-6058, 1996.

PubMed

17) Rouvier, E., Luciani, M. F. and Golstein, P.:Fas involvement in Ca (2+) independent T cell-mediated cytotoxicity. J. Exp. Med. 177 (1) :195 200, 1993.

17) White, C. E., Hunter, M. J., Meininger, D. P. et al.:The fifth epidermal growth factor-like domain of thrombomodulin does not have an epidermal growth factor-like disulfide bonding pattern. Proc. Natl. Acad. Sci. USA 93 (19) :10177-10182, 1996.

17) Ott, I., Fischer, E. G., Miyagi, Y. et al.:A role for tissue factor in cell adhesion and migration mediated by interaction with actin binding protein 280. J. Cell Biol. 140 (5) :1241-1253, 1998.

PubMed

17) Muzykantov, V. R., Atochina, E. N., Ischiropoulos, H. et al.:Immunotargeting of antioxidant enzyme to the pulmonary endothelium. Proc. Natl. Acad. Sci. USA 93 (11) :5213-5218, 1996.

17) Nickells, M. W., Alvarez, J. J., Lublin, D. M. et al.:Characterization of DAF 2, a high molecular weight form of decay-accelerating factor (DAF;CD 55) , as a covalently cross linked dimer of DAF-1. J. Immunol. 152 (2) :676-685, 1994.

17) Hwang, S. J., Ballantyne, C. M., Sharrett, A. R. et al.:Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases:the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96 (12) :4219-4225, 1997.

17) Nehme, C. L., Fayos, B. E. and Bartles, J. R.:Distribution of the integral plasma membrane glycoprotein CE 9 (MRC OX 47) among rat tissues and its induction by diverse stimuli of metabolic activation. Biochem. J. 310 (Pt 2) :693 698, 1995.

17) Suzuki, S., Argraves, W. S., Pytela, R. et al.:cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc. Natl. Acad. Sci. USA 83 (22) :8614-8618, 1986.

PubMed

17) Starling, G. C., McLellan, A. D., Egner, W. et al.:Intercellular adhesion molecule 3 is the predominant co-stinlulatory. Eur. J. Immunol. 25 (9) :2528 2532, 1995.

17) Linsley, P. S., Nadler, S. G., Bajorath, J. et al.:Binding stoichiometry of the cytotoxic T lymphocyte-associated 4 (CTLA-4) . A disulfide linked homodimer binds two CD 86 molecules. J. Biol. Chem. 270 (25) :15417 15424, 1995.

17) Yang, J. T., Rayburn, H. and Hynes, R. O.:Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 119 (4) :1093-1105, 1993.

PubMed

17) Grouard, G., Rissoan, M. C., Filgueira, L. et al.:The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL) 3 and CD 40 ligand. J. Exp. Med. 185 (6) :1101 1111, 1997.

17) Parker, C. M., Pujades, C., Brenner, M. B. et al.:Alpha 4/180, a novel form of the integrin alpha 4 subunit. J. Biol. Chem. 268 (10) :7028-7035, 1993.

PubMed

17) Zhang, S. and Racaniello, V. R.:Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. J. Virol. 71 (7) :4915-4920, 1997.

PubMed

17) Wayner, E. A., Gil, S. G., Murphy, G. F. et al.:Epiligrin, a component of epithelial basement membranes, is an ligand for alpha 3 beta 1 positive T lymphocytes. J. Cell Biol. 121 (5) :1141-1152, 1993.

PubMed

17) Zutter, M. M. and Santoro, S. A.:Widespread histologic distribution of the alpha 2 beta 1 integrin cellsurface collagen receptor. Anz. J. Pathol. 137 (1) :113-120, 1990.

17) Vely, F., Olivero, S., Olcese, L. et al.:Differential association of phosphatases with hematopoietic coreceptors bearing immunoreceptor tyrosine-based inhibition motifs. Eur. J. Immunol. 27 (8) :1994-2000, 1997.

PubMed

17) van der Merwe, P. A., McNamee, P. N., Davies, E. A. et al.:Topology of the CD 2 CD 48 cell-adhesion molecule complex:for antigen recognition by T cells. Curr. Biol. 5 (1) :74 84, 1995.

17) Lanier, L. L., Chang, C. and Phillips, J. H.:Human NKR-P 1 A. A disulfide linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 153 (6) :2417-2428, 1994.

17) Ouyang, Y., Lane, W. S. and Moore, K. L.:Tyrosylprotein sulfotransferase:purification and molecular cloning of an enzyme that catalyzes tyrosine O-sulfation, a common posttranslational modification of eukaryotic proteins. Proc. Natl. Acad. Sci. USA 95 (6) :2896-2901, 1998.

PubMed

17) Maisner, A., Zimmer, G., Liszewski, M. K. et al.:Membrane cofactor protein (CD 46) is a basolateral protein that is not endocytosed. Importance of the tetrapeptide FTSL at the carboxyl terminus. J. Biol. Chem. 272 (33) :20793-20799, 1997.

17) Matsuda, A., Motoya, S., Kimura, S. et al.:Disruption of lymphocyte function and signaling in CD 45-associated protein-null mice. J. Exp. Med. 187 (11) :1863-1870, 1998.

17) Screaton, G. R., Bell, M. V., Jackson, D. G. et al.:Genomic structure of DNA encoding the lymphocyte homing receptor reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA 89 (24) :12160-12164, 1992.

PubMed

17) Schmid, K., Hediger, M. A., Brossmer, R. et al.:Amino acid sequence of human plasma galactoglycoprotein:identity the extracellular region of CD 43 (sialophorin) . Proc. Natl. Acad. Sci. USA 89 (2) :663-667, 1992.

17) Mazzucato, M., Marco, L. D., Masotti, A. et al.:Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation. J. Biol. Chem. 273 (4) :1880-1887, 1998.

PubMed

17) Kamata, T., Irie, A., Tokuhira, M. et al.:Critical residues of integrin alpha IIb subunit for binding of alpha IIb beta 3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP 3) . J. Biol. Chem. 271 (31) :18610-18615, 1996.

17) Lei, X. F., Ohkawara, Y., Stampfli, M. R. et al.:Disruption of antigen induced inflammatory responses in CD 40 ligand knockout mice. J. Clin. Invest. 101 (6) :13423453, 1998.

17) Tang, Y., Taylor, K. T., Sobieski, D. A. et al.:Identification of a human CD 36 isoform produced by exonskipping. Conservation of exon organization and pre-mRNA splicing patterns with CD 36 gene familymember, CLA-1. J. Biol. Chem. 269 (8) :6011-6015, 1994.

17) Subramanian, V. B., Clemenza, L., Krych, M. et al.:Substitution of two amino acids confers C 3 b bindingto the C 4 b binding site of CR 1 (CD 35) . Analysis based on ligand binding by chimpanzee erythrocytecomplement receptor. J. Immunol. 157 (3) :1242-1247, 1996.

17) Satterthwaite, A. B., Burn, T. C., Le Beau, M. M. et al.:Structure of the gene encoding CD 34, a humanhematopoietic stem cell antigen. Genomics 12 (4) :788794, 1992.

17) Warmerdam, P. A., Nabben, N. M., van de Graaf, S. A. et al.:The human low affinity immunoglobulin G Fc receptor IIC gene is a result of an unequal crossover event. J. Biol. Chem. 268 (10) :7346-7349, 1993.

PubMed

17) Tanaka, Y., Albelda, S. M., Horgan, K. J. et al.:CD 31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J. Exp. Med. 176 (1) :245-253, 1992.

17) Smith, C. A., Gruss, HJ., Davis, T. et al.:CD 30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73 (7) :1349-1360, 1993.

17) Takada, Y. and Puzon, W.:Identification of a regulatory region of integrin beta 1 subunit using activating and inhibiting antibodies. J. Biol. Chem. 268 (23) :17597 17601, 199. 3.

17) Vallejo, A. N., Nestel, A. R., Schirmer, M. et al.:Aging-related deficiency of CD 28 expression in CD 4+T cells is associated with the loss of gene-specific nuclear factor binding activity. J. Biol. Chem. 273 (14) :8119-8129, 1998.

17) Oravecz, T., Roderiquez, G., Koffi, J. et al.:CD 26 expression correlates with entry, replication and cytopathicity mollocytotropic IIIV 1 strains in a T cell line. Nat. Med. 1 (9) :919 926, 1995.

17) Uchiyama, T., Broder, S. and Waldmann, T. A.:A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. J. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J. Immunol. 126 (4) :1393-1397, 1981.

17) Wenger, R. H., Rochelle, J. M., Seldin, M. F. et al.:The heat stable antigen (mouse CD 24) gene is differentially regulated but has a housekeeping promoter. J. Biol. Chem. 268 (31) :23345-23352, 1993.

17) Ludin, C., Hofstetter, H., Sarfati, M. et al.:Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor. EMBO J. 6 (1) :109-114, 1987.

PubMed

17) Stamenkovic, I. and Seed, B.:The B-cell antigen CD 22 mediates monocyte and erythrocyte adhesion. Nature 345 (6270) :74-77, 1990.

17) Molina, H., Kinoshita, T., Inoue, K. et al.:A molecular and immunochemical characterization of mouse CR 2. for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145 (9) :2974-2983, 1990.

17) Tuveson, D. A., Carter, R. H., Soltoff, S. P. et al.:CD 19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260 (5110) :986-989, 1993.

17) Weitzman, J. B., Wells, C. E., Wright, A. H. et al.:The gene organisation of the human beta 2 integrin subunit (CD 18) . FEBS Lett. 294 (1-2) :97-103, 1991.

17) Takada, A., Ohmori, K., Yoneda, T. et al.:Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53 (2) :354-361, 1993.

PubMed

17) Savill, J.:Apoptosis. Phagocytic docking without shocking. Nature 392 (6675) :442-443, 1998.

PubMed

17) Xu, Y., Wellner, D. and Scheinberg, D. A.:Substance P and bradykinin are natural inhibitors of CD 13/aminopeptidase N. Biochem. Biophys. Res. Commun. 208 (2) :664-674, 1995.

17) Stacker, S. A. and Springer, T. A.:Leukocyte integrin P 150, 95 (CD 11c/CD 18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium. J. Immunol. 146 (2) :648-655, 1991.

17) Oxvig, C. and Springer, T. A.:Experimental support for a beta-propeller domain in integrin alpha-subunits and a calcium binding site on its lower surface. Proc. Natl. Acad. Sci. USA 95 (9) :4870-4875, 1998.

17) Schmits, R., Kundig, T. M., Baker, D. M. et al.:LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J. Exp. Med. 183 (4) :1415-1426, 1996.

PubMed

17) Rubinstein, E., Le Naour, F., Lagaudriere-Gesbert, C. et al.:CD 9, CD 63, CD 81, and CD 82 are components of a surface tetraspan connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26 (11) :2657-2665, 1996.

17) Robey, E., Chang, D., Itano, A. et al.:An activated form of Notch influences the choice between CD 4 and CD 8 T cell lineages. Cell 87 (3) :483-492, 1996.

17) Shimizu, Y., van Seventer, G. A., Ennis, E. et al.:Crosslinking of the T cell-specific accessory molecules CD 7 and CD 28 modulates T cell adhesion. J. Exp. Med. 175 (2) :577-582, 1992.

17) Whitney, G., Bowen, M., Neubauer, M. et al.:Cloning and characterization of murine CD 6. Mol. Immunol. 32 (1) :89-92, 1995.

17) Van de Velde, H., von Hoegen, I., Luo, W. et al.:The B-cell surface protein CD 72/Lyb. 2 is the ligand for CD 5. Nature 351 (6328) :662-665, 1991.

17) Turner, J. M., Brodsky, M. H., Irving, B. A. et al.:Interaction of the unique N-terminal region of tyrosine kinase p 56 lck with cytoplasmic domains of CD 4 and CD 8 is mediated by cysteine. Cell 60 (5) :755-765, 1990.

17) Rao, P. E., Newman, W., Meyer, E. et al.:Identification of anti CD3 antibodies that do not modulate antigen but induce mitogenes and block the mixed lymphocyte reaction. Hum. Immunol. 33 (4) :275-283, 1992.

17) Kingsmore, S. F., Souryal, C. A., Watson, M. L. et al.:Physical and genetic linkage of the genes encoding Ly-9and CD 48 on mouse and human chromosomes 1. Immunogenetics 42 (1) :59-62, 1995.

17) Martin, L. H., Calabi, F., Lefebvre, FA. et al.:Structure and expression of the human thymocyte antigens CD 1a, CD 1c. Proc. Natl. Acad. Sci. USA 84 (24) :9189-9193, 1987.

18) Tavecchia, L., Zanolin, E., Bonfante, V. et al.:Serum level of the soluble form of the CD 30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome. Blood 91 (8) :3011-3016, 1998.

18) Stamenkovic, I., Amiot, M., Pesando, J. M. et al.:A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56 (6) :1057-1062, 1989.

PubMed

18) Viville, S., Neefjes, J., Lotteau, V. et al.:Mice lacking the MHC class II-associated invariant chain. Cell 72 (4) :635-648, 1993.

PubMed

18) Torres, R. M., Law, C. L., Santos-Argumedo, L. et al.:Identification and characterization of the murine homologue of CD 22, a B lymphocyte-restricted adhesion molecule. J. Immunol. 149 (8) :2641-2649, 1992.

18) Suzuki, S., Argraves, W. S., Arai, H. et al.:Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs. J. Biol. Chem. 262 (29) :14080-14085, 1987.

PubMed

18) Smith, A., Metcalf, D. and Nicola, N. A.:ytoplasmic domains of the common beta chain of the GM-CSF/ IL 3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines. EMBO J. 16 (3) :451-464, 1997.

PubMed

18) Prabhu Das, M. R., Zamvil, S. S., Borriello, F. et al.:Reciprocal expression of co stimulatory molecules, B7 1 and B7 2, on murine T cells fonowing activation. Eur. J. Immunol. 25 (1) :207 211, 1995.

18) Mosselman, S., Claesson-Welsh, L., Kamphuis, J. S. et al.:Developmentally regulated expression of two novel platelet-derived growth factor alpha-receptor transcripts in human teratocarcinoma cells. Cancer Res. 54 (1) :220-225, 1994.

PubMed

18) Poggi, A., Costa, P., Morelli, L. et al.:Expression of human NKRP 1 A by CD 34+immature thymocytes:NKRP 1 A-mediated regulation of proliferation and cytolytic activity. Eur. J. Immunol. 26 (6) :1266-1272, 1996.

18) Salter, R. D., Benjamin, R. J., Wesley, P. K. et al.:A binding site for the T-cell co-receptor CD 80n the alpha 3domain of HLA-A 2. Nature 345 (6270) :41-46, 1990.

18) Smith, T. J., Ducharme, L. A., Shaw, S. K. et al.:Murine M 290 integrin expression modulated by mast cell activation. Immunity 1 (5) :393-403, 1994.

18) Tamkun, J. W., DeSimone, D. W., Fonda, D. et al.:Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell 46 (2) :271-282, 1986.

PubMed

18) Veazey, R. S., DeMaria, M., Chalifoux, L. V. et al.:Gastrointestinal tract as a major site of CD4+T cell depletion and viral replication in SIV infection. Science 280 (5362) :427-431, 1998.

18) Schlosshauer, B. and Herzog, K. H.:Neurothelin:an inducible cell surface glycoprotein of blood brain barrier specific endothelial cells and distinct neurons. J. Cell Biol. 110 (4) :1261 1274, 1990.

18) Vaughan, H. A., Henning, M. M., Purcell, D. F. et al.:The isolation of cDNA clones for CD 48. Immunogenetics 33 (2) :113-117, 1991.

PubMed

18) Isobe, M., Suzuki, J., Yamazaki, S. et al.:Regulation by differential development of Th 1 and Th 2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion. Circulation 96 (7) :2247-2253, 1997.

PubMed

18) Wright, S. D. and Jong, M. T.:Adhesion-promoting receptors on human macrophages recognize. J. Exp. Med. 164 (6) :1876-1888, 1986.

PubMed

18) Plater-Zyberk, C. and Bonnefoy, J. Y.:Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD 23 in vivo. Nat. Med. 1 (8) :781-785, 1995.

18) Suzuki, H., Yamaji, N., Egashira, A. et al.:Effect of the sugar chain of soluble recombinant CD59 on complement inhibitory activity. FEBS Lett. 399 (3) :272-276, 1996.

PubMed

18) Tsudo, M., Kitamura, F. and Miyasaka, M.:Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. Proc. Natl. Acad. Sci. USA 86 (6) :1982-1986, 1989.

PubMed

18) Wagtmann, N., Rajagopalan, S., Winter, C. C. et al.:Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3 (6) :801-809, 1995.

PubMed

18) van der Merwe, P. A., Bodian, D. L., Daenke, S. et al.:CD 80 (B 7-1) binds both CD 28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185 (3) :393-403, 1997.

18) Zhang, Y., Weiler-Guettler, H., Chen, J. et al.:Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J. Clin. Invest. 101 (7) :1301-1309, 1998.

PubMed

18) Rauprich, P., Kasper, B., Tidow, N. et al.:The protein tyrosine kinase JAK 2 is activated in neutrophils from patients with severe congenital neutropenia. Blood 86 (12) :4500 4505, 1995.

18) Tippett, P.:What is important on the red blood cell surface. Immunol. Invest. 24 (1-2) :173-186, 1995.

18) Sata, M. Perlman, H., Muruve, D. A. et al.:Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus mediated T cell response. Proc. Natl. Acad. Sci. USA 95 (3) :1213-1217, 1998.

18) Vandenberghe, P. and Ceuppens, J. L.:Immobilized anti-CD 5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth:evidence for signal transduction through CD 5. Eur. J. Immunol. 21 (2) :251 259, 1991.

18) Wilson, R. W., O'Brien, W. E. and Beaudet, A. L.:Nucleotide sequence of the cDNA from the mouse leukocyte adhesion protein CD 18. Nucleic. Acids. Res. 17 (13) :5397, 1989.

18) Parry, G. C., Erlich, J. H., Carmeliet, P. et al.:Low levels of tissue factor are compatible with development and hemostasis in mice. J. Clin. Invest. 101 (3) :560 569, 1998.

18) Tang, B., Mano, H., Yi, T. et al.:Tec kinase associates with c-kit and is tyrosine phosphorylated and activated following stem cell factor binding. Mol. Cell. Biol. 14 (12) :8432-8437, 1994.

18) Powell, R. M., Ward, T., Evans, D. J. et al.:Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD 55) :evidence for a secondary cellular factor in A particle formation. J. Virol. 71 (12) :9306-9312, 1997.

18) Tajima, S., Tsuji, K., Ebihara, Y. et al.:Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD 34+cells. J. Exp. Med. 184 (4) :1357-1364, 1996.

18) Majeti, R., Bilwes, A. M., Noel, J. P. et al.:Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279 (5347) :88-91, 1998.

PubMed

18) Tao, N., Wagner, S. J. and Lublin, D. M.:CD 36 is palmitoylated on both N-and C-terminal cytoplasmictails. J. Biol. Chem. 271 (37) :22315-22320, 1996.

18) Voss, S. D., Daley, J., Ritz, J. et al.:Participation of the CD 94 receptor complex in costimulation of human natural killer cells. J. Immunol. 160 (4) :1618-1626, 1998.

18) Tittle, T. V., Weinberg, A. D., Steinkeler, C. N. et al.:Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease. Blood 89 (12) :4652-4658, 1997.

18) Ogata, S., Misumi, Y. and Ikehara, Y.:Primary structure of rat liver dipeptidyl peptidase IV deduced from its cDNA and identification of the NH 2 terminal signal sequence as the membrane anchoring domain. J. Biol. Chem. 264 (6) :3596 3601, 1989.

18) Szollosi, J., Horejsi, V., Bene, L. et al.:Supramolecular complexes of MHC class I, MHC class II, CD 20, and tetraspan molecules (CD 53, CD 81, and CD 82) at the surface of a B cell line JY. J. Immunol. 157 (7) :2939-2946, 1996.

18) Till, K. J., Burthem, J., Lopez. A. et al.:Granulocyte-macrophage colony stimulating factor receptor:stage specific expression and function on late B cells. Blood 88 (2) :479 486, 1996.

18) Virji, M., Watt, S. M., Barker, S. et al.:The N domain of the human CD66 a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol. Microbiol. 22 (5) :929-939, 1996.

18) Serrador, J. M., Nieto, M., Alonso-Lebrero, J. L. et al.:CD 43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood 91 (12) :4632-4644, 1998.

18) Suzuki, R., Yamamoto, K., Seto, M. et al.:CD 7+and CD 56+myeloid/natural killer cell precursor acute leukemia:a distinct hematolymphoid disease entity. Blood 90 (6) :2417-2428, 1997.

18) Yeager, C. L., Ashmun, R. A., Williams, R. K. et al.:Human aminopeptidase N is a receptor for human coronavirus 229 E. Nature 357 (6377) :420-422, 1992.

18) Nagi, D. K., Foy, C. A., Mohamed-Ali, V. et al.:Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. Metabolism 47 (5) :622-626, 1998.

PubMed

18) Zutter, M. M., Painter, A. A., Staatz, W. D. et al.:Regulation of alpha 2 integrin gene expression in cells with megakaryocytic features:a common theme of three necessary elements. Blood 86 (8) :3006-3014, 1995.

PubMed

18) Yasuda, K., Nemoto, T., Ohashi, Y. et al.:Prolongation of allograft survival by administration of mAb specific for the three subunits of IL-2 receptor. Int. Immunol. 10 (5) :561-567, 1998.

PubMed

18) Williams, A. F. and Gagnon, J.:Neuronal cell Thy-1 glycoprotein:homology with immunoglobulin. Science 216 (4547) :696-703, 1982.

PubMed

18) Weitzman, J. B., Pasqualini, R., Takada, Y. et al.:The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. J. Biol. Chem. 268 (12) :8651-8657, 1993.

PubMed

18) Pulido, R., Elices, M. J., Campanero, M. R. et al.:Functional evidence for three distinct and independently inhibitable with distinct alpha 4 epitopes. J. Biol. Chem. 266:10241-10245, 1991.

PubMed

18) Zhang, J. G., Hilton, D. J., Willson, T. A. et al.:Identification, purification, and characterization of a soluble interleukin (IL) -13-binding protein. Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor alpha-chains. J. Biol. Chem. 272 (14) :9474-9480, 1997.

PubMed

18) Wong, W. W., Cahill, J. M., Rosen, M. D. et al.:Structure of the human CR l gene. Molecular basis of thestructural and quantitative polymorphisms and identification of a new CR 1-like allele. J. Exp. Med. 169 (3) :847-863, 1989.

18) Sonnenberg, A., Linders, C. J., Daams, J. H. et al.:The alpha 6 beta 1 (VLA-6) and alpha 6 beta 4 protein complexes :distribution and biochemical properties. J. Cell Sci. 96 (Pt 2) :207-217, 1990.

18) Spertini, O., Luscinskas, F. W., Gimbrone, M. A. Jr. et al.:Monocyte attachment to activated humanvascular endothelium in vitro mediated by leukocyte adhesion molecule 1 (L selectin) under nonstatic conditions. J. Exp. Med. 175 (6) :1789 1792, 1992.

18) Wallin, J. J., Gackstetter, E. R. and Koshland, M. E.:Dependence of BSAP repressor and activator functions on BSAP concentration. Science 279 (5358) :1961-1964, 1998.

PubMed

18) Moody, D. B., Reinhold, B. B., Guy, M. R. et al.:Structural requirements for glycolipid antigen recognition by CD 1b-restricted T cells. Science 278 (5336) :283-286, 1997.

18) Morio, T., Hanissian, S. and Geha, R. S.:Characterization of a 23 kDa protein associated with CD 40. Proc. Natl. Acad Sci. USA 92 (25) :11633 11636, 1995.

18) Zeigler, F. C., Bennett, B. D., Jordan, C. T. et al.:Cellular and molecular characterization of the role of the flk-2/flt-3. receptor tyrosine kinase in hematopoietic stem cells. Blood 84 (8) :2422-2430, 1994.

PubMed

18) Kumar, A., Hoover, J. L., Simmons, C. A. et al.:Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation 96 (12) :4333-4342, 1997.

PubMed

18) Steegmaier, M., Levinovitz, A., Isenmann, S. et al.:The E-selectin-ligand ESL-1 is a variant of a receptorfor fibroblast growth factor. Nature 373 (6515) :615-620, 1995.

18) Schwarz, H., Blanco, F. J., von Kempis, J. et al.:ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood 87 (7) :2839-2845, 1996.

18) Wright, S. D., Ramos, R. A., Tobias, P. S. et al.:CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding Protein. Science 249 (4975) :1431-1433, 1990.

18) Simmons, D. L., Satterthwaite, A. B., Tenen, D. G. et al.:Molecular cloning of a cDNA encoding CD 34, asialomucin of human hematopoietic stem cells. J. Immunol. 148 (1) :267271, 1992.

18) Naismith, J. H., Devine, T. Q., Brandhuber, B. J. et al.:Crystallographic evidence for dimerization ofunliganded tumor necrosis factor receptor. J. Biol. Chem. 270 (22) :13303-13307, 1995.

PubMed

18) Peters, M., Schirmacher, P., Goldschmitt, J. et al.:Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL) -6-sIL-6 R double transgenic mice. J. Exp. Med. 185 (4) :755-766, 1997.

18) Shen, L., Lasser, R. and Fanger, M. W.:My 43, a monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function. J. Immunol. 143 (12) :4117-4122, 1989.

PubMed

18) Lazetic, S., Chang, C., Houchins, J. P. et al.:Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD 94 and NKG 2 subunits. J. Immunol. 157 (11) :4741-4745, 1996.

18) Pelletier, R. P., Ohye, R. G., Vanbuskirk, A. et al.:Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J. Immunol. 149 (7) :2473-2481, 1992.

PubMed

18) Mitchell, E. L., Jones, D., White, G. R. et al:Determination of the gene order of the three loci CD 2, NGFB, and NRAS at human chromosome band 1 p 13 and refinement of their localisation at the subband level by fluorescence in situ hybridisation. Cytogenet. Cell Genet. 70 (3-4) :183-185, 1995.

18) Noguchi, M., Sarin, A., Aman, M. J. et al.:Functional cleavage of the common cytokine receptor gamma chain (gammac) by calpain. Proc. Natl. Acad. Sci. USA 94 (21) :11534-11539, 1997.

PubMed

18) Pytela, R.:Amino acid sequence of the murine Mac-1 alpha chain reveals homology with the integrin family and an additional domain related to von Willebrand factor. EMBO J. 7 (5) :1371-1378, 1988.

18) Wood, W. J. Jr., Thompson, A. A., Korenberg, J. et al.:Isolation and chromosomal mapping of the human immunoglobulin-associated B 29 gene (IGB) . Genomics 16 (1) :187-192, 1993.

18) Yasue, T., Nishizumi, H., Aizawa, S. et al.:A critical role of Lyn and Fyn for B cell responses to CD 38 ligation and interleukin 5. Proc. Natl. Acad. Sci. USA 94 (19) :10307-10312, 1997.

18) Weinrich, V., Sondermann, P., Bewarder, N. et al.:Epitope mapping of new monoclonal antibodies recognizing distinct FcRII (CD 32) isoforms. Hybridoma 15 (2) :109-116, 1996.

18) Manchester, M., Gairin, J. E., Patterson, J. B. et al.:Measles virus recognizes its receptor, CD 46, via two distinct binding domains within SCR 1 2. Virology 233 (1) :174 184, 1997.

18) Henn, V., Slupsky, J. R., Grafe, M. et al.:CD 40 ligand on activated platelets triggers an inflammatory reaction endothelial cells. Nature 391 (6667) :591 594, 1998.

18) Stockmeyer, B., Valerius, T., Repp, R. et al.:Preclinical studies with Fc (gamma) R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer. Cancer Res. 57 (4) :696-701, 1997.

PubMed

18) Merlin, G., van der Leede, B. J., McKune, K. et al.:The gene for the ligand binding chain of the human interferon gamma receptor. Immunogenetics 45 (6) :413-421, 1997.

PubMed

18) Moriki, T., Murata, M., Kitaguchi, T. et al.:Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met 239→Val) reported in patients with platelet-type von Willebrand disease. Blood 90 (2) :698-705, 1997.

18) Tu, L., Chen, A., Delahunty, M. D. et al.:L-selectin binds to P-selectin glycoprotein ligand-1 on leukocytes:interactions between the lectin, epidermal growth factor, and consensus repeat domains of the selectins determine ligand binding specificity. J. Immunol. 157 (9) :3995-4004, 1996.

18) Ravichandran, K. S., Lee, K. K., Songyang, Z. et al.:Interaction of She with the zeta chain of the T cell receptor upon T cell activation. Science 262 (5135) :902 905, 1993.

18) Pouyani, T. and Seed, B.:PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSG-1 amino terminus. Cell 83 (2) :333-343, 1995.

18) Molina, H., Holers, V. M., Li, B. et al.:Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl. Acad. Sci. USA 93 (8) :3357 3361, 1996.

18) O'Toole, T. E., Plow, E. F., Glass, A. et al.:A beta 3 integrin mutation abohshes ligand binding and alters divalent cation-dependent conformation. Science 249 (4971) :915-918, 1990.

18) Sims, J. E., Gayle, M. A., Slack, J. L. et al.:Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90 (13) :6155-6159, 1993.

PubMed

18) Treutiger, C. J., Heddini, A., Fernandez, V. et al.:PECAM-1/CD 31, an endothelial receptor for binding Plasmodium infected erythrocytes. Nat. Med. 3 (12) :1405-1408, 1997.

18) Wei, Y., Waltz, D. A., Rao, N. et al.:Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269 (51) :32380-32388, 1994.

PubMed

18) Subramanian, S. V., Fitzgerald, M. L. and Bernfield, M.:Regulated shedding of syndecan-1 and-4 ectodomains by thrombin and growth factor receptor activation. J. Biol. Chem. 272 (23) :14713-14720, 1997.

PubMed

18) Rubinstein, E., Poindessous-Jazat, V., Le Naour, F. et al.:CD 9, but not other tetraspans, associates with the beta 1 integrin precursor. Eur. J. Immunol. 27 (8) :1919-1927, 1997.

18) Kleiman, N. S., Lincoff, A. M., Kereiakes, D. J. et al.:Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin:evidence for a complex interaction in a multicenter trial. EPILOG Investigators. Circulation 97 (19) :1912-1920, 1998.

18) Mattern, T., Flad, H. D., Brade, L. et al.:Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J. Immunol. 160 (7) :3412-3418, 1998.

18) Yonemura, S., Hirao, M., Doi. Y. et al.:Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta membrane cytoplasmic domain of CD44, CD 43, and ICAM 2. J. Cell. Biol. 140 (4) :885 895, 1998.

18) Linsley, P. S., Bradshaw, J., Greene, J. et al:Intracellular trafficking of CTLA 4 and focal localization towards sites of TCR engagement. Immunity 4 (6) :535-543, 1996.

PubMed

18) Van der Vieren, M., Le Trong, H., Wood, C. L. et al.:A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM 3. Immunity 3 (6) :683690, 1995.

19) Yamanaka, Y., Nakajima, K., Fukada, T. et al.:Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat 3 activation. EMBO J. 15 (7) :1557-1565, 1996.

19) Wurfel, M. M., Hailman, E. and Wright, S. D.:Soluble CD 14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181 (5) :1743-1754, 1995.

19) van de Winkel, J. G., de Wit, T. P., Ernst, L. K. et al.:Molecular basis for a familial defect in phagocyteexpression of IgG receptor I (CD 64) . J. Immunol. 154 (6) :2896-2903, 1995.

19) Saito, K., Sakurai, J., Ohata, J. et J.:Involvement of CD 40 ligand CD 40 and CTLA 4 B 7 pathways in murine acute graft versus-host disease induced by allogeneic T cells lacking CD 28. J. Immunol. 160 (9) :4225-4231, 1998.

19) Yasuda, K., Nemoto, T., Ohashi, Y. et al.:Prolongation of allograft survival by administration of mAb specific for the three subunits of IL-2 receptor. Int. Immunol. 10 (5) :561-567, 1998.

PubMed

19) Qiu, Y., Ravi, L. and Kung, H. J.:Requirement of ErbB 2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393 (6680) :83-85, 1998.

PubMed

19) Yoshida, T., Ikuta, K., Sugaya, H. et al.:Defective B 1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5 R alpha deficient mice. Immunity 4 (5) :483 494, 1996.

19) Zuany-Amorim, C., Ruffie, C., Haile, S. et al.:Requirement for gammadelta T cells in allergic airway inflammation. Science 280 (5367) :1265-1267, 1998.

PubMed

19) Sako, D., Chang, X. J., Barone, K. M. et al.:Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 75 (6) :1179-1186, 1993.

19) Poggi, A., Costa, P., Tomasello, E. et al.:IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. Eur. J. Immunol. 28 (5) :1611-1616, 1998.

PubMed

19) Wagtmann, N., Biassoni, R., Cantoni, C. et al.:Molecular clones of the p 58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains. Immunity 2 (5) :439-449, 1995.

19) Uhlemann, AC., Brenner, B., Gulbins, E. et al.:Stimulation of TK 1 lymphoma cells via alpha 4 beta 7 integrin results in activation of src-tyrosine-and MAP-kinases. Biochem. Biophys. Res. Commun. 239 (1) :68-73, 1997.

19) Tontonoz, P., Nagy, L., Alvarez, J. G. et al.:PPARgamma promotes monocyte/macrophage differentiation and oxidized LDL. Cell 93 (2) :241-252, 1998.

PubMed

19) Wong, Y. W., Williams, A. F., Kingsmore, S. F. et al.:Structure, expression, and genetic linkage of the mouse BCM 1 (OX 45 or Blast-1) antigen. Evidence for genetic duplication giving rise to the BCM 1 region on mouse chromosome 1 and the CD 2/LFA 3 region on mouse chromosome 3. J. Exp. Med. 171 (6) :2115-2130, 1990.

19) Williams, A. F., Parekh, R. B., Wing, D. R. et al.:Comparative analysis of the N-glycans of rat, mouse and human Thy-1. Site-specific oligosaccharide patterns of neural Thy-1, a member of the immunoglobulin superfamily. Glycobiology 3 (4) :339-348, 1993.

19) Rosen, G. D., Sanes, J. R., LaChance, R. et al.:Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell 69 (7) :1107-1119, 1992.

PubMed

19) Sieling, P. A., Chatterjee, D., Porcelli, S. A. et al.:CD 1-restricted T cell recognition of microbial lipoglycan antigens. Science 269 (5221) :227-230, 1995.

PubMed

19) Tamura, R. N., Rozzo, C., Starr, L. et al.:Epithelial integrin alpha 6 beta 4 :complete primary structure of alpha 6 and variant forms of beta 4. J. Cell. Biol. 111 (4) :1593-1604, 1990.

PubMed

19) Suzuki, A., Andrew, D. P., Gonzalo, J. A. et al.:CD 34 deficient mice have reduced eosinophn accumulationafter exposure and show a novel crossreactive 90-kD protein. Blood 87 (9) :35503562, 1996.

19) Toyabe, S., Kuwano, Y., Takeda, K. et al.:IgA nephropathy-specific expression of the IgA Fc receptors (CD 89) on blood phagocytic cells. Clin. Exp. Immunol. 110 (2) :226-232, 1997.

19) Schraven, B., Wild, M., Kirchgessner, H. et al.:Alterations of CD 2 association with T cell receptor signaling molecules in "CD 2 unresponsive" human T lymphocytes. Eur. J. Immunol. 23 (1) :119-123, 1993.

19) Knezevic, I., Leisner, T. M. and Lam, S. C. T.:Direct binding of the platelet integrin alpha IIb/beta 3 (GP II b-IIIa) to talin. Evidence that interaction is mediated through the cytoplasmic domains of both alpha IIb and beta 3. J. Biol. Chem. 271 (27) :16416-16421, 1996.

19) Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D. et al.:The human T cell antigen gp 39, a member of the TNF gene family, is a ligand for the CD 40 receptor:expression of a soluble form of gp 39 with B cell costimulatory activity. EMBO J. 11 (12) :4313 4321, 1992.

19) Polte, T., Newman, W., Raghunathan, G. et al.:Structural and functional studies of full-length vascular cell adhesion molecule-1 :internal duplication and homology to several adhesion proteins. DNA Cell Biol. 10 (5) :349-357, 1991.

PubMed

19) Xue, W., Kindzelskii, A. L., Todd, R. F. et al.:Physical association of complement receptor type 3 andurokinase-type plasminogen activator receptor in neutrophil membranes. J. Immunol. 152 (9) :4630-4640, 1994.

PubMed

19) Mandelboim, O., Pazmany, L., Davis, D. M. et al.:Multiple receptors for HLA-G on human natural killer cells. Proc. Natl. Acad. Sci. USA 94 (26) :14666-14670, 1997.

PubMed

19) Tunnacliffe, A., Buluwela, L. and Rabbitts, T. H.:Physical linkage of three CD3 genes on human chromosome 11. EMBO J. 6 (10) :2953, 2957, 1987.

19) Xie, Y. and Muller, W. A.:Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Proc. Natl. Acad. Sci. USA 90 (12) :5569-5573, 1993.

PubMed

19) Luhder, F., Hoglund, P., Allison, J. P. et al.:Cytotoxic T lymphocyte associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187 (3) :427 432, 1998.

19) Ronchese, F., Hausmann, B., Hubele, S. et al.:Mice transgenic for a solube form of murine CTLA-4 show enhanced expansion of antigen specific CD 4' T cells and defective antibody production in vivo. J. Exp. Med. 179 (3) :809 817, 1994.

19) van Kooyk, Y., Binnerts, M. E., Edwards, C. P. et J.:Critical amillo acids in the lymphocyte function-associated antigen 1 I domain mediate intercellular adhesion molecule 3 binding and immulle function. J. Exp. Med. 183 (3) :1247 1252, 1996.

19) Wada, J., Kumar, A., Liu, Z. et al.:Cloning of mouse integrin alpha V cDNA and role of the alpha V-related matrix receptors in metanephric development. Cell Biol. 132 (6) :1161-1176, 1996.

PubMed

19) Spring, F. A., Holmes, C. H., Simpson, K. L. et al.:The Oka blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX 47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues. Eur. J. Immunol. 27 (4) :891 897, 1997.

19) Tanaka, Y., Adams, D. H., Hubscher, S. et al.:T-cell adhesion induced by proteoglycan immobilized cytokine MIP-1. Nature 361 (6407) :79-82, 1993.

PubMed

19) Wang, J. H., Yan, Y. W., Garrett, T. P. et al.:Atomic structure of a fragment of human CD 4 containing two immunoglobulin-like domains. Nature 348 (6300) :411-418, 1990.

19) Kolanus, W., Nagel, W., Schiller, B. et al.:Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 86 (2) :233-242, 1996.

PubMed

19) Shelley, C. S., Remold, O., Donnell, E. et al.:Structure of the human sialophorin (CD 43) gene. Identification of features atypical of genes encoding integral membrane proteins. Biochem. J. 270 (3) :569-576, 1990.

PubMed

19) Wu, Y., Zhou, Q., Zheng, P. et al.:CD 28-independent induction of T helper cells and immunoglobulin class switches requires costimulation by the heat-stable antigen. J. Exp. Med. 187 (7) :1151-1156, 1998.

19) Shimozaki, K., Nakajima, K., Ihrallo, T. et al.:Involvement of STAT 3 in the granulocyte colonystimulating factor-induced differentiation of myeloid cells. J. Biol. Chem. 272 (40) :25184 25189, 1997.

19) Verwilghen, J., Vandenberghe, P., Wallays, G. et al.:Simultaneous ligation of CD 5 and CD 280n resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD 3 occupancy. J. Immunol. 150 (3) :835 846, 1993.

19) Post, T. W., Arce, M. A., Liszewski, M. K. et al.:Structure of the gene for human complement protein decay accelerating factor. J. Immunol. 144 (2) :740 744, 1990.

19) Takahashi, S., Doss, C., Levy, S. et al.:TAPA-1, the target of an antiproliferative antibody, is associated on. J. Immunol. 145 (7) :2207-2213, 1990.

19) Shipp, M. A. and Look, A. T.:Hematopoietic differentiation antigens that are membrane associated enzymes:cutting is the key! Blood 82 (4) :1052 1070, 1993.

19) Watanabe, S., Kubota, H., Sakamoto, K. M. et al.:Characterization of cis acting sequences and trans acting signals regulating early growth response 1 and c-fos promoters through the granulocyte macrophage colony stimulating factor receptor in BA/F3 cells. Blood 89 (4) :1197 1206, 1997.

19) O'Donnell, C. J., Lindpaintner, K., Larson, M. G. et al.:Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97 (18) :1766-1772, 1998.

19) Scaffidi, C., Fulda, S., Srinivasan, A. et al.:Two CD 95 (APO-1/Fas) signaling pathways. EMBO J. 17 (6) :1675-1687, 1998.

19) Ward, S. G., Parry, R., LeFeuvre, C. et al.:Antibody ligation of CD 7 leads to association with phosphoinositide 3-killase and phosphatidylinsitol 3, 4, 5 trisphosphate formation in T lymphocytes. Eur. Immunol. 25 (2) :502 507, 1995.

19) Nabavi, N., Freeman, G. J., Gault, A. et al.:Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360 (6401) :266268, 1992.

19) Pendurthi, U. R., Alok, D. and Rao, L. V.:Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells:up regulation of poly (A) polymerase. Proc. Natl. Acad. Sci. USA 94 (23) :12598 12603, 1997.

19) Tone, M., Walsh, L. A. and Waldmann, H.:Gene structure of human CD 59 and demonstration that discrete mRNAs generated by alternative polyadenylation. J. Mol. Biol. 227 (3) :971-976, 1992.

19) Turner, A. M., Bennett, L. G., Lin, N. L. et al.:Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood 85 (8) :2052-2058, 1995.

PubMed

19) Yu, P., Kosco-Vilbois, M., Richards, M. et al.:Negative feedback regulation of IgE synthesis by murine CD 23. Nature 369 (6483) :753-756, 1994.

19) Shen, H., Miller, J. F., Fan, X. et al.:Compartmentalization of bacterial antigens:differential effects on priming of CD 8 T cells and protective immunity. Cell 92 (4) :535-545, 1998.

19) Morimoto, C., Letvin, N. L., Distaso, J. A. et al.:The isolation and characterization of the human suppressor inducer T cell subset. J. Immunol. 134 (3) :1508-1515, 1985.

PubMed

19) Schatteman, G. C., Morrison-Graham, K., van Koppen, A. et al.:Regulation and role of PDGF receptoralpha-subunit expression during embryogenesis. Development 115 (1) :123-131, 1992.

19) van der Merwe, P. A., Crocker, P. R., Vinson, M. et al.:Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD 22. J. Biol. Chem. 271 (16) :9273-9280, 1996.

19) Taher, T. E., Smit, L., Griffioen, A. W. et al.:Signaling through CD 44 is mediated by tyrosine kinases. Association with p 56 lck in T lymphocytes. J. Biol. Chem. 271 (5) :2863-2867, 1996.

19) Vihinen, T., Maatta, A., Jaakkola, P. et al.:Functional characterization of mouse syndecan-1 promoter. J. Biol. Chem. 271 (21) :12532-12541, 1996.

PubMed

19) Shaw, A. R., Domanska, A., Mak, A. et al.:Ectopic expression of human and feline CD 9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J. Biol. Chem. 270 (41) :24092-24099, 1995.

19) Moore, M. D., Cooper, N. R., Tack, B. F. et al.:Molecular cloning of the cDNA encoding the Epstein-Barr virus/C 3 d receptor (complement receptor type 2) of human B lymphocytes. Proc. Natl. Acad . Sci. USA 84 (24) :9194 9198, 1987.

19) Ridker, P. M., Hennekens, C. H., Schmitz, C. et al.:PIA 1/A 2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349 (9049) :385-388, 1997.

19) Newport, M. J., Huxley, C. M., Huston, S. et al.:A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335 (26) :1941-1949, 1996.

19) Zhou, Z., Kim, S., Hurtado, J. et al.:Characterization of human homologue of 4-1 BB and its ligand. Immunol Lett. 45 (1-2) :67-73, 1995.

19) Walz, G., Aruffo, A., Kolanus, W. et al.:Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science 250 (4984) :1132-1135, 1990.

PubMed

19) Zhou, L. J., Ord, D. C., Hughes, A. L. et al.:Structure and domain organization of the CD 19 antigen of human, and guinea pig B lymphocytes. Conservation of the extensive cytoplasmic domain. J. Immunol. 147 (4) :1424-1432, 1991.

19) Page, D. M., Roberts, E. M., Peschon, J. J. et al.:TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol. 160 (1) :120-133, 1998.

PubMed

19) Tedder, T. F., Isaacs, C. M., Ernst, T. J. et al.:Isolation and chromosomal localization of cDNAs encodinganovel lymphocyte cell surface molecule, LAM 1. Homology with the mouse lymphocyte homing receptor and other human adhesion proteins. J. Exp. Med. 170 (1) :123-133, 1989.

PubMed

19) Matsumoto, M., Takeda, J., Inoue, N. et al.:A novel protein that participates in nonself discrimination of malignant cells by homologous complement. Nat. Med. 3 (11) :1266-1270, 1997.

19) Weinberg, A. D., Bourdette, D. N., Sullivan, T. J. et al.:Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat. Med. 2 (2) :183-189, 1996.

PubMed

19) Wilson, R. W., Ballantyne, C. M., Smith, C. W. et al.:Gene targeting yields a CD 18-mutant mouse for study of inflammation. J. Immunol. 151 (3) :1571-1578, 1993.

19) Russell, S. M., Keegan, A. D., Harada, N. et al.:Interleukin-2 receptor gamma chain:a functional component of the interleukin-4 receptor. Science 262 (5141) :1880-1883, 1993.

PubMed

19) Liu, W., Ramachandran, V., Kang, J. et al.:Identification of N-terminal residues on P-selectin glyco-protein ligand-1 required for binding to P-selectin. J. Biol. Chem. 273 (12) :7078-7087, 1998.

19) Schick, P. K. and Walker, J.:The acylation of megakaryocyte proteins:glycoprotein IX is primarily myristoylated while glycoprotein Ib is palmitoylated. Blood 87 (4) :1377-1384, 1996.

19) Sims, J. E., Painter, S. L. and Gow, I. R.:Genomic organization of the type I and type II IL-1 receptors. Cytokine 7 (6) :483-490, 1995.

PubMed

19) Stomski, F. C., Woodcock, J. M. Zacharakis, B. et al.:Identification of a Cys motif in the common beta chain of the interleukin 3, granulocyte-macrophage colony stimulating factor, and interleukin 5 receptors essential for disulfide-linked receptor heterodimerization and activation of all three receptors. J. Biol. Chem. 273 (2) :1192-1199, 1998.

PubMed

19) Thornton, B. P., Vetvicka, V., Pitman, M. et al.:Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD 11b/CD 18) . J. Immunol. 156 (3) :1235, 1246, 1996.

20) Marengere, L. E., Waterhouse, P., Duncan, G. S. et al.:Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA 4. Science 272 (5265) :1170-1173, 1996.

PubMed

20) van den Berg, C. W. and Morgan, B. P.:Complement-inhibiting activities of human CD59 and analogues from sheep, and pig are not homologously restricted. J. Immunol. 152 (8) :4095-4101, 1994.

PubMed

20) Niewiesk, S., Schneider-Schaulies, J., Ohnimus, H. et al.:CD 46 expression does not overcome the intracellular block of measles virus replication in transgenic rats. J. Virol. 71 (10) :7969-7973, 1997.

20) Ryncarz, R. E. and Anasetti, C.:Expression of CD 86 on human marrow CD34 (+) cells identifies immunocompetent committed precursors of macrophages and dendritic cells. Blood 91 (10) :3892 3900, 1998.

20) Yayon, A., Klagsbrun, M., Esko, J. D. et al.:Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64 (4) :841-848, 1991.

PubMed

20) Wenger, R. H., Kieffer, N., Wicki, A. N. et al.:Structure of the human blood platelet membrane glycoprotein Ib alpha gene. Biochem. Biophys. Res. Commun. 156 (1) :389-395, 1988.

PubMed

20) Mingari, M. C., Vitale, C., Cambiaggi, A. et al.:Cytolytic T lymphocytes displaying natural killer (NK) -like activity:expression of NK-related functional receptors for HLA class I molecules (p 58 and CD 94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 7 (4) :697-703, 1995.

PubMed

20) Yan, H. C., Baldwin, H. S., Sun, J. et al.:Alternative splicing of a specific cytoplasmic exon alters the binding characteristics of murine platelet/endothelial cell adhesion molecule-1 (PECAM 1) . J. Biol. Chem. 270 (40) :23672-23680, 1995.

PubMed

20) Scharton-Kersten, T., Nakajima, H., Yap, G. et al.:Infection of mice lacking the common cytokine receptor gamma-chain (gamma (c)) reveals an unexpected role for CD 4+T lymphocytes in early IFN-gamma-dependent resistance to Toxoplasma gondii. J. Immunol. 160 (6) :2565-2569, 1998.

20) Tai, X. G., Yashiro, Y., Abe, R. et al.:A role for CD 9 molecules in T cell activation. J. Exp. Med. 184 (2) :753-758, 1996.

20) Sako, D., Comess, K. M., Barone, K. M. et al.:A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell 83 (2) :323-331, 1995.

PubMed

20) Paterson, R. L., Kelleher, C. A., Streib, J. E. et al.:Activation of human thymocytes after infection by EBV. J. Immunol. 154 (3) :1440 1449, 1995.

20) Zhang, L. and Plow, E. F.:Overlapping, but not identical, sites are involved in the recognition of C 3 bi, neutrophil inhibitory factor, and adhesive ligands by the alphaMbeta 2 integrin. J. Biol. Chem. 271 (30) :18211, 18216, 1996.

20) Sussman, J. J., Shu, S., Sondak, V. K. et al.:Activation of T lymphocytes for the adoptive immunotherapy of cancer. Ann. Sug. Oncol 1 (4) :296-306, 1994.

20) Ricard, I., Payet, M. D. and Dupuis, G.:VCAM-1 is internalized by a clathrin-related pathway in human endothelial cells but its alpha 4 beta 1 integrin counter-receptor remains associated with the plasma membrane in human T lymphocytes. Eur. J. Immunol. 28 (5) :1708-1718, 1998.

20) Zhang, J., Kuvelkar, R., Cheewatrakoolpong, B. et al.:Evidence for multiple promoters of the human IL-5receptor alpha subunit gene:a novel 6-base pair element determines cell specific promoter function. J. Immunol. 159 (11) :5412 5421, 1997.

20) Seftor, R. E., Seftor, E. A., Gehlsen, K. R. et al.:Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc. Natl. Acad. Sci. USA 89 (5) :1557-1561, 1992.

PubMed

20) Warren, H. S., Altin, J. G., Waldron, J. C. et al.:A carbohydrate structure associated with CD 15 (Lewis x) on myeloid cells is a novel ligand for human CD 2. J. Immunol. 156 (8) :2866-2873, 1996.

20) Somers, W., Stahl, M. and Seehra, J. S.:1. 9 A crystal structure of interleukin 6:implications for a novel mode of receptor dimerization and signaling. EMBO J. 16 (5) :989-997, 1997.

PubMed

20) Sadir, R., Forest, E. and Lortat-Jacob, H.:The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation. J. Biol. Chem. 273 (18) :10919-10925, 1998.

PubMed

20) Kato, K., Cantwell, M. J., Sharma, S. et al.:Gene transfer of CD 40 ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J. Clin. Invest. 101 (5) :1133 1141, 1998.

20) Valerius, T., Stockmeyer, B., van Spriel, A. B. et al.:Fc alpha RI (CD 89) as a novel trigger molecule for bispecific antibody therapy. Blood 90 (11) :4485-4492, 1997.

20) Sempowski, G. D., Rozenblit, J., Smith, T. J. et al.:Human orbital fibroblasts are activated through CD 40 to induce proinflammatory cytokine production. Am. J. Physiol. 274 (3 Pt 1) :C 707 714, 1998.

20) Tavian, M., Coulombel, L., Luton, D. et al.:Aorta associated CD 34+ hematopoietic cells in the early human. Blood 87 (1) :67 72, 1996.

20) Vidal, F., Aberdam, D., Miquel, C. et al.:Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat. Genet. 10 (2) :229-234, 1995.

PubMed

20) Mayadas, T. J. R. C., Rayburn, H., Hynes, R. O. et al.:Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 74 (3) :541-554, 1993.

20) Watson, M. L., Kingsmore, S. F., Johnston, G. J. et al.:Genomic organization of the selectin family ofleukocyte adhesion molecules on human and mouse chromosome 1. J. Exp. Med. 172 (1) :263-272, 1990.

20) Smiley, S. T., Kaplan, M. H. and Grusby, M. J.:Immunoglobulin E production in the absence of interleukin-4-secreting CD 1-dependent cells. Science 275 (5302) :977-979, 1997.

20) Zhou, L. J., Ord, D. C., Omori, S. A. et al.:Structure of the genes encoding the CD 19 antigen of human and mouse B lymphocytes. Immunogenetics 35 (2) :102-111, 1992.

20) Yu, B., Hailman, E. and Wright, S. D.:Lipopolysaccharide binding protein and soluble CD 14 catalyze exchange of phospholipids. J. Clin. Invest. 99 (2) :315-324, 1997.

20) Kolodziej, M. A., Vilaire, G., Rifat, S. et al.:Effect of deletion of glycoprotein IIb exon 28 on the expression of the platelet glycoprotein IIb/IIIa complex. Blood 78 (9) :2344-2353, 1991.

PubMed

20) Yoshida, K., Taga, T., Saito, M. et al.:Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 93 (1) :407-411, 1996.

PubMed

20) Rott, L. S., Briskin, M. J., Andrew, D. P. et al.:A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation. J. Immunol. 156 (10) :3727-3736, 1996.

PubMed

20) Woodcock, J. M., McClure, B. J., Stomski, F. C. et al.:The human granulocyte macrophage colony stimulating factor (GM CSF) receptor exists as a preformed receptor complex that can be activated by GM-CSF, interleukin 3, or interleukin 5. Blood 90 (8) :3005-3017, 1997.

PubMed

20) Ribichini, F., Steffenino, G., Dellavalle, A. et al.:Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme:a major risk factor and a marker of risk for coronary stent restenosis. Circulation 97 (2) :147-154, 1998.

20) Tanaka, T., Camerini, D., Seed, B. et al.:Cloning and functional expression of the T cell activation antigen CD 26. J. Immunol. 149 (2) :481 486, 1992.

20) Slack, J., McMahan, C. J., Waugh, S. et al.:Independent binding of interleukin 1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors. J. Biol. Chem. 268 (4) :2513 2524, 1993.

20) Peach, R. J., Bajorath, J., Naemura, J. et al.:Both extracellular immunoglobin-like domains of CD 80 contain residues critical for binding T cell surface receptors CTLA-4 and CD 28. J. Biol. Chem. 270 (36) :21181-21187, 1995.

20) van Eeden, S. F., Saito, Y., Okazawa, M. et al.:Functional changes in aging polymorphonuclear leukocytes. Circulation 97 (1) :91-98, 1998.

PubMed

20) Shafren, D. R., Bates, R. C., Agrez, M. V. et al.:Coxsackieviruses B 1, B 3, and B 5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 69 (6) :3873-3877, 1995.

20) Poulsen, L. K., Jacobsen, N., Sorensen, B. B. et al.:Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J. Biol. Chem. 273 (11) :6228-6232, 1998.

PubMed

20) Srinivasan, A., Li, F., Wong, A. et al.:Bcl-xL functions downstream of caspase 8 to inhibit Fas-and tumor necrosis factor receptor 1-induced apotosis of MCF 7 breast carcinoma. J. Biol. Chem. 273 (8) :4523-4529, 1998.

20) Telen, M. J., Udani, M., Washington, M. K. et al.:A blood group-related polymorphism of CD 44 abolishes a hyaluronan-binding consensus sequence without preventing hyaluronan binding. J. Biol. Chem. 271 (12) :7147-7153, 1996.

20) Tsitsikov, E. N., Gutierrez-Ramos, J. C. and Geha, R. S.:Impaired CD 19 expression and signaling, enhanced antibody, response to type II T independent antigen and reduction of B-1 cells in CD 81-deficient mice. Proc. Natl. Acad. Sci. USA 94 (20) :10844-10849, 1997.

20) Tidow, N., Pilz, C., Teichmann, B. et al.:Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony stimulating factor receptor gene in patients with severe congenital neutropenia. Blood 89 (7) :2369-2375, 1997.

PubMed

20) Wang, R., Nelson, A., Kimachi, K. et al.:The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. USA 95 (7) :3804-3809, 1998.

PubMed

20) Kumasaka, T., Quinlan, W. M., Doyle, N. A. et al.:Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J. Clin. Invest. 97 (10) :2362-2369, 1996.

PubMed

20) Santee, S. M. and Owen-Schaub, L. B.:Human tumor necrosis factor receptor p75/80 (CD 120 b) gene structure promoter characterization. J. Biol. Chem. 271 (35) :21151-21159, 1996.

20) Tavernier, J., Devos, R., Cornelis, S. et al.:A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM CSF. Cell 66 (6) :1175 1184, 1991.

20) Yang, X. D., Sytwu, H. K., McDevitt, H. O. et al.:Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice. Diabetes 46 (10) :1542-1547, 1997.

PubMed

20) Sperling, A. I., Green, J. M., Mosley, R. L. et al.:CD 43 is a murine T cell costimulatory receptor that functions independently of CD 28. J. Exp. Med. 182 (1) :139-146, 1995.

20) Ziober, B. L., Vu, M. P., Waleh, N. et al.:Alternative extracellular and cytoplasmic domains of the integrin 7 subunit are differentially expressed during development. J. Biol. Chem. 268 (35) :26773-26783, 1993.

PubMed

20) van Vugt, M. J., Heijnen, A. F., Capel, P. J. et al.:FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD 64) in vivo. Blood 87 (9) :3593-3599, 1996.

20) Tanchot, C., Lemonnier, FA., Perarnau, B. et al.:Differential requirements for survival and proliferation of CD 8 naive or memory T cells. Science 276 (5321) :2057-2062, 1997.

PubMed

20) Uchida, N., Tsukamoto, A., He, D. et al.:High doses of purified stem cells cause early hematopoietic recovery syngeneic and allogeneic hosts. J. Clin. Invest. 101 (5) :961-966, 1998.

PubMed

20) Voll, R. E., Herrmann, M., Roth, E. A. et al.:Immunosuppressive effects of apoptotic cells. Nature 390 (6658) :350-351, 1997.

PubMed

20) Schneller, M., Vuori, K. and Ruoslahti, E.:Alphavbeta 3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J. 16 (18) :5600-5607, 1997.

20) Zappacosta, F., Borrego, F., Brooks, A. G. et al.:Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc. Natl. Acad. Sci. USA 94 (12) :6313-6318, 1997.

PubMed

20) Seulberger, I. L., Lottspeich, F. and Risau, W.:The inducible blood brain barrier specific molecule HT7 is a novel immunoglobulin like cell surface glycoprotein. EMBO J. 9 (7) :2151 2158, 1990.

20) Okumura, M., Matthews, R. J., Robb, B. et al.:Comparison of CD 45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains. J. Immunol. 157 (4) :1569-1575, 1996.

20) Wilson, G. L., Fox, C. H., Fauci, A. S. et al.:cDNA cloning of the B cell membrane protein CD 22 :a mediator of B-B cell interactions. J. Exp. Med. 173 (1) :137-146, 1991.

20) Poggi, A., Rubartelli, A. and Zocchi, M. R.:Involvement of dihydropyridine-sensitive calcium channels in human dendritic cell function. Competition by HIV-1 Tat. J. Biol. Chem. 273 (13) :7205-7209, 1998.

20) Vazeux, R., Hoffman, P. A., Tomita, J. K. et al.:Cloning and characterization of a new intercellular adhesion molecule ICAM R. Nature 360 (6403) :485-488, 1992.

PubMed

21) Yong, K. L., Watts, M., Shaun, Thomas, N. et al.:Transmigration of CD 34+ cells across specialized and nonspecialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD 31) . Blood 91 (4) :1196 1205, 1998.

21) Lyman, S., Aster, R. H., Visentin, G. P. et al.:Polymorphism of human platelet membrane glycoproteinIIb associated with the Baka/Bakb alloantigen system. Blood 75 (12) :2343-2348, 1990.

21) Shao, J. Y., Ting-Beall, H. P. and Hochmuth, R. M.:Static and dynamic lengths of neutrophil microvilli. Proc. Natl. Acad. Sci. USA 95 (12) :6797-6802, 1998.

PubMed

21) Stamenkovic, L., Clark, E. A. and Seed, B.:A B lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokineg. in carcinomas. EMBO J. 8 (5) :1403-1410, 1989.

21) Renedo, M., Arce, I., Rodriguez, A. et al.:The human natural killer gene complex is located on chromosome 12p12-p13. Immunogenetics 46 (4) :307-311, 1997.

PubMed

21) Sagara, H., Matsuda, H., Wada, N. et al.:A monoclonal antibody against very late activation antigen-4 inhibits eosinophil accumulation and late asthmatic response in a guinea pig model of asthma. Int. Arch. Allergy Immunol. 112 (3) :287-294, 1997.

21) Kilger, E., Kieser, A., Baumann, M. et al.:Epstein Barr virus mediated B cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD 40 receptor. EMBO J. 17 (6) :1700-1709, 1998.

21) Peach, R. J., Bajorath, J., Naemura, J. el al, :Both extracellular immunoglobin like domains of CD 80 contain residues critical for binding T cell surface receptors CTLA-4 and CD 28. J. Biol. Chem. 270 (36) :21181 21187, 1995.

21) Suda, T., Takahashi, T., Golstein, P. et al.:Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75 (6) :1169 1178, 1993.

21) Languino, L. R., Plescia, J., Duperray, A. et al.:Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 73 (7) :1423-1434, 1993.

PubMed

21) Ruiz, J., Blanche, H., Cohen, N. et al.:Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 91 (9) :3662-3665, 1994.

PubMed

21) Samad, F., Pandey, M. and Loskutoff, D. J.:Tissue factor gene expression in the adipose tissues of obese mice. Proc. Natl. Acad. Sci. USA 95 (13) :7591-7596, 1998.

PubMed

21) Seifert, R. A., Hart, C. E., Phillips, P. E. et al.:Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J. Biol. Chem. 264 (15) :8771-8778, 1989.

PubMed

21) Wilson, G. L., Najfeld, V., Kozlow, E. et al.:Genomic structure and chromosomal mapping of the human CD 22 gene. J. Immunol. 150 (11) :5013-5024, 1993.

21) Yamashina, M., Ueda, E., Kinoshita, T. et al.:Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD 59) as a cause of paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 323 (17) :1184-1189, 1990.

21) Petzer, A. L., Schulz, T. F., Stauder, R. et al.:Structural and functional analysis of CR 2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion. Immunology 63 (1) :47-53, 1988.

21) Shattil, S. J., O'Toole, T., Eigenthaler, M. et al.:Beta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunit. J. Cell Biol. 131 (3) :807-816, 1995.

PubMed

21) von Andrian, U. H., Hasslen, S. R., Nelson, R. D. et al.:A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell 82 (6) :989 999, 1995.

21) Takeshita, T., Asao, H., Ohtani, K. et al.:Cloning of the gamma chain of the human IL-2 receptor. Science 257 (5068) :379-382, 1992.

PubMed

21) Romano, M., Mezzetti, A., Procopio, A. et al.:Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 97 (10) :953-957, 1998.

PubMed

21) Woodcock, J. M., McClure, B. J., Stomski, F. C. et al.:The human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor exists as a preformed receptor complex that can be activated by GM-CSF, interleukin-3, or interleukin-5. Blood 90 (8) :3005-3017, 1997.

PubMed

21) Wang, X. J., Taga, T., Yoshida, K. et al.:gp130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T cells in vivo by interleukin-6. Blood 91 (9) :3308-3314, 1998.

21) van Vugt, M. J., van den Herik-Oudijk, I. E. and van de Winkle, J. G.:Binding of PE-CY 5 conjugates to the human high-affinity receptor for IgG. Blood 88 (6) :2358-2361, 1996.

21) Ward, L. D., Hammacher, A., Howlett, G. J. et al.:Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6/receptor complex. J. Biol. Chem. 271 (33) :20138-20144, 1996.

PubMed

21) Wesche, H., Korherr, C., Kracht, M. et al.:The interleukin 1 receptor accessory protein (IL-1RAcP) is essential for IL 1 induced activation of interleukin 1 receptor associated kinase (IRAK) and stress-activated protein kinases (SAP kinases) . J. Biol. Chem. 272 (12) :7727 7731, 1997.

21) Schall, T. J., Lewis, M., Koller, K. J. et al.:Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61 (2) :361-370, 1990.

PubMed

21) Soh, J., Donnelly, R. J., Kotenko, S. et al.:Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell 76 (5) :793 802, 1994.

21) Ullrich, A. and Schlessinger, J.:Signal transduction by receptors with tyrosine kinase activity. Cell 61 (2) :203-212, 1990.

PubMed

21) Toy, L. S., Yio, X. Y., Lin, A. et al.:Defective expression of gp 180, a novel CD 8 ligand on intestinal epithelial cells, in inflammatory bowel disease. J. Clin. Invest. 100 (8) :2062-2071, 1997.

21) Pulaski, B. A. and Ostrand-Rosenberg, S.:Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7. 1 cell-based tumor vaccines. Cancer Res. 58 (7) :1486-1493, 1998.

PubMed

21) Yasuda, Y., Nishijima, I., Watanabe, S. et al.:Human granulocyte macrophage colony stimulating factor (hGM CSF) induces inhibition of intrathymic T-cell development in hGM CSF receptor transgenic mice. Blood 89 (4) :1349 1264, 1997.

21) Uzumaki, H., Okabe, T., Sasaki, N. et al.:Identification and characterization of receptors for grarnulocyte stimulating factor on human placenta and trophoblastic cells. Proc. natl. Acad. Sci. USA 86 (23) :9323-9326, 1989.

PubMed

21) Pende, D., Sivori, S., Accame, L. et al.:HLA-G recognition by human natural killer cells. Involvement of CD 94 both as inhibitory and as activating receptor complex. Eur. J. Immunol. 27 (8) :1875-1880, 1997.

21) Seino, K., Azuma, M., Bashuda, H. et al.:CD86 (B70/B7 2) on endothelial cells co-stimulates allogeneic CD 4+T cells. Int. Immunol. 7 (8) :1331 1337, 1995.

21) van den Elsen, P., Shepley, B. A., Borst, J. et al.:Isolation of cDNA clones encoding the 20 K T 3 glyco-protein of human cell receptor complex. Nature 312 (5993) :413-418, 1984.

21) Sainio-Pollanen, S., Sundstrom, J., Erkkila, S. et al.:CD 106 (VCAM-1) in testicular immunoregulation. J. Reprod. Immunol. 33 (3) :221-238, 1997.

21) Wyss, D. F., Choi, J. S., Li, J. et al.:Conformation and function of the N-linked glycan in the adhesion domain of human CD 2. Science 269 (5228) :1273-1278, 1995.

21) Woolfson, A. and Milstein, C.:Alternative splicing generates secretory isoforms of human CD 1. Proc. Natl. Acad. Sci. USA 91 (14) :6683-6687, 1994.

PubMed

21) Okada, N., Liszewski, M. K., Atkinson, J. P. et al.:Membrane cofactor protein (CD 46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc. Natl. Acad. Sci. USA 92 (7) :2489-2493, 1995.

21) van Zanten, G. H., Heijnen, H. F., Wu, Y. et al.:A fifty percent reduction of platelet surface glycoprotein Ib does not affect platelet adhesion under flow conditions. Blood 91 (7) :2353-2359, 1998.

21) Perillo, N. L., Pace, K. E., Seilhamer, J. J. et al.:Apoptosis of T cells mediated by galectin-1. Nature 378 (6558) :736-739, 1995.

PubMed

21) Stockton, B. M., Cheng, G., Manjunath, N. et al.:Negative regulation of T cell homing by CD 43. Immunity 8 (3) :373-381, 1998.

21) Tsukita, S., Oishi, K., Sato, N. et al.:ERM family members as molecular linkers between the cell surface glycoprotein CD 44 and actin-based cytoskeletons. J. Cell Biol. 126 (2) :391-401, 1994.

22) Savage, B., Bottini, E. and Ruggeri, Z. M.:Interaction of integrin alpha IIb beta 3 with multiple fibrinogen. J. Biol. Chem. 270 (48) :28812-28817, 1995.

PubMed

22) Yamasaki, K., Naito, S., Anaguchi, H et al.:Solution structure of an extracellular domain containing the WSxWS. motif of the granulocyte colony stimulating factor receptor and its interaction with ligand. Nat. Struct. Biol. 4 (6) :498-504, 1997.

PubMed

22) Thurman, E. C., Walker, J., Jayaraman, S. et al.:Regulation of in vitro and in vivo T cell activation by CD 43. Int. Immunol. 10 (5) :691-701, 1998.

22) Ronchese, F., Hausmann, B., Hubele, S. et al.:Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD 4+Tcells and defective antibody production in vivo. J. Exp. Med. 179 (3) :809-817, 1994.

22) Tozer, E. C., Liddington, R. C., Sutcliffe, M. J. et al.:Ligand binding to integrin alpha IIbbeta 3 is dependent on a MIDAS-like domain in the beta 3 subunit. J. Biol. Chem. 271 (36) :21978-21984, 1996.

22) Schweighoffer, T., Tanaka, Y., Tidswell, M. et al.:Selective expression of integrin alpha 4 beta 7 on asubset of human CD 4+ memory T cells with hallmarks of gut-trophism. J. Immunol. 151 (2) :717-729, 1993.

22) Tanner, J., Weis, J., Fearon, D. et al:Epstein-Barr virus gp 350/220 binding to the B lymphocyte C3d mediates adsorption, capping, and endocytosis. Cell 50 (2) :203-213, 1987.

22) Yu, J., Abagyan, R., Dong, S. et al.:Mapping the active site of CD59. J. Exp. Med. 185 (4) :745-753, 1997.

PubMed

22) Wilson, SB., Kent, S. C., Patton, K. T. et al.:Extreme Th 1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391 (6663) :177-181, 1998.

22) Smith, C. A., Davis, T., Anderson, D. et al.:A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248 (4958) :1019-1023, 1990.

22) Vandenbark, G. R., deCastro, C. M., Taylor, H. et al.:Cloning and structural analysis of the human c-kit gene. Oncogene 7 (7) :1259-1266, 1992.

22) Soriano, P.:Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 8 (16) :1888-1896, 1994.

PubMed

22) Wang, Y., Tao, L., Mitchell, E. et al.:Generation of CD 8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques. Proc. Natl. Acad. Sci. USA 95 (9) :5223-5228, 1998.

22) Kirk, A. D., Harlan, D. M., Armstrong. N. N. et al:CTLA 4-Ig and anti CD 40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94 (16) :8789-8794, 1997.

22) Post, T. W., Liszewski, M. K., Adams, E. M. et al.:Membrane cofactor protein of the complement system:alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J. Exp. Med. 174:93-102, 1991.

PubMed

22) Ushiyama, S., Laue, T. M., Moore, K. L. et al.:Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin. J. Biol. Chem. 268:15229-15237, 1993.

PubMed

22) Watallabe, T., Song, Y., Hirayama. Y. et al.:Sequence and expression of a rat cDNA for LECAM-1. Biochim. Biophys. Acta 1131 (3) :321-324, 1992.

PubMed

22) Schecter, A. D., Giesen, P. L., Taby, O. et al.:Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J. Clin. Invest. 100 (9) :2276-2785, 1997.

PubMed

22) Pingel, J. T. and Thomas, M. L.:Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 58 (6) :1055-1065, 1989.

22) Seko, Y., Takahashi, N., Ishiyama, S. et al.:Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy. Circulation 97 (7) :637-639, 1998.

PubMed

22) Zhang, J. G., Zhang, Y., Owczarek, C. M. et al.:Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma. J. Biol. Chem. 273 (17) :10798-10805, 1998.

22) Vonderheide, R. H., Tedder, T. F., Springer, T. A. et al.:Residues within a conserved amino acid motif of domains 1 and 4 of 1 are required for binding to VLA-4. J. Cell Biol. 125 (1) :215-222, 1994.

PubMed

22) Ryan, J. C., Niemi, E. C., Nakamura, M. C. et al.:NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J. Exp. Med. 181 (5) :1911-1915, 1995.

PubMed

22) Snapp, K. R., Ding, H., Atkins, K. et al.:A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P-and L-selectin. Blood 91 (1) :154-164, 1998.

22) Sharma, P., Smith, I., Maguire, G. et al.:Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet 349 (9065) :1602-1603, 1997.

PubMed

22) Wallace, P. K., Keler, T., Guyre, P. M. et al.:Fc gamma RI blockade and modulation for immunotherapy. Cancer Immunol. Immunother. 45 (3-4) :137-141, 1997.

22) Wiest, D. L., Burgess, W. H., McKean, D. et al.:The molecular chaperone calnexin is expressed on the surface of immature thymocytes in association with clonotype independent CD 3 complexes. EMBO J. 14 (14) :3425-3433, 1995.

22) Perez-Villar, J. J., Melero, I., Rodriguez, A. et al.:Functional ambivalence of the Kp43 (CD 94) NK cell associated surface antigen. J. Immunol. 154 (11) :5779-5788, 1995.

22) Teoh, G., Urashima, M., Greenfield, E. A. et al.:The 86 kI) subunit of Ku autoantigen mediates homotypic and heterotypic adhesion of multiple myeloma cells. J. Clin. Invest. 101 (6) :13791388, 1998.

22) Ueda, Y., Levine, B. L., Huang, M. L. et al.:Both CD 28 ligands CD80 (B7 1) and CD86 (B7 2) activate phosphatidylinositol 3 kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int. Immunol. 7 (6) :957 966, 1995.

22) Walter, M. R., Windsor, W. T., Nagabhushan, T. L. et al.:Crystal structure of a complex between interferon gamma and its high affinity receptor. Nature 376 (6537) :230 235, 1995.

22) McCourt, P. A., Ek, B., Forsberg, N. et al.:Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J. Biol. Chem. 269 (48) :30081-30084, 1994.

PubMed

22) Yonemura, S., Hirao, M., Doi, Y. et al.:Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD 44, CD 43, and ICAM-2. J. Cell Biol. 140 (4) :885-895, 1998.

22) Takahashi, R., Deveraux, Q., Tamm, I. et al.:A single BIR domain of XIAP sufficient for inhibiting caspases. J. Biol. Chem. 273 (14) :7787-7790, 1998.

PubMed

23) Yonemura, S., Hirao, M., Doi, Y. et al.:Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD 44, CD 43, and ICAM-2. J. Cell Biol. 140 (4) :885-895, 1998.

23) Wang, J. H., Pepinsky, R. B., Stehle, T. et al.:The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1) :a cyclic peptide based on the domain 1 C-D loop can inhibit VCAM-1-alpha 4 integrin interaction. Proc. Natl. Acad. Sci. USA 92:5714-5718, 1995.

23) Miller, J., Knorr, R., Ferrone, M. et al.:Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J. Exp. Med. 182 (5) :1231-1241, 1995.

PubMed

23) Wang, A. V., Scholl, P. R. and Geha, R. S.:Physical and functional association of the high affinity immunoglobulin G receptor (Fc gamma R I) with the kinases Hck and Lyn. J. Exp. Med. 180 (3) :1165-1170, 1994.

23) Zhang, D. E., Zhang, P., Wang, N. D. et al.:Absence of granulocyte colony stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha deficient mice. Proc. Natl. J. Acad. Sci. USA 94 (2) :569-574, 1997.

23) Racila, E., Euhus, D., Weiss, A. J. et al.:Detection and characterization of carcinoma cells in the blood. Proc. Natl. Acad. Sci. USA 95 (8) :4589-4594, 1998.

PubMed

23) Watson, M. L., Kingsmore, S. F., Johnston, G. J. et al.:Genomic organization of the selectin family of leukocyte adhesion molecules on human and mouse chromosome 1. J. Exp. Med. 172 (1) :263-272, 1990.

23) Tu, L., Chen, A., Delahunty, M. D. et al.:L-selectin binds to P-selectin glycoprotein ligand-1 on leukocytes:interactions between the lectin, epidermal growth factor, and consensus repeat domains of the selectins determine ligand binding specificity. J. Immunol. 157 (9) :3995-4004, 1996.

23) Takayama, H., Kojima, H. and Shinohara, N.:Cytotoxic T lymphocytes:the newly identified Fas (CD 95) -mediated killing mechanism and a novel aspect of their biological functions. Adv. Immunol. 60:289-321, 1995.

23) Torres, R. M. and Clark, E. A.:Differential increase of an alternatively polyadenylated mRNA species of murine CD 40 upon B lymphocyte activation. J. Immunol. 148 (2) :620626, 1992.

23) Walter, D. H., Schachinger, V., Elsner, M. et al.:Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 350 (9086) :1217-1219, 1997.

PubMed

23) Wajant, H., Johannes, F. J., Haas, E. et al.:Dominant-negative FADD inhibits TNFR 60-, Fas/Apo 1-and TRAIL-R/Apo 2-mediated cell death but not gene induction. Curr. Biol. 8 (2) :113-116, 1998.

23) Solovey, A., Gui, L., Key, N. S. et al.:Tissue factor expression by endothelial cells in sickle cell anemia. J. Clin. Invest. 101 (9) :1899-1904, 1998.

PubMed

23) Weissman, A. M., Hou, D., Orloff, D. G. et al.:Molecular cloning and chromosomal localization of the human T cell receptor zeta chain:distinction from the molecular CD 3 complex. Proc. Natl. Acad. Sci. US 85 (24) :9709-9713, 1988.

23) Tuveson, D. A., Ahearn, J. M., Matsumoto, A. K. et al.:Molecular interactions of complement receptors on B lymphocytes :a CR 1/CR 2 complex distinct from the CR 2/CD 19 complex. J. Exp. Med. 173 (5) :1083-1089, 1991.

23) Soubrier, F., Alhenc-Gelas, F., Hubert, C. et al.:Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. USA 85 (24) :9386-9390, 1988.

PubMed

23) Walcheck, B., Kahn, J., Fisher, J. M. et al.:Neutrophil rolling altered by inhibition of L selectin sheddingin vitro. Nature 380 (6576) :720-723, 1996.

PubMed

23) Soilu-Hanninen, M., Roytta, M., Salmi, A. et al.:Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis. J. Neuroimmunol. 72 (1) :95-105, 1997.

PubMed

23) Purcell, D. F., McKenzie, I. F., Lublin, D. M. et al.:The human cell-surface glycoproteins HuLy-m 5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD 46. Immunology 70 (2) :155-161, 1990.

23) Perez-Villar, J. J., Carretero, M., Navarro, F. et al.:Biochemical and serologic evidence for the existence of functionally distinct forms of the CD 94 NK cell receptor. J. Immunol. 157 (12) :5367-5374, 1996.

23) Worobec, A. S., Oh, C. K., Chowdhury, B. A. et al.:Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc. Natl. Acad. Sci. USA 92 (23) :10560-10564, 1995.

PubMed

23) Weber, G. F., Ashkar, S., Glimcher, M. J. et al.:Receptor-ligand interaction between CD 44 and osteopontin (Eta-1) . Science 271 (5248) :509-512, 1996.

23) Yu, C. Y. and Milstein, C.:A physical map linking the five CD 1 human thymocyte differentiation antigen genes. EMBO J. 8 (12) :3727-3732, 1989.

PubMed

23) Selvakumar, A., Mohanraj, B. K., Eddy, R. L. et al.:Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7. Immunogenetics 36 (3) :175-181, 1992.

23) Wheeler, C. J., Chen, J. Y., Potter, T. A. et al.:Mechanisms of CD 8 beta-mediated T cell response enhancement:with MHC class I/beta 2-microglobulin and functional coupling to TCR/CD 3. J. Immunol. 160 (9) :4199-4207, 1998.

23) Siegall, C. B., Haggerty, H. G., Warner, G. L. et al.:Prevention of immunotoxin-induced immunogenicity by coadministration with CTLA41g enhances antitumor efficacy. J. Immunol. 159 (10) :5168-5173, 1997.

23) Kornbluth, R. S., Kee, K. and Richman, D. D.:CD 40 ligand (CD 154) stimulation of macrophages to produce HIV 1 suppressive beta-chemokines. Proc. Natl. Acad. Sci. USA. 95 (9) :5205 5210, 1998.

23) Tiesman, J. and Hart, C. E.:Identification of a soluble receptor for platelet-derived growth factor in cell conditioned medium and human plasma. J. Biol. Chem. 268 (13) :9621-9628, 1993.

PubMed

24) Yang, Z., Oemar, B. S., Carrel, T. et al.:Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels:role of PDGF receptors, mitogen-activated protein kinase, and cyclindependent kinase inhibitors. Circulation 97 (2) :181-187, 1998.

PubMed

24) White, D. W. and Harty, J. T.:Perforin-deficient CD 8+T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD 95 and IFN-gamma but requires TNF-alpha. J. Immunol. 160 (2) :898-905, 1998.

24) Weiss, E. J., Bray, P. F., Tayback, M. et al.:A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N. Engl. J. Med. 334 (17) :1090-1094, 1996.

24) Yarden, Y., Kuang, W. J., Yang-Feng, T. et al.:Human proto-oncogene c-kit:a new cell surface receptor tyrosine for an unidentified ligand. EMBO J. 6 (11) :3341-3351, 1987.

PubMed

24) Watson, M. L., Kingsmore, S. F., Johnston, G. I. et al.:Genomic organization of the selectin family ofleukocyte adhesion molecules on human and mouse chromosome 1. J. Exp. Med. 172 (1) :263 272, 1990.

24) Phillips, J. H., Chang, C., Mattson, J. et al.:CD 94 and a novel associated protein (94 AP) form a NK cellreceptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 5 (2) :163-172, 1996.

24) Toomey, J. R., Kratzer, K. E., Lasky, N. M. et al.:Effect of tissue factor deficiency on mouse and tumor development. Proc. Natl. Acad. Sci. USA 94 (13) :6922-6926, 1997.

PubMed

24) Subauste, C. S., de Waal, Malefyt, R. and Fuh, F.:Role of CD80 (B7. 1) and CD86 (B7. 2) in the immune response to an intracellular pathogen. J. Immunol. 160 (4) :1831-1840, 1998.

24) Tiret, L., Bonnardeaux, A., Poirier, O. et al.:Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344 (8927) :910-913, 1994.

PubMed

24) Ziegler, S. F., Bird, T. A., Morella, K. K. et al.:Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction. Mol. Cell. Biol. 13 (4) :2384-2390, 1993.

PubMed

24) Patel, S. S., Thiagarajan, R., Willerson, J. T. et al.:Inhibition of alpha 4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation 97 (1) :75-81, 1998.

24) Vachino, G., Chang, X. J., Veldman, G. M. et al.:P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J. Biol. Chem. 270 (37) :21966-21974, 1995.

24) Tivol, E. A., Borriello, F., Schweitzer, A. N. et al.:Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3 (5) :541-547, 1995.

PubMed

24) Streuli, M., Krueger, N. X., Thai, T. et al.:Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. EMBO J. 9 (8) :2399-2407, 1990.

PubMed

24) Kuhne, M. R., Robbins, M., Hambor, J. E. et al.:Assembly and regulation of the CD 40 receptor complex in human B cells. J. Exp. Med. 186 (2) :337 342, 1997.

24) Springer, T. A.:Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep paradigm. Cell 76 (2) :301-314, 1994.

PubMed

24) Worm, M. M., Tsytsykova, A. and Geha, R. S.:CD 40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin alpha promoter in B cells. Eur. J. Immunol. 28 (3) :901-906, 1998.

24) Trauth, B. C., Klas, C., Peters, A. M. et al.:Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245 (4915) :301-305, 1989.

PubMed

24) Rivailler, P., Trescol-Biemont, M. C., Gimenez, C. et al.:Enhanced MHC class II-restricted presentation of measles virus (MV) hemagglutinin in transgenic mice expressing human MV receptor CD 46. Eur. J. Immunol. 28 (4) :1301-1314, 1998.

25) Yamada, K., Yamakawa, M., Imai, Y. et al.:Expression of cytokine receptors on follicular dendritic cells. Blood 90 (12) :4832-4841, 1997.

PubMed

25) Simmons, D., Makgoba, M. W. and Seed, B.:ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature 331 (6157) :624-627, 1988.

25) Veldman, G. M., Bean, K. M., Cumming, D. A. et al.:Genomic organization and chromosomal localization of the gene encoding human P-selectin glycoprotein ligand. J. Biol. Chem. 270 (27) :16470-16475, 1995.

25) Takada, Y., Elices, M. J., Crouse, C. et al.:The primary structure of the alpha 4 subunit of VLA-4:homology to other integrins and a possible cell-cell adhesion function. EMBO J. 8 (5) :1361-1368, 1989.

25) Yu, Z., Su, L., Hoglinger, O. et al.:SHP-1 associates with both platelet-derived growth factor receptor and the p 85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 273 (6) :3687-3694, 1998.

25) Vidal, S., Kono, D. H. and Theofilopoulos, A. N.:Loci predisposing to autoimmunity in MRL-Fas 1pr and C 57 BL/6-Faslpr mice. J. Clin. Invest. 101 (3) :696-702, 1998.

25) van der Merwe, P. A., Bodian, D. L., Daenke, S. et al.:CD 80 (B7-1) binds both CD 28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185 (3) :393-403, 1997.

25) Zotz, R. B., Winkelmann, B. R., Nauck, M. et al.:Polymorphism of platelet membrane glycoprotein IIIa:human platelet antigen 1 b (HPA-1 b/PIA 2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb. Haemost. 79(4) :731-735, 1998.

25) Lei, X. F., Ohkawara, Y., Stampfli, M. R. et al:Disruption of antigen induced inflammatory responses in CD 40 ligand knockout mice. J. Clin. Invest. 101 (6) :1342-1353, 1998.

25) Zapata, J. M., Pulido, R., Acevedo, A. et al.:Human CD 45 RC specificity. A novel marker for T cells at different maturation and activation stages. J. Immunol. 152 (8) :3852-3861, 1994.

25) Wykes, M., Poudrier, J., Lindstedt, R. et al.:Regulation of cytoplasmic, surface and soluble forms of CD 40 ligand in mouse B cells. Eur. J. Immunol. 28 (2) :548-559, 1998.

25) Seya, T., Hara, T., Matsumoto, M. et al.:Quantitative analysis of membrane cofactor protein (MCP) of high expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J. Immunol. 145 (1) :238-245, 1990.

PubMed

25) Rodriguez, A., Carretero, M., Glienke, J. et al.:Structure of the human CD 94 C-type lectin gene. Immunogenetics 47 (4) :305-309, 1998.

25) van der Merwe, P. A., Bodian, D. L., Daenke, S. et al.:CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185 (3) :393-403, 1997.

PubMed

26) Yeh, W. C., Pompa, J. L., McCurrach, M. E. et al.:FADD:essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279 (5358) :1954-1958, 1998.

26) Thorley, B. R., Milland, J., Christiansen, D. et al.:Transgenic expression of a CD 46 (membrane cofactor protein) studies of xenotransplantation and measles virus infection. Eur. J. Immunol. 27 (3) :726-734, 1997.

26) Walunas, T. L., Lenschow, D. J., Bakker, C. Y. et al.:CTLA-4 can function as a negative regulator of T cell activation. Immunity 1 (5) :405-413, 1994.

PubMed

26) Mackey, M. F., Gum, J. R., Ting, P. P. et al.:Protective immunity induced by tumor vaccines requires interaction between CD 40 and its ligand, CD 154. Cancer Res. 57 (13) :2569 2574, 1997.

26) Walcheck, B., Moore, K. L., McEver, R. P. et al.:Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J. Clin. Invest. 98 (5) :1081-1087, 1996.

PubMed

26) Watanabe-Fukunaga, R., Brannan, C. I., Itoh., N. et al.:The cDNA structure, expression, and chromosomal assignment of the Fas antigen. J. Immunol. 148 (4) :1274-1279, 1992.

PubMed

26) Uhrberg, M., Valiante, N. M., Shum, B. P. et al.:Human diversity in killer cell inhibitory receptor genes. Immunity 7 (6) :753-763, 1997.

PubMed

26) Stanley, P., Bates, P. A., Harvey, J. et al.:Integrin LFA-1 alpha subunit contains an ICAM-1 binding site in domains V and VI. EMBO J. 13 (8) :1790-1798, 1994.

PubMed

26) Van Parijs, L., Sethna, M. P., Schweitzer, A. N. et al.:Functional consequences of dysregulated B7-1 (CD 80) and B7-2 (CD 86) expression in B or T lymphocytes of transgenic mice. J. Immunol. 159 (11) :5336-5344, 1997.

PubMed

27) Vecchiarelli, A., Monari, C., Retini, C. et al.:Cryptococcus neoformans differently regulates B7-1 (CD 80) and B7-2 (CD 86) expression on human monocytes. Eur. J. Immunol. 28 (1) :114-121, 1998.

27) Walunas, T. L. and Bluestone, J. A.:CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol. 160 (8) :3855-3860, 1998.

27) Wilkins, P. P., Moore, K. L., McEver, R. P. et al.:Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin. J. Biol. Chem. 270 (39) :22677-22680, 1995.

27) Vakeva, A., Bukusoglu, C., Zund, G. et al.:Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation 96 (1) :326-333, 1997.

PubMed

27) Yamaguchi, K., Kinosaki, M., Goto, M. et al.:Characterization of structural domains of human inhibitory factor. J. Biol. Chem. 273 (9) :5117-5123, 1998.

27) Renshaw, B. R., Fanslow, W. Cr., Armitage, R. J. et al.:Humoral immune responses CD 40 ligand-deficient mice. J. Exp. med. 180 (5) :1889 1900, 1994.

27) Valiante, N. M., Uhrberg, M., Shilling, H. G. et al.:Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7 (6) :739-751, 1997.

PubMed

27) Yamamura, M., Hinoda, Y., Sasaki, S. et al.:A human/mouse chimeric monoclonal antibody against intercellular adhesion molecule-1 for tumor radioimmunoimaging. Jpn. J. Cancer Res. 87 (4) :405-411, 1996

PubMed

28) Vitale, M., Bottino, C., Marcenaro, E. et al.:CD 94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles:identification of the inhibitory form of CD 94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 26 (10) :2487-2492, 1996.

28) Spriggs, M. K., Armitage, R. J., Strockbine, L. et al.:Recombinant human CD 40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176 (6) :1543-1550, 1992.

28) Yeh, W. C., Pompa, J. L., McCurrach, M. E. et al.:FADD:essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279 (5358) :1954-1958, 1998.

28) Waterhouse, P., Penninger, J. M., Timms, E. et al.:Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270 (5238) :985-988, 1995.

PubMed

29) Zhou, P. and Seder, R. A.:CD 40 ligand is not essential for induction of type I cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum. J. Exp. Med. 187 (8) :1315-1324, 1998.

29) Yonehara, S., Ishii, A. and Yonehara, M.:A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169 (5) :1747-1756, 1989.

PubMed

30) Zhang, J., Cado, D., Chen, A. et al.:Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort 1. Nature 392 (6673) :296-300, 1998.

20 Zhu, M. H., Berry, J. A., Russell, S. M. et al.:Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak 1 and Jak 3. Jak 1-independent functional recruitment of Jak 3 to IL-2Rbeta. J. Biol. Chem. 273 (17) :10719-10725, 1998.

PubMed

書評

書評を投稿する

CD分類ハンドブック 追補版（1996） 細胞膜分化抗原の国際分類

商品紹介

目次

この書籍の参考文献

V. 一覧表と索引集の利用の仕方

VI. 改変または新規に登録されたCD分類の項目別解説

VIII. 全CD分類に関する文献リスト一覧

書評

最近チェックした商品履歴

CD分類ハンドブック追補版（1996）細胞膜分化抗原の国際分類